About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
3403 genotypes with 6790 annotations displayed of selected term and subterms
Searched Term: abnormal glucose homeostasis
Allelic Composition
(Genetic Background)		 Annotated Term Reference
1700030J22Rikem1(IMPC)J/1700030J22Rikem1(IMPC)J
(C57BL/6NJ-1700030J22Rikem1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
2010003K11Rikem1Cya/2010003K11Rikem1Cya
(C57BL/6-2010003K11Rikem1Cya/Cya) 		impaired glucose tolerance J:326325
increased circulating insulin level J:326325
increased fasting circulating glucose level J:326325
insulin resistance J:326325
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp) 		impaired glucose tolerance J:211773
4833411C07Rikem1Cecad/4833411C07Rikem1Cecad
(C57BL/6N-4833411C07Rikem1Cecad) 		impaired glucose tolerance J:285483
increased circulating glucose level J:285483
insulin resistance J:285483
4930505A04Riktm1b(KOMP)Wtsi/4930505A04Riktm1b(KOMP)Wtsi
(C57BL/6N-4930505A04Riktm1b(KOMP)Wtsi/Bay) 		decreased circulating glucose level J:211773
4930563E22Riktm1.1(KOMP)Vlcg/4930563E22Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4930563E22Riktm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
4933402J07Rikem1(IMPC)J/4933402J07Rikem1(IMPC)J
(C57BL/6NJ-4933402J07Rikem1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased circulating glucose level J:168271
improved glucose tolerance J:168271
a/Ay
Guq1KK/Guq1KK
(involves: C57BL/6J * KK-Ay) 		increased urine glucose level J:131439
a/Ay
Guq2C57BL/6J/Guq2C57BL/6J
(involves: C57BL/6J * KK-Ay) 		increased urine glucose level J:131439
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Dusp12em1Zhzy/Dusp12em1Zhzy
(involves: FVB/N) 		insulin resistance J:345360
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA) 		decreased circulating glucose level J:281365
decreased circulating insulin level J:281365
decreased fasting circulating glucose level J:281365
impaired gluconeogenesis J:281365
improved glucose tolerance J:281365
increased insulin sensitivity J:281365
increased liver glycogen level J:281365
Ay/a
(involves: KK) 		hyperglycemia J:26460
impaired glucose tolerance J:26460
increased circulating insulin level J:26460
increased urine glucose level J:26460
insulin resistance J:26460
Ay/a
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl) 		hyperglycemia J:177084
increased circulating insulin level J:177084
insulin resistance J:177084
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased circulating glucose level J:168271
improved glucose tolerance J:168271
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl) 		impaired glucose tolerance J:211773
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppt+
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Abca7tm2b(EUCOMM)Hmgu/Abca7tm2b(EUCOMM)Hmgu
(B6N(Cg)-Abca7tm2b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H) 		decreased circulating glucose level J:211773
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver glycogen level J:67548
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
Abcc8em1(IMPC)J/Abcc8em1(IMPC)J
(C57BL/6NJ-Abcc8em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas) 		decreased circulating glucose level J:208932
decreased insulin secretion J:208932
impaired glucose tolerance J:208932
increased circulating glucose level J:208932
increased insulin secretion J:208932
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6) 		decreased insulin secretion J:79352
hypoglycemia J:79352
impaired glucose tolerance J:79352
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6) 		hypoglycemia J:61356
impaired glucose tolerance J:61356
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ) 		abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc8tm1Jbry/Abcc8tm1Jbry
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129X1/SvJ) 		abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1) 		hypoglycemia J:71840
improved glucose tolerance J:71840
increased insulin sensitivity J:71840
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6) 		hypoglycemia J:122438
Abcg2em1Omw/Abcg2em1Omw
(C57BL/6J-Abcg2em1Omw) 		increased circulating glucose level J:292268
increased circulating insulin level J:292268
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB) 		abnormal glucose homeostasis J:201884
decreased liver glycogen level J:201884
impaired glucose tolerance J:201884
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:160725
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal glucose homeostasis J:197835
decreased circulating glucose level J:197835
decreased circulating insulin level J:197835
improved glucose tolerance J:197835
Abhd6tm1a(EUCOMM)Hmgu/Abhd6+
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		increased insulin secretion J:215257
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		decreased circulating insulin level J:234876
decreased insulin secretion J:234876
improved glucose tolerance J:234876
increased circulating insulin level J:215257
increased insulin secretion J:215257, J:234876
increased insulin sensitivity J:234876
Abhd6tm1c(EUCOMM)Hmgu/Abhd6tm1c(EUCOMM)Hmgu
Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6N * CD-1) 		improved glucose tolerance J:215257
increased circulating insulin level J:215257
increased insulin secretion J:215257
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6) 		decreased circulating glucose level J:294591
decreased circulating insulin level J:294591
improved glucose tolerance J:294591
increased insulin sensitivity J:294591
Abhd12bem1(IMPC)J/Abhd12bem1(IMPC)J
(C57BL/6NJ-Abhd12bem1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Abhd14atm2a(EUCOMM)Wtsi/Abhd14atm2a(EUCOMM)Wtsi
(C57BL/6N-Abhd14atm2a(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(C57BL/6N-Abhd16atm1a(EUCOMM)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Abhd17atm1a(KOMP)Wtsi/Abhd17atm1a(KOMP)Wtsi
(C57BL/6N-Abhd17atm1a(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Abi2tm1b(EUCOMM)Wtsi/Abi2tm1b(EUCOMM)Wtsi
(C57BL/6N-Abi2tm1b(EUCOMM)Wtsi/Tcp) 		increased fasting circulating glucose level J:211773
Abtb1em1(IMPC)Ccpcz/Abtb1em1(IMPC)Ccpcz
(C57BL/6N-Abtb1em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Acacatm2Sjw/Acacatm2Sjw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB) 		abnormal glucose homeostasis J:110200
hyperglycemia J:110200
increased circulating insulin level J:110200
Acacbtm1.1Dejs/Acacbtm1.1Dejs
(B6.Cg-Acacbtm1.1Dejs) 		abnormal glucose homeostasis J:157000
increased skeletal muscle glycogen level J:157000
Acacbtm1.2Lowl/Acacbtm1.2Lowl
(involves: 129S6/SvEvTac * FVB/N) 		increased circulating insulin level J:159285
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified) 		decreased circulating glucose level J:68427
decreased liver glycogen level J:68427
Acad12tm1b(EUCOMM)Wtsi/Acad12tm1b(EUCOMM)Wtsi
(C57BL/6N-Acad12tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac) 		hypoglycemia J:51660
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:115759
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ) 		hypoglycemia J:14707
Acadvlem1(IMPC)H/Acadvlem1(IMPC)H
(C57BL/6NTac-Acadvlem1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6) 		impaired glucose tolerance J:102010
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6) 		decreased glycogen level J:106714
hypoglycemia J:106714
Acadvltm1Zkhu/Acadvltm1Zkhu
Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr) 		decreased circulating glucose level J:208711
Acap1tm1.1(KOMP)Vlcg/Acap1tm1.1(KOMP)Vlcg
(B6N(Cg)-Acap1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased insulin secretion J:128859
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased insulin secretion J:128859
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal glucose homeostasis J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating glucose level J:182660
improved glucose tolerance J:182660
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6) 		abnormal gluconeogenesis J:183258
abnormal glucose homeostasis J:183258
improved glucose tolerance J:183258
Acox3em1(IMPC)J/Acox3em1(IMPC)J
(C57BL/6NJ-Acox3em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
Acsl1tm1Rcol/Acsl1tm1Rcol
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6) 		hypoglycemia J:162996
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Acsm2tm1.1(KOMP)Vlcg/Acsm2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsm2tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Acss1tm1Jsak/Acss1tm1Jsak
(B6.129-Acss1tm1Jsak/Jsak) 		hypoglycemia J:146647
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss) 		decreased glycogen level J:78070
decreased liver glycogen level J:78070
decreased skeletal muscle glycogen level J:78070
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Camk2a-cre)#Szi/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Hsp70-1-cre)6Arge/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * SJL) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Syn1-cre)671Jxm/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J) 		decreased circulating insulin level J:160212
decreased fasting circulating glucose level J:160212
improved glucose tolerance J:160212
Acyp1em1(IMPC)J/Acyp1em1(IMPC)J
(C57BL/6NJ-Acyp1em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Ad/Ad
(involves: Chr 7 marker stock * Wild stock) 		increased circulating insulin level J:6095
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock) 		increased circulating insulin level J:6095
Adad2em1(IMPC)J/Adad2em1(IMPC)J
(C57BL/6NJ-Adad2em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Adamts15tm1.1(KOMP)Vlcg/Adamts15tm1.1(KOMP)Vlcg
(C57BL/6N-Adamts15tm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Adartm1b(EUCOMM)Wtsi/Adar+
(B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J) 		decreased circulating glucose level J:211773
Adartm1Knk/Adartm1Knk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		hyperglycemia J:87714
Adcy1tm1b(EUCOMM)Wtsi/Adcy1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy1tm1b(EUCOMM)Wtsi/H) 		improved glucose tolerance J:211773
Adcy3Jll/Adcy3+
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating glucose level J:223554
decreased circulating insulin level J:223554
Adcy9tm1b(EUCOMM)Wtsi/Adcy9+
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Adcyap1tm1Eid/Adcyap1tm1Eid
(involves: 129S4/SvJae * C57BL/6) 		hypoglycemia J:73702
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6)) 		decreased liver glycogen level J:71968
hypoglycemia J:71968
increased circulating insulin level J:71968
Adcyap1r1tm1Bbt/Adcyap1r1tm1Bbt
(involves: 129 * C57BL/6J) 		decreased circulating insulin level J:62115
impaired glucose tolerance J:62115
increased circulating insulin level J:62115
Adgra1tm1.1Zgwg/Adgra1tm1.1Zgwg
(Not Specified) 		decreased fasting circulating glucose level J:329982
Adgra1tm1b(EUCOMM)Hmgu/Adgra1tm1b(EUCOMM)Hmgu
(B6N(Cg)-Adgra1tm1b(EUCOMM)Hmgu/J) 		improved glucose tolerance J:211773
Adgrb1tm2a(EUCOMM)Wtsi/Adgrb1tm2a(EUCOMM)Wtsi
(C57BL/6N-Adgrb1tm2a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Adgrf5m1Btlr/Adgrf5m1Btlr
(C57BL/6J-Adgrf5m1Btlr) 		increased circulating glucose level J:225045
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp) 		increased fasting circulating glucose level J:211773
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg) 		decreased circulating insulin level J:304292
improved glucose tolerance J:304292
increased insulin sensitivity J:304292
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
Lepob/Lepob
(B6.Cg-Adigtm1.1(KOMP)Vlcg Lepob) 		impaired glucose tolerance J:304292
Adip1LG/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1) 		decreased circulating glucose level J:153477
Adip1SM/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x SM/J)F1) 		decreased circulating glucose level J:153477
Adipoqtm1Far/Adipoqtm1Far
(involves: C57BL/6J) 		impaired glucose tolerance J:111346
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J) 		impaired glucose tolerance J:111346
increased circulating glucose level J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose tolerance J:111346
decreased circulating glucose level J:111346
Adipoqtm1Ish/Adipoq+
Bglap/Bglap2tm1Kry/Bglap+
(involves: 129S7/SvEvBrd) 		insulin resistance J:126780
Adipoqtm1Ish/Adipoq+
Bglap/Bglap2tm1Kry/Bglap2+
(involves: 129S7/SvEvBrd) 		insulin resistance J:126780
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal glucose homeostasis J:199264
decreased insulin secretion J:199264
hyperglycemia J:77479, J:103106
impaired glucose tolerance J:199264
increased circulating glucose level J:106599
increased circulating insulin level J:77479
insulin resistance J:77479
Adipoqtm1Ish/Adipoqtm1Ish
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:199264
increased circulating glucose level J:199264
Adipoqtm1Pesch/Adipoqtm1Pesch
(involves: 129S7/SvEvBrd) 		abnormal gluconeogenesis J:107486
impaired glucose tolerance J:107486
Adipoqtm1Pesch/Adipoqtm1Pesch
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:107486
Adipoqtm1Tka/Adipoq+
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:77876
insulin resistance J:77876
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:77876
insulin resistance J:77876
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc) 		impaired glucose tolerance J:122027
Adipor1tm1Tka/Adipor1tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:117919
hyperglycemia J:117919
impaired glucose tolerance J:117919
increased circulating glucose level J:117919
increased circulating insulin level J:117919
insulin resistance J:117919
Adipor1tm1Tka/Adipor1tm1Tka
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		abnormal circulating glucose level J:117919
abnormal gluconeogenesis J:117919
abnormal glucose homeostasis J:117919
hyperglycemia J:117919
impaired glucose tolerance J:117919
insulin resistance J:117919
Adipor1tm2Tka/Adipor1tm2Tka
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn) 		abnormal glucose homeostasis J:159462
increased circulating glucose level J:159462
increased circulating insulin level J:159462
insulin resistance J:159462
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen) 		decreased circulating insulin level J:122027
improved glucose tolerance J:122027
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:117919
hyperglycemia J:117919
impaired glucose tolerance J:117919
increased circulating insulin level J:117919
insulin resistance J:117919
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:129554
decreased circulating insulin level J:129554
increased circulating glucose level J:129554
Adissptm1c(EUCOMM)Hmgu/Adissptm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		impaired glucose tolerance J:332979
increased circulating glucose level J:332979
increased fasting circulating glucose level J:332979
insulin resistance J:332979
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H) 		increased circulating glucose level J:211773
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Adora2btm1.1(KOMP)Vlcg/Adora2btm1.1(KOMP)Vlcg
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:87718
decreased skeletal muscle glycogen level J:87718
hyperglycemia J:87718
impaired glucose tolerance J:87718
increased circulating insulin level J:87718
increased liver glycogen level J:87718
insulin resistance J:87718
Adra2am1Btlr/Adra2am1Btlr
(C57BL/6J-Adra2am1Btlr) 		decreased circulating glucose level J:267700
increased circulating insulin level J:267700
Adra2am2Btlr/Adra2am2Btlr
(C57BL/6J-Adra2am2Btlr) 		decreased circulating glucose level J:267701
Adra2atm1.1(KOMP)Vlcg/Adra2atm1.1(KOMP)Vlcg
(C57BL/6N-Adra2atm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal glucose homeostasis J:130781
hypoglycemia J:130781
Adrb2tm1Kry/Adrb2+
Lepob/Lep+
Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6 * C57BL/10J * FVB) 		decreased circulating glucose level J:145998
increased circulating insulin level J:145998
Adrb2tm1Kry/Adrb2tm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		abnormal insulin secretion J:145998
decreased circulating glucose level J:145998
increased circulating insulin level J:145998
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd) 		improved glucose tolerance J:211773
Afmidtm1a(EUCOMM)Wtsi/Afmidtm1a(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1a(EUCOMM)Wtsi/H) 		hyperglycemia J:226537
Afmidtm1b(EUCOMM)Wtsi/Afmid+
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:226537
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H) 		decreased insulin secretion J:226537
impaired glucose tolerance J:226537
increased circulating glucose level J:211773, J:226537
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:103404
Agap2tm1.1Kye/Agap2tm1.1Kye
(Not Specified) 		abnormal gluconeogenesis J:174775
hyperglycemia J:174775
increased insulin sensitivity J:174775
insulin resistance J:174775
Agap2tm1Kye/Agap2tm1Kye
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2) 		abnormal gluconeogenesis J:174775
hyperglycemia J:174775
impaired glucose tolerance J:174775
increased circulating insulin level J:174775
insulin resistance J:174775
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:82491
Agertm1.1Hyam/Ager+
Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2) 		hyperglycemia J:116040
Agertm1.1Hyam/Agertm1.1Hyam
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		increased circulating glucose level J:116507
Agertm1.1Hyam/Agertm1.1Hyam
Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2) 		hyperglycemia J:116040
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		hypoglycemia J:212003
increased cardiac muscle glycogen level J:212003
increased liver glycogen level J:212003
increased skeletal muscle glycogen level J:212003
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno) 		decreased circulating glucose level J:218471
decreased fasting circulating glucose level J:218471
increased brain glycogen level J:218471
increased cardiac muscle glycogen level J:218471
increased glycogen level J:218471
increased liver glycogen level J:218471
increased skeletal muscle glycogen level J:218471
Ago2tm1.1Tara/Ago2tm1.1Tara
Lepob/Lepob
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		decreased circulating glucose level J:210552
decreased circulating insulin level J:210552
improved glucose tolerance J:210552
increased circulating insulin level J:210552
Ago2tm1.1Tara/Ago2tm1.1Tara
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		improved glucose tolerance J:210552
Agpat1tm1.1(KOMP)Vlcg/Agpat1+
(B6N(Cg)-Agpat1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased urine glucose level J:211773
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating glucose level J:250301
hypoglycemia J:250301
impaired gluconeogenesis J:250301
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		hyperglycemia J:186035
increased circulating glucose level J:186035
increased circulating insulin level J:186035
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		abnormal glucose homeostasis J:146649
hyperglycemia J:146649
improved glucose tolerance J:231617
increased circulating glucose level J:231617
increased circulating insulin level J:231617, J:146649
insulin resistance J:231617, J:146649
Agpat2tm1Garg/Agpat2tm1Garg
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac) 		improved glucose tolerance J:231617
increased circulating glucose level J:231617
increased circulating insulin level J:231617
insulin resistance J:231617
Agpat4tm1b(KOMP)Wtsi/Agpat4tm1b(KOMP)Wtsi
(C57BL/6N-Agpat4tm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Agrptm2(HBEGF)Rpa/Agrp+
Lepob/Lepob
(involves: 129S4/SvJaeSor * C57BL/6) 		improved glucose tolerance J:181947
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd) 		abnormal circulating insulin level J:105210
abnormal glucose homeostasis J:105210
increased insulin sensitivity J:105210
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N) 		increased circulating insulin level J:263253
insulin resistance J:263253
Ahnaktm1b(KOMP)Mbp/Ahnak+
(C57BL/6N-Ahnaktm1b(KOMP)Mbp/H) 		improved glucose tolerance J:211773
Ahsgtm1Mbl/Ahsgtm1Mbl
(B6.129-Ahsgtm1Mbl) 		decreased circulating insulin level J:78087
improved glucose tolerance J:78087
increased insulin sensitivity J:78087
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N) 		hyperglycemia J:262001
increased circulating insulin level J:262001
increased liver glycogen level J:262001
insulin resistance J:262001
Aifm1tm2Pngr/Y
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB) 		abnormal glucose homeostasis J:113016
Aifm3em1(IMPC)Rbrc/Aifm3em1(IMPC)Rbrc
(C57BL/6NJcl-Aifm3em1(IMPC)Rbrc/Rbrc) 		increased fasting circulating glucose level J:211773
Ak1tm1Bew/Ak1tm1Bew
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:66101
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6) 		decreased circulating insulin level J:190017
decreased insulin secretion J:190017
improved glucose tolerance J:190017
increased insulin sensitivity J:190017
Akap5tm1Gsm/Akap5tm1Gsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:190017
Akap5tm1Jsco/Akap5tm1Jsco
Tg(Ins2-cre)25Mgn/0
(involves: 129S * C57BL/6 * DBA) 		decreased circulating insulin level J:190017
impaired glucose tolerance J:190017
increased insulin secretion J:190017
Akap5tm1Mdaq/Akap5tm1Mdaq
(involves: 129 * C57BL/6 * C57BL/6J) 		decreased circulating insulin level J:190017
decreased insulin secretion J:190017
improved glucose tolerance J:190017
increased insulin sensitivity J:190017
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N) 		decreased circulating glucose level J:213427
Akap13em1(IMPC)Mbp/Akap13em1(IMPC)Mbp
(C57BL/6N-Akap13em1(IMPC)Mbp/MbpMmucd) 		improved glucose tolerance J:211773
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129) 		increased circulating insulin level J:208505
insulin resistance J:208505
Akr1b8tm1.1(KOMP)Vlcg/Akr1b8tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1b8tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Akr1d1tm1.1(KOMP)Vlcg/Akr1d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1d1tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		decreased insulin secretion J:149156
hyperglycemia J:149156
impaired glucose tolerance J:149156
increased circulating insulin level J:149156
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ) 		hyperglycemia J:149156
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
Ptentm1Ppp/Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		impaired glucose tolerance J:149156
increased circulating insulin level J:149156
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		abnormal gluconeogenesis J:182721
abnormal glucose homeostasis J:182721
improved glucose tolerance J:182721
increased insulin sensitivity J:182721
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:71491
impaired glucose tolerance J:71491
increased circulating insulin level J:71491
insulin resistance J:71491
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd) 		hyperglycemia J:160759
impaired glucose tolerance J:160759
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb) 		decreased circulating glucose level J:155432
increased circulating insulin level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		increased circulating glucose level J:155432
increased circulating insulin level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		hyperglycemia J:160759
impaired glucose tolerance J:160759
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Lepob/Lepob
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		increased circulating glucose level J:155432
Akt2tm1Hem/Akt2tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:114675
impaired glucose tolerance J:114675
increased circulating insulin level J:114675
insulin resistance J:114675
Akt2tm1Hem/Akt2tm1Hem
Akt3tm1Hem/Akt3tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:114675
impaired glucose tolerance J:114675
increased circulating insulin level J:114675
insulin resistance J:114675
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg) 		abnormal glucose homeostasis J:84606
decreased circulating insulin level J:84606
hyperglycemia J:84606
impaired glucose tolerance J:84606
increased circulating insulin level J:84606
insulin resistance J:84606
Akt2tm1Rsg/Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ) 		impaired glucose tolerance J:149156
increased circulating insulin level J:149156
insulin resistance J:149156
Akt2tm1Rsg/Akt2tm1Rsg
Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ) 		impaired glucose tolerance J:149156
Akt2tm1Rsg/Akt2tm1Rsg
Ptentm1Ppp/Pten+
(involves: 129S1/Sv * C57BL/6 * DBA/1LacJ) 		decreased circulating insulin level J:149156
impaired glucose tolerance J:149156
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal circulating glucose level J:197607
abnormal glucose homeostasis J:197607
abnormal glycogen homeostasis J:197607
decreased insulin secretion J:197607
impaired glucose tolerance J:197607
increased liver glycogen level J:197607
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA) 		decreased insulin secretion J:232360
hyperglycemia J:232360
impaired glucose tolerance J:232360
increased glucagon secretion J:232360
increased insulin secretion J:232360
insulin resistance J:232360
Aldh1b1tm1Vvas/Aldh1b1tm1Vvas
(B6J.Cg-Aldh1b1tm1Vvas) 		increased fasting circulating glucose level J:228677
Alg2tm1.1(KOMP)Vlcg/Alg2+
(B6N(Cg)-Alg2tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
increased circulating insulin level J:211773
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J) 		abnormal glucose homeostasis J:298649
decreased fasting circulating glucose level J:198968
increased circulating insulin level J:198968
increased hepatic glucose production J:198968
increased insulin sensitivity J:198968
Alms1bbb/Alms1bbb
(C57BL/6JSfdAnu-Alms1bbb/Anu) 		hyperglycemia J:104190
increased circulating insulin level J:104190
Alms1foz/Alms1foz
(involves: NOD) 		hyperglycemia J:107058
increased circulating insulin level J:107058
insulin resistance J:107058
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		hyperglycemia J:100403
increased circulating insulin level J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD) 		increased circulating insulin level J:118221
Alms1m2Btlr/Alms1m2Btlr
(C57BL/6J-Alms1m2Btlr) 		impaired glucose tolerance J:264648
Alms1m3Btlr/Alms1m3Btlr
(C57BL/6J-Alms1m3Btlr) 		impaired glucose tolerance J:264649
increased circulating insulin level J:264649
increased fasting circulating glucose level J:264649
Alox15tm1.1Nadl/Alox15tm1.1Nadl
Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:224344
increased insulin secretion J:224344
Alx3tm1Hubr/Alx3+
(involves: 129P2/OlaHsd) 		impaired glucose tolerance J:166436
increased circulating glucose level J:166436
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd) 		decreased insulin secretion J:166436
impaired glucose tolerance J:166436
increased circulating insulin level J:166436
increased fasting circulating glucose level J:166436
insulin resistance J:166436
Amtem1(IMPC)Tcp/Amt+
(C57BL/6NCrl-Amtem1(IMPC)Tcp/Tcp) 		improved glucose tolerance J:211773
Anapc2tm1Kna/Anapc2tm2Kna
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased liver glycogen level J:87782
Anapc7em1(IMPC)J/Anapc7em1(IMPC)J
(C57BL/6NJ-Anapc7em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo) 		improved glucose tolerance J:152387
increased insulin sensitivity J:152387
Angptl3tm2b(KOMP)Wtsi/Angptl3tm2b(KOMP)Wtsi
(C57BL/6N-Angptl3tm2b(KOMP)Wtsi/Ccpcz) 		increased fasting circulating glucose level J:211773
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:97552
increased circulating insulin level J:97552
insulin resistance J:97552
Ank2tm2.1Bnt/Ank2+
(STOCK Ank2tm2Bnt/J) 		impaired glucose tolerance J:222913
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J) 		abnormal gluconeogenesis J:222913
impaired glucose tolerance J:222913
increased circulating glucose level J:222913
insulin resistance J:222913
Ank2tm3.1Bnt/Ank2+
(B6.129(C)-Ank2tm3.1Bnt/J) 		impaired glucose tolerance J:222913
increased circulating glucose level J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J) 		abnormal gluconeogenesis J:222913
abnormal glucose homeostasis J:222913
decreased circulating insulin level J:222913
decreased insulin secretion J:222913
impaired glucose tolerance J:222913
increased circulating glucose level J:222913
insulin resistance J:222913
Ankhd1tm1a(KOMP)Wtsi/Ankhd1tm1a(KOMP)Wtsi
(C57BL/6N-Ankhd1tm1a(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Ankib1tm1b(EUCOMM)Hmgu/Ankib1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ankib1tm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating insulin level J:130984
insulin resistance J:130984
anx/anx
(B6C3Fe a/a-anx/J) 		hypoglycemia J:7689
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified) 		increased circulating insulin level J:115806
Anxa7tm1Pll/Anxa7+
(Not Specified) 		decreased insulin secretion J:58572
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased circulating glucose level J:226582
Ap1s2em1(IMPC)Mbp/Ap1s2em1(IMPC)Mbp
(C57BL/6N-Ap1s2em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Ap2a1em1(IMPC)J/Ap2a1em1(IMPC)J
(C57BL/6NJ-Ap2a1em1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
Ap3s1tm1b(EUCOMM)Hmgu/Ap3s1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ap3s1tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Ap4e1em1(IMPC)J/Ap4e1+
(C57BL/6NJ-Ap4e1em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ccpcz) 		increased fasting circulating glucose level J:211773
Apbb2M1Btlr/Apbb2M1Btlr
(C57BL/6J-Apbb2M1Btlr) 		impaired glucose tolerance J:265064
Apbb2m2Btlr/Apbb2m2Btlr
(C57BL/6J-Apbb2m2Btlr) 		impaired glucose tolerance J:265072
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs) 		decreased circulating glucose level J:247647
improved glucose tolerance J:247647
increased insulin sensitivity J:247647
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae) 		decreased circulating glucose level J:37250
decreased circulating insulin level J:37250
Apobtm2Sgy/Apobtm2Sgy
Apoetm1Unc/Apoetm1Unc
Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		hyperglycemia J:133453
impaired glucose tolerance J:133453
increased circulating insulin level J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased circulating insulin level J:227165
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating insulin level J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		impaired glucose tolerance J:141333
increased circulating glucose level J:141333
increased circulating insulin level J:141333
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL) 		abnormal fasting circulating glucose level J:227165
increased circulating insulin level J:227165
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J) 		increased circulating glucose level J:105136
insulin resistance J:105136
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg) 		impaired glucose tolerance J:211773
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev) 		decreased circulating glucose level J:219838
decreased circulating insulin level J:219838
improved glucose tolerance J:219838
increased insulin sensitivity J:219838
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		decreased circulating glucose level J:73202
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		decreased circulating insulin level J:184647
impaired glucose tolerance J:184647
increased circulating glucose level J:184647
insulin resistance J:184647
Apoetm1Unc/Apoetm1Unc
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Apoetm1Unc) 		decreased circulating glucose level J:102223
improved glucose tolerance J:102223
increased insulin sensitivity J:102223
Apoetm1Unc/Apoetm1Unc
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating glucose level J:143903
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:151284
impaired glucose tolerance J:151284
Apol6em1Hsul/Apol6em1Hsul
(Not Specified) 		improved glucose tolerance J:344362
increased insulin sensitivity J:344362
Appl1Gt(RRS819)Byg/Appl1Gt(RRS819)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatic glucose production J:211794
impaired glucose tolerance J:211794
increased circulating insulin level J:211794
increased fasting circulating glucose level J:211794
insulin resistance J:211794
Appl2tm1Smoc/Appl2tm1Smoc
Tg(Ckmm-cre)5Khn/0
(involves: FVB) 		improved glucose tolerance J:230004
increased insulin sensitivity J:230004
Aqp1tm1Ask/Aqp1tm1Ask
Aqp7tm1.1Suc/Aqp7tm1.1Suc
(involves: 129S2/SvPas * C57BL/6J) 		increased urine glucose level J:102454
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
Aqp7tm1.1Suc/Aqp7tm1.1Suc
(involves: 129S2/SvPas * C57BL/6J) 		increased urine glucose level J:102454
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating insulin level J:125011
increased insulin secretion J:125011
Aqp7tm1Tfun/Aqp7tm1Tfun
(B6N.129X1-Aqp7tm1Tfun) 		hypoglycemia J:95278
Aqp9tm1Nlsn/Aqp9tm1Nlsn
Leprdb/Leprdb
(involves: 129S1/Sv * C57BL/6 * C57BLKS/J) 		decreased circulating glucose level J:123742
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		hyperglycemia J:98775
impaired glucose tolerance J:98775
increased circulating glucose level J:98775
increased circulating insulin level J:98775
insulin resistance J:98775
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:196857
impaired glucose tolerance J:196857
increased circulating insulin level J:196857
insulin resistance J:196857
Arel1tm1b(EUCOMM)Hmgu/Arel1tm1b(EUCOMM)Hmgu
(C57BL/6N-Arel1tm1b(EUCOMM)Hmgu/Mhzh) 		increased fasting circulating glucose level J:211773
Arf2tm1.1(KOMP)Wtsi/Arf2tm1.1(KOMP)Wtsi
(B6N(Cg)-Arf2tm1.1(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong) 		abnormal glucose homeostasis J:216529
hyperglycemia J:216529
impaired glucose tolerance J:216529
increased circulating insulin level J:216529
increased insulin secretion J:216529
insulin resistance J:216529
Arhgap17tm1b(EUCOMM)Wtsi/Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Arhgef10tm1.1(KOMP)Vlcg/Arhgef10tm1.1(KOMP)Vlcg
(B6N(Cg)-Arhgef10tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Arhgef11tm1.1Mak/Arhgef11tm1.1Mak
(B6.129P2(C)-Arhgef11tm1.1Mak) 		abnormal glucose homeostasis J:233950
Arid1bem1(IMPC)Tcp/Arid1b+
(C57BL/6NCrl-Arid1bem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J) 		increased circulating insulin level J:211773
Armcx3tm1.1Eso/Y
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		decreased circulating glucose level J:345411
improved glucose tolerance J:345411
increased circulating insulin level J:345411
increased insulin sensitivity J:345411
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr) 		impaired glucose tolerance J:268298
increased circulating insulin level J:268298
increased fasting circulating glucose level J:268298
Arpc5ltm1.1(KOMP)Vlcg/Arpc5l+
(B6N(Cg)-Arpc5ltm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Arrdc3Gt(CSE151)Byg/Arrdc3+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:179646
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:179646
decreased circulating glucose level J:179646
decreased circulating insulin level J:179646
increased insulin sensitivity J:179646
ArtlesC57BL/6J/?
(involves: C57BL/6J * CAST/Ei) 		increased circulating insulin level J:70961
ArtlesCAST/EiJ/?
(involves: C57BL/6J * CAST/Ei) 		decreased circulating insulin level J:70961
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		decreased fasting circulating glucose level J:263695
improved glucose tolerance J:263695
increased insulin sensitivity J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		decreased fasting circulating glucose level J:241193
hypoglycemia J:241193
improved glucose tolerance J:241193
Arxtm1Gldn/Arxtm1Gldn
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss
Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL) 		hyperglycemia J:177838
Arxtm1Pgr/Y
(involves: 129/Sv * NMRI) 		hypoglycemia J:86206
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Asf1atm1b(KOMP)Wtsi/Asf1a+
(B6N(Cg)-Asf1atm1b(KOMP)Wtsi/2J) 		increased circulating insulin level J:211773
Ash1ltm2b(EUCOMM)Hmgu/Ash1l+
(C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju) 		increased fasting circulating glucose level J:211773
Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi
(C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(B6Dnk;B6Brd;B6N-Asxl1tm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH) 		decreased circulating glucose level J:175295
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased circulating glucose level J:155421
Atf2tm1b(EUCOMM)Hmgu/Atf2+
(C57BL/6N-Atf2tm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Atf2tm1Sis/Atf2+
Creb5tm1Sis/Creb5+
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:156376
increased insulin sensitivity J:156376
Atf3tm1.2Kitab/Atf3tm1.2Kitab
Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA) 		decreased circulating glucose level J:231262
improved glucose tolerance J:231262
increased insulin sensitivity J:231262
Atf4tm1Kry/Atf4tm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6J * FVB) 		abnormal glucose homeostasis J:152695
abnormal glycogen homeostasis J:152695
decreased circulating glucose level J:152695
impaired gluconeogenesis J:152695
improved glucose tolerance J:152695
increased insulin secretion J:152695
increased insulin sensitivity J:152695
Atf4tm1Tow/Atf4+
Ptprvtm1Asmi/Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		decreased circulating glucose level J:152695
increased circulating insulin level J:152695
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		decreased circulating glucose level J:152695
impaired gluconeogenesis J:152695
improved glucose tolerance J:152695
increased circulating insulin level J:152695
increased insulin secretion J:152695
increased insulin sensitivity J:152695
Atf6tm1Hota/Atf6tm1Hota
Tg(Ins2-cre)25Mgn/0
(B6.Cg-Atf6tm1Hota Tg(Ins2-cre)25Mgn) 		increased insulin sensitivity J:213542
Atg5tm1Myok/Atg5tm1Myok
Tg(Kap-cre)1Isa/0
(involves: 129S/SvEv * C57BL/6 * DBA) 		increased urine glucose level J:179961
Atg12tm1.1Jdth/Atg12tm1.1Jdth
Tg(Pomc1-cre)1Gsb/0
(involves: C57BL/6 * FVB/N) 		impaired glucose tolerance J:232686
Atmtm1Pmc/Atm+
(B6.Cg-Atmtm1Pmc) 		impaired glucose tolerance J:222034
insulin resistance J:222034
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc) 		impaired glucose tolerance J:222034
insulin resistance J:222034
Atp1a3tm1b(EUCOMM)Hmgu/Atp1a3+
(C57BL/6N-Atp1a3tm1b(EUCOMM)Hmgu/H) 		improved glucose tolerance J:211773
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2+
(C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Atp5if1em1Jpy/Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy) 		improved glucose tolerance J:313048
insulin resistance J:313048
Atp5mc2tm2b(EUCOMM)Hmgu/Atp5mc2+
(C57BL/6N-Atp5mc2tm2b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Atp5mktm1b(EUCOMM)Wtsi/Atp5mktm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mktm1b(EUCOMM)Wtsi/H) 		decreased circulating glucose level J:211773
Atp5potm1.1(KOMP)Vlcg/Atp5po+
(B6N(Cg)-Atp5potm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Atp6v0d1em1Nju/Atp6v0d1em1Nju
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		improved glucose tolerance J:346448
insulin resistance J:346448
Atp8a2em1(IMPC)J/Atp8a2+
(C57BL/6NJ-Atp8a2em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Atp8a2wl/Atp8a2wl
(Not Specified) 		hypoglycemia J:14851
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Atp13a3em1(IMPC)J/Atp13a3em1(IMPC)J
(C57BL/6NJ-Atp13a3em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Atrtm1b(KOMP)Wtsi/Atr+
(B6N(Cg)-Atrtm1b(KOMP)Wtsi/2J) 		decreased circulating glucose level J:211773
Atriptm1b(KOMP)Wtsi/Atrip+
(B6N(Cg)-Atriptm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:135320
increased circulating insulin level J:135320
increased insulin secretion J:135320
increased liver glycogen level J:135320
AU021092tm1b(KOMP)Wtsi/AU021092tm1b(KOMP)Wtsi
(C57BL/6N-AU021092tm1b(KOMP)Wtsi/Ucd) 		decreased circulating glucose level J:211773
Avpr2tm1Jwe/Y
(involves: 129S1/Sv * 129X1/SvJ * CF-1) 		hypoglycemia J:66094
Azin2Gt(IST12418H6)Tigm/Azin2Gt(IST12418H6)Tigm
(involves: C57BL/6N) 		decreased circulating insulin level J:204392
B2mtm1Jae/B2mtm1Jae
Tg(B2m)1Rms/0
Tg(INS-cre)2Rms/0
(involves: 129S2/SvPas * NOD) 		abnormal glucose homeostasis J:83635
B2mtm1Unc/B2mtm1Unc
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum) 		abnormal glucose homeostasis J:107051
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
Bach1tm1.1(KOMP)Vlcg/Bach1+
(B6N(Cg)-Bach1tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg) 		decreased circulating glucose level J:211773
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae) 		decreased circulating insulin level J:133563
decreased insulin secretion J:133563
increased circulating glucose level J:133563
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ) 		abnormal circulating glucose level J:133563
decreased insulin secretion J:133563
increased circulating insulin level J:133563
Badtm1Sjk/Badtm1Sjk
Tg(Ins2-Mirc13)E4Biat/0
(involves: 129X1/SvJ * C57BL/6N) 		hyperglycemia J:314874
Badtm2Meg/Badtm2Meg
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased insulin secretion J:133563
impaired glucose tolerance J:133563
Bag2em1(IMPC)J/Bag2em1(IMPC)J
(C57BL/6NJ-Bag2em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased circulating insulin level J:144416
hypoglycemia J:144416
Baiap2l1tm1Zgh/Baiap2l1tm1Zgh
(B6.Cg-Baiap2l1tm1Zgh) 		impaired glucose tolerance J:238622
increased circulating insulin level J:238622
increased fasting circulating glucose level J:238622
increased hepatic glucose production J:238622
insulin resistance J:238622
Baz1btm2a(KOMP)Wtsi/Baz1b+
(Not Specified) 		decreased circulating glucose level J:165965
Baz2aem1(IMPC)Tcp/Baz2aem1(IMPC)Tcp
(C57BL/6NCrl-Baz2aem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Baz2bem1(IMPC)Wtsi/Baz2bem1(IMPC)Wtsi
(C57BL/6N-Baz2bem1(IMPC)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd) 		increased circulating glucose level J:134093
increased circulating insulin level J:134093
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Bbs10tm1.2Vmar/Bbs10tm1.2Vmar
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose tolerance J:227230
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating glucose level J:189019
increased insulin sensitivity J:189019
BC048562tm1b(KOMP)Wtsi/BC048562tm1b(KOMP)Wtsi
(C57BL/6N-BC048562tm1b(KOMP)Wtsi/Bay) 		decreased fasting circulating glucose level J:211773
Bcar3em1(IMPC)Mbp/Bcar3em1(IMPC)Mbp
(C57BL/6N-Bcar3em1(IMPC)Mbp/MbpMmucd) 		increased circulating insulin level J:211773
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N) 		abnormal glucose homeostasis J:129967
decreased circulating glucose level J:129967
decreased circulating insulin level J:129967
improved glucose tolerance J:129967
increased insulin sensitivity J:129967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		impaired glucose tolerance J:278806
insulin resistance J:278806
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL) 		abnormal circulating glucose level J:181308
abnormal circulating insulin level J:181308
abnormal glucose homeostasis J:181308
abnormal glucose tolerance J:181308
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		decreased circulating insulin level J:271078
decreased fasting circulating glucose level J:271078
impaired gluconeogenesis J:271078
increased insulin sensitivity J:271078
Bcl11btm1.1(KOMP)Vlcg/Bcl11b+
(B6N(Cg)-Bcl11btm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		decreased liver glycogen level J:189652
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp) 		decreased circulating glucose level J:273501
Bdnftm1Par/Bdnf+
(B6.129S1-Bdnftm1Par) 		increased circulating insulin level J:59077
Bdnftm3Jae/Bdnftm3Jae
Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * CBA/J) 		increased circulating glucose level J:71969
increased circulating insulin level J:71969
insulin resistance J:71969
Becn2tm1.1Blev/Becn2+
(B6.Cg-Becn2tm1.1Blev) 		impaired glucose tolerance J:203842
increased circulating glucose level J:203842
insulin resistance J:203842
Betalinc1tm1Suss/Betalinc1tm1Suss
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:231585
increased circulating insulin level J:231585
insulin resistance J:231585
Bfq1LP/J/Bfq1LP/J
(involves: C57BL/10SnJ * LP/J) 		decreased circulating insulin level J:42700
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:126780
decreased circulating insulin level J:126780
decreased insulin secretion J:126780
impaired glucose tolerance J:126780
increased circulating glucose level J:126780
insulin resistance J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N) 		increased circulating insulin level J:145998
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:126780
decreased circulating insulin level J:126780
decreased insulin secretion J:126780
impaired glucose tolerance J:126780
increased circulating glucose level J:126780
insulin resistance J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N) 		increased circulating insulin level J:145998
Bglu1C57BL/6Slc/Bglu1C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu1C57BL/6Slc/Bglu1C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu2C57BL/6Slc/Bglu2C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu2C57BL/6Slc/Bglu2C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu3C3H/HeJ/Bglu3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased circulating glucose level J:108422
Bglu3C3H/HeJ/Bglu3C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating glucose level J:108422
Bglu4NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu5NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu6NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu7NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu8NZB/BlNJ/Bglu8NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu8NZW/LacJ/Bglu8NZW/LacJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu10NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu11NZB/BlNJ/Bglu11NZB/BlNJ
Bglu9NZB/BlNJ/Bglu9NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(B6N(Cg)-Bhlhe40tm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Bivmtm1b(KOMP)Wtsi/Bivmtm1b(KOMP)Wtsi
(C57BL/6N-Bivmtm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Blcapem1(IMPC)J/Blcapem1(IMPC)J
(C57BL/6NJ-Blcapem1(IMPC)J/J) 		increased fasting circulating glucose level J:211773
Bltp1tm1b(EUCOMM)Hmgu/Bltp1+
(C57BL/6N-Bltp1tm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N) 		decreased liver glycogen level J:237631
impaired glucose tolerance J:237631
increased circulating insulin level J:237631
increased fasting circulating glucose level J:237631
insulin resistance J:237631
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J) 		abnormal gluconeogenesis J:177865
abnormal glucose homeostasis J:177865
decreased circulating insulin level J:177865
decreased insulin secretion J:177865
hyperglycemia J:177865
impaired glucose tolerance J:177865
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129) 		abnormal glucose homeostasis J:131694
impaired gluconeogenesis J:131694
increased insulin sensitivity J:131694
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6) 		decreased circulating glucose level J:135933
decreased insulin secretion J:162641
Bmal1tm2Bra/Bmal1tm2Bra
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA * ICR) 		decreased insulin secretion J:162641
hyperglycemia J:162641
impaired glucose tolerance J:162641
Bmp4tm1Blh/Bmp4+
(involves: 129S2/SvPas * C57BL/6) 		increased circulating glucose level J:173500
Bmp10tm3b(EUCOMM)Hmgu/Bmp10+
(C57BL/6N-Bmp10tm3b(EUCOMM)Hmgu/Ics) 		improved glucose tolerance J:211773
Bnip3em1(IMPC)Mbp/Bnip3em1(IMPC)Mbp
(C57BL/6N-Bnip3em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Bola2tm1(KOMP)Wtsi/Bola2tm1(KOMP)Wtsi
(C57BL/6N-Bola2tm1(KOMP)Wtsi/Nju) 		improved glucose tolerance J:211773
Bola3tm1a(EUCOMM)Wtsi/Bola3tm1a(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * C57BL/6N * FVB/NJ) 		impaired glucose tolerance J:287367
Bpifcem1(IMPC)J/Bpifcem1(IMPC)J
(C57BL/6NJ-Bpifcem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Braftm1Sva/Braftm1.1Sva
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		hypoglycemia J:121660
Braftm1Wds/Braftm1.1Wds
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		hypoglycemia J:121660
Brcc3dcem1(IMPC)J/Brcc3dcem1(IMPC)J
(C57BL/6NJ-Brcc3dcem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		decreased circulating glucose level J:159964
improved glucose tolerance J:159964
increased circulating glucagon level J:159964
increased circulating insulin level J:159964
Brpf3tm1a(EUCOMM)Wtsi/Brpf3+
(B6JTyr;B6N-Brpf3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Brs3tm1Hoh/Brs3tm1Hoh
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:44242
increased circulating insulin level J:44242
Brs3tm1Jfb/Brs3tm1Jfb
(B6.129X1-Brs3tm1Jfb) 		increased circulating insulin level J:134021
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor) 		increased circulating insulin level J:211072
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal glucose homeostasis J:183701
decreased circulating glucose level J:183701
increased circulating glucose level J:183701
increased circulating insulin level J:183701
insulin resistance J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		impaired glucose tolerance J:173404
increased circulating glucose level J:173404
increased circulating insulin level J:211072, J:173404
insulin resistance J:173404
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics) 		improved glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno) 		hyperglycemia J:200947
impaired glucose tolerance J:200947
increased circulating glucose level J:200947
increased circulating insulin level J:200947
insulin resistance J:200947
Bsxtm1Tre/Bsxtm1Tre
Lepob/Lepob
(B6.Cg-Lepob Bsxtm1Tre) 		hyperglycemia J:122746
increased circulating insulin level J:122746
Btbd9tm1b(EUCOMM)Wtsi/Btbd9tm1b(EUCOMM)Wtsi
(C57BL/6N-Btbd9tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Btg2tm1b(KOMP)Mbp/Btg2tm1b(KOMP)Mbp
(B6N(Cg)-Btg2tm1b(KOMP)Mbp/2J) 		increased fasting circulating glucose level J:211773
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		hypoglycemia J:234643
improved glucose tolerance J:234643
increased insulin sensitivity J:234643
Bub1btm1Jvd/Bub1btm1Jvd
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		hypoglycemia J:234643
improved glucose tolerance J:234643
increased insulin sensitivity J:234643
Bud23em2(IMPC)H/Bud23+
(C57BL/6N-Bud23em2(IMPC)H/H) 		decreased circulating glucose level J:211773
Bvestm1.1(KOMP)Vlcg/Bvestm1.1(KOMP)Vlcg
(C57BL/6N-Bvestm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Bwt1HRS/J/Bwt1HRS/J
Find1C57BLKS/J/Find1C57BLKS/J
(involves: C57BLKS/J * HRS/J) 		increased circulating glucose level J:100832
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
C1qatm1b(EUCOMM)Wtsi/C1qatm1b(EUCOMM)Wtsi
(B6N(Cg)-C1qatm1b(EUCOMM)Wtsi/3J) 		decreased circulating glucose level J:211773
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex) 		impaired glucose tolerance J:344722
insulin resistance J:344722
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex) 		impaired glucose tolerance J:241403
increased circulating insulin level J:241403
insulin resistance J:241403
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased circulating insulin level J:237401
decreased fasting circulating glucose level J:237401
impaired gluconeogenesis J:237401
improved glucose tolerance J:237401
increased insulin secretion J:237401
increased insulin sensitivity J:237401
C1qtnf5tm1.1(KOMP)Vlcg/C1qtnf5+
(B6N(Cg)-C1qtnf5tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg) 		decreased circulating glucose level J:244352
improved glucose tolerance J:244352
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg) 		increased circulating insulin level J:212299
increased insulin secretion J:212299
insulin resistance J:212299
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm) 		abnormal glucose homeostasis J:284780
decreased hepatic glucose production J:284780
impaired glucose tolerance J:284780
increased fasting circulating glucose level J:284780
insulin resistance J:284780
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6) 		abnormal glucose homeostasis J:60633, J:58966
decreased circulating glucose level J:60633, J:58966
decreased circulating insulin level J:60633
C3tm1Hrc/C3tm1Hrc
(involves: 129) 		decreased circulating insulin level J:87945
C3tm1Hrc/C3tm1Hrc
Lepob/Lepob
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:80546
decreased circulating insulin level J:80546
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:123294
increased circulating insulin level J:123294
cab/cab
(STOCK Cacna1smdg) 		abnormal glucose homeostasis J:7797
decreased glycogen level J:6195, J:7797
hypoglycemia J:7797
Cabp5tm1b(KOMP)Wtsi/Cabp5tm1b(KOMP)Wtsi
(C57BL/6N-Cabp5tm1b(KOMP)Wtsi/BayMmucd) 		impaired glucose tolerance J:211773
Cacna1atg-rol/Cacna1a+
(involves: C3Hf/Nga * C57BL/6 * SIII) 		abnormal glucose homeostasis J:3611
Cacna1atg-rol/Cacna1atg-rol
(involves: C3Hf/Nga * C57BL/6 * SIII) 		abnormal glucose homeostasis J:3611
Cacna1btm1b(KOMP)Wtsi/Cacna1btm1b(KOMP)Wtsi
(C57BL/6N-Cacna1btm1b(KOMP)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA) 		decreased circulating glucagon level J:105212
decreased circulating insulin level J:105212
improved glucose tolerance J:105212
Cacna1ctm3Hfm/Cacna1ctm3Hfm
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating insulin level J:84919
decreased insulin secretion J:84919
impaired glucose tolerance J:84919
increased circulating glucose level J:84919
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating insulin level J:72316
decreased insulin secretion J:72316
impaired glucose tolerance J:72316
increased insulin sensitivity J:72316
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6) 		abnormal glucagon secretion J:95377
decreased circulating glucagon level J:95377
decreased insulin secretion J:95377
impaired glucose tolerance J:95377
increased circulating glucose level J:95377
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: BALB/cJ * C57BL/6) 		decreased glucagon secretion J:101873
decreased insulin secretion J:95636
hyperglycemia J:95636
impaired glucose tolerance J:95636
increased circulating glucose level J:101873
Cacna1ftm1.1(KOMP)Vlcg/Cacna1ftm1.1(KOMP)Vlcg
(C57BL/6N-Cacna1ftm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Cacna1stm1.1(KOMP)Vlcg/Cacna1s+
(B6N(Cg)-Cacna1stm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Cacna2d1em1(IMPC)Mbp/Cacna2d1em1(IMPC)Mbp
(C57BL/6N-Cacna2d1em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Cacna2d3tm1b(KOMP)Wtsi/Cacna2d3+
(B6N(Cg)-Cacna2d3tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Cacnb2tm1.1(KOMP)Vlcg/Cacnb2tm1.1(KOMP)Vlcg
(C57BL/6N-Cacnb2tm1.1(KOMP)Vlcg/Tcp) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified) 		decreased insulin secretion J:131014
impaired glucose tolerance J:131014
increased glucagon secretion J:131014
increased insulin sensitivity J:131014
Cadpstm1Bros/Cadps+
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified) 		abnormal glucose homeostasis J:131014
decreased insulin secretion J:131014
impaired glucose tolerance J:131014
increased glucagon secretion J:131014
increased insulin sensitivity J:131014
Calrtm1Mlk/Calrtm1Mlk
(involves: 129S4/SvJae * C57BL/6J) 		increased cardiac muscle glycogen level J:119647
Camk1tm2b(EUCOMM)Hmgu/Camk1tm2b(EUCOMM)Hmgu
(C57BL/6N-Camk1tm2b(EUCOMM)Hmgu/Bay) 		decreased fasting circulating glucose level J:211773
Camk2btm1b(EUCOMM)Hmgu/Camk2b+
(C57BL/6N-Camk2btm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Camkk2tm1.1Arm/Camkk2tm1.1Arm
(involves: C57BL/6) 		abnormal glucose homeostasis J:136219
improved glucose tolerance J:136219
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Cand1em1(IMPC)Mbp/Cand1+
(C57BL/6NCrl-Cand1em1(IMPC)Mbp/Mmucd) 		increased fasting circulating glucose level J:211773
Candy/Candy
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy2/Candy2
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy3/Candy3
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy4/Candy4
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy5/Candy5
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:163957
Capn11tm1b(EUCOMM)Wtsi/Capn11tm1b(EUCOMM)Wtsi
(C57BL/6N-Capn11tm1b(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Capn12tm1b(EUCOMM)Hmgu/Capn12tm1b(EUCOMM)Hmgu
(C57BL/6N-Capn12tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating glucose level J:211773
Car5atm1Sly/Car5atm1Sly
Car5btm1Sly/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:196135
Car5atm1Sly/Car5atm1Sly
Car5btm1Sly/Car5btm1Sly
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:196135
Car13tm1b(KOMP)Wtsi/Car13tm1b(KOMP)Wtsi
(C57BL/6N-Car13tm1b(KOMP)Wtsi/Bay) 		impaired glucose tolerance J:211773
Carmil2tm1b(KOMP)Mbp/Carmil2tm1b(KOMP)Mbp
(C57BL/6N-Carmil2tm1b(KOMP)Mbp/Orl) 		increased circulating glucose level J:211773
Cartpttm1Amgn/Cartpttm1Amgn
(involves: 129X1/SvJ * Black Swiss) 		decreased insulin secretion J:103911
impaired glucose tolerance J:103911
increased circulating insulin level J:103911
Casp4tm1b(KOMP)Wtsi/Casp4tm1b(KOMP)Wtsi
(C57BL/6N-Casp4tm1b(KOMP)Wtsi/Ucd) 		increased circulating glucose level J:211773
increased circulating insulin level J:211773
Casttm1.1(KOMP)Vlcg/Casttm1.1(KOMP)Vlcg
(B6N(Cg)-Casttm1.1(KOMP)Vlcg/2J) 		decreased fasting circulating glucose level J:211773
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL) 		increased circulating insulin level J:84260
insulin resistance J:84260
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls) 		abnormal glucose homeostasis J:182288
decreased liver glycogen level J:182288
enhanced gluconeogenesis J:182288
hyperglycemia J:182288
increased circulating insulin level J:182288
increased liver glycogen level J:182288
insulin resistance J:182288
Cav1tm1Pesch/Cav1tm1Pesch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn) 		decreased circulating glucose level J:182288
Cavin1tm1Pfp/Cavin1tm1Pfp
(involves: 129S6/SvEvTac * C57BL/6) 		impaired glucose tolerance J:143425
increased circulating insulin level J:143425
insulin resistance J:143425
Cbltm1Ddlb/Cbl+
(involves: 129S1/Sv * C57BL/6) 		improved glucose tolerance J:121012
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:94416
decreased circulating insulin level J:94416
improved glucose tolerance J:94416
increased insulin sensitivity J:94416
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6) 		decreased circulating insulin level J:121012
improved glucose tolerance J:121012
increased insulin sensitivity J:121012
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi) 		decreased circulating glucose level J:236022
Cbx5tm1a(EUCOMM)Wtsi/Cbx5tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx5tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J) 		impaired glucose tolerance J:228688
increased circulating insulin level J:228688
increased hepatic glucose production J:228688
insulin resistance J:228688
Ccar2tm1Dac/Ccar2tm1Dac
Lepob/Lepob
(involves: 129 * C57BL/6J) 		impaired glucose tolerance J:228688
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J) 		abnormal glucose homeostasis J:220560
increased circulating glucose level J:220560
increased insulin sensitivity J:220560
Ccdc25em1(IMPC)Mbp/Ccdc25+
(C57BL/6N-Ccdc25em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Ccdc28bem1Jlba/Ccdc28bem1Jlba
(C57BL/6J-Ccdc28bem1Jlba) 		abnormal glucose tolerance J:325766
increased circulating glucose level J:325766
Ccdc51em1(IMPC)J/Ccdc51em1(IMPC)J
(C57BL/6NJ-Ccdc51em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Ccdc57tm1a(EUCOMM)Wtsi/Ccdc57+
(B6JTyr;B6N-Ccdc57tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm) 		decreased circulating insulin level J:189183
impaired glucose tolerance J:189183
increased circulating glucose level J:189183
increased insulin secretion J:189183
Ccdc88bem1(IMPC)Tcp/Ccdc88bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc88bem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp) 		improved glucose tolerance J:332421
increased insulin sensitivity J:332421
Ccdc116tm1.1(KOMP)Vlcg/Ccdc116tm1.1(KOMP)Vlcg
(C57BL/6N-Ccdc116tm1.1(KOMP)Vlcg/Ucd) 		impaired glucose tolerance J:211773
Ccdc120tm1.1(KOMP)Vlcg/Y
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ccdc120tm1.1(KOMP)Vlcg/Ccdc120tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J) 		abnormal gluconeogenesis J:110277
abnormal glucose homeostasis J:126512
decreased circulating insulin level J:110277
impaired glucose tolerance J:126512
improved glucose tolerance J:110277
increased circulating glucose level J:126512
increased circulating insulin level J:126512
increased insulin sensitivity J:110277
Ccl25em1(IMPC)H/Ccl25em1(IMPC)H
(C57BL/6N-Ccl25em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Ccl26tm1.1(KOMP)Vlcg/Ccl26tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccl26tm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Ccr2tm1.1(CCR2)Rodb/Ccr2tm1.1(CCR2)Rodb
(involves: C57BL/6) 		abnormal glucose homeostasis J:203000
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz/J) 		decreased skeletal muscle glycogen level J:264446
Ccr9em1(IMPC)H/Ccr9em1(IMPC)H
(C57BL/6N-Ccr9em1(IMPC)H/H) 		impaired glucose tolerance J:211773
Cd5ltm1b(KOMP)Mbp/Cd5ltm1b(KOMP)Mbp
(C57BL/6N-Cd5ltm1b(KOMP)Mbp/H) 		decreased circulating glucose level J:211773
Cd33tm1.1(KOMP)Vlcg/Cd33tm1.1(KOMP)Vlcg
(B6N(Cg)-Cd33tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6) 		decreased cardiac muscle glycogen level J:83611
decreased fasting circulating glucose level J:56081
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe) 		abnormal gluconeogenesis J:87372
abnormal glucose homeostasis J:87372
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv) 		decreased circulating glucose level J:220343
decreased skeletal muscle glycogen level J:220343
Cd36tm2.1Mfe/Cd36tm2.1Mfe
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk) 		abnormal glucose homeostasis J:225392
Cd38tm1Lnd/Cd38tm1Lnd
(B6.129P2-Cd38tm1Lnd) 		insulin resistance J:116576
Cd38tm1Okam/Cd38tm1Okam
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:52933
impaired glucose tolerance J:52933
Cd248tm1.1(KOMP)Vlcg/Cd248tm1.1(KOMP)Vlcg
(C57BL/6N-Cd248tm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Cd300etm1.1(KOMP)Vlcg/Cd300etm1.1(KOMP)Vlcg
(C57BL/6N-Cd300etm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Cdc20tm1.1(KOMP)Vlcg/Cdc20+
(B6N(Cg)-Cdc20tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Cdc34tm1.1(KOMP)Mbp/Cdc34+
(B6N(Cg)-Cdc34tm1.1(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Cdh1tm2Kem/Cdh1tm2Kem
Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		decreased insulin secretion J:196410
impaired glucose tolerance J:196410
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Cdk4tm1Bbd/Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased circulating insulin level J:54534
hyperglycemia J:54534
increased urine glucose level J:54534
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6) 		increased urine glucose level J:57854
Cdk4wnch/Cdk4wnch
(C57BL/6JAnu-Cdk4wnch) 		abnormal glucose homeostasis J:104190
Cdk5rap1tm1.2Tomik/Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik) 		decreased circulating glucose level J:220703
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3+
(C57BL/6N-Cdk5rap3tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA) 		decreased fasting circulating glucose level J:272566
hypoglycemia J:272566
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased circulating insulin level J:281075
improved glucose tolerance J:281075
increased circulating glucose level J:281075
increased insulin secretion J:281075
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6N * FVB/N) 		improved glucose tolerance J:281075
increased insulin secretion J:281075
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj) 		abnormal glucose homeostasis J:195460
decreased circulating glucose level J:195460
decreased circulating insulin level J:195460
decreased insulin secretion J:195460
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik
Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn) 		abnormal insulin secretion J:178248
decreased insulin secretion J:178248
impaired glucose tolerance J:178248
increased circulating glucose level J:178248
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		impaired glucose tolerance J:118516
insulin resistance J:118516
Cdkn1btm1Kin/Cdkn1b+
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased circulating glucose level J:96047
increased circulating insulin level J:96047
Cdkn1btm1Kin/Cdkn1b+
Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J) 		hyperglycemia J:96047
increased circulating insulin level J:96047
Cdkn1btm1Kin/Cdkn1btm1Kin
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased circulating glucose level J:96047
increased circulating insulin level J:96047
Cdkn1btm1Kin/Cdkn1btm1Kin
Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J) 		increased circulating insulin level J:96047
Cdo1tm1.1Mhst/Cdo1tm1.1Mhst
(involves: C57BL/6) 		decreased circulating glucose level J:182195
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:181979
abnormal glycogen homeostasis J:181979
impaired glucose tolerance J:181979
increased circulating insulin level J:181979
increased insulin secretion J:181979
insulin resistance J:181979
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal gluconeogenesis J:28320
abnormal glucose homeostasis J:28320
abnormal glycogen homeostasis J:28320
decreased liver glycogen level J:28320
hypoglycemia J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased circulating insulin level J:93579
impaired glucose tolerance J:93579
increased circulating glucose level J:93579
increased liver glycogen level J:93579
insulin resistance J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:35795
decreased liver glycogen level J:35795
hypoglycemia J:35795
Cebpatm1Timc/Cebpatm1Timc
(Not Specified) 		decreased circulating glucose level J:163725
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating insulin level J:120098
decreased liver glycogen level J:120098
impaired glucose tolerance J:120098
increased circulating glucose level J:120098
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		hypoglycemia J:136134
Cebpbtm1.1Maka/Cebpbtm1.1Maka
Ins2Akita/Ins2Akita
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J) 		decreased circulating insulin level J:156725
decreased insulin secretion J:156725
increased circulating glucose level J:156725
Cebpbtm1.1Maka/Cebpbtm1.1Maka
Leprdb/Leprdb
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J) 		hyperglycemia J:156725
increased circulating insulin level J:156725
Cebpbtm1.1Maka/Cebpbtm1.1Maka
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		increased insulin secretion J:156725
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1) 		abnormal gluconeogenesis J:52286
abnormal glucose homeostasis J:62132, J:52286
decreased circulating insulin level J:62132
decreased glycogen catabolism rate J:52286
hypoglycemia J:62132, J:52286
increased insulin sensitivity J:62132
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6 * MF1) 		abnormal gluconeogenesis J:49673
abnormal glucose homeostasis J:49673
hypoglycemia J:49673
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6) 		increased circulating glucose level J:117502
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:124658
insulin resistance J:124658
Celf4tm1a(EUCOMM)Wtsi/Celf4+
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Cenpetm1b(EUCOMM)Hmgu/Cenpe+
(C57BL/6N-Cenpetm1b(EUCOMM)Hmgu/Cnrm) 		increased fasting circulating glucose level J:211773
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cenpjtm1a(EUCOMM)Wtsi/Wtsi) 		abnormal glucose tolerance J:194085
Cenpotm1b(KOMP)Mbp/Cenpo+
(B6N(Cg)-Cenpotm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac) 		impaired glucose tolerance J:206667
increased circulating glucose level J:206667
insulin resistance J:206667
Cep57l1tm1b(KOMP)Wtsi/Cep57l1+
(B6N(Cg)-Cep57l1tm1b(KOMP)Wtsi/2J) 		increased fasting circulating glucose level J:211773
Cep126tm1b(KOMP)Mbp/Cep126tm1b(KOMP)Mbp
(C57BL/6N-Cep126tm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Cept1tm1.1Sem/Cept1tm1.1Sem
Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL) 		decreased circulating glucose level J:249456
improved glucose tolerance J:249456
increased insulin sensitivity J:249456
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N) 		decreased circulating insulin level J:215519
improved glucose tolerance J:215519
Cers6tm1Arte/Cers6tm1Arte
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6N * FVB/N) 		improved glucose tolerance J:215519
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac) 		decreased circulating glucose level J:158743
improved glucose tolerance J:158743
increased insulin sensitivity J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6) 		abnormal glucose homeostasis J:262803
decreased fasting circulating glucose level J:262803
increased circulating insulin level J:262803
increased insulin sensitivity J:262803
insulin resistance J:262803
Cfbtm1.1(KOMP)Wtsi/Cfbtm1.1(KOMP)Wtsi
(C57BL/6N-Cfbtm1.1(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi) 		abnormal glucose tolerance J:330596
decreased circulating insulin level J:330596
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6) 		decreased insulin secretion J:157614
impaired glucose tolerance J:157614
Chmp3tm1b(EUCOMM)Hmgu/Chmp3+
(C57BL/6N-Chmp3tm1b(EUCOMM)Hmgu/Bay) 		impaired glucose tolerance J:211773
Chn1em1(IMPC)J/Chn1+
(C57BL/6NJ-Chn1em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Chp2tm1b(KOMP)Mbp/Chp2+
(B6N(Cg)-Chp2tm1b(KOMP)Mbp/J) 		decreased fasting circulating glucose level J:211773
Chrdl1em1(IMPC)H/Chrdl1em1(IMPC)H
(C57BL/6NTac-Chrdl1em1(IMPC)H/H) 		increased fasting circulating glucose level J:211773
Chrm3tm1Jwe/Chrm3+
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating insulin level J:91888
decreased insulin secretion J:91888
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:67919
decreased circulating glucagon level J:91888
decreased circulating glucose level J:91888
decreased circulating insulin level J:91888, J:67919
decreased glucagon secretion J:91888
decreased insulin secretion J:91888
improved glucose tolerance J:91888
increased insulin sensitivity J:67919
Chrm3tm2.1Jwe/Chrm3tm2.1Jwe
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N) 		decreased circulating glucose level J:158245
Chrm3tm2Jwe/Chrm3tm2Jwe
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased insulin secretion J:129643
impaired glucose tolerance J:129643
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ) 		abnormal circulating glucose level J:85229
abnormal glucose homeostasis J:85229
Cidebtm1Pli/Cidebtm1Pli
(Not Specified) 		increased insulin sensitivity J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel) 		increased circulating insulin level J:226899
insulin resistance J:226899
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka) 		decreased circulating glucose level J:140863
improved glucose tolerance J:140863
Cidectm1Pli/Cidectm1Pli
(Not Specified) 		improved glucose tolerance J:140122
increased insulin sensitivity J:140122
Cidectm1Pli/Cidectm1Pli
Lepob/Lepob
(involves: C57BL/10J) 		improved glucose tolerance J:140122
increased insulin sensitivity J:140122
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum) 		abnormal circulating glucose level J:106081
Cinptm1.1(KOMP)Vlcg/Cinp+
(B6N(Cg)-Cinptm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Cisd2tm1a(EUCOMM)Wtsi/Cisd2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cisd2tm1a(EUCOMM)Wtsi/H) 		abnormal glucose homeostasis J:165965
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts) 		abnormal glucose homeostasis J:148467
decreased insulin secretion J:148467
impaired glucose tolerance J:148467
increased insulin sensitivity J:148467
Ckmtm1Bew/Ckmtm1Bew
(involves: 129S7/SvEvBrd * C57BL/6) 		increased glycogen catabolism rate J:76699
increased skeletal muscle glycogen level J:76699
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating glucose level J:80901
Clcn5tm1Gug/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased urine glucose level J:66560
Clcn5tm1Tjj/Y
(involves: 129) 		increased urine glucose level J:160701
Clcn5tm2.1Tjj/Y
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased urine glucose level J:160701
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg) 		decreased fasting circulating glucose level J:279934
increased circulating glucose level J:279934
Cldn13em1(IMPC)J/Cldn13em1(IMPC)J
(C57BL/6NJ-Cldn13em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
Cldn13tm1.1(KOMP)Vlcg/Cldn13tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn13tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Cldnd2tm1b(EUCOMM)Hmgu/Cldnd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cldnd2tm1b(EUCOMM)Hmgu/Orl) 		increased fasting circulating glucose level J:211773
Clec16atm1.1Hhak/Clec16atm1.1Hhak
Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL) 		decreased insulin secretion J:214528
hyperglycemia J:214528
impaired glucose tolerance J:214528
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6) 		decreased circulating glucose level J:160186
decreased circulating insulin level J:160186
increased circulating glucagon level J:160186
Cln6tm1b(EUCOMM)Hmgu/Cln6tm1b(EUCOMM)Hmgu
(C57BL/6N-Cln6tm1b(EUCOMM)Hmgu/Tcp) 		impaired glucose tolerance J:211773
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt) 		increased circulating glucose level J:98343
Clockm1Jt/Clockm1Jt
(involves: C57BL/6) 		abnormal glucose homeostasis J:131694
impaired gluconeogenesis J:131694
increased insulin sensitivity J:131694
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J) 		decreased insulin secretion J:162641
hyperglycemia J:162641
impaired glucose tolerance J:162641
increased insulin sensitivity J:162641
insulin resistance J:162641
Clockm1Jt/Clockm1Jt
Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR) 		decreased circulating glucose level J:135847
decreased circulating insulin level J:135847
increased circulating glucose level J:135847
increased circulating insulin level J:135847
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Clstn3tm1b(EUCOMM)Hmgu/Clstn3tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		decreased circulating glucose level J:293885
increased insulin sensitivity J:293885
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6) 		increased insulin sensitivity J:148522
Clutm1b(EUCOMM)Hmgu/Clutm1b(EUCOMM)Hmgu
(C57BL/6N-Clutm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Cluhtm1.1Eir/Cluhtm1.1Eir
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL) 		decreased fasting circulating glucose level J:249661
hypoglycemia J:249661
Cluhtm1.2Eir/Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL) 		decreased fasting circulating glucose level J:249661
Clvs1tm1.1(KOMP)Vlcg/Clvs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Clvs1tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Cnot3em1(IMPC)Rbrc/Cnot3+
(C57BL/6NJcl-Cnot3em1(IMPC)Rbrc/Rbrc) 		improved glucose tolerance J:211773
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya) 		decreased circulating glucose level J:180033
decreased fasting circulating glucose level J:180033
improved glucose tolerance J:180033
increased insulin sensitivity J:180033
Cnot3tm1.1Tya/Cnot3+
Lepob/Lepob
(involves: 129P2/OlaHsd * C57BL/6J) 		improved glucose tolerance J:180033
increased insulin sensitivity J:180033
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya) 		abnormal circulating glucose level J:274297
abnormal circulating insulin level J:274297
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating insulin level J:93697
increased insulin sensitivity J:93697
Cog3tm1b(EUCOMM)Hmgu/Cog3+
(C57BL/6N-Cog3tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating insulin level J:211773
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased circulating glucose level J:166568
decreased circulating insulin level J:166568
improved glucose tolerance J:166568, J:177113
increased insulin sensitivity J:166568, J:177113
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		decreased liver glycogen level J:174049
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		decreased circulating glucose level J:217463
Col1a1tm2(CAG-IDH2*R172K)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6) 		increased cardiac muscle glycogen level J:209629
increased skeletal muscle glycogen level J:209629
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased circulating glucose level J:211215
decreased circulating insulin level J:211215
decreased insulin secretion J:211215
improved glucose tolerance J:211215
increased insulin sensitivity J:211215
Col1a1tm2(tetO-LIN28B)Gqda/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		hypoglycemia J:177113
improved glucose tolerance J:177113
increased insulin sensitivity J:177113
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6) 		increased skeletal muscle glycogen level J:209629
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		impaired glucose tolerance J:210545
insulin resistance J:210545
Col1a1tm3(tetO-Mirlet7g/Mir21)Gqda/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		impaired glucose tolerance J:177113
increased circulating glucose level J:177113
increased circulating insulin level J:177113
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm) 		impaired glucose tolerance J:211773
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal glucose homeostasis J:171817
decreased circulating insulin level J:171817
decreased insulin secretion J:171817
hyperglycemia J:171817
impaired glucose tolerance J:171817
insulin resistance J:171817
Col6a1tm1Sngi/Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi) 		impaired glucose tolerance J:278926
Col14a1tm1b(KOMP)Wtsi/Col14a1tm1b(KOMP)Wtsi
(C57BL/6N-Col14a1tm1b(KOMP)Wtsi/Bay) 		impaired glucose tolerance J:211773
Col18a1tm1.1(KOMP)Vlcg/Col18a1tm1.1(KOMP)Vlcg
(B6N(Cg)-Col18a1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
Cops7atm1b(KOMP)Mbp/Cops7atm1b(KOMP)Mbp
(C57BL/6N-Cops7atm1b(KOMP)Mbp/Ucd) 		improved glucose tolerance J:211773
Coq6tm1b(EUCOMM)Hmgu/Coq6+
(C57BL/6N-Coq6tm1b(EUCOMM)Hmgu/Ics) 		increased fasting circulating glucose level J:211773
Coq8btm1b(EUCOMM)Hmgu/Coq8b+
(B6N(Cg)-Coq8btm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Corttm1Ldl/Corttm1Ldl
(involves: C57BL/6J) 		increased circulating glucose level J:179095
insulin resistance J:179095
Cox4i2tm1Hutt/Cox4i2tm1Hutt
(B6.129-Cox4i2tm1Hutt) 		improved glucose tolerance J:187640
Cox7ctm1b(KOMP)Mbp/Cox7c+
(B6N(Cg)-Cox7ctm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Cpb1tm1.1(KOMP)Vlcg/Cpb1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cpb1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Cpdem1(IMPC)J/Cpd+
(C57BL/6NJ-Cpdem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Cpefat/Cpefat
(involves: HRS/J) 		hyperglycemia J:10872
hypoglycemia J:13651
increased circulating insulin level J:13651, J:10872
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J) 		hyperglycemia J:10872
increased circulating insulin level J:24436, J:10872
Cpefat/Cpefat
Find1HRS/J/Find1HRS/J
(involves: C57BLKS/J * HRS/J) 		increased circulating glucose level J:100832
Cpefat/Cpefat
Find2C57BLKS/J/Find2C57BLKS/J
(involves: C57BLKS/J * HRS/J) 		decreased circulating insulin level J:100832
increased circulating glucose level J:100832
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
(C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:95741
impaired glucose tolerance J:95741
increased circulating glucose level J:95741
increased circulating insulin level J:95741
insulin resistance J:95741
Cpmem1(IMPC)Ccpcz/Cpmem1(IMPC)Ccpcz
(C57BL/6NCrl-Cpmem1(IMPC)Ccpcz/Ccpcz) 		increased circulating glucose level J:211773
Cpt1atm1Pwo/Cpt1a+
(either: 129S6/SvEvTac-Cpt1atm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac)) 		decreased circulating glucose level J:101934
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J) 		enhanced gluconeogenesis J:148205
increased circulating glucose level J:148205
increased circulating insulin level J:148205
insulin resistance J:148205
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6) 		insulin resistance J:109455
Crattm1.1Pbrc/Crattm1.1Pbrc
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB) 		abnormal glucose homeostasis J:184778
impaired glucose tolerance J:184778
increased circulating glucose level J:184778
insulin resistance J:184778
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp) 		decreased circulating glucose level J:208570
decreased circulating insulin level J:208570
improved glucose tolerance J:208570
increased insulin sensitivity J:208570
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac) 		decreased circulating insulin level J:345514
decreased fasting circulating glucose level J:345514
improved glucose tolerance J:345514
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:75361
increased circulating insulin level J:75361
increased insulin sensitivity J:75361
Crebbptm1Few/Crebbp+
(Not Specified) 		abnormal glucose homeostasis J:91133
decreased circulating glucagon level J:91133
impaired glucose tolerance J:91133
increased circulating glucose level J:91133
increased circulating insulin level J:91133
increased liver glycogen level J:91133
insulin resistance J:91133
Crebbptm1Few/Crebbptm1Few
(Not Specified) 		abnormal glucose homeostasis J:91133
decreased circulating glucagon level J:91133
impaired glucose tolerance J:91133
increased circulating glucose level J:91133
increased circulating insulin level J:91133
increased liver glycogen level J:91133
Creg1em1Yal/Creg1em1Yal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal glucose homeostasis J:263073
decreased glycogen level J:263073
impaired glucose tolerance J:263073
increased circulating insulin level J:263073
increased fasting circulating glucose level J:263073
insulin resistance J:263073
Creg2em1(IMPC)J/Creg2em1(IMPC)J
(C57BL/6NJ-Creg2em1(IMPC)J/Mmjax) 		decreased fasting circulating glucose level J:211773
Creld2tm1.1Emass/Creld2tm1.1Emass
(B6.129P2(SJL)-Creld2tm1.1Emass) 		insulin resistance J:316411
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J) 		abnormal glucose homeostasis J:208708
hyperglycemia J:208708
impaired glucose tolerance J:208708
increased circulating glucagon level J:208708
increased circulating insulin level J:208708
increased urine glucose level J:208708
insulin resistance J:208708
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J) 		abnormal circulating glucose level J:23082
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating glucose level J:102987, J:105629
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:83683
increased insulin sensitivity J:83683
Crispld2tm1Lex/Crispld2tm1Lex
(B6;129S5-Crispld2tm1Lex/Mmucd) 		improved glucose tolerance J:171883
Crls1tm1Geno/Crls1tm1Geno
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		increased fasting circulating glucose level J:266083
insulin resistance J:266083
Crls1tm1Geno/Crls1tm1Geno
Tg(Ucp1-cre/ERT2)426Biat/0
(involves: C57BL/6N) 		insulin resistance J:266083
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:142448
impaired glucose tolerance J:142448
increased circulating insulin level J:142448
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N) 		abnormal glucose homeostasis J:151618
decreased glycogen level J:151618
Crtc2tm1Mmy/Crtc2tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:157556
decreased fasting circulating glucose level J:157556
decreased hepatic glucose production J:157556
impaired gluconeogenesis J:157556
increased insulin sensitivity J:157556
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:167211
decreased circulating insulin level J:167211
increased insulin sensitivity J:167211
Crxem1(IMPC)Ccpcz/Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Cry1em1(IMPC)H/Cry1em1(IMPC)H
(C57BL/6N-Cry1em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Asn/Cry2tm1Asn
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:128437
increased insulin sensitivity J:128437
Cstm1.1(KOMP)Wtsi/Cs+
(C57BL/6N-Cstm1.1(KOMP)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg) 		increased circulating glucose level J:145518
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating glucose level J:142440
decreased circulating insulin level J:142440
enhanced gluconeogenesis J:142440
Csf2tm1Mlg/Csf2tm1Mlg
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli) 		hyperglycemia J:145518
impaired glucose tolerance J:145518
Csmd1tm1Lex/Csmd1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6NTac) 		improved glucose tolerance J:209700
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg) 		increased circulating glucose level J:211773
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd) 		decreased circulating glucose level J:211773
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ) 		impaired glucose tolerance J:184220
insulin resistance J:184220
Ctbsem1(IMPC)J/Ctbsem1(IMPC)J
(C57BL/6NJ-Ctbsem1(IMPC)J/J) 		impaired glucose tolerance J:211773
Ctdspltm1.1(KOMP)Mbp/Ctdspltm1.1(KOMP)Mbp
(C57BL/6N-Ctdspltm1.1(KOMP)Mbp/Ucd) 		impaired glucose tolerance J:211773
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd) 		hyperglycemia J:176727
increased circulating insulin level J:176727
insulin resistance J:176727
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli) 		increased circulating glucose level J:192096
increased liver glycogen level J:192096
increased skeletal muscle glycogen level J:192096
insulin resistance J:192096
Ctifem1(IMPC)J/Ctifem1(IMPC)J
(C57BL/6NJ-Ctifem1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H) 		decreased circulating glucose level J:211773
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde) 		hyperglycemia J:153355
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde) 		hyperglycemia J:153355
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr) 		hyperglycemia J:153355
Ctsmtm1(KOMP)Wtsi/Ctsmtm1(KOMP)Wtsi
(C57BL/6N-Ctsmtm1(KOMP)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae) 		hyperglycemia J:153355
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae) 		hyperglycemia J:153355
Cul4atm1b(EUCOMM)Hmgu/Cul4atm1b(EUCOMM)Hmgu
(C57BL/6N-Cul4atm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Cxadrtm1Dvst/Cxadrtm1Dvst
(involves: 129X1/SvJ * C57BL/6) 		increased cardiac muscle glycogen level J:100174
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA) 		decreased circulating glucose level J:126841
decreased circulating insulin level J:126841
impaired glucose tolerance J:126841
improved glucose tolerance J:126841
increased insulin sensitivity J:126841
Cxcr1tm1a(EUCOMM)Wtsi/Cxcr1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr1tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Cxcr3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:101679
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN) 		abnormal glucose homeostasis J:91486
decreased circulating insulin level J:91486
decreased insulin secretion J:91486
impaired glucose tolerance J:91486
increased circulating glucose level J:91486
increased insulin sensitivity J:91486
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Cyb561a3tm2b(EUCOMM)Hmgu/Cyb561a3tm2b(EUCOMM)Hmgu
(C57BL/6N-Cyb561a3tm2b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Cybbtm1.1Abk/Cybbtm1.1Abk
Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk) 		decreased circulating insulin level J:245699
decreased fasting circulating glucose level J:245699
Cybc1tm1a(KOMP)Wtsi/Cybc1tm1a(KOMP)Wtsi
(C57BL/6N-Cybc1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Cyp4b1tm1b(KOMP)Wtsi/Cyp4b1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4b1tm1b(KOMP)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Cyp4f16tm1b(KOMP)Wtsi/Cyp4f16tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4f16tm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Cyp7b1tm1b(EUCOMM)Wtsi/Cyp7b1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7b1tm1b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating insulin level J:147610
impaired glucose tolerance J:147610
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac) 		abnormal glucose homeostasis J:65805
increased circulating insulin level J:65805
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J) 		impaired glucose tolerance J:82070
increased circulating glucose level J:82070
insulin resistance J:82070
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi) 		decreased circulating glucose level J:272118
decreased liver glycogen level J:272118
insulin resistance J:272118
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Daam2tm1a(KOMP)Wtsi/Daam2tm1a(KOMP)Wtsi
(C57BL/6N-Daam2tm1a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Dact3tm1b(KOMP)Wtsi/Dact3tm1b(KOMP)Wtsi
(C57BL/6N-Dact3tm1b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J) 		abnormal glucose homeostasis J:85772
decreased circulating glucagon level J:85772
decreased circulating glucose level J:85772
decreased glucagon secretion J:85772
increased circulating insulin level J:85772
insulin resistance J:85772
Dbil5tm1(KOMP)Wtsi/Dbil5tm1(KOMP)Wtsi
(C57BL/6N-Dbil5tm1(KOMP)Wtsi/Nju) 		increased circulating glucose level J:211773
Dbm1A/J/Dbm1A/J
Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc) 		increased circulating glucose level J:112869
increased circulating insulin level J:112869
Dbm2C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal glucose homeostasis J:112869
increased circulating glucose level J:112869
Dbm3C57BL/6J/?
Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc) 		abnormal circulating glucose level J:112869
Dbm4C57BL/6J/?
Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc) 		abnormal circulating glucose level J:112869
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6NCrl-Dbn1tm1b(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl) 		increased circulating glucose level J:211773
Dbsq3C3H/HeJ/Dbsq3C3H/HeJ
Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS) 		increased circulating glucose level J:116038
Dbsq3C57BLKS/J/Dbsq3C3H/HeJ
Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS) 		increased circulating glucose level J:116038
Dbsty1NZO/HlLt/Dbsty1NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
increased circulating insulin level J:65256
Dbsty1NZO/HlLt/Dbsty1NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
increased circulating insulin level J:65256
Dbsty3NON/ShiLtJ/Dbsty3NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		insulin resistance J:65256
Dbsty3NZO/HlLt/Dbsty3NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		insulin resistance J:65256
Dbsty4NZO/HlLt/Dbsty4NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
Dbsty4NZO/HlLt/Dbsty4NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
Dbts1SM/J/?
(involves: LG/J * SM/J) 		impaired glucose tolerance J:94605
Dbts2SM/J/?
(involves: LG/J * SM/J) 		impaired glucose tolerance J:94605
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Dcxtm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Dcxtm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Ddi2tm1b(EUCOMM)Hmgu/Ddi2+
(C57BL/6N-Ddi2tm1b(EUCOMM)Hmgu/Ccpcz) 		impaired glucose tolerance J:211773
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		impaired glucose tolerance J:214136
insulin resistance J:214136
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng) 		increased circulating glucose level J:134371
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh) 		decreased circulating glucose level J:151622
Defb20tm1b(EUCOMM)Hmgu/Defb20tm1b(EUCOMM)Hmgu
(C57BL/6N-Defb20tm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd) 		increased insulin sensitivity J:203554
Del(7)Tyrc-3H/Del(7)Tyrc-3H
(involves: 101/H * C3H/HeH) 		decreased circulating glucose level J:5063
hypoglycemia J:5063
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6) 		abnormal insulin secretion J:227939
improved glucose tolerance J:227939
increased circulating insulin level J:227939
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA) 		decreased circulating glucose level J:92536
increased circulating insulin level J:92536
increased insulin secretion J:92536
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj) 		decreased circulating glucose level J:199416
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Depdc5tm1b(EUCOMM)Hmgu/Depdc5+
(C57BL/6N-Depdc5tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Deptortm1.1Mala/Deptortm1.1Mala
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA) 		decreased fasting circulating glucose level J:275931
decreased liver glycogen level J:275931
increased insulin sensitivity J:275931
Derl2tm1.2Hpl/Derl2tm1.2Hpl
(involves: BALB/cJ) 		hypoglycemia J:170650
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating glucose level J:111346
improved glucose tolerance J:111346
increased insulin sensitivity J:61885
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver glycogen level J:88742
hypoglycemia J:88742
Dgcr2tm1b(EUCOMM)Wtsi/Dgcr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dgcr2tm1b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Dgkdem1(IMPC)H/Dgkd+
(C57BL/6NTac-Dgkdem1(IMPC)H/H) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		decreased circulating glucose level J:294620
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6) 		decreased circulating glucose level J:267178
improved glucose tolerance J:267178
increased circulating insulin level J:267178
increased insulin secretion J:267178
increased insulin sensitivity J:267178
increased liver glycogen level J:267178
Dhx29tm1.1(KOMP)Vlcg/Dhx29+
(C57BL/6N-Dhx29tm1.1(KOMP)Vlcg/J) 		impaired glucose tolerance J:211773
Dhx30tm1.1(KOMP)Vlcg/Dhx30+
(C57BL/6N-Dhx30tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Dibg1129S6/SvEvTac/Dibg1129S6/SvEvTac
(involves: 129S6/SvEvTac * C57BL/6) 		hyperglycemia J:142949
Dis3tm1e.1(EUCOMM)Hmgu/Dis3+
(C57BL/6N-Dis3tm1e.1(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Diwg1C57BL/6/Diwg1C57BL/6
(involves: 129S6/SvEvTac * C57BL/6) 		hyperglycemia J:142949
Dkk1tm1.1Svo/Dkk1tm1.2Svo
Pax8tm1.1(cre)Mbu/Pax8+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		decreased urine glucose level J:173125
Dlgap2em1(IMPC)Mhzh/Dlgap2em1(IMPC)Mhzh
(C57BL/6N-Dlgap2em1(IMPC)Mhzh/Mhzh) 		increased fasting circulating glucose level J:211773
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Dlk1em1(IMPC)Wtsi/Dlk1em1(IMPC)Wtsi
(C57BL/6N-Dlk1em1(IMPC)Wtsi/WtsiIeg) 		decreased circulating glucose level J:211773
Dmbx1tm1Sse/Dmbx1tm1Sse
Lepob/Lepob
(involves: ICR) 		abnormal circulating glucose level J:125193
Dmwdem1(IMPC)J/Dmwdem1(IMPC)J
(C57BL/6NJ-Dmwdem1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Dnaja4tm1b(KOMP)Wtsi/Dnaja4tm1b(KOMP)Wtsi
(C57BL/6N-Dnaja4tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Dnajb3tm1.1(KOMP)Vlcg/Dnajb3tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb3tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Dnajb7tm1.1(KOMP)Vlcg/Dnajb7tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb7tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg) 		decreased liver glycogen level J:226674
hypoglycemia J:226674
increased circulating glucagon level J:226674
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg) 		abnormal circulating glucose level J:226674
decreased circulating insulin level J:226674
decreased liver glycogen level J:226674
hypoglycemia J:226674
increased circulating glucagon level J:226674
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh) 		hyperglycemia J:98194
increased circulating insulin level J:98194
increased urine glucose level J:98194
Dnajc5gtm1.1(KOMP)Vlcg/Dnajc5g+
(C57BL/6N-Dnajc5gtm1.1(KOMP)Vlcg/J) 		increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg) 		abnormal glycogen homeostasis J:204025
increased glycogen level J:204025
increased kidney glycogen level J:204025
increased liver glycogen level J:204025
Dnajc15tm1b(KOMP)Wtsi/Dnajc15tm1b(KOMP)Wtsi
(C57BL/6N-Dnajc15tm1b(KOMP)Wtsi/Bay) 		increased circulating glucose level J:211773
Dnajc19tm1a(EUCOMM)Hmgu/Dnajc19tm1a(EUCOMM)Hmgu
(C57BL/6N-Dnajc19tm1a(EUCOMM)Hmgu/H) 		increased circulating glucose level J:165965
Dnajc30tm1.1(KOMP)Vlcg/Dnajc30tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajc30tm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Dok1tm1Yyam/Dok1tm1Yyam
(B6.129S4-Dok1tm1Yyam) 		decreased circulating insulin level J:133566
improved glucose tolerance J:133566
increased insulin sensitivity J:133566
Dpm2tm1b(EUCOMM)Hmgu/Dpm2+
(C57BL/6N-Dpm2tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Dpp4tm1b(EUCOMM)Wtsi/Dpp4tm1b(EUCOMM)Wtsi
(C57BL/6N-Dpp4tm1b(EUCOMM)Wtsi/Ics) 		improved glucose tolerance J:211773
Dpp4tm1Lex/Dpp4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J) 		improved glucose tolerance J:195941
Dpp4tm1Nwa/Dpp4tm1Nwa
(C57BL/6-Dpp4tm1Nwa) 		improved glucose tolerance J:62709
increased circulating glucagon level J:62709
increased circulating insulin level J:62709
increased insulin secretion J:62709
Dpp8em1(IMPC)J/Dpp8em1(IMPC)J
(C57BL/6NJ-Dpp8em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Draxintm1Lex/Draxintm1Lex
(B6;129S5-Draxintm1Lex/Mmucd) 		decreased circulating insulin level J:171883
Dsc3tm1b(EUCOMM)Wtsi/Dsc3+
(C57BL/6N-Dsc3tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Dspptm1.1(KOMP)Vlcg/Dspptm1.1(KOMP)Vlcg
(C57BL/6N-Dspptm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Dtnbp1tm1b(EUCOMM)Hmgu/Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Dtx1em1(IMPC)H/Dtx1em1(IMPC)H
(C57BL/6N-Dtx1em1(IMPC)H/H) 		increased circulating glucose level J:211773
Dtx4em1(IMPC)Ccpcz/Dtx4+
(C57BL/6N-Dtx4em1(IMPC)Ccpcz/Ccpcz) 		impaired glucose tolerance J:211773
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd) 		increased fasting circulating glucose level J:211773
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		increased hepatic glucose production J:129718
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Dusp4tm1a(EUCOMM)Wtsi/Dusp4tm1a(EUCOMM)Wtsi
(C57BL/6N-Dusp4tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Dusp8em1(IMPC)Mbp/Dusp8em1(IMPC)Mbp
(C57BL/6N-Dusp8em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Dusp26em1Jhxia/Dusp26em1Jhxia
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased liver glycogen level J:279111
impaired glucose tolerance J:279111
increased circulating glucose level J:279111
increased fasting circulating glucose level J:279111
insulin resistance J:279111
Dync1h1tm1dIcs/Dync1h1+
(C57BL/6N-Dync1h1tm1dIcs/Ics) 		impaired glucose tolerance J:211773
Dynll1tm1(KOMP)Wtsi/Dynll1+
(C57BL/6N-Dynll1tm1(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Dynlrb2tm1a(KOMP)Wtsi/Dynlrb2+
(C57BL/6N-Dynlrb2tm1a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating insulin level J:89720
decreased circulating glucose level J:89720
decreased circulating insulin level J:89720
decreased insulin secretion J:89720
impaired glucose tolerance J:89720
increased insulin sensitivity J:89720
E2f3tm1b(KOMP)Wtsi/E2f3+
(C57BL/6N-E2f3tm1b(KOMP)Wtsi/Kmpc) 		impaired glucose tolerance J:211773
Edn2tm1.1Nat/Edn2tm1.1Nat
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased circulating glucose level J:201436
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac) 		decreased circulating glucose level J:201436
Eef2kmttm1b(EUCOMM)Wtsi/Eef2kmttm1b(EUCOMM)Wtsi
(C57BL/6N-Eef2kmttm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Efna4tm1.1(KOMP)Vlcg/Efna4tm1.1(KOMP)Vlcg
(C57BL/6N-Efna4tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Efna5tm1b(EUCOMM)Wtsi/Efna5tm1b(EUCOMM)Wtsi
(C57BL/6N-Efna5tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd) 		impaired glucose tolerance J:211773
Egfem1em1(IMPC)J/Egfem1em1(IMPC)J
(C57BL/6NJ-Egfem1em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Ehfem1(IMPC)Kmpc/Ehfem1(IMPC)Kmpc
(C57BL/6NTac-Ehfem1(IMPC)Kmpc/Kmpc) 		decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ) 		impaired glucose tolerance J:207678
increased circulating glucose level J:207678
increased circulating insulin level J:207678
insulin resistance J:207678
Eid2bem1(IMPC)J/Eid2b+
(C57BL/6NJ-Eid2bem1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac) 		abnormal insulin secretion J:76661
decreased circulating insulin level J:76661
hyperglycemia J:76661
impaired glucose tolerance J:76661
increased liver glycogen level J:76661
Eif2ak3tm1Dron/Eif2ak3+
(either: 129S6/SvEvTac-Eif2ak3tm1Dron or (involves: 129S6/SvEvTac * C57BL/6)) 		impaired glucose tolerance J:70005
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster) 		decreased circulating insulin level J:70005
hyperglycemia J:70005
Eif2b5tm1a(EUCOMM)Wtsi/Eif2b5+
(C57BL/6N-Eif2b5tm1a(EUCOMM)Wtsi/Ics) 		decreased circulating glucose level J:165965
Eif2s1tm1Rjk/Eif2s1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ) 		decreased circulating insulin level J:70004
decreased insulin secretion J:70004
hypoglycemia J:70004
Eif2s1tm1Rjk/Eif2s1tm1Rjk
Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd) 		hypoglycemia J:144954
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * BALB/c) 		hypoglycemia J:72217
Eif4g1em1(IMPC)Hmgu/Eif4g1+
(C57BL/6NCrl-Eif4g1em1(IMPC)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Eif4g2tm1b(KOMP)Wtsi/Eif4g2+
(C57BL/6N-Eif4g2tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Elapor1tm1b(EUCOMM)Hmgu/Elapor1+
(C57BL/6N-Elapor1tm1b(EUCOMM)Hmgu/Ics) 		increased circulating glucose level J:211773
Elk1tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Elk1tm1.1(KOMP)Vlcg/J) 		increased circulating insulin level J:211773
Elmo1tm1a(EUCOMM)Wtsi/Elmo1tm1a(EUCOMM)Wtsi
(C57BL/6N-Elmo1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H) 		decreased circulating glucose level J:165965
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:130031
improved glucose tolerance J:130031
increased insulin sensitivity J:130031
ElptC57BL/6J/ElptC57BL/6J
HypnC57BL/6/HypnC57BL/6
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos) 		increased circulating insulin level J:83539
Emc4tm1(KOMP)Wtsi/Emc4+
(C57BL/6N-Emc4tm1(KOMP)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Emc10Gt(OST181617)Lex/Emc10Gt(OST181617)Lex
(B6;129S5-Emc10Gt(OST181617)Lex/Mmucd) 		improved glucose tolerance J:171883
Emc10tm1b(EUCOMM)Wtsi/Emc10tm1b(EUCOMM)Wtsi
(C57BL/6N-Emc10tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Eml1em1(IMPC)Wtsi/Eml1em1(IMPC)Wtsi
(C57BL/6N-Eml1em1(IMPC)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Emsyem1(IMPC)Ccpcz/Emsy+
(C57BL/6NCrl-Emsyem1(IMPC)Ccpcz/Ccpcz) 		impaired glucose tolerance J:211773
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl) 		impaired glucose tolerance J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl) 		impaired glucose tolerance J:225402
increased circulating insulin level J:225402
increased fasting circulating glucose level J:225402
insulin resistance J:225402
Eno3em1(IMPC)Bay/Eno3+
(C57BL/6N-Eno3em1(IMPC)Bay/BayMmucd) 		impaired glucose tolerance J:211773
Enpp5tm1b(KOMP)Mbp/Enpp5tm1b(KOMP)Mbp
(C57BL/6N-Enpp5tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg) 		abnormal glucose homeostasis J:165965
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		hypoglycemia J:163795
Epb41l4atm1b(KOMP)Mbp/Epb41l4atm1b(KOMP)Mbp
(C57BL/6N-Epb41l4atm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H) 		decreased circulating glucose level J:211773
epi/?
(involves: CBA/J) 		decreased circulating glucose level J:5421
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		hypoglycemia J:173769
improved glucose tolerance J:173769
increased cardiac muscle glycogen level J:173769
increased insulin sensitivity J:173769
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal gluconeogenesis J:204966
abnormal glucose homeostasis J:204966
abnormal glycogen homeostasis J:204966
decreased circulating glucose level J:204966
decreased liver glycogen level J:204966
improved glucose tolerance J:204966
Eprs1tm1.1Xen/Eprs1tm1.1Xen
(C57BL/6-Eprs1tm1.1Xen) 		impaired glucose tolerance J:244749
increased insulin sensitivity J:244749
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased circulating glucose level J:117488
decreased circulating insulin level J:117488
Ercc5tm2b(EUCOMM)Hmgu/Ercc5+
(C57BL/6N-Ercc5tm2b(EUCOMM)Hmgu/Bay) 		increased fasting circulating glucose level J:211773
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh) 		hypoglycemia J:122013
increased liver glycogen level J:122013
Ern1tm1Dron/Ern1+
(129S.129S6-Ern1tm1Dron) 		abnormal glucose homeostasis J:132805
Ero1aGt(XST171)Byg/Ero1aGt(XST171)Byg
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		impaired glucose tolerance J:158805
Ero1bGt(P077G11)Wrst/Ero1b+
(involves: 129S2/SvPas * C57BL/6) 		abnormal glucose homeostasis J:158805
decreased insulin secretion J:158805
impaired glucose tolerance J:158805
increased circulating glucose level J:158805
Ero1bGt(P077G11)Wrst/Ero1b+
Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc) 		decreased insulin secretion J:158805
impaired glucose tolerance J:158805
increased circulating glucose level J:158805
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		abnormal glucose homeostasis J:158805
decreased insulin secretion J:158805
impaired glucose tolerance J:158805
increased circulating glucose level J:158805
Esr1tm1.1Gust/Esr1tm1.1Gust
(B6.129X1-Esr1tm1.1Gust) 		increased circulating glucose level J:186230
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		insulin resistance J:66077
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd) 		impaired glucose tolerance J:151012
increased circulating glucose level J:151012
insulin resistance J:151012
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Esr1tm1Ksk) 		impaired glucose tolerance J:65806
insulin resistance J:65806
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		insulin resistance J:66077
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd) 		decreased circulating glucose level J:151012
decreased insulin secretion J:151012
increased circulating glucose level J:151012
increased insulin sensitivity J:151012
Evi5tm1a(KOMP)Wtsi/Evi5tm1a(KOMP)Wtsi
(C57BL/6N-Evi5tm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Evltm1b(KOMP)Wtsi/Evltm1b(KOMP)Wtsi
(C57BL/6N-Evltm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Exoc3tm2b(EUCOMM)Hmgu/Exoc3+
(C57BL/6N-Exoc3tm2b(EUCOMM)Hmgu/Wtsi) 		decreased fasting circulating glucose level J:211773
Exoc3l2em1(IMPC)J/Exoc3l2+
(C57BL/6N-Exoc3l2em1(IMPC)J/J) 		impaired glucose tolerance J:211773
Exoc6bem1(IMPC)Hmgu/Exoc6b+
(C57BL/6NCrl-Exoc6bem1(IMPC)Hmgu/Ieg) 		decreased circulating glucose level J:211773
Exosc3tm1.1(KOMP)Vlcg/Exosc3+
(C57BL/6N-Exosc3tm1.1(KOMP)Vlcg/Ucd) 		increased fasting circulating glucose level J:211773
Extl3tm1.1Okam/Extl3tm1Okam
Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR) 		decreased circulating insulin level J:148348
decreased insulin secretion J:148348
impaired glucose tolerance J:148348
Ezh1tm1b(EUCOMM)Wtsi/Ezh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ezh1tm1b(EUCOMM)Wtsi/Nju) 		increased circulating glucose level J:211773
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:130781
improved glucose tolerance J:130781
Faahem1(IMPC)H/Faahem1(IMPC)H
(C57BL/6NTac-Faahem1(IMPC)H/H) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Fabp1tm1Bin/Fabp1tm1Bin
(involves: 129/Ola * C57BL/6) 		abnormal glucose homeostasis J:83875
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:87278
decreased circulating insulin level J:87278
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto) 		increased circulating insulin level J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:167535
decreased circulating glucose level J:167535
decreased liver glycogen level J:167535
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c) 		hypoglycemia J:54614
Fabp3tm1Jshr/Fabp3+
(B6.129-Fabp3tm1Jshr) 		decreased circulating glucose level J:102858
increased insulin sensitivity J:102858
Fabp4tm1Brsp/Fabp4tm1Brsp
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal glucose homeostasis J:37027
decreased circulating insulin level J:57864
hypoglycemia J:37027
insulin resistance J:37027
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota) 		decreased circulating glucose level J:111878
increased insulin sensitivity J:111878
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		decreased circulating glucose level J:217245
decreased glycogen level J:217245
decreased skeletal muscle glycogen level J:217245
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob) 		abnormal gluconeogenesis J:111878
abnormal glucose homeostasis J:111878
abnormal glycogen homeostasis J:111878
decreased circulating glucose level J:111878
decreased circulating insulin level J:111878
improved glucose tolerance J:111878
increased insulin sensitivity J:111878
Fabp4tm1Brsp/Fabp4tm1Brsp
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Lepob) 		improved glucose tolerance J:111878
increased insulin sensitivity J:111878
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota) 		decreased circulating glucose level J:81609
improved glucose tolerance J:81609
increased insulin sensitivity J:81609
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(involves: 129 * C57BL/6J * C57BL/10J * SJL) 		decreased circulating glucose level J:81609
improved glucose tolerance J:81609
increased circulating insulin level J:81609
increased insulin sensitivity J:81609
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp5tm1Hota Lepob) 		improved glucose tolerance J:111878
increased insulin sensitivity J:111878
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Faf1em1(IMPC)H/Faf1em1(IMPC)H
(C57BL/6NTac-Faf1em1(IMPC)H/H) 		decreased circulating glucose level J:211773
Fahtm1Mgo/Fahtm1Mgo
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		hypoglycemia J:16046
Fam3btm1Bkht/Fam3btm1Bkht
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal glucose homeostasis J:167823
abnormal insulin clearance J:167823
decreased insulin secretion J:167823
impaired glucose tolerance J:167823
increased circulating insulin level J:167823
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi) 		impaired glucose tolerance J:258290
insulin resistance J:258290
Fam83aem1(IMPC)J/Fam83aem1(IMPC)J
(C57BL/6NJ-Fam83aem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Fam83dem1(IMPC)Ccpcz/Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Fam184btm2b(EUCOMM)Wtsi/Fam184btm2b(EUCOMM)Wtsi
(C57BL/6N-Fam184btm2b(EUCOMM)Wtsi/Tcp) 		increased circulating glucose level J:211773
Fam186btm1b(KOMP)Mbp/Fam186btm1b(KOMP)Mbp
(C57BL/6N-Fam186btm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Fam217btm1.1(KOMP)Vlcg/Fam217btm1.1(KOMP)Vlcg
(C57BL/6N-Fam217btm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Fam221aem1(IMPC)Ccpcz/Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz) 		increased circulating glucose level J:211773
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Farp1tm1b(EUCOMM)Hmgu/Farp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Farp1tm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Farsatm2a(EUCOMM)Wtsi/Farsa+
(C57BL/6N-Farsatm2a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating glucose level J:127793
decreased circulating insulin level J:127793
increased circulating glucagon level J:127793
Fasntm1Sem/Fasntm1Sem
Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		increased circulating glucose level J:127482
increased circulating insulin level J:127482
Fastktm1.1(KOMP)Vlcg/Fastktm1.1(KOMP)Vlcg
(C57BL/6N-Fastktm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Fastkd5em1(IMPC)J/Fastkd5em1(IMPC)J
(C57BL/6NJ-Fastkd5em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Fbgl1KK/Ta/Fbgl1KK/Ta
(involves: BALB/c * KK/Ta) 		hyperglycemia J:88209
Fbgl2KK/Ta/Fbgl2KK/Ta
(involves: BALB/c * KK/Ta) 		hyperglycemia J:88209
Fbp1m1Btlr/Fbp1m1Btlr
(C57BL/6J-Fbp1m1Btlr) 		hypoglycemia J:267693
Fbxl9em1(IMPC)Bay/Fbxl9em1(IMPC)Bay
(C57BL/6N-Fbxl9em1(IMPC)Bay/BayMmucd) 		impaired glucose tolerance J:211773
Fbxl19tm1b(EUCOMM)Wtsi/Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju) 		decreased circulating glucose level J:211773
Fbxo2tm1b(EUCOMM)Wtsi/Fbxo2tm1b(EUCOMM)Wtsi
(C57BL/6N-Fbxo2tm1b(EUCOMM)Wtsi/Nju) 		decreased fasting circulating glucose level J:211773
increased circulating glucose level J:211773
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju) 		decreased circulating glucose level J:211773
Fbxo11tm2b(EUCOMM)Wtsi/Fbxo11+
(C57BL/6N-Fbxo11tm2b(EUCOMM)Wtsi/H) 		increased fasting circulating glucose level J:211773
Fbxo30tm1b(KOMP)Wtsi/Fbxo30+
(C57BL/6N-Fbxo30tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Fcortm1Jnak/Fcortm1Jnak
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		impaired glucose tolerance J:184684
insulin resistance J:184684
Fem1btm1Jfma/Fem1btm1Jfma
(involves: 129X1/SvJ * C57BL/6) 		decreased insulin secretion J:100017
impaired glucose tolerance J:100017
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating insulin level J:141957
decreased circulating glucagon level J:141957
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified) 		abnormal gluconeogenesis J:129843
decreased circulating insulin level J:129843
decreased insulin secretion J:129843
improved glucose tolerance J:129843
increased insulin sensitivity J:129843
Ffar1tm1Lex/Ffar1tm1Lex
(involves: 129 * C57BL/6) 		decreased insulin secretion J:122092
Ffar1tm1Lex/Ffar1tm1Lex
(involves: C57BL/6 * C57BL/6J) 		abnormal glucagon secretion J:200805
increased circulating glucose level J:200805
Ffar2tm1Fmgb/Ffar2tm1Fmgb
(involves: 129S/SvEv) 		decreased circulating insulin level J:191508
impaired glucose tolerance J:191508
Ffar2tm1Soff/Ffar2tm1Soff
(B6.129-Ffar2tm1Soff) 		increased circulating insulin level J:227939
Ffar2tm2Soff/Ffar2tm2Soff
Ffar3tm2.1Soff/Ffar3tm2.1Soff
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal insulin secretion J:227939
improved glucose tolerance J:227939
increased circulating insulin level J:227939
Ffar3tm1Fmgb/Ffar3tm1Fmgb
(involves: 129S/SvEv) 		impaired glucose tolerance J:191508
Ffar3tm1Soff/Ffar3tm1Soff
(B6.129-Ffar3tm1Soff) 		increased circulating insulin level J:227939
Ffar4tm1.1Mbj/Ffar4tm1.1Mbj
(involves: C57BL/6) 		abnormal insulin secretion J:211675
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:182599
increased circulating glucose level J:182599
increased circulating insulin level J:182599
insulin resistance J:182599
Fgbtm1.1(KOMP)Vlcg/Fgbtm1.1(KOMP)Vlcg
(C57BL/6N-Fgbtm1.1(KOMP)Vlcg/Ucd) 		impaired glucose tolerance J:211773
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd) 		decreased circulating glucose level J:211773
Fgf21tm1.1Djm/Fgf21tm1.1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal gluconeogenesis J:150831
decreased circulating glucose level J:150831
hypoglycemia J:150831
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf) 		abnormal glucose homeostasis J:157309
impaired glucose tolerance J:157309
increased circulating glucose level J:157309
increased circulating insulin level J:157309
increased liver glycogen level J:157309
Fgf23tm1Blan/Fgf23tm1Blan
(involves: 129/Sv * C57BL/6) 		decreased circulating insulin level J:121006
hypoglycemia J:121006
improved glucose tolerance J:121006
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA) 		hypoglycemia J:88172
Fgfr2tm2.3Dsn/Fgfr2+
(involves: 129 * C57BL/6 * FVB/N) 		hypoglycemia J:72517
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal gluconeogenesis J:199844
hyperglycemia J:199844
impaired glucose tolerance J:199844
Fglu2KK/?
(involves: C57BL/6J * KK-Ay) 		hyperglycemia J:81517
FgluKK/TaJcl/FgluKK/TaJcl
(involves: C57BL/6Jcl * KK.B6-Ay/Jcl) 		hyperglycemia J:51880
Fhip1bem1(IMPC)Tcp/Fhip1bem1(IMPC)Tcp
(C57BL/6NCrl-Fhip1bem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Fhip2aem1(IMPC)J/Fhip2aem1(IMPC)J
(C57BL/6NJ-Fhip2aem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:212437
increased circulating insulin level J:212437
insulin resistance J:212437
Fkbp1btm1.1Okam/Fkbp1btm1.1Okam
(ICR.129-Fkbp1btm1.1Okam) 		decreased insulin secretion J:136192
impaired glucose tolerance J:136192
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe) 		abnormal glucose homeostasis J:223365
decreased circulating glucose level J:223365
decreased fasting circulating glucose level J:223365
Fndc4tm1.1(KOMP)Vlcg/Fndc4tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc4tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1) 		increased liver glycogen level J:187318
Fnip1m1Btlr/Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr) 		increased cardiac muscle glycogen level J:234285
Focadem1(IMPC)Bay/Focad+
(C57BL/6N-Focadem1(IMPC)Bay/BayMmucd) 		improved glucose tolerance J:211773
Fosl2tm2Wag/Fosl2tm2Wag
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased circulating glucose level J:211215
impaired glucose tolerance J:211215
insulin resistance J:211215
Foxa1tm1Gsc/Foxa1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating insulin level J:53312
decreased circulating glucagon level J:53312
hypoglycemia J:53312
Foxa1tm1Khk/Foxa1tm1Khk
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL) 		hyperglycemia J:143476
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified) 		abnormal glucose homeostasis J:57493
decreased circulating glucagon level J:57493
decreased circulating insulin level J:57493
decreased insulin secretion J:57493
hypoglycemia J:57493
impaired glucose tolerance J:57493
Foxa2tm1.1Stf/Foxa2tm1.1Stf
Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln) 		decreased circulating glucose level J:155391
decreased circulating insulin level J:155391
improved glucose tolerance J:155391
increased insulin sensitivity J:155391
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:95662
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		abnormal insulin secretion J:70409
decreased circulating glucagon level J:70409
hypoglycemia J:70409
increased circulating insulin level J:70409
increased glycogen level J:70409
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		decreased circulating glucagon level J:96332
hypoglycemia J:96332
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk) 		decreased fasting circulating glucose level J:72595
decreased hepatic glucose production J:72595
increased insulin sensitivity J:216477
Foxi2tm1.1(KOMP)Vlcg/Foxi2tm1.1(KOMP)Vlcg
(C57BL/6N-Foxi2tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Foxm1tm1Rhc/Foxm1tm1Rhc
Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal glucose homeostasis J:111026
abnormal insulin secretion J:111026
impaired glucose tolerance J:111026
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J) 		abnormal glucose homeostasis J:215526
decreased circulating insulin level J:215526
decreased insulin secretion J:215526
hyperglycemia J:215526
impaired glucose tolerance J:215526
Foxo1tm1Rdp/Foxo1tm1Rdp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA * FVB) 		improved glucose tolerance J:137845
Foxo1tm1Whb/Foxo1+
(Not Specified) 		decreased liver glycogen level J:79560
Foxo1tm1Whb/Foxo1+
Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating glucose level J:79560
Foxo1tm1Whb/Foxo1+
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased circulating glucose level J:109010
increased circulating insulin level J:109010
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified) 		abnormal gluconeogenesis J:179687
abnormal glucose homeostasis J:179687
increased circulating glucose level J:179687
increased circulating insulin level J:179687
insulin resistance J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
Insrtm1Dac/Insr+
(involves: 129S4/SvJae * C57BL/6) 		increased circulating insulin level J:179687
insulin resistance J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
Leprdb/Leprdb
(B6.Cg-Foxo1tm2.1Dac Leprdb) 		impaired glucose tolerance J:179687
increased circulating insulin level J:179687
Foxo3tm1.1(KOMP)Vlcg/Foxo3tm1.1(KOMP)Vlcg
(C57BL/6N-Foxo3tm1.1(KOMP)Vlcg/J) 		impaired glucose tolerance J:211773
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		impaired glucose tolerance J:118179, J:84269
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg) 		abnormal gluconeogenesis J:236585
decreased circulating glucose level J:236585
decreased circulating insulin level J:236585
decreased fasting circulating glucose level J:236585
improved glucose tolerance J:236585
increased insulin sensitivity J:236585
FpliC57BL/6J/?
(involves: C57BL/6J * KK-Ay) 		increased circulating insulin level J:81517
Fshrtm1(KOMP)Vlcg/Fshrtm1(KOMP)Vlcg
(C57BL/6N-Fshrtm1(KOMP)Vlcg/Nju) 		increased fasting circulating glucose level J:211773
Fstl1tm1.1Ning/Fstl1tm1.1Ning
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		increased glycogen level J:171347
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased liver glycogen level J:119526
improved glucose tolerance J:119526
increased circulating insulin level J:119526
increased insulin sensitivity J:119526
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J) 		decreased circulating insulin level J:152163
increased circulating glucagon level J:152163
increased circulating glucose level J:152163
Ftotm1.2Rdc/Ftotm1.2Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		improved glucose tolerance J:194922
Ftotm1Urt/Ftotm1Urt
Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		insulin resistance J:219118
Fzd3tm1b(EUCOMM)Hmgu/Fzd3+
(C57BL/6N-Fzd3tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased circulating insulin level J:209000
improved glucose tolerance J:209000
increased insulin sensitivity J:209000
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd) 		improved glucose tolerance J:219653
increased insulin sensitivity J:219653
G6pc1em1Jyc/G6pc1em1Jyc
(involves: 129S4/SvJae * C57BL/6) 		hypoglycemia J:320697
increased liver glycogen level J:320697
G6pc1tm1.1Ics/G6pc1tm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J) 		increased liver glycogen level J:195257
G6pc1tm1.1Ics/G6pc1tm1.1Ics
Tg(Kap-icre)29066/2Sig/0
(involves: 129S2/SvPas * C57BL/6J * SJL) 		increased kidney glycogen level J:238264
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae) 		abnormal glucose homeostasis J:33212
decreased circulating glucose level J:33212
increased kidney glycogen level J:33212
increased liver glycogen level J:33212
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		hypoglycemia J:155990
increased kidney glycogen level J:155990
increased liver glycogen level J:155990
G6pc2tm1Lex/G6pc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating glucose level J:141593
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating glucagon level J:117664
Gaatm1.1Rabn/Gaatm1.1Rabn
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased brain glycogen level J:76435
increased cardiac muscle glycogen level J:76435, J:48839
increased skeletal muscle glycogen level J:76435, J:48839
Gaatm1Rabn/Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6) 		increased brain glycogen level J:76435
increased cardiac muscle glycogen level J:235790, J:76435, J:48839
increased liver glycogen level J:235790
increased skeletal muscle glycogen level J:235790, J:48839, J:73924
Gaatm1Rabn/Gaatm1Rabn
Stbd1tm1Bsn/Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6) 		increased cardiac muscle glycogen level J:235790
increased liver glycogen level J:235790
increased skeletal muscle glycogen level J:235790
Gaatm1Rabn/Gaatm1Rabn
Tg(CMV-GAA*P545L)#Kjv/0
(involves: 129X1/SvJ * C57BL/6) 		increased glycogen level J:219022
increased skeletal muscle glycogen level J:219022
Gaatm1Vdp/Gaatm1Vdp
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB)) 		abnormal glycogen homeostasis J:45386
Gaatm2Rabn/Gaatm2Rabn
(involves: 129X1/SvJ * C57BL/6) 		increased brain glycogen level J:76435
increased cardiac muscle glycogen level J:76435
increased skeletal muscle glycogen level J:76435
Gab1tm1Gsf/Gab1tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:98318
decreased circulating glucose level J:98318
decreased circulating insulin level J:98318
decreased glycogen level J:98318
improved glucose tolerance J:98318
increased insulin sensitivity J:98318
Gabra2em1(IMPC)H/Gabra2em1(IMPC)H
(C57BL/6N-Gabra2em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Gad2tm1b(EUCOMM)Wtsi/Gad2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gad2tm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya) 		increased circulating glucose level J:88785
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong
Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		decreased insulin secretion J:220742
impaired glucose tolerance J:220742
Gaktm2Legr/Gaktm2Legr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased liver glycogen level J:180119
Gal3st1em1(IMPC)Rbrc/Gal3st1em1(IMPC)Rbrc
(C57BL/6NJcl-Gal3st1em1(IMPC)Rbrc/Rbrc) 		improved glucose tolerance J:211773
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		abnormal circulating insulin level J:105628
decreased insulin secretion J:105628
Gasttm1(INS)Ez/Gast+
(involves: 129S4/SvJae * C57BL/6) 		abnormal insulin secretion J:99270
improved glucose tolerance J:99270
increased circulating insulin level J:99270
Gasttm1(INS)Ez/Gast+
Ins2Akita/Ins2+
(involves: 129S4/SvJae * C57BL/6NSlc) 		abnormal circulating glucose level J:99270
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb) 		abnormal gluconeogenesis J:191142
abnormal glucose homeostasis J:191142
decreased circulating glucose level J:191142
decreased circulating insulin level J:191142
improved glucose tolerance J:191142
GaucKK/?
(involves: C57BL/6J * KK-Ay) 		impaired glucose tolerance J:81517
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty) 		decreased cardiac muscle glycogen level J:167233
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:176889
decreased liver glycogen level J:176889
decreased skeletal muscle glycogen level J:176889
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd) 		abnormal glucose tolerance J:176889
decreased circulating glucose level J:176889
decreased glycogen catabolism rate J:176889
increased liver glycogen level J:176889
increased skeletal muscle glycogen level J:176889
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:226481
abnormal muscle glycogen level J:226481
decreased fasting circulating glucose level J:226481
increased brain glycogen level J:226481
increased glycogen level J:226481
increased liver glycogen level J:226481
Gbe1tm2Hoa/Gbe1tm2Hoa
(involves: 129S7/SvEvBrd) 		abnormal muscle glycogen level J:226481
increased brain glycogen level J:226481
increased glycogen level J:226481
increased liver glycogen level J:226481
Gbp2tm1b(KOMP)Wtsi/Gbp2tm1b(KOMP)Wtsi
(C57BL/6N-Gbp2tm1b(KOMP)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Gctm1.1(KOMP)Vlcg/Gctm1.1(KOMP)Vlcg
(C57BL/6N-Gctm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Gcgtm1Yhys/Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys) 		decreased circulating insulin level J:154694
improved glucose tolerance J:154694
increased circulating glucose level J:154694
increased insulin sensitivity J:154694
Gcgrem1Tshu/Gcgrem1Tshu
(involves: C57BL/6J) 		decreased fasting circulating glucose level J:279017
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		decreased fasting circulating glucose level J:300368
improved glucose tolerance J:300368
increased circulating glucagon level J:300368
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd) 		decreased circulating insulin level J:211773
decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		decreased circulating glucose level J:176507
decreased circulating insulin level J:176507
increased circulating glucagon level J:176507, J:73926
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL) 		decreased circulating glucose level J:81772
decreased circulating insulin level J:251829
hypoglycemia J:251829, J:81772
improved glucose tolerance J:81772
increased circulating glucagon level J:251829, J:81772
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL) 		decreased circulating insulin level J:208604
improved glucose tolerance J:208604
increased circulating glucagon level J:208604
increased glucagon secretion J:208604
increased insulin sensitivity J:208604
Gcgrtm1Mjch/Gcgrtm1Mjch
Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL) 		decreased circulating insulin level J:251829
hypoglycemia J:251829
increased circulating glucagon level J:251829
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		abnormal glucose homeostasis J:208604
decreased circulating glucose level J:208604
decreased circulating insulin level J:208604
hypoglycemia J:208604
improved glucose tolerance J:208604
increased circulating glucagon level J:208604
increased insulin sensitivity J:208604
Gckem1(IMPC)H/Gck+
(C57BL/6NTac-Gckem1(IMPC)H/H) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
GckGena348/Gck+
(involves: BALB/c * C3H/He) 		hyperglycemia J:82809, J:79719, J:90389
impaired glucose tolerance J:90389
GckGena348/GckGena348
(involves: BALB/c * C3H/He) 		hyperglycemia J:90389
impaired glucose tolerance J:90389
GckGls006/Gck+
(C3HeB/FeJ-GckGls006) 		decreased circulating insulin level J:189544
decreased insulin secretion J:189544
hyperglycemia J:189544
impaired glucose tolerance J:189544
increased circulating glucose level J:189544
GckGls006/GckGls006
(C3HeB/FeJ-GckGls006) 		hyperglycemia J:137483, J:189544
increased circulating glucose level J:189544
GckHlb62/?
(C57BL/6J-GckHlb62/J) 		hyperglycemia J:214141, J:82961
impaired glucose tolerance J:214141
GckM1Btlr/Gck+
(C57BL/6J-GckM1Btlr) 		impaired glucose tolerance J:221479
GckM1Btlr/GckM1Btlr
(C57BL/6J-GckM1Btlr) 		impaired glucose tolerance J:221479
Gckm1Rge/Gck+
(involves: C3HeB/FeJ) 		decreased insulin secretion J:162903
hyperglycemia J:162903
impaired glucose tolerance J:162903
increased circulating insulin level J:162903
insulin resistance J:162903
Gckm1Rge/Gckm1Rge
(involves: C3HeB/FeJ) 		hyperglycemia J:162903
increased urine glucose level J:162903
Gckm2Btlr/Gckm2Btlr
(C57BL/6J-Gckm2Btlr) 		impaired glucose tolerance J:264650
GckRgsc149/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
GckRgsc149/Gck+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
GckRgsc210/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
impaired glucose tolerance J:88919
GckRgsc210/GckRgsc210
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hyperglycemia J:88919
increased urine glucose level J:88919
GckRgsc236/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
GckRgsc272/Gck+
(involves: C57BL/6J * DBA/2J) 		decreased circulating insulin level J:88919
hyperglycemia J:88919
impaired glucose tolerance J:88919
GckRgsc341/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
impaired glucose tolerance J:88919
GckRgsc392/Gck+
(involves: C57BL/6J * DBA/2J) 		decreased circulating insulin level J:88919
hyperglycemia J:88919
impaired glucose tolerance J:88919
GckRgsc392/GckRgsc392
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hyperglycemia J:88919
GckRgsc475/Gck+
(involves: C57BL/6J * DBA/2J) 		decreased circulating insulin level J:88919
hyperglycemia J:88919
impaired glucose tolerance J:88919
GckRgsc552/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
GckRgsc553/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
GckRgsc702/Gck+
(involves: C57BL/6J * DBA/2J) 		decreased circulating insulin level J:88919
hyperglycemia J:88919
impaired glucose tolerance J:88919
GckRgsc702/GckRgsc702
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hyperglycemia J:88919
increased urine glucose level J:88919
GckRgsc735/Gck+
(involves: C57BL/6J * DBA/2J) 		hyperglycemia J:88919
GckRgsc960/Gck+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
GckSgrd-2Nwu/Gck+
(C57BL/6J-GckSgrd-2Nwu) 		hyperglycemia J:196563
GckSgrd-2Nwu/GckSgrd-2Nwu
(C57BL/6J-GckSgrd-2Nwu) 		decreased circulating insulin level J:196563
hyperglycemia J:196563
GckSgrd/Gck+
(C57BL/6J-GckSgrd) 		decreased circulating insulin level J:196563
hyperglycemia J:196563
GckSgrd/GckSgrd-2Nwu
(C57BL/6J-GckSgrd/GckSgrd-2Nwu) 		decreased circulating insulin level J:196563
hyperglycemia J:196563
GckSgrd/GckSgrd
(C57BL/6J-GckSgrd) 		decreased circulating insulin level J:196563
hyperglycemia J:196563
Gcktm1.1Mgn/Gck+
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased glycogen level J:51826
decreased insulin secretion J:51826
hyperglycemia J:51826
impaired glucose tolerance J:51826
Gcktm1.1Mgn/Gcktm1.1Mgn
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating glucose level J:51826
Gcktm1.1Mgn/Gcktm1.1Mgn
(129S6/SvEvTac-Gcktm1.1Mgn) 		increased circulating glucose level J:51826
Gcktm1.1Mgn/Gcktm1.1Mgn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal glucose homeostasis J:51826
decreased glycogen level J:51826
decreased insulin secretion J:51826
impaired glucose tolerance J:51826
increased circulating glucose level J:51826
increased circulating insulin level J:51826
insulin resistance J:51826
Gcktm1.1Mgn/Gcktm1.1Mgn
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased circulating insulin level J:51826
decreased liver glycogen level J:51826
hyperglycemia J:51826
Gcktm1.2Mgn/Gck+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased insulin secretion J:51826
decreased liver glycogen level J:51826
hyperglycemia J:51826
impaired glucose tolerance J:51826
Gcktm1.2Mgn/Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating insulin level J:51826
decreased liver glycogen level J:51826
hyperglycemia J:51826
Gcktm1Efr/Gck+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:28756
hyperglycemia J:28756
impaired glucose tolerance J:28756
Gcktm1Hrt/Gck+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		impaired glucose tolerance J:250069, J:105247
increased circulating glucose level J:105247
increased fasting circulating glucose level J:250069
insulin resistance J:250069
Gcktm1Mgn/Gcktm1Mgn
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating glucose level J:51826
Gcktm1Tka/Gck+
(involves: 129X1/SvJ * ICR) 		decreased insulin secretion J:30334
hyperglycemia J:30334
impaired glucose tolerance J:30334
increased urine glucose level J:30334
Gcktm1Tka/Gck+
Irs1tm1Tka/Irs1tm1Tka
(involves: 129X1/SvJ * C57BL/6 * CBA * ICR) 		impaired glucose tolerance J:38899
increased circulating insulin level J:38899
insulin resistance J:38899
Gcktm1Tka/Gcktm1Tka
(involves: 129X1/SvJ * ICR) 		decreased circulating insulin level J:30334
decreased insulin secretion J:30334
hyperglycemia J:30334
increased urine glucose level J:30334
Gcktm1Ts/Gck+
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J)) 		hyperglycemia J:29255
impaired glucose tolerance J:29255
Gcktm1Ts/Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J)) 		decreased liver glycogen level J:29255
Gcktm1Ydor/Gck+
Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6 * C57BL/6J * CD-1) 		hypoglycemia J:302600
impaired glucose tolerance J:302600
Gcktm1Ydor/Gck+
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA) 		decreased fasting circulating glucose level J:302600
hypoglycemia J:302600
impaired glucose tolerance J:302600
increased circulating insulin level J:302600
increased insulin secretion J:302600
Gcktm2Mgn/Gck+
(129S6/SvEvTac-Gcktm2Mgn) 		abnormal glucose homeostasis J:121910
abnormal insulin secretion J:121910
hyperglycemia J:121910
impaired glucose tolerance J:121910
Gcktm2Mgn/Gck+
(B6.129S6-Gcktm2Mgn) 		hyperglycemia J:121910
Gcktm2Mgn/Gcktm2Mgn
(129S6/SvEvTac-Gcktm2Mgn) 		hyperglycemia J:121910
Gcktm3Mgn/Gck+
(B6.129S6-Gcktm3Mgn) 		hypoglycemia J:121910
Gcktm3Mgn/Gck+
(129S6/SvEvTac-Gcktm3Mgn) 		abnormal glucose homeostasis J:121910
abnormal insulin secretion J:121910
hypoglycemia J:121910
Gcktm3Mgn/Gcktm3Mgn
(129S6/SvEvTac-Gcktm3Mgn) 		abnormal circulating insulin level J:121910
abnormal glucose homeostasis J:121910
abnormal insulin secretion J:121910
decreased circulating glucose level J:121910
hypoglycemia J:121910
Gckrem1(IMPC)H/Gckrem1(IMPC)H
(C57BL/6NTac-Gckrem1(IMPC)H/H) 		impaired glucose tolerance J:211773
Gckrtm1Bms/Gckrtm1Bms
(involves: 129S1/Sv * ICR) 		abnormal glucose homeostasis J:58949
decreased liver glycogen level J:58949
impaired glucose tolerance J:58949
Gckrtm1Bms/Gckrtm1Bms
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:58949
increased circulating glucose level J:58949
increased circulating insulin level J:58949
insulin resistance J:58949
Gckrtm1Jfg/Gckrtm1Jfg
(involves: 129S/SvEv * C57BL/6J) 		decreased circulating insulin level J:61183
impaired glucose tolerance J:61183
Gcn1em1(IMPC)J/Gcn1+
(C57BL/6NJ-Gcn1em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Gdf3tm1Zuk/Gdf3tm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6J) 		improved glucose tolerance J:143083
Gdf15tm1Sjl/Gdf15tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased urine glucose level J:202996
Gdf15tm1Sjl/Gdf15tm1Sjl
Leprdb/Leprdb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J) 		hyperglycemia J:202996
increased urine glucose level J:202996
Gdi2tm1b(EUCOMM)Hmgu/Gdi2+
(C57BL/6N-Gdi2tm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Gdpd2tm1a(KOMP)Wtsi/Y
(C57BL/6N-Gdpd2tm1a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Gemtm1.1Jgun/Gemtm1.1Jgun
(involves: BALB/c * C57BL/6) 		decreased insulin secretion J:187922
impaired glucose tolerance J:187922
Gena346/Gena346+
(involves: BALB/c * C3H/HeH) 		hyperglycemia J:169366
Gena391/Gena391+
(involves: BALB/c * C3H/He) 		abnormal circulating glucose level J:82809
Gena394/Gena394+
(involves: BALB/c * C3H/HeH) 		impaired glucose tolerance J:169366
Gena396/Gena396+
(involves: BALB/c * C3H/HeH) 		hyperglycemia J:169366
Gena397/Gena397+
(involves: BALB/c * C3H/HeH) 		hypoglycemia J:169366
Gfpt2tm1b(EUCOMM)Wtsi/Gfpt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gfpt2tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Gfraltm1Lex/Gfraltm1Lex
(B6.129S5-Gfraltm1Lex) 		impaired glucose tolerance J:254140
Gga1Gt(AN0619)Wtsi/Gga1Gt(AN0619)Wtsi
(B6J.129P2-Gga1Gt(AN0619)Wtsi) 		hypoglycemia J:184229
Gga1Gt(AN0619)Wtsi/Gga1Gt(AN0619)Wtsi
Gga3Gt(RRC067)Byg/Gga3Gt(RRC067)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		hypoglycemia J:184229
Gga2Gt(IST10483E10)Tigm/Gga2Gt(IST10483E10)Tigm
(involves: C57BL/6J * C57BL/6N) 		hypoglycemia J:184229
Gga3Gt(RRC067)Byg/Gga3Gt(RRC067)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		hypoglycemia J:184229
Ggcxtm1.1Kry/Ggcxtm1.1Kry
Tg(BGLAP-cre)1Clem/0
(involves: FVB/NJ) 		improved glucose tolerance J:264734
Ggcxtm1.1Kry/Ggcxtm1.1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB/N) 		hypoglycemia J:264734
improved glucose tolerance J:264734
increased insulin sensitivity J:264734
Ggps1tm1b(EUCOMM)Wtsi/Ggps1+
(C57BL/6N-Ggps1tm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
Ggt1tm1Zuk/Ggt1tm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal glucose homeostasis J:34309
Ghtm1.1(KOMP)Vlcg/Ghtm1.1(KOMP)Vlcg
(C57BL/6N-Ghtm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Ghrtm1.1Dlr/Ghrtm1.1Dlr
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA) 		decreased insulin secretion J:173909
increased circulating glucose level J:173909
Ghrtm1.1Masp/Ghrtm1.1Masp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6 * DBA) 		impaired glucose tolerance J:152627
increased circulating insulin level J:152627
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased circulating glucose level J:105686, J:110613
decreased circulating insulin level J:105686, J:110613
increased insulin sensitivity J:110613
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6) 		decreased circulating glucose level J:103286
decreased circulating insulin level J:103286
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased circulating glucagon level J:107763
decreased circulating glucose level J:107763
decreased circulating insulin level J:107763
hypoglycemia J:107763
increased insulin sensitivity J:107763
Ghrtm1Mwat/Ghrtm1Mwat
(involves: 129X1/SvJ * C57BL) 		hyperglycemia J:95149
Ghrtm2Mwat/Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL) 		hyperglycemia J:95149
Ghrhtm1b(EUCOMM)Wtsi/Ghrhtm1b(EUCOMM)Wtsi
(C57BL/6N-Ghrhtm1b(EUCOMM)Wtsi/Tcp) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit/J) 		abnormal glucose homeostasis J:95779
decreased circulating glucose level J:95779
increased circulating insulin level J:95779
Ghrhrlit/Ghrhrlit
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating glucose level J:95779
impaired glucose tolerance J:95779
increased circulating glucose level J:95779
increased circulating insulin level J:95779
insulin resistance J:95779
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ghrltm1Mko/Ghrltm1Mko
(B6.Cg-Ghrltm1Mko) 		abnormal glucose homeostasis J:121019
decreased circulating glucose level J:121019
improved glucose tolerance J:121019
increased circulating insulin level J:121019
increased insulin secretion J:121019
Ghsrtm1Lowl/Ghsrtm1Lowl
(involves: C57BL/6J) 		decreased circulating glucose level J:104704
Gigyf2tm1b(EUCOMM)Wtsi/Gigyf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gigyf2tm1b(EUCOMM)Wtsi/Bay) 		increased fasting circulating glucose level J:211773
Gimap6tm1a(KOMP)Wtsi/Gimap6tm1a(KOMP)Wtsi
(C57BL/6N-Gimap6tm1a(KOMP)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Gimap6tm1b(KOMP)Wtsi/Gimap6tm1b(KOMP)Wtsi
(C57BL/6N-Gimap6tm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Giprtm1Thor/Giprtm1Thor
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating insulin level J:88159
impaired glucose tolerance J:88159
increased circulating glucose level J:88159
Giprtm1Thor/Giprtm1Thor
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		decreased circulating insulin level J:88159
impaired glucose tolerance J:88159
increased circulating glucose level J:88159
Giprtm1Yse/Giprtm1Yse
(involves: 129P2/Ola * C57BL/6J) 		abnormal glucose homeostasis J:59087
decreased circulating insulin level J:59087
hyperglycemia J:59087
Giq1KK/?
(involves: C57BL/6J * KK-Ay) 		impaired glucose tolerance J:81517
Gjb1tm1Kwi/Y
(involves: 129S4/SvJae * C57BL/6) 		increased liver glycogen level J:36146
Gjd2tm1Kwi/Gjd2tm1Kwi
(involves: 129P2/OlaHsd) 		decreased insulin secretion J:117402
Gjd2tm1Kwi/Gjd2tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal insulin secretion J:122093
Gjd2tm4Kwi/Gjd2tm4Kwi
Tg(Ins2-cre)23Herr/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal glucose tolerance J:174834
increased insulin secretion J:174834
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		hypoglycemia J:43449, J:100255
Gktm1Wjc/Gk+
(involves: 129S7/SvEvBrd) 		decreased circulating glucose level J:148831
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(C57BL/6N-Gkn2tm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
Glb1l2tm1Lex/Glb1l2tm1Lex
(B6;129S5-Glb1l2tm1Lex/Mmucd) 		impaired glucose tolerance J:171883
Glis3tm1.2Chan/Glis3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:177082
decreased insulin secretion J:177082
Glis3tm1.2Chan/Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:177082
decreased insulin secretion J:177082
hyperglycemia J:177082
increased circulating glucose level J:177082
Glis3tm1Amj/Glis3tm1Amj
(involves: 129 * C57BL/6) 		hyperglycemia J:148994
increased circulating insulin level J:148994
Glis3tm1Hiha/Glis3tm1Hiha
(involves: C57BL/6 * CBA) 		impaired glucose tolerance J:150077
increased circulating glucose level J:150077
Glmptm1Lex/Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd) 		decreased circulating glucose level J:171883
Glo1Gt(VICTR48)1493Lex/Glo1Gt(VICTR48)1493Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:82809
hyperglycemia J:82809
Glp1rtm1.1Stof/Glp1rtm1.1Stof
Tg(CMV-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * SJL) 		abnormal glucose homeostasis J:206563
Glp1rtm1.2Stof/Glp1rtm1.2Stof
(Not Specified) 		abnormal circulating insulin level J:203834
abnormal glucose tolerance J:203834
impaired glucose tolerance J:203834
Glp1rtm1b(KOMP)Mbp/Glp1rtm1b(KOMP)Mbp
(C57BL/6N-Glp1rtm1b(KOMP)Mbp/H) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129S1/Sv * 129X1/SvJ) 		decreased circulating insulin level J:36918, J:206563
impaired glucose tolerance J:36918
increased circulating glucose level J:36918, J:206563
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129/Sv * C57BL/6) 		decreased circulating insulin level J:88159
impaired glucose tolerance J:88159
increased circulating glucose level J:88159
Glp1rtm1Ddr/Glp1rtm1Ddr
(B6.129-Glp1rtm1Ddr) 		increased circulating glucose level J:200805
Gls001/Gls001+
(C3HeB/FeJ-Gls001) 		hyperglycemia J:137483
Gls2em1Xen/Gls2em1Xen
(involves: C57BL/6NTac) 		decreased fasting circulating glucose level J:271619
decreased hepatic glucose production J:271619
increased circulating glucagon level J:271619
Gls007/Gls007+
(C3HeB/FeJ-Gls007) 		hyperglycemia J:137483
Glt8d2tm1a(KOMP)Wtsi/Glt8d2tm1a(KOMP)Wtsi
(C57BL/6N-Glt8d2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
glu5/glu5
(Not Specified) 		hyperglycemia J:85113
impaired glucose tolerance J:85113
Gluchos1C57BL/6J/Gluchos1C57BL/6J
(C57BL/6J) 		decreased insulin secretion J:109356
impaired glucose tolerance J:109356
Gluchos3C3H/HeH/Gluchos3C57BL/6J
(involves: C3H/HeH * C57BL/6J) 		decreased circulating insulin level J:106692
Gluchos3C57BL/6J/Gluchos3C57BL/6J
(involves: C3H/HeH * C57BL/6J) 		decreased circulating insulin level J:106692
Glud1tm1.1Pma/Glud1tm1.1Pma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased insulin secretion J:145558
Glud1tm1.1Pma/Glud1tm1.1Pma
Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL) 		decreased circulating insulin level J:145558
decreased insulin secretion J:145558
Glultm3Whla/Glultm1Whla
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased circulating glucose level J:162067
Glultm3Whla/Glultm3Whla
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased circulating glucose level J:162067
Gm572tm1b(EUCOMM)Hmgu/Gm572+
(C57BL/6N-Gm572tm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Gm16364tm1Zhaoy/Gm16364tm1Zhaoy
(involves: C57BL/6) 		improved glucose tolerance J:322340
increased insulin sensitivity J:322340
Gm16364tm2Zhaoy/Gm16364tm2Zhaoy
(involves: C57BL/6) 		improved glucose tolerance J:322340
increased insulin sensitivity J:322340
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq) 		impaired glucose tolerance J:341056
increased circulating insulin level J:341056
Gnao1tm1b(EUCOMM)Hmgu/Gnao1+
(C57BL/6N-Gnao1tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Gnao1tm3Lbi/Gnao1tm3Lbi
(involves: 129S7/SvEvBrd) 		decreased circulating glucose level J:168245
improved glucose tolerance J:168245
increased circulating insulin level J:168245
increased insulin secretion J:168245
Gnao1tm4Lbi/Gnao1tm4Lbi
Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		abnormal glucose tolerance J:169627
increased circulating insulin level J:169627
increased insulin secretion J:169627
Gnastm1Kel/Gnas+
(involves: 129S2/SvPas * C57BL/6J) 		decreased circulating glucagon level J:91703
decreased circulating glucose level J:91703
decreased circulating insulin level J:91703
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1) 		abnormal glucose homeostasis J:106729
decreased circulating glucose level J:106729
decreased circulating insulin level J:106729
improved glucose tolerance J:106729
increased insulin sensitivity J:106729
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss * CD-1) 		abnormal glucose homeostasis J:99237
impaired glucose tolerance J:99237
increased circulating glucose level J:99237
increased circulating insulin level J:99237
insulin resistance J:99237
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		decreased circulating insulin level J:102504
hypoglycemia J:102504
improved glucose tolerance J:102504
increased circulating glucagon level J:102504
increased liver glycogen level J:102504
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0
(involves: FVB) 		decreased circulating insulin level J:159612
hypoglycemia J:159612
improved glucose tolerance J:159612
increased insulin sensitivity J:159612
Gng7tm1Lex/Gng7tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating insulin level J:103485
Gng13tm1.1(KOMP)Vlcg/Gng13+
(C57BL/6N-Gng13tm1.1(KOMP)Vlcg/Ucd) 		increased circulating glucose level J:211773
Gngt2em1(IMPC)Bay/Gngt2em1(IMPC)Bay
(C57BL/6N-Gngt2em1(IMPC)Bay/BayMmucd) 		increased fasting circulating glucose level J:211773
Gnl1em1(IMPC)Tcp/Gnl1em1(IMPC)Tcp
(C57BL/6N-Gnl1em1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6) 		decreased circulating glucose level J:147857
increased liver glycogen level J:147857
Golga3tm1b(EUCOMM)Hmgu/Golga3tm1b(EUCOMM)Hmgu
(C57BL/6N-Golga3tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Golt1atm1b(KOMP)Wtsi/Golt1atm1b(KOMP)Wtsi
(C57BL/6N-Golt1atm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Got1tm1b(EUCOMM)Hmgu/Got1+
(C57BL/6N-Got1tm1b(EUCOMM)Hmgu/H) 		decreased circulating glucose level J:211773
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ) 		insulin resistance J:134068
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating insulin level J:84541
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6) 		decreased circulating glucose level J:213618
improved glucose tolerance J:213618
Gpbar1tm1.2Auw/Gpbar1tm1.2Auw
(involves: 129 * C57BL/6J) 		impaired glucose tolerance J:152388
increased circulating insulin level J:152388
Gpbp1tm1b(EUCOMM)Wtsi/Gpbp1+
(C57BL/6N-Gpbp1tm1b(EUCOMM)Wtsi/Ieg) 		improved glucose tolerance J:211773
Gpc3tm1Arge/Y
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J)) 		hypoglycemia J:75054
Gpc4tm2b(EUCOMM)Wtsi/Y
(C57BL/6N-Gpc4tm2b(EUCOMM)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB) 		abnormal muscle glycogen level J:345630
hyperglycemia J:345630
impaired glucose tolerance J:345630
increased insulin secretion J:345630
Gpd2tm1Tka/Gpd2tm1Tka
(involves: C57BL/6 * CBA) 		decreased insulin secretion J:75839
Gpd2tm1Tka/Gpd2tm1Tka
(B6.Cg-Gpd2tm1Tka) 		decreased circulating insulin level J:124766
Gpd2tm1Tka/Gpd2tm1Tka
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct) 		decreased circulating insulin level J:124766
hypoglycemia J:124766
Gper1tm1.1Lmlf/Gper1tm1.1Lmlf
(B6.129-Gper1tm1.1Lmlf) 		decreased circulating glucagon level J:146345
decreased glucagon secretion J:146345
decreased insulin secretion J:146345
impaired glucose tolerance J:146345
increased circulating glucose level J:146345
Gpi1b-m1Neu/Gpi1b-m1Neu
(C3.Cg-Gpi1b-m1Neu) 		increased circulating glucose level J:35956
Gpi1b-m2Neu/Gpi1b-m2Neu
(C3.Cg-Gpi1b-m2Neu) 		increased circulating glucose level J:35956
Gpnmbtm1.1(KOMP)Vlcg/Gpnmb+
(C57BL/6N-Gpnmbtm1.1(KOMP)Vlcg/Ucd) 		increased fasting circulating glucose level J:211773
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen) 		increased circulating glucose level J:111942
Gpr15em1(IMPC)J/Gpr15em1(IMPC)J
(C57BL/6NJ-Gpr15em1(IMPC)J/J) 		impaired glucose tolerance J:211773
Gpr21tm1Dgen/Gpr21tm1Dgen
(B6.129P2-Gpr21tm1Dgen) 		improved glucose tolerance J:181127
increased insulin sensitivity J:181127
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6) 		abnormal glucose homeostasis J:189617
impaired glucose tolerance J:189617
increased circulating glucose level J:189617
increased circulating insulin level J:189617
Gpr27tm1Tac/Gpr27tm1Tac
(B6.129S-Gpr27tm1Tac) 		decreased circulating insulin level J:286854
decreased insulin secretion J:286854
impaired glucose tolerance J:286854
Gpr39tm1Dgen/Gpr39tm1Dgen
(B6.129P2-Gpr39tm1Dgen) 		decreased circulating insulin level J:151806
increased circulating glucose level J:151806
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating insulin level J:302257
Gpr68tm1.1Aha/Gpr68tm1.1Aha
(B6.129(C)-Gpr68tm1.1Aha) 		decreased circulating insulin level J:189192
decreased insulin secretion J:189192
Gpr68tm1Aha/Gpr68tm1Aha
(B6.129-Gpr68tm1Aha) 		decreased circulating glucagon level J:189192
decreased circulating glucose level J:189192
decreased circulating insulin level J:189192
decreased insulin secretion J:189192
increased insulin sensitivity J:189192
Gpr82tm1Shbg/Y
(C3Fe.Cg-Gpr82tm1Shbg) 		decreased circulating glucose level J:301613
decreased circulating insulin level J:301613
decreased fasting circulating glucose level J:301613
improved glucose tolerance J:301613
Gpr82tm1Shbg/Gpr82tm1Shbg
(C3Fe.Cg-Gpr82tm1Shbg) 		decreased circulating insulin level J:301613
improved glucose tolerance J:301613
increased insulin sensitivity J:301613
Gpr83em1(IMPC)Ccpcz/Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz) 		impaired glucose tolerance J:211773
Gpr119tm1Tjkw/Gpr119tm1Tjkw
(C57BL/6J-Gpr119tm1Tjkw) 		decreased circulating insulin level J:244912
Gpr142tm1Lex/Gpr142tm1Lex
(B6.129S-Gpr142tm1Lex) 		abnormal circulating glucose level J:249154
abnormal circulating insulin level J:249154
decreased circulating insulin level J:249154
decreased insulin secretion J:249154
increased fasting circulating glucose level J:249154
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:144372
abnormal glucose tolerance J:144372
decreased circulating insulin level J:144372
increased circulating glucose level J:144372
increased insulin sensitivity J:144372
Gpx3tm1b(KOMP)Wtsi/Gpx3+
(C57BL/6N-Gpx3tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
Gramd1ctm1b(KOMP)Wtsi/Gramd1ctm1b(KOMP)Wtsi
(C57BL/6N-Gramd1ctm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Gramd2bem1(IMPC)J/Gramd2bem1(IMPC)J
(C57BL/6NJ-Gramd2bem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Grb10Gt(Betageo)1Ward/Grb10+
(involves: C57BL/6 * CBA) 		increased liver glycogen level J:84425
Grb10GT(XC302)Byg/Grb10GT(XC302)Byg
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6) 		increased insulin sensitivity J:125128
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Adipoq-cre)#Pesch/0
(involves: 129S/SvEv * FVB) 		impaired glucose tolerance J:213603
increased circulating insulin level J:213603
insulin resistance J:213603
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv) 		impaired glucose tolerance J:213603
increased circulating insulin level J:213603
insulin resistance J:213603
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:208498
decreased circulating glucose level J:208498
improved glucose tolerance J:208498
increased insulin secretion J:208498
Grb14tm1Daly/Grb14tm1Daly
(involves: 129X1/SvJ * C57BL/6) 		improved glucose tolerance J:87892
increased insulin sensitivity J:87892
Grhl3tm1a(EUCOMM)Wtsi/Grhl3+
(C57BL/6N-Grhl3tm1a(EUCOMM)Wtsi/Ics) 		increased circulating glucose level J:165965
Grik3em1(IMPC)Mbp/Grik3em1(IMPC)Mbp
(C57BL/6N-Grik3em1(IMPC)Mbp/MbpMmucd) 		increased fasting circulating glucose level J:211773
Grik4em1(IMPC)Mbp/Grik4em1(IMPC)Mbp
(C57BL/6N-Grik4em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Grm3tm1b(KOMP)Wtsi/Grm3tm1b(KOMP)Wtsi
(C57BL/6N-Grm3tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
Grm8tm1Duv/Grm8tm1Duv
(B6.129S1-Grm8tm1Duv) 		insulin resistance J:101087
Grpel1tm1c(EUCOMM)Wtsi/Grpel1tm1c(EUCOMM)Wtsi
Tg(ACTA1-cre/ERT2)97.16Mtz/0
(involves: C57BL/6N) 		decreased circulating glucose level J:330869
Gsk3atm1.1Jrw/Gsk3atm1.1Jrw
(involves: 129S6/SvEvTac * C57BL/6) 		improved glucose tolerance J:130033
increased insulin sensitivity J:130033
increased liver glycogen level J:130033
Gsk3atm1a(EUCOMM)Wtsi/Gsk3atm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Gsk3atm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased liver glycogen level J:98263
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
Gys1tm1.1Arte/Gys1tm1.1Arte
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glycogen homeostasis J:167911
Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal glycogen homeostasis J:98263
Gsk3btm1Jrw/Gsk3b+
(involves: 129 * C57BL/6J) 		abnormal glucose homeostasis J:135659
decreased circulating glucose level J:135659
decreased circulating insulin level J:135659
Gsk3btm1Jrw/Gsk3b+
Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J) 		abnormal circulating glucose level J:135659
abnormal circulating insulin level J:135659
improved glucose tolerance J:135659
insulin resistance J:135659
Gsk3btm1Jrw/Gsk3b+
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal circulating glucose level J:135659
increased circulating glucose level J:135659
increased circulating insulin level J:135659
insulin resistance J:135659
Gsk3btm2Jrw/Gsk3btm2Jrw
Irs2tm1Mfw/Irs2tm1Mfw
Tg(Ins2-cre)23Herr/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal circulating glucose level J:135659
increased circulating insulin level J:135659
Gsk3btm2Jrw/Gsk3btm2Jrw
Tg(Ggt1-cre)M3Egn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased glycogen level J:167190
Gsta4Gt(OST203280)Lex/Gsta4Gt(OST203280)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:103485
Gstm6tm1b(EUCOMM)Hmgu/Gstm6tm1b(EUCOMM)Hmgu
(C57BL/6N-Gstm6tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating glucose level J:211773
Gstt1tm1a(EUCOMM)Hmgu/Gstt1tm1a(EUCOMM)Hmgu
(Not Specified) 		increased circulating glucose level J:165965
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/?
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Pmch-cre)1Lowl/0
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/NJ) 		impaired glucose tolerance J:167906
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/Gt(ROSA)26Sor+
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6 * CBA/J) 		abnormal circulating glucagon level J:146650
abnormal circulating glucose level J:146650
decreased circulating glucagon level J:146650
decreased circulating insulin level J:146650
decreased insulin secretion J:146650
hyperglycemia J:146650
increased circulating glucagon level J:146650
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1) 		decreased circulating glucose level J:292094
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg
Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N) 		abnormal glucose homeostasis J:201507
decreased circulating insulin level J:201507
decreased insulin secretion J:201507
hyperglycemia J:201507
impaired glucose tolerance J:201507
increased circulating glucose level J:201507
insulin resistance J:201507
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		decreased circulating insulin level J:210493
hyperglycemia J:210493
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+
Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA) 		decreased fasting circulating glucose level J:210493
increased circulating insulin level J:210493
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+
Trp53tm1Brn/Trp53tm1Brn
Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		hyperglycemia J:210493
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas
Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		hyperglycemia J:210493
Gt(ROSA)26Sortm1(Gphb5)Lmac/Gt(ROSA)26Sor+
(Not Specified) 		decreased circulating glucose level J:96633
decreased circulating insulin level J:96633
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sor+
(Not Specified) 		abnormal glucose homeostasis J:170965
hyperglycemia J:170965
increased circulating insulin level J:170965
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:169459
decreased circulating glucose level J:169459
decreased circulating insulin level J:169459
impaired glucose tolerance J:169459
increased insulin sensitivity J:169459
Gt(ROSA)26Sortm1(Irx3*)Hui/Gt(ROSA)26Sor+
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		improved glucose tolerance J:208887
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+
Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating insulin level J:144715
decreased insulin secretion J:144715
increased circulating glucagon level J:144715
increased circulating glucose level J:144715
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+
Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		hyperglycemia J:210493
Gt(ROSA)26Sortm1(Mir7-1,-EGFP)Horn/Gt(ROSA)26Sor+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA) 		decreased glucagon secretion J:187631
decreased insulin secretion J:187631
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Lepob/Lepob
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		hyperglycemia J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		hyperglycemia J:237232
increased circulating insulin level J:237232
insulin resistance J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Neurog3-cre)C1Able/0
(involves: 129S4/SvJaeSor) 		hyperglycemia J:190530
Gt(ROSA)26Sortm1(ptxA)Cgh/Gt(ROSA)26Sor+
Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal glucose homeostasis J:130781
hypoglycemia J:130781
improved glucose tolerance J:130781
increased circulating insulin level J:130781
Gt(ROSA)26Sortm1(ptxA)Cgh/Gt(ROSA)26Sor+
Tg(Pdx1-cre)6Cvw/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		improved glucose tolerance J:130781
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB) 		abnormal glucose homeostasis J:194290
decreased circulating insulin level J:194290
decreased fasting circulating glucose level J:194290
decreased liver glycogen level J:194290
hypoglycemia J:194290
increased insulin sensitivity J:194290
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
Tg(Agrp-cre)1Gsb/?
(involves: C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:133218
decreased circulating glucose level J:133218
decreased circulating insulin level J:133218
improved glucose tolerance J:133218
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		impaired glucose tolerance J:166829
increased circulating insulin level J:166829
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/Gt(ROSA)26Sor+
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		decreased circulating insulin level J:286108
decreased fasting circulating glucose level J:286108
decreased insulin secretion J:286108
improved glucose tolerance J:286108
increased insulin sensitivity J:286108
Gt(ROSA)26Sortm3(H1/tetO-RNAi:Mir143)Jcbr/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6) 		impaired glucose tolerance J:176266
increased circulating insulin level J:176266
insulin resistance J:176266
Gt(ROSA)26Sortm3(Irf4)Evdr/Gt(ROSA)26Sor+
Tg(Ucp1-cre)1Evdr/0
(involves: 129 * C57BL/6J * FVB) 		improved glucose tolerance J:214637
increased insulin sensitivity J:214637
Gt(ROSA)26Sortm31(H1/tetO-RNAi:Insr)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6) 		hyperglycemia J:151686
insulin resistance J:151686
Gtpbp10tm1b(KOMP)Mbp/Gtpbp10tm1b(KOMP)Mbp
(C57BL/6N-Gtpbp10tm1b(KOMP)Mbp/J) 		decreased fasting circulating glucose level J:211773
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar) 		impaired glucose tolerance J:178241
increased circulating insulin level J:178241
Gyg1tm1a(KOMP)Wtsi/Gyg1+
(involves: C57BL/6N) 		increased cardiac muscle glycogen level J:244440
increased skeletal muscle glycogen level J:244440
Gyg1tm1a(KOMP)Wtsi/Gyg1tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal glucose homeostasis J:244440
abnormal glycogen homeostasis J:244440
decreased lung glycogen level J:300001
increased cardiac muscle glycogen level J:244440
increased skeletal muscle glycogen level J:244440
Gys1Gt(OST33395)Lex/Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J) 		decreased glycogen level J:92245
Gys1tm1.1Arte/Gys1+
(involves: C57BL/6J) 		abnormal glycogen homeostasis J:167911
decreased skeletal muscle glycogen level J:167911
Gys1tm1.1Arte/Gys1tm1.1Arte
(involves: C57BL/6J) 		abnormal glycogen homeostasis J:167911
decreased skeletal muscle glycogen level J:167911
increased glycogen catabolism rate J:167911
Gys1tm1a(EUCOMM)Wtsi/Gys1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased lung glycogen level J:300001
Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL) 		decreased brain glycogen level J:218886
Gys2m1Btlr/Gys2m1Btlr
(C57BL/6J-Gys2m1Btlr) 		decreased fasting circulating glucose level J:265256
Gys2m2Btlr/Gys2m2Btlr
(C57BL/6J-Gys2m2Btlr) 		decreased fasting circulating glucose level J:265257
Gys2m3Btlr/Gys2m3Btlr
(C57BL/6J-Gys2m3Btlr) 		impaired glucose tolerance J:265258
Gys2tm1.1Arte/Gys2+
(Not Specified) 		decreased glycogen catabolism rate J:208923
impaired glucose tolerance J:208923
Gys2tm1.1Arte/Gys2tm1.1Arte
(Not Specified) 		abnormal gluconeogenesis J:208923
abnormal glucose homeostasis J:208923
decreased circulating glucose level J:208923
decreased circulating insulin level J:208923
decreased glycogen catabolism rate J:208923
decreased liver glycogen level J:208923
impaired glucose tolerance J:208923
insulin resistance J:208923
Gys2tm1.1Pro/Gys2tm1.1Pro
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		abnormal gluconeogenesis J:162043
abnormal glucose homeostasis J:162043
decreased circulating glucose level J:162043
decreased circulating insulin level J:162043
decreased glycogen catabolism rate J:162043
decreased glycogen level J:162043
impaired glucose tolerance J:162043
Gys2tm1a(KOMP)Wtsi/Gys2tm1a(KOMP)Wtsi
(B6J.B6N-Gys2tm1a(KOMP)Wtsi) 		decreased liver glycogen level J:208923
Gys2tm1a(KOMP)Wtsi/Gys2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Gys2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:175295, J:165965
H1f8tm1b(KOMP)Wtsi/H1f8tm1b(KOMP)Wtsi
(C57BL/6N-H1f8tm1b(KOMP)Wtsi/Tcp) 		improved glucose tolerance J:211773
H1f10tm1.1(KOMP)Vlcg/H1f10tm1.1(KOMP)Vlcg
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv) 		increased circulating glucose level J:59245
increased urine glucose level J:59245
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA) 		increased circulating glucose level J:68641
increased urine glucose level J:68641
H2g7/H2g7
Ins2tm1Jja/Ins2tm1Jja
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased circulating glucose level J:111874
H6pdtm1c(EUCOMM)Wtsi/H6pdtm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		decreased circulating insulin level J:292236
decreased fasting circulating glucose level J:292236
improved glucose tolerance J:292236
increased insulin sensitivity J:292236
H6pdtm1Pmst/H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:189132
increased skeletal muscle glycogen level J:189132
H6pdtm1Pmst/H6pdtm1Pmst
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased circulating glucose level J:189132
increased skeletal muscle glycogen level J:189132
H13tm1b(KOMP)Wtsi/H13+
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Haaotm2b(KOMP)Mbp/Haaotm2b(KOMP)Mbp
(C57BL/6N-Haaotm2b(KOMP)Mbp/Ucd) 		increased circulating glucose level J:211773
Hacd2tm1a(EUCOMM)Hmgu/Hacd2tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		hypoglycemia J:333944
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg) 		decreased circulating glucose level J:179084
increased circulating insulin level J:179084
increased insulin secretion J:179084
Hadhtm1Csta/Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		abnormal glucose homeostasis J:166803
decreased circulating glucose level J:166803
increased circulating insulin level J:166803
Hadhatm1Jib/Hadha+
(involves: 129X1/SvJ * NIH Black Swiss) 		increased circulating insulin level J:101304
insulin resistance J:101304
Hadhatm1Jib/Hadhatm1Jib
(involves: 129X1/SvJ * NIH Black Swiss) 		hypoglycemia J:69846
Hadhbem1(IMPC)Bay/Hadhb+
(C57BL/6N-Hadhbem1(IMPC)Bay/BayMmucd) 		decreased fasting circulating glucose level J:211773
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan) 		decreased circulating glucose level J:117738
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Hctm1b(EUCOMM)Wtsi/Hctm1b(EUCOMM)Wtsi
(C57BL/6N-Hctm1b(EUCOMM)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Hccstm1Tcc/Y
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv) 		decreased cardiac muscle glycogen level J:143285
Hdac3tm1Swh/Hdac3tm1.1Swh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal glucose homeostasis J:134288
decreased circulating glucagon level J:134288
decreased circulating insulin level J:134288
decreased liver glycogen level J:134288
hypoglycemia J:134288
Hdac3tm1Swh/Hdac3tm1.1Swh
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased liver glycogen level J:134288
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		impaired glucose tolerance J:85774
increased circulating insulin level J:85774
Hecw1tm2b(EUCOMM)Hmgu/Hecw1tm2b(EUCOMM)Hmgu
(C57BL/6N-Hecw1tm2b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J) 		hypoglycemia J:107145
Helz2tm1Tesa/Helz2tm1Tesa
(B6.Cg-Helz2tm1Tesa) 		abnormal glucose homeostasis J:218127
decreased circulating insulin level J:218127
decreased fasting circulating glucose level J:218127
Herc1em3(IMPC)Wtsi/Herc1em3(IMPC)Wtsi
(C57BL/6N-Herc1em3(IMPC)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Herpud1tm1Kame/Herpud1tm1Kame
(B6CrSlc.129-Herpud1tm1Kame) 		impaired glucose tolerance J:210654
increased circulating glucose level J:210654
Hibadhtm1b(EUCOMM)Wtsi/Hibadhtm1b(EUCOMM)Wtsi
(C57BL/6N-Hibadhtm1b(EUCOMM)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Hif1atm1Stom/Hif1atm1Stom
Tg(Vil1-cre)20Syr/0
(B6.Cg-Hif1atm1Stom Tg(Vil1-cre)20Syr) 		decreased circulating insulin level J:325395
improved glucose tolerance J:325395
increased insulin sensitivity J:325395
Hif1atm3Rsjo/Hif1atm3Rsjo
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal gluconeogenesis J:152724
decreased circulating glucose level J:152724
decreased liver glycogen level J:152724
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal glucose homeostasis J:97761
Hif1antm1.1Rsjo/Hif1antm1.1Rsjo
Tg(Nes-cre)1Wme/0
(involves: 129 * C57BL/6 * CBA) 		decreased circulating insulin level J:160941
increased insulin sensitivity J:160941
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo) 		decreased circulating glucose level J:160941
decreased circulating insulin level J:160941
increased insulin sensitivity J:160941
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		decreased circulating glucagon level J:237329
decreased insulin secretion J:237329
impaired glucose tolerance J:237329
increased circulating insulin level J:237329
increased insulin sensitivity J:237329
Hipk3Gt(OST51087)Lex/Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd) 		decreased insulin secretion J:194563
impaired glucose tolerance J:194563
Hipk3tm1b(EUCOMM)Hmgu/Hipk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Hipk3tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Hipq1C57BL/6Wehi/Hipq1C57BL/6Wehi
(involves: C57BL/6Wehi * DBA/2Wehi) 		decreased insulin secretion J:129498
impaired glucose tolerance J:129498
Hipq1DBA/2Wehi/Hipq1DBA/2Wehi
(involves: C57BL/6Wehi * DBA/2Wehi) 		increased insulin secretion J:129498
Hkdc1tm1a(KOMP)Wtsi/Hkdc1+
(involves: C57BL/6N) 		impaired glucose tolerance J:240354
Hlb289/?
(C57BL/6J-Hlb289/J) 		hyperglycemia J:82961
Hlb290/?
(C57BL/6J-Hlb290/J) 		hyperglycemia J:82961
hlb437/?
(C57BL/6J-hlb437/J) 		hyperglycemia J:77944
Hltftm1.2Geno/Hltftm1.2Geno
(B6.129S2-Hltftm1.2Geno) 		hypoglycemia J:203735
Hmga1tm1Brun/Hmga1+
(Not Specified) 		decreased circulating insulin level J:99652
decreased insulin secretion J:99652
impaired glucose tolerance J:99652
increased insulin sensitivity J:99652
insulin resistance J:99652
Hmga1tm1Brun/Hmga1tm1Brun
(Not Specified) 		decreased circulating insulin level J:99652
decreased insulin secretion J:99652
impaired glucose tolerance J:99652
increased insulin sensitivity J:99652
insulin resistance J:99652
Hmgb1tm1Meb/Hmgb1tm1Meb
(involves: 129P2/OlaHsd * BALB/c) 		decreased glycogen catabolism rate J:55880
hypoglycemia J:55880
Hmgcltm2Gam/Hmgcltm2Gam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hmgcltm2Gam Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal gluconeogenesis J:204294
hypoglycemia J:204294
Hmgcrtm2Ishi/Hmgcrtm2Ishi
Tg(Alb1-cre)1Dlr/0
(involves: 129S7/SvEvBrd * C57BL/6J) 		hypoglycemia J:201488
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(B6.Cg-Hmgn3tm1.2Mbus) 		decreased circulating insulin level J:153774
impaired glucose tolerance J:153774
increased circulating glucose level J:153774
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose tolerance J:199604
increased circulating glucose level J:199604
Hmgn5tm1.2Mbus/Y
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose tolerance J:199604
Hmgn5tm1.2Mbus/Hmgn5tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose tolerance J:199604
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N) 		improved glucose tolerance J:214639
increased insulin sensitivity J:214639
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		increased insulin sensitivity J:214639
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:47008
hyperglycemia J:47008
increased urine glucose level J:47008
Hnf1atm1.1Ylee/Hnf1atm2Ylee
(involves: 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:81639
hyperglycemia J:81639
Hnf1atm1.1Ylee/Hnf1atm2Ylee
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating insulin level J:81639
hyperglycemia J:81639
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas) 		abnormal renal glucose reabsorption J:31627
decreased insulin secretion J:48230
increased circulating glucose level J:48230
increased urine glucose level J:31627
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas) 		abnormal renal glucose reabsorption J:31627
increased urine glucose level J:31627
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N) 		decreased circulating insulin level J:306082
decreased insulin secretion J:306082
hyperglycemia J:306082
impaired glucose tolerance J:306082
increased fasting circulating glucose level J:306082
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz
Tg(Ins2-cre)25Mgn/0
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating insulin level J:108652
impaired glucose tolerance J:108652
Hnf4atm1.1Mwei/Hnf4atm1.1Mwei
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		impaired glucose tolerance J:106993
Hnf4atm1b(EUCOMM)Hmgu/Hnf4a+
(C57BL/6N-Hnf4atm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Hnf4atm1Sad/Hnf4atm1Sad
Six2tm1(tTA,tetO-EGFP/cre)Amc/Six2+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased urine glucose level J:266356
Hnf4atm1Sad/Hnf4atm1Sad
Tg(Alb1-cre)1Khk/0
(involves: C57BL/6 * SJL) 		decreased liver glycogen level J:84076
Hnrnpctm1b(EUCOMM)Hmgu/Hnrnpc+
(C57BL/6N-Hnrnpctm1b(EUCOMM)Hmgu/J) 		improved glucose tolerance J:211773
Hnrnpftm1Jsdc/Hnrnpftm1Jsdc
Pax8tm1.1(cre)Mbu/Pax8+
(involves: 129P2/OlaHsd * C57BL/6) 		increased urine glucose level J:284239
Hoxa2tm1b(EUCOMM)Wtsi/Hoxa2+
(C57BL/6N-Hoxa2tm1b(EUCOMM)Wtsi/Ieg) 		improved glucose tolerance J:211773
Hpcaem1(IMPC)H/Hpcaem1(IMPC)H
(C57BL/6NTac-Hpcaem1(IMPC)H/H) 		impaired glucose tolerance J:211773
Hprt1tm1(CAG-Gys1*)Jjg/?
Myl1tm1(cre)Sjb/Myl1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		increased skeletal muscle glycogen level J:244440
Hprt1tm1(CAG-Gys1*)Jjg/?
Tg(Nes-cre)1Kag/?
(involves: 129P2/OlaHsd) 		increased brain glycogen level J:210491
Hprt1tm1(Camk2a-APP*Swe*Lon,-MAPT*P301L*R406W)Geno/Hprt1+
Tg(PSEN1)5Dbo/0
(involves: 129P2/OlaHsd) 		abnormal glucose homeostasis J:180977
Hprt1tm1(Ins2-HBEGF)Herr/Y
(involves: 129 * C57BL/6) 		decreased insulin secretion J:159291
hyperglycemia J:159291
increased insulin secretion J:159291
Hprt1tm1(Ins2-HBEGF)Herr/Hprt1tm1(Ins2-HBEGF)Herr
(involves: 129 * C57BL/6) 		hyperglycemia J:159291
Hprt1tm2(CAG-Ppp1r3c)Jjg/?
(Not Specified) 		increased brain glycogen level J:210491
Hprt1tm2(CAG-Ppp1r3c)Jjg/?
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		increased brain glycogen level J:210491
Hpse2Gt(OST411605)Lex/Hpse2Gt(OST411605)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating glucose level J:219597
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn) 		decreased circulating insulin level J:107191
Hrh3tm1.1Jhwa/Hrh3tm1.1Jhwa
(involves: C57BL/6 * C57BL/6NTac) 		abnormal glucose homeostasis J:174155
increased circulating glucose level J:174155
Hrh3tm1Kot/Hrh3tm1Kot
(involves: 129X1/SvJ * C57BL/6N) 		increased circulating insulin level J:80824
insulin resistance J:80824
Hsd11b1tm1.2Tuck/Hsd11b1tm1.2Tuck
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal circulating insulin level J:203302
Hsd11b1tm1Ggla/Hsd11b1tm1Ggla
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal glucose tolerance J:189059
decreased circulating insulin level J:189059
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1) 		abnormal glucose homeostasis J:37960
decreased circulating glucose level J:37960, J:45085
improved glucose tolerance J:72402
increased liver glycogen level J:45085
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(B6.129P2(Cg)-Hsd11b1tm1Yko) 		improved glucose tolerance J:89080
Hsd17b1tm1.1(KOMP)Vlcg/Hsd17b1tm1.1(KOMP)Vlcg
(C57BL/6N-Hsd17b1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Hsf1tm1.1(KOMP)Vlcg/Hsf1+
(C57BL/6N-Hsf1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Hsf2tm1b(KOMP)Wtsi/Hsf2tm1b(KOMP)Wtsi
(C57BL/6N-Hsf2tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Hsf2bptm1a(EUCOMM)Hmgu/Hsf2bptm1a(EUCOMM)Hmgu
(C57BL/6N-Hsf2bptm1a(EUCOMM)Hmgu/Cnrm) 		decreased circulating glucose level J:165965
increased circulating glucose level J:165965
Hsf5em1(IMPC)J/Hsf5em1(IMPC)J
(C57BL/6NJ-Hsf5em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6) 		increased insulin sensitivity J:287930
Hspb3tm1.1(KOMP)Vlcg/Hspb3tm1.1(KOMP)Vlcg
(C57BL/6N-Hspb3tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Htr2btm1Kry/Htr2btm1Kry
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J) 		decreased circulating insulin level J:284574
Htr2ctm1Jul/Y
(B6.129S-Htr2ctm1Jul) 		hyperglycemia J:50262
impaired glucose tolerance J:50262
increased circulating insulin level J:50262
insulin resistance J:50262
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk) 		decreased circulating glucose level J:142503
decreased circulating insulin level J:142503
Htr2ctm2Jke/Y
Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		hyperglycemia J:207704
increased circulating glucagon level J:207704
increased circulating glucose level J:207704
increased circulating insulin level J:207704
insulin resistance J:207704
Htr2ctm2Jke/Y
Tg(Pomc-cre/ERT2)#Jke/0
(involves: 129X1/SvJ * C57BL/6J) 		increased circulating glucagon level J:207704
increased circulating glucose level J:207704
increased circulating insulin level J:207704
Htr2ctm2Jke/Y
Tg(Zp3-cre)93Knw/0
(involves: 129X1/SvJ * C57BL/6J) 		hyperglycemia J:207704
Htr2ctm2Jke/Htr2ctm2Jke
Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		hyperglycemia J:207704
increased circulating glucagon level J:207704
increased circulating glucose level J:207704
increased circulating insulin level J:207704
insulin resistance J:207704
Htr2ctm2Jke/Htr2ctm2Jke
Tg(Pomc-cre/ERT2)#Jke/0
(involves: 129X1/SvJ * C57BL/6J) 		increased circulating glucagon level J:207704
increased circulating glucose level J:207704
increased circulating insulin level J:207704
Htr7tm1b(KOMP)Wtsi/Htr7tm1b(KOMP)Wtsi
(C57BL/6N-Htr7tm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Hunktm1b(EUCOMM)Wtsi/Hunktm1b(EUCOMM)Wtsi
(C57BL/6N-Hunktm1b(EUCOMM)Wtsi/Ieg) 		increased circulating glucose level J:211773
Huwe1tm1Wgu/Y
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J) 		decreased circulating insulin level J:182446
hyperglycemia J:182446
impaired glucose tolerance J:182446
increased circulating glucose level J:182446
Huwe1tm1Wgu/Y
Tg(Ins2-cre)23Herr/0
Trp53tm1Thl/Trp53tm1Thl
(involves: C57BL/6J * CBA/J) 		hyperglycemia J:182446
Hyal3tm1.1(KOMP)Vlcg/Hyal3tm1.1(KOMP)Vlcg
(C57BL/6N-Hyal3tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Hyal6em1(IMPC)H/Hyal6em1(IMPC)H
(C57BL/6NTac-Hyal6em1(IMPC)H/H) 		impaired glucose tolerance J:211773
Hycc1em1(IMPC)Ccpcz/Hycc1em1(IMPC)Ccpcz
(C57BL/6N-Hycc1em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
HypismC57BL/6J/HypismPERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ) 		increased circulating insulin level J:94548
Hypn2C57BL/6/Hypn2C57BL/6
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating insulin level J:142949
Hypn3C57BL/6/Hypn3C57BL/6
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating insulin level J:142949
HypnC57BL/6/?
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos) 		increased circulating insulin level J:83539
HypnC57BL/6/HypnC57BL/6
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating insulin level J:142949
Iapptm1Sgm/Iapptm1Sgm
(involves: 129P2/OlaHsd * C57BL/6) 		improved glucose tolerance J:50042
increased circulating insulin level J:50042
Ica1tm1Mdos/Ica1tm1Mdos
(NOD.129-Ica1tm1Mdos) 		abnormal glucose homeostasis J:83526
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay/J) 		increased circulating glucose level J:118466
Idd1NOD/ShiLt/Idd1NOD/ShiLt
(involves: NOD/Lt * NON/Lt) 		abnormal glucose homeostasis J:29464
Idd2NON/ShiLtJ/Idd2NON/ShiLtJ
(involves: NOD/Lt * NON.NOD-H2g7/LtJ) 		abnormal glucose homeostasis J:28967
Idd3129S6/SvEvTac/Idd3129S6/SvEvTac
(NOD.129-Idd3129S6/SvEvTac) 		abnormal glucose homeostasis J:108210
Idd3C57BL/6/Idd3C57BL/6
(involves: C57BL/6 * NOD) 		abnormal glucose homeostasis J:52572
Idd3C57BL/6/Idd3C57BL/6
(NOD.B6-Idd3C57BL/6) 		abnormal glucose homeostasis J:108210
Idd3C57BL/6/Idd3C57BL/6
Idd5C57BL/10SnJ/Idd5C57BL/10SnJ
(involves: C57BL/6 * C57BL/10SnJ * NOD) 		abnormal glucose homeostasis J:71276
Idd3C57BL/10SnJ/Idd3C57BL/10SnJ
Idd5.3C57BL/10SnJ/Idd5.3C57BL/10SnJ
Idd5.1C57BL/10SnJ/Idd5.1C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac) 		abnormal glucose homeostasis J:143549
Idd3C57BL/10SnJ/Idd3C57BL/10SnJ
Idd5C57BL/10SnJ/Idd5C57BL/10SnJ
(involves: C57BL/10 * NOD/MrkTac) 		abnormal glucose homeostasis J:88667
Idd3NOD/?
(involves: C57BL/10 * NOD) 		abnormal glucose homeostasis J:3351, J:17906
Idd4C57BL/6J/?
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:73763
Idd4MSM/Idd4MSM
(involves: MSM * NOD/Shi) 		abnormal glucose homeostasis J:55926
Idd4NOD/Jsd/?
(involves: NOD/Jsd * NOR/LtJ) 		abnormal glucose homeostasis J:99002
Idd4NOD/?
(involves: C57BL/10 * NOD) 		abnormal glucose homeostasis J:3351
Idd4NOR/LtJ/?
(involves: NOD/Jsd * NOR/LtJ) 		abnormal glucose homeostasis J:99002
Idd5.1C57BL/6J/Idd5.1C57BL/6J
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:72900
Idd5.1C57BL/6J/Idd5.1NOD
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:72900
Idd5.1C57BL/10SnJ/Idd5.1C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac) 		abnormal glucose homeostasis J:88667, J:90924, J:143549
Idd5.1NOD/Idd5.1NOD
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:72900
Idd5.2C57BL/10SnJ/Idd5.2C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac) 		abnormal glucose homeostasis J:88667, J:90924
Idd5.3C57BL/10SnJ/Idd5.3C57BL/10SnJ
Idd5.4C57BL/10SnJ/Idd5.4C57BL/10SnJ
Idd5.1C57BL/10SnJ/Idd5.1C57BL/10SnJ
Idd5.2C57BL/10SnJ/Idd5.2C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac) 		abnormal glucose homeostasis J:143549
Idd5.4C57BL/10SnJ/Idd5.4C57BL/10SnJ
Idd5.3C57BL/10SnJ/Idd5.3C57BL/10SnJ
Idd5.2C57BL/10SnJ/Idd5.2C57BL/10SnJ
(involves: C57BL/10SnJ * NOD/MrkTac) 		abnormal glucose homeostasis J:143549
Idd5NOD/?
(involves: C57BL/10 * NOD) 		abnormal glucose homeostasis J:71276
Idd5NOD/Idd5NOD
(involves: C57BL/10 * NOD) 		abnormal glucose homeostasis J:33172
Idd5NOR/LtJ/Idd5NOR/LtJ
(NOD.NOR-Idd5/Jsd) 		abnormal glucose homeostasis J:99002
Idd6C57BL/6JOrl/Idd6C57BL/6JOrl
(NOD.B6-Klrb1ca) 		abnormal glucose homeostasis J:68580
Idd6C57BL/6JOrl/Idd6NOD/Necker
(NOD.B6-Klrb1ca) 		abnormal glucose homeostasis J:68580
Idd6NOD/ShiLt/Idd6NOD/ShiLt
(involves: C3H/HeJ * NOD/Lt) 		abnormal glucose homeostasis J:69992
Idd6NON/ShiLtJ/Idd6NON/ShiLtJ
(involves: NOD/Lt * NON.NOD-H2g7/LtJ) 		abnormal glucose homeostasis J:28947
Idd7NOD/ShiLt/Idd7NOD/ShiLt
(involves: NOD/Lt * NON.NOD-H2g7/LtJ) 		abnormal glucose homeostasis J:28947
Idd7NOD/ShiLt/Idd7NOD/ShiLt
(involves: B10.NOD-H2g7 * NOD/Lt) 		abnormal glucose homeostasis J:13557, J:28947
Idd8NOD/ShiLt/Idd8NOD/ShiLt
(involves: B10.NOD-H2g7 * NOD/Lt) 		abnormal glucose homeostasis J:13557
Idd9.1C57BL/10SnJ/Idd9.1C57BL/10SnJ
(NOD.B10-Idd9.1C57BL/10SnJ) 		abnormal glucose homeostasis J:63670
Idd9.2C57BL/10SnJ/Idd9.2C57BL/10SnJ
(NOD.B10-Idd9.2C57BL/10SnJ) 		abnormal glucose homeostasis J:63670
Idd9.3C57BL/10SnJ/Idd9.3C57BL/10SnJ
(NOD.B10-Idd9.3C57BL/10SnJ) 		abnormal glucose homeostasis J:63670
Idd9C57BL/10SnJ/Idd9C57BL/10SnJ
(NOD.B10-Idd9C57BL/10SnJ) 		abnormal glucose homeostasis J:63670
Idd9NOD/ShiLt/Idd9NOD/ShiLt
(involves: NOD/Lt * NON.NOD-H2g7/LtJ) 		abnormal glucose homeostasis J:28947
Idd10C57BL/6J/Idd10C57BL/6J
(involves: C57BL/6 * NOD) 		abnormal glucose homeostasis J:42103
Idd10C57BL/6J/Idd10C57BL/6J
Idd3C57BL/6/Idd3C57BL/6
(involves: C57BL/6 * NOD) 		abnormal glucose homeostasis J:42103
Idd10C57BL/6J/Idd10C57BL/6J
Idd17C57BL/6J/Idd17C57BL/6J
(involves: C57BL/6 * NOD) 		abnormal glucose homeostasis J:42103
Idd10C57BL/6J/Idd10C57BL/6J
Idd18C57BL/6/Idd18C57BL/6
(involves: C57BL/6 * NOD) 		abnormal glucose homeostasis J:46659
Idd10C57BL/10SnJ/Idd10C57BL/10SnJ
(involves: C57BL/10SnJ * NOD) 		abnormal glucose homeostasis J:42103
Idd10C57BL/10SnJ/Idd10C57BL/10SnJ
Idd17C57BL/10SnJ/Idd17C57BL/10SnJ
(involves: C57BL/10SnJ * NOD) 		abnormal glucose homeostasis J:42103
Idd10IIS/Shi/Idd10IIS/Shi
(NOD.IIS-Idd10) 		abnormal glucose homeostasis J:97940
Idd10IIS/Shi/Idd10NOD/Shi
(NOD.IIS-Idd10) 		abnormal glucose homeostasis J:97940
Idd11NOD/ShiLt/Idd11NOD/ShiLt
(involves: C57BL/6 * NOD/Lt) 		abnormal glucose homeostasis J:19245
Idd11NOD/ShiLt/Idd11NOD/ShiLt
(involves: NOD/Lt * SJL) 		abnormal glucose homeostasis J:19245
Idd12NOD/ShiLt/Idd12NOD/ShiLt
(involves: C57BL/6 * NOD/Lt) 		abnormal glucose homeostasis J:19245
Idd12NOD/ShiLt/Idd12NOD/ShiLt
(involves: NOD/Lt * SJL) 		abnormal glucose homeostasis J:19245
Idd13NOR/Lt/Idd13NOR/Lt
(involves: NOD/Lt * NOR/Lt) 		abnormal glucose homeostasis J:20685
Idd14NOD/ShiLt/Idd14NOD/ShiLt
(involves: NOD/Lt * NON.NOD-H2g7/LtJ) 		abnormal glucose homeostasis J:28947
Idd15NOD/ShiLt/Idd15NOD/ShiLt
(involves: NOD/Lt * NON.NOD-H2g7/LtJ) 		abnormal glucose homeostasis J:28947
Idd16.1ALR/LtJ/Idd16.1ALR/LtJ
(involves: ALR/LtJ * NOD/LtJ) 		abnormal glucose homeostasis J:98187
Idd16ALR/Lt/Idd16NOD/ShiLt
(involves: ALR/Lt * NOD/Lt) 		abnormal glucose homeostasis J:86633
Idd16C57BL/6J/Idd16C57BL/6J
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:77545, J:94603
Idd16C57BL/6J/Idd16NOD
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:94603
Idd16NOD/ShiLt/Idd16NOD/ShiLt
(involves: ALR/Lt * NOD/Lt) 		abnormal glucose homeostasis J:86633
Idd16NOD/ShiLt/Idd16NOD/ShiLt
Idd22NOD/ShiLt/Idd22NOD/ShiLt
(involves: ALR/Lt * NOD/Lt) 		abnormal glucose homeostasis J:86633
Idd17C57BL/6J/Idd17C57BL/6J
(involves: C57BL/6 * NOD) 		abnormal glucose homeostasis J:42103
Idd17C57BL/10SnJ/Idd17C57BL/10SnJ
(involves: C57BL/10SnJ * NOD) 		abnormal glucose homeostasis J:42103
Idd19NOD/ShiLt/?
(involves: C3H/HeJ * NOD/Lt) 		abnormal glucose homeostasis J:69992
Idd19PWK/?
(involves: NOD * PWK) 		abnormal glucose homeostasis J:48505
Idd21.1ABH/Idd21.1ABH
(involves: ABH * NOD) 		abnormal glucose homeostasis J:101740
Idd21.2ABH/Idd21.2ABH
(involves: ABH * NOD) 		abnormal glucose homeostasis J:101740
Idd21.3ABH/Idd21.3ABH
(involves: ABH * NOD) 		abnormal glucose homeostasis J:101740
Idd21NOD/Idd21NOD
(involves: ABH * NOD) 		abnormal glucose homeostasis J:83136
Idd23C57BL/6J/Idd23C57BL/6J
(involves: C57BL/6J * NOD) 		abnormal glucose homeostasis J:94603
Idd25NOD/ShiLt/Idd25NOR/Lt
(involves: NOD/Lt * NOR/Lt) 		abnormal glucose homeostasis J:100365
Idd25NOR/Lt/Idd25NOR/Lt
(involves: NOD/Lt * NOR/Lt) 		abnormal glucose homeostasis J:100365
Idd26NOR/Lt/?
(involves: NOD/Lt * NOR/Lt) 		abnormal glucose homeostasis J:100365
IdeGt(OST132429)Lex/IdeGt(OST132429)Lex
(involves: 129S5/SvEvBrd * C57BL/6-Tyrc) 		hyperglycemia J:82747
impaired glucose tolerance J:82747
increased circulating insulin level J:82747
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn
Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1) 		abnormal glucose homeostasis J:336782
decreased circulating insulin level J:336782
decreased insulin secretion J:336782
hyperglycemia J:336782
impaired glucose tolerance J:336782
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA) 		abnormal glucose homeostasis J:336782
decreased circulating insulin level J:336782
decreased insulin secretion J:336782
hyperglycemia J:336782
impaired glucose tolerance J:336782
increased circulating glucose level J:336782
increased fasting circulating glucose level J:336782
Ift88Tg737Rpw/Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw) 		decreased circulating glucose level J:95813
impaired glucose tolerance J:95813
Igf1tm1.1Dlr/Igf1tm1.1Dlr
(involves: C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:69518
decreased circulating glucose level J:69518
increased circulating insulin level J:69518
Igf1tm1.1Dlr/Igf1tm1.1Dlr
Tg(Ttr-IGF1)1Sykr/0
(FVB.Cg-Igf1tm1.1Dlr Tg(Ttr-IGF1)1Sykr) 		decreased circulating insulin level J:157350
Igf1tm1Dlr/Igf1tm1Dlr
Tg(Serpina1e-cre/ERT)1Sykr/0
(involves: 129/Sv * C57BL/6J * FVB/N) 		increased circulating insulin level J:155733
Igf1tm2Ts/Igf1tm2Ts
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased circulating glucose level J:37969
Igf1rtm1.1Mhz/Igf1rtm1.1Mhz
Tg(Ins2-cre)25Mgn/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		hyperglycemia J:121640
impaired glucose tolerance J:121640
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Tg(Fabp4-cre)1Abel/?
(involves: C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:141321
increased circulating glucose level J:141321
increased insulin sensitivity J:141321
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini) 		decreased circulating glucose level J:271356
decreased circulating insulin level J:271356
decreased fasting circulating glucose level J:271356
improved glucose tolerance J:271356
increased insulin sensitivity J:271356
Igfbp3tm1Jep/Igfbp3tm1Jep
Igfbp4tm1Jep/Igfbp4tm1Jep
Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J) 		abnormal glucose homeostasis J:112029
decreased circulating glucose level J:112029
increased circulating insulin level J:112029
increased insulin secretion J:112029
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal glucose homeostasis J:168345
increased circulating glucose level J:168345
increased circulating insulin level J:168345
Igfbp4tm1Jep/Igfbp4tm1Jep
(involves: 129S/SvEv * C57BL/6J) 		impaired glucose tolerance J:112029
Ighmtm1Cgn/Ighm+
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		increased circulating glucose level J:91865
Igs2em5(CAG-Mir802)Gpt/Igs2em5(CAG-Mir802)Gpt
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA) 		decreased circulating insulin level J:287584
decreased insulin secretion J:287584
impaired glucose tolerance J:287584
Igsf8em1(IMPC)Wtsi/Igsf8em1(IMPC)Wtsi
(C57BL/6N-Igsf8em1(IMPC)Wtsi/WtsiIeg) 		impaired glucose tolerance J:211773
Igsf11tm1b(KOMP)Wtsi/Igsf11tm1b(KOMP)Wtsi
(C57BL/6N-Igsf11tm1b(KOMP)Wtsi/Ucd) 		increased fasting circulating glucose level J:211773
Ikbketm1Dgen/Ikbketm1Dgen
(B6.129P2-Ikbketm1Dgen) 		decreased circulating glucose level J:171942
increased insulin sensitivity J:171942
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		decreased circulating glucose level J:118336
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		impaired glucose tolerance J:108634
increased circulating insulin level J:108634
insulin resistance J:108634
Il2ratm1b(EUCOMM)Wtsi/Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Il2rgtm1Wjl/Il2rgtm1Wjl
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz) 		abnormal glucose homeostasis J:138005
hyperglycemia J:138005
Il4tm1Cgn/Il4tm1Cgn
(NOD.129P2-Il4tm1Cgn) 		increased circulating glucose level J:95105
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		increased circulating glucose level J:105633
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J) 		abnormal glucose homeostasis J:109359
decreased glucagon secretion J:139138
decreased insulin secretion J:139138
impaired glucose tolerance J:139138
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		abnormal glycogen homeostasis J:166367
decreased insulin secretion J:166367
decreased liver glycogen level J:166367
impaired glucose tolerance J:166367
increased glycogen catabolism rate J:166367
increased insulin secretion J:166367
insulin resistance J:166367
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * ICR) 		decreased liver glycogen level J:54660
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:129479
decreased circulating insulin level J:129479
increased insulin sensitivity J:129479
Il10ratm1b(KOMP)Wtsi/Il10ratm1b(KOMP)Wtsi
(C57BL/6N-Il10ratm1b(KOMP)Wtsi/Orl) 		improved glucose tolerance J:211773
Il10rbtm1a(KOMP)Wtsi/Il10rbtm1a(KOMP)Wtsi
(C57BL/6N-Il10rbtm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Il12bem1(IMPC)H/Il12bem1(IMPC)H
(C57BL/6NTac-Il12bem1(IMPC)H/H) 		impaired glucose tolerance J:211773
Il15tm1b(EUCOMM)Hmgu/Il15tm1b(EUCOMM)Hmgu
(C57BL/6N-Il15tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Ildr2Dbsm1-DBA/2J/Ildr2Dbsm1-DBA/2J
(B6.D2-Ildr2Dbsm1-DBA/2J) 		hyperglycemia J:138216
Ildr2Dbsm1-DBA/2J/Ildr2Dbsm1-DBA/2J
Lepob/Lepob
(B6.Cg-Ildr2Dbsm1-DBA/2J Lepob) 		decreased circulating insulin level J:138216
hyperglycemia J:138216
impaired glucose tolerance J:138216
Ildr2W87*/Ildr2W87*
(involves: C3HeB/FeJ) 		decreased circulating insulin level J:138216
impaired glucose tolerance J:138216
Ilrunem1(IMPC)Tcp/Ilrunem1(IMPC)Tcp
(C57BL/6NCrl-Ilrunem1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Ilruntm1a(KOMP)Wtsi/Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased insulin secretion J:302091
impaired glucose tolerance J:302091
Imgt1KK/Ta/Imgt1KK/Ta
(involves: BALB/c * KK/Ta) 		impaired glucose tolerance J:88209
ImmtGt(AW0256)Wtsi/Immt+
(involves: 129P2/OlaHsd) 		increased circulating glucose level J:344896
Impacttm1.1Casb/Impacttm1.1Casb
(involves: C57BL/6J) 		decreased fasting circulating glucose level J:279071
increased insulin sensitivity J:279071
Ing5em1(IMPC)J/Ing5em1(IMPC)J
(C57BL/6NJ-Ing5em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Inhbatm1Zuk/Inhbatm2Zuk
(involves: 129S7/SvEvBrd) 		hypoglycemia J:63882
Inmtem1(IMPC)Mbp/Inmtem1(IMPC)Mbp
(C57BL/6N-Inmtem1(IMPC)Mbp/MbpMmucd) 		improved glucose tolerance J:211773
Inpp5ktm1Brd/Inpp5k+
(B6.Cg-Inpp5ktm1Brd) 		decreased circulating glucose level J:139745
decreased circulating insulin level J:139745
improved glucose tolerance J:139745
increased insulin sensitivity J:139745
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas) 		abnormal glucose homeostasis J:77595, J:40377
increased urine glucose level J:40377
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell) 		increased circulating glucose level J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Mnt/Ins2tm1Mnt
Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		abnormal circulating insulin level J:152798
hyperglycemia J:152798
increased circulating glucose level J:152798
Ins1tm1Jja/Ins1tm1Jja
Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)1Ell) 		increased circulating glucose level J:98583
Ins2Akita/?
(involves: C57BL/6NSlc) 		abnormal glucose homeostasis J:130021
decreased circulating insulin level J:130021
hyperglycemia J:130021
insulin resistance J:130021
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita) 		decreased circulating insulin level J:40063
decreased insulin secretion J:40063, J:47883
hyperglycemia J:40063, J:125256
impaired glucose tolerance J:40063
Ins2Akita/Ins2+
(involves: C3H * C57BL/6NJcl * C57BL/6NSlc) 		hyperglycemia J:40063
impaired glucose tolerance J:40063
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita/J) 		hyperglycemia J:99412, J:76224
increased insulin sensitivity J:76224
Ins2Akita/Ins2+
(involves: C57BL/6NSlc) 		decreased insulin secretion J:200802
increased circulating glucose level J:200802
Ins2Akita/Ins2+
Prf1tm1Sdz/Prf1tm1Sdz
Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz) 		abnormal glucose homeostasis J:138005
hyperglycemia J:138005
Ins2Akita/Ins2+
Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N * C57BL/6NSlc) 		decreased insulin secretion J:200802
impaired glucose tolerance J:200802
increased circulating glucose level J:200802
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita) 		decreased insulin secretion J:47883
hyperglycemia J:47883
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita/J) 		hyperglycemia J:76224
Ins2Akita/Ins2Akita
(involves: C57BL/6NSlc) 		decreased circulating insulin level J:156725
decreased insulin secretion J:156725
hyperglycemia J:156725
Ins2Akita/Ins2Akita
(C.B6N-Ins2Akita) 		hyperglycemia J:198186
Ins2Akita/Ins2Akita
Itga1tm1Gdnr/Itga1tm1Gdnr
(C.Cg-Ins2Akita Itga1tm1Gdnr) 		hyperglycemia J:198186
Ins2Akita/Ins2Akita
Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi
Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J) 		abnormal glucose homeostasis J:303318
increased circulating glucose level J:303318
Ins2Akita/Ins2Akita
Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Ins2Akita Ldlrtm1Her) 		decreased circulating insulin level J:174983
hyperglycemia J:174983
impaired glucose tolerance J:174983
Ins2Akita/Ins2Akita
Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(FVB.Cg-Rpl13atm1.1Jesc Ins2Akita) 		abnormal circulating glucose level J:237822
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S) 		decreased circulating insulin level J:122098
decreased insulin secretion J:122098
hyperglycemia J:122098, J:137483
increased circulating glucose level J:122098
increased urine glucose level J:122098
insulin resistance J:122098
Ins2C95S/Ins2C95S
(C3HeB/FeJ-Ins2C95S) 		increased circulating glucose level J:122098
increased urine glucose level J:122098
Ins2em#Arak/Ins2+
(C.129-Rag2tm1Fwa Ins2em#Arak Jak3tm1Tks/Arak) 		hyperglycemia J:294041
impaired glucose tolerance J:294041
Ins2tm1Delt/Ins2+
(involves: 129S2/SvPas * Black Swiss) 		increased urine glucose level J:94589
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas) 		increased insulin secretion J:77595
Ins2tm1Jja/Ins2tm1Jja
(NOD.129S2-Ins2tm1Jja) 		abnormal glucose homeostasis J:85309
Insig1em1(IMPC)Ccpcz/Insig1em1(IMPC)Ccpcz
(C57BL/6N-Insig1em1(IMPC)Ccpcz/Ccpcz) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Insl5tm1Imad/Insl5tm1Imad
(129(B6)-Insl5tm1Imad) 		decreased circulating insulin level J:189146
hyperglycemia J:189146
impaired glucose tolerance J:189146
Insm2em1Tcai/Insm2em1Tcai
(involves: C57BL/6J) 		decreased circulating insulin level J:334013
impaired glucose tolerance J:334013
increased fasting circulating glucose level J:334013
Insq2SM/J/?
(involves: A/J * SM/J) 		increased circulating insulin level J:64138
Insq3SM/J/?
(involves: A/J * SM/J) 		increased circulating insulin level J:64138
Insq4SM/J/?
(involves: A/J * SM/J) 		increased circulating insulin level J:64138
Insq5SM/J/?
(involves: A/J * SM/J) 		decreased circulating insulin level J:64138
Insq6C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6) 		increased circulating insulin level J:61489
Insq7C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6) 		increased circulating insulin level J:61489
Insq8C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6) 		increased circulating insulin level J:61489
Insq9C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6) 		increased circulating insulin level J:61489
Insq10129/SvIr/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6) 		increased circulating insulin level J:61489
InsrM2Btlr/InsrM2Btlr
(C57BL/6J-InsrM2Btlr) 		increased insulin secretion J:267535
InsrRgsc294/Insr+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
increased circulating insulin level J:133634
increased urine glucose level J:133634
InsrRgsc824/Insr+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
increased circulating insulin level J:133634
increased urine glucose level J:133634
InsrRgsc1777/Insr+
(involves: C3H * C57BL/6JJcl) 		hyperglycemia J:133634
increased circulating insulin level J:133634
Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J) 		increased circulating insulin level J:135659
insulin resistance J:135659
Insrtm1Dac/Insr+
(involves: C3H/HeH * C57BL/6) 		increased circulating insulin level J:141688
increased insulin secretion J:141688
Insrtm1Dac/Insr+
(B6.129S4-Insrtm1Dac/J) 		increased circulating insulin level J:246319
insulin resistance J:246319
Insrtm1Dac/Insr+
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:80826
Insrtm1Dac/Insr+
Ppp2r2aigt10/Ppp2r2a+
(involves: 129S4/SvJae * C3H/HeH * C57BL/6J) 		hyperglycemia J:246319
impaired glucose tolerance J:246319
increased circulating insulin level J:246319
increased urine glucose level J:246319
insulin resistance J:246319
Insrtm1Dac/Insr+
Sox4Igt4/Sox4+
(involves: C3H/HeH * C57BL/6) 		impaired glucose tolerance J:141688
Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:79560
hyperglycemia J:33408
increased circulating insulin level J:33408
Insrtm1Dac/Insrtm1Dac
Insrrtm1Dac/Insrrtm1Dac
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6J) 		hyperglycemia J:70602
impaired glucose tolerance J:70602
increased circulating insulin level J:70602
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L1Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased liver glycogen level J:91350
increased circulating glucose level J:91350
increased circulating insulin level J:91350
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased liver glycogen level J:91350
hyperglycemia J:91350
increased circulating glucose level J:91350
increased circulating insulin level J:91350
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased liver glycogen level J:32538
hyperglycemia J:32538
increased circulating insulin level J:32538
increased urine glucose level J:32538
Insrtm1Jja/Insrtm1Jja
Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2) 		decreased liver glycogen level J:80773
increased circulating glucose level J:80773
increased urine glucose level J:80773
Insrtm1Khn/Insrtm1Dac
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6J * FVB) 		hyperglycemia J:51266
increased circulating insulin level J:51266
Insrtm1Khn/Insrtm1Khn
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N) 		hyperglycemia J:192274
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB) 		abnormal glucose homeostasis J:63878
abnormal insulin clearance J:63878
hyperglycemia J:63878
impaired glucose tolerance J:63878
increased circulating insulin level J:63878
increased insulin secretion J:63878
insulin resistance J:63878
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased circulating glucose level J:121640
hyperglycemia J:121640
impaired glucose tolerance J:121640
increased circulating insulin level J:121640
insulin resistance J:121640
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		decreased liver glycogen level J:234643
hyperglycemia J:234643
impaired glucose tolerance J:234643
increased circulating insulin level J:234643
insulin resistance J:234643
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased insulin secretion J:121640
hyperglycemia J:121640
impaired glucose tolerance J:121640
increased circulating insulin level J:121640
insulin resistance J:121640
Insrtm1Khn/Insrtm1Khn
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased insulin secretion J:121640
hyperglycemia J:121640
impaired glucose tolerance J:121640
Insrtm1Khn/Insrtm1Khn
Tg(Myhca-cre)1Abel/0
(involves: 129S4/SvJae * FVB) 		abnormal glucose homeostasis J:75348
increased cardiac muscle glycogen level J:75348
Insrtm1Khn/Insrtm1Khn
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6J * SJL) 		increased circulating insulin level J:64790
insulin resistance J:64790
Insrtm1Khn/Insrtm1Khn
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		abnormal glucose homeostasis J:109359
Insrtm1Khn/Insrtm1Khn
Tg(Pdgfrb-cre)#Rha/0
(involves: 129S4/SvJae * C57BL/6J) 		increased circulating insulin level J:327000
Insrtm1Khn/Insrtm1Khn
Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB) 		abnormal glucose homeostasis J:169404
decreased liver glycogen level J:169404
hyperglycemia J:169404
impaired glucose tolerance J:169404
increased circulating glucose level J:169404
increased circulating insulin level J:169404
insulin resistance J:169404
Insrtm1Shs/Insr+
(involves: C57BL/6CrSlc) 		hyperglycemia J:98723
impaired glucose tolerance J:98723
increased circulating insulin level J:98723
increased insulin sensitivity J:98723
insulin resistance J:98723
Insyn2bem1(IMPC)J/Insyn2bem1(IMPC)J
(C57BL/6NJ-Insyn2bem1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Ip6k1Gt(OST137568)Lex/Ip6k1Gt(OST137568)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased circulating insulin level J:103485
impaired glucose tolerance J:103485
Ip6k1tm1.1Snyd/Ip6k1tm1.1Snyd
(involves: 129X1/SvJ * BALB/c * C57BL/6) 		decreased circulating insulin level J:132167
increased insulin sensitivity J:132167
Ipo7em1(IMPC)Mbp/Ipo7+
(C57BL/6N-Ipo7em1(IMPC)Mbp/Ucd) 		increased circulating insulin level J:211773
Ipo11tm1.1(KOMP)Vlcg/Ipo11+
(C57BL/6N-Ipo11tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Ipptm1.1(KOMP)Vlcg/Ipptm1.1(KOMP)Vlcg
(C57BL/6N-Ipptm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Iqcetm1b(EUCOMM)Hmgu/Iqcetm1b(EUCOMM)Hmgu
(C57BL/6N-Iqcetm1b(EUCOMM)Hmgu/Ics) 		decreased circulating glucose level J:211773
Iqcf1em1(IMPC)J/Iqcf1em1(IMPC)J
(C57BL/6NJ-Iqcf1em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Iqsec3tm3b(KOMP)Wtsi/Iqsec3tm3b(KOMP)Wtsi
(C57BL/6N-Iqsec3tm3b(KOMP)Wtsi/Bay) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Irag1em1(IMPC)Ccpcz/Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz) 		increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv) 		impaired glucose tolerance J:229884
Irf4tm1Rdf/Irf4tm1Rdf
Tg(Ucp1-cre)1Evdr/0
(involves: 129S1/Sv * C57BL/6J * FVB) 		impaired glucose tolerance J:214637
insulin resistance J:214637
Irf8tm1b(KOMP)Wtsi/Irf8tm1b(KOMP)Wtsi
(C57BL/6N-Irf8tm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Irgm1em1(IMPC)Wtsi/Irgm1em1(IMPC)Wtsi
(C57BL/6N-Irgm1em1(IMPC)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Irs1m1Btlr/Irs1m1Btlr
(C57BL/6J-Irs1m1Btlr) 		increased circulating insulin level J:267531
Irs1Sml/Irs1+
(C3.Cg-Irs1Sml H2b/GrsrJ) 		increased circulating insulin level J:163661
Irs1Sml/Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ) 		decreased circulating glucose level J:163661
impaired glucose tolerance J:163661
increased circulating insulin level J:163661
insulin resistance J:163661
Irs1tm1Jos/Irs1+
Irs2tm2Mfw/Irs2tm2Mfw
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:93415
hyperglycemia J:93415
Irs1tm1Jos/Irs1tm1Jos
(involves: 129S2/SvPas * C57BL/6) 		impaired glucose tolerance J:21374
increased circulating insulin level J:21374
insulin resistance J:21374
Irs1tm1Jos/Irs1tm1Jos
Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		hyperglycemia J:80976
impaired glucose tolerance J:80976
increased circulating insulin level J:80976
insulin resistance J:80976
Irs1tm1Jos/Irs1tm1Jos
Irs4tm1Lhd/Y
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:80976
increased circulating insulin level J:80976
insulin resistance J:80976
Irs1tm1Jos/Irs1tm1Jos
Irs4tm1Lhd/Irs4tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:80976
increased circulating insulin level J:80976
insulin resistance J:80976
Irs1tm1Mfw/Irs1+
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N) 		impaired glucose tolerance J:156999
Irs1tm1Mfw/Irs1tm1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased liver glycogen level J:137845
hyperglycemia J:137845
impaired glucose tolerance J:137845
increased circulating glucose level J:137845
increased circulating insulin level J:137845
insulin resistance J:137845
Irs1tm1Mfw/Irs1tm1Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		impaired glucose tolerance J:137845
Irs1tm1Mfw/Irs1tm2.1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N) 		impaired glucose tolerance J:156999
increased circulating insulin level J:156999
insulin resistance J:156999
Irs1tm1Tka/Irs1tm1Tka
(Not Specified) 		abnormal glucose homeostasis J:21373
increased circulating insulin level J:21373
insulin resistance J:21373
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA) 		decreased insulin secretion J:65485
increased circulating insulin level J:61479
insulin resistance J:99746
Irs1tm2.1Mfw/Irs1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased circulating insulin level J:156999
Irs1tm2.1Mfw/Irs1tm2.1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		impaired glucose tolerance J:156999
increased circulating insulin level J:156999
insulin resistance J:156999
Irs1tm2.1Mfw/Irs1tm2.1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N) 		impaired glucose tolerance J:156999
increased circulating insulin level J:156999
Irs1tm2Tka/Irs1tm2Tka
Irs2tm2Tka/Irs2tm2Tka
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		insulin resistance J:137846
Irs1tm2Tka/Irs1tm2Tka
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased circulating insulin level J:137846
insulin resistance J:137846
Irs2M1Btlr/Irs2M1Btlr
(C57BL/6J-Irs2M1Btlr) 		hyperglycemia J:267533
increased insulin secretion J:267533
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal circulating glucose level J:74303
abnormal circulating insulin level J:94000
abnormal glucose homeostasis J:64791, J:74303
decreased skeletal muscle glycogen level J:74303
hyperglycemia J:135659, J:94000, J:96047, J:46134
impaired glucose tolerance J:64791, J:46134
increased circulating insulin level J:135659, J:46134
insulin resistance J:135659, J:46134
Irs2tm1Mfw/Irs2tm1Mfw
Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:87249
impaired glucose tolerance J:87249
increased insulin sensitivity J:87249
Irs2tm1Mfw/Irs2tm1Mfw
Tg(Ins2-Irs2)13Mfw/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating insulin level J:94000
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA) 		hyperglycemia J:99746
impaired glucose tolerance J:65485
increased circulating insulin level J:65485
increased insulin secretion J:65485
insulin resistance J:65485, J:99746
Irs2tm1With/Irs2tm1With
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6J) 		impaired glucose tolerance J:97406
increased circulating glucose level J:97406
increased circulating insulin level J:97406
Irs2tm1With/Irs2tm1With
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6J) 		impaired glucose tolerance J:97406
increased circulating glucose level J:97406
increased circulating insulin level J:97406
Irs2tm2Mfw/Irs2tm2Mfw
Irs4tm1.1Mfw/Y
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal glucose homeostasis J:221293
impaired glucose tolerance J:221293
increased circulating glucose level J:221293
increased circulating insulin level J:221293
increased fasting circulating glucose level J:221293
insulin resistance J:221293
Irs2tm2Mfw/Irs2tm2Mfw
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		impaired glucose tolerance J:93415
increased circulating glucose level J:93415
increased circulating insulin level J:93415
insulin resistance J:93415
Irs2tm2Mfw/Irs2tm2Mfw
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal glucose homeostasis J:221293
impaired glucose tolerance J:221293
increased circulating glucose level J:221293
increased circulating insulin level J:221293
increased fasting circulating glucose level J:221293
insulin resistance J:221293
Irs2tm2Tka/Irs2tm2Tka
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased circulating insulin level J:137846
insulin resistance J:137846
Irs2tm2Tka/Irs2tm2Tka
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:93416
increased circulating glucose level J:93416
insulin resistance J:93416
Irs4tm1.1Mfw/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating glucose level J:221293
Irs4tm1Lhd/Y
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating glucose level J:59964
impaired glucose tolerance J:59964
Irs4tm1Lhd/Y
(involves: 129S4/SvJae * BALB/c) 		impaired glucose tolerance J:59964
Irs4tm1Lhd/Irs4tm1Lhd
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose tolerance J:59964
Irx3em2(IMPC)H/Irx3em2(IMPC)H
(C57BL/6N-Irx3em2(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Irx3tm1Hui/Irx3tm1Hui
(involves: 129S1/Sv * 129X1/SvJ) 		improved glucose tolerance J:208887
increased insulin sensitivity J:208887
Ism1em1.1Kajs/Ism1em1.1Kajs
(involves: C57BL/6J * FVB/N) 		impaired glucose tolerance J:309734
insulin resistance J:309734
Itchtm1b(EUCOMM)Hmgu/Itchtm1b(EUCOMM)Hmgu
(C57BL/6N-Itchtm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Itga8tm1b(KOMP)Wtsi/Itga8+
(C57BL/6N-Itga8tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Itga11em1(IMPC)H/Itga11em1(IMPC)H
(C57BL/6N-Itga11em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Itgb2tm1Bay/Itgb2tm1Bay
(B6.129S7-Itgb2tm1Bay/J) 		increased circulating glucose level J:118466
Itgb3tm1Hyn/Itgb3tm1Hyn
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased circulating glucose level J:83615
Itpr1opt/Itpr1+
(B6C3Fe-a/a-Itpr1opt/J) 		decreased insulin secretion J:222913
impaired glucose tolerance J:222913
Itpr2tm1Kmik/Itpr2tm1Kmik
Itpr3tm1Kmik/Itpr3tm1Kmik
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating glucose level J:101380
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa) 		abnormal glucose homeostasis J:144968
decreased circulating glucose level J:144968
decreased circulating insulin level J:144968
improved glucose tolerance J:144968
increased insulin sensitivity J:144968
Izumo1rtm2a(KOMP)Wtsi/Izumo1rtm2a(KOMP)Wtsi
(C57BL/6N-Izumo1rtm2a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Jade2em1(IMPC)Tcp/Jade2em1(IMPC)Tcp
(C57BL/6N-Jade2em1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		hypoglycemia J:199153
Jakmip2em1(IMPC)J/Jakmip2em1(IMPC)J
(C57BL/6NJ-Jakmip2em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Jam3tm1.1(KOMP)Vlcg/Jam3+
(C57BL/6N-Jam3tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Jmjd4em1(IMPC)Wtsi/Jmjd4em1(IMPC)Wtsi
(C57BL/6N-Jmjd4em1(IMPC)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Jmjd7em1(IMPC)Wtsi/Jmjd7em1(IMPC)Wtsi
(C57BL/6N-Jmjd7em1(IMPC)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Jmjd8em1Kaso/Jmjd8em1Kaso
(C57BL/6-Jmjd8em1Kaso) 		decreased circulating insulin level J:319518
improved glucose tolerance J:319518
increased insulin sensitivity J:319518
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J) 		decreased circulating glucose level J:210545
Juptm1.1(KOMP)Vlcg/Jup+
(C57BL/6N-Juptm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Kat2bem1(IMPC)Wtsi/Kat2bem1(IMPC)Wtsi
(C57BL/6N-Kat2bem1(IMPC)Wtsi/WtsiIeg) 		impaired glucose tolerance J:211773
Kbtbd2em1Btlr/Kbtbd2em1Btlr
(Not Specified) 		increased circulating insulin level J:236520
increased fasting circulating glucose level J:236520
insulin resistance J:236520
Kbtbd2em1Btlr/Kbtbd2em1Btlr
Pik3r1em1Btlr/Pik3r1em1Btlr
(Not Specified) 		decreased circulating glucose level J:236520
decreased circulating insulin level J:236520
increased insulin sensitivity J:236520
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr) 		increased circulating insulin level J:236520
increased fasting circulating glucose level J:236520
insulin resistance J:236520
Kcna3tm1Gvd/Kcna3tm1Gvd
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:88651
decreased circulating insulin level J:88651
increased insulin sensitivity J:88651
Kcnb1tm1Dgen/Kcnb1tm1Dgen
(involves: C57BL/6) 		hypoglycemia J:129963
improved glucose tolerance J:129963
increased circulating insulin level J:129963
increased insulin secretion J:129963
Kcnh3tm1.1(KOMP)Vlcg/Kcnh3tm1.1(KOMP)Vlcg
(C57BL/6N-Kcnh3tm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Kcnh6em1Jkya/Kcnh6em1Jkya
(involves: C57BL/6N) 		abnormal glucose homeostasis J:271003
abnormal insulin secretion J:271003
decreased circulating glucose level J:271003
decreased circulating insulin level J:271003
decreased insulin secretion J:271003
impaired glucose tolerance J:271003
increased circulating insulin level J:271003
increased fasting circulating glucose level J:271003
increased insulin secretion J:271003
Kcnh6em2Jkya/Kcnh6em2Jkya
(involves: C57BL/6N) 		abnormal glucose homeostasis J:271003
decreased circulating glucose level J:271003
decreased circulating insulin level J:271003
decreased insulin secretion J:271003
impaired glucose tolerance J:271003
increased circulating insulin level J:271003
increased fasting circulating glucose level J:271003
Kcnj11tm1b(EUCOMM)Wtsi/Kcnj11tm1b(EUCOMM)Wtsi
(C57BL/6N-Kcnj11tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Kcnj11tm1Sse/Kcnj11+
Tg(Ins1-Kcnj11*)#Nich/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased insulin secretion J:94610
impaired glucose tolerance J:94610
improved glucose tolerance J:94610
increased circulating glucose level J:94610
increased circulating insulin level J:94610
increased insulin secretion J:94610
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse) 		abnormal glucose homeostasis J:69163
decreased glucagon secretion J:69163
hypoglycemia J:69163
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd) 		decreased circulating insulin level J:49755
impaired glucose tolerance J:49755
increased insulin sensitivity J:49755
Kcnj11tm1Sse/Kcnj11tm1Sse
Tg(Ins1-Kcnj11*)#Nich/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased insulin secretion J:94610
impaired glucose tolerance J:94610
increased circulating glucose level J:94610
Kcnj11Y12stop/Kcnj11Y12stop
(involves: BALB/c * C3H/HeH) 		decreased glucagon secretion J:122088
increased insulin secretion J:122088
Kcnk16tm1.1Lex/Kcnk16tm1.1Lex
(B6.129S-Kcnk16tm1.1Lex) 		abnormal fasting circulating glucose level J:259519
increased insulin secretion J:259519
Kcnn4em1(IMPC)Ccpcz/Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Kctd1Mhdahst014/Kctd1+
(C3HeB/FeJ-Kctd1Mhdahst014) 		increased circulating glucose level J:250423
Kctd7em2(IMPC)Bay/Kctd7em2(IMPC)Bay
(C57BL/6N-Kctd7em2(IMPC)Bay/BayMmucd) 		increased fasting circulating glucose level J:211773
Kdm3aem1(IMPC)Mbp/Kdm3aem1(IMPC)Mbp
(C57BL/6N-Kdm3aem1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Kdm3atm1.1Jsak/Kdm3atm1.1Jsak
(involves: C57BL/6 * CBA) 		increased circulating glucose level J:158258
increased circulating insulin level J:158258
insulin resistance J:158258
Kdm8tm1a(EUCOMM)Wtsi/Kdm8+
(C57BL/6N-Kdm8tm1a(EUCOMM)Wtsi/Ics) 		abnormal glucose homeostasis J:165965
Kif5btm1Njen/Kif5b+
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL) 		decreased insulin secretion J:170198
impaired glucose tolerance J:170198
Kif5btm1Njen/Kif5btm1.1Njen
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL) 		decreased circulating insulin level J:170198
decreased insulin secretion J:170198
hyperglycemia J:170198
impaired glucose tolerance J:170198
Kif21atm1b(EUCOMM)Hmgu/Kif21a+
(C57BL/6N-Kif21atm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Kifap3tm1a(KOMP)Wtsi/Kifap3+
(C57BL/6N-Kifap3tm1a(KOMP)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae) 		increased circulating glucose level J:181650
Kittm1Rosay/Kit+
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		hyperglycemia J:168676
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J) 		decreased circulating glucose level J:229255
Klkl/Kl+
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating insulin level J:64878
decreased insulin secretion J:64878
hypoglycemia J:64878
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J)) 		decreased insulin secretion J:44109
hypoglycemia J:44109
Klkl/Klkl
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating insulin level J:64878
decreased insulin secretion J:64878
hypoglycemia J:64878
increased insulin sensitivity J:64878
Klkl/Klkl
(involves: C3H/J * C57BL/6J) 		abnormal glucose homeostasis J:66078
decreased circulating insulin level J:66078
hypoglycemia J:66078
improved glucose tolerance J:66078
increased insulin sensitivity J:66078
Klbtm1.1Akha/Klbtm1.1Akha
(C57BL/6-Klbtm1.1Akha) 		abnormal circulating glucose level J:195570
abnormal circulating insulin level J:195570
decreased circulating insulin level J:195570
Klbtm1.1Sakl/Klbtm1.1Sakl
Tg(Fabp4-cre)1Rev/0
(involves: 129 * C57BL/6 * SJL) 		abnormal glucose homeostasis J:189018
increased insulin sensitivity J:189018
Klbtm1.2Sakl/Klb+
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased circulating glucose level J:189018
decreased circulating insulin level J:189018
improved glucose tolerance J:189018
increased insulin sensitivity J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		abnormal glucose homeostasis J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		abnormal glucose homeostasis J:189018
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain) 		abnormal gluconeogenesis J:129763
decreased circulating glucose level J:129763
decreased liver glycogen level J:129763
hypoglycemia J:129763
improved glucose tolerance J:129763
increased circulating glucagon level J:129763
Klf16em1(IMPC)J/Klf16+
(C57BL/6NJ-Klf16em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Klhdc10em1(IMPC)J/Klhdc10em1(IMPC)J
(C57BL/6NJ-Klhdc10em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Klhl32em1(IMPC)J/Klhl32em1(IMPC)J
(C57BL/6NJ-Klhl32em1(IMPC)J/Mmjax) 		decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH) 		decreased insulin secretion J:203736
impaired glucose tolerance J:203736
increased circulating glucose level J:79719, J:203736
increased circulating insulin level J:203736
insulin resistance J:203736
Kmt2bm1H/Kmt2b+
(involves: BALB/c * C3H/HeH) 		decreased insulin secretion J:203736
impaired glucose tolerance J:203736
increased circulating glucose level J:203736
increased circulating insulin level J:203736
insulin resistance J:203736
Kmt2btm1Afst/Kmt2b+
(involves: 129P2/OlaHsd) 		decreased insulin secretion J:203736
impaired glucose tolerance J:203736
increased circulating glucose level J:203736
increased circulating insulin level J:203736
insulin resistance J:203736
Kmt2ctm1.1Jwle/Kmt2c+
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd * 129X1/SvJ) 		improved glucose tolerance J:301497
increased insulin sensitivity J:301497
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd) 		improved glucose tolerance J:301497
increased insulin sensitivity J:301497
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Tg(Nkx2-1-cre)2Sand/0
(involves: C57BL/6) 		decreased circulating glucose level J:301083
Knl1tm1b(EUCOMM)Hmgu/Knl1+
(C57BL/6N-Knl1tm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Knstrntm1b(KOMP)Wtsi/Knstrntm1b(KOMP)Wtsi
(C57BL/6N-Knstrntm1b(KOMP)Wtsi/Ics) 		increased fasting circulating glucose level J:211773
Kntc1tm1b(EUCOMM)Hmgu/Kntc1+
(C57BL/6N-Kntc1tm1b(EUCOMM)Hmgu/J) 		increased fasting circulating glucose level J:211773
Krt8tm1b(EUCOMM)Hmgu/Krt8+
(C57BL/6N-Krt8tm1b(EUCOMM)Hmgu/Ics) 		improved glucose tolerance J:211773
Krt80em1(IMPC)J/Krt80em1(IMPC)J
(C57BL/6NJ-Krt80em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Krtcap2em1(IMPC)J/Krtcap2em1(IMPC)J
(C57BL/6NJ-Krtcap2em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Kyem1(IMPC)J/Ky+
(C57BL/6NJ-Kyem1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL) 		increased cardiac muscle glycogen level J:328713
Lamp2tm1Amcu/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal glucose homeostasis J:215605
decreased fasting circulating glucose level J:215605
decreased hepatic glucose production J:215605
decreased liver glycogen level J:215605
improved glucose tolerance J:215605
Lamtor5tm1Lye/Lamtor5tm1Lye
(Not Specified) 		decreased insulin secretion J:258406
Lamtor5tm1Lye/Lamtor5tm1Lye
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		decreased circulating insulin level J:258406
decreased insulin secretion J:258406
impaired glucose tolerance J:258406
increased fasting circulating glucose level J:258406
Laptm4atm1b(EUCOMM)Hmgu/Laptm4atm1b(EUCOMM)Hmgu
(C57BL/6N-Laptm4atm1b(EUCOMM)Hmgu/Ics) 		increased fasting circulating glucose level J:211773
Larp1tm1c(EUCOMM)Hmgu/Larp1tm1c(EUCOMM)Hmgu
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		impaired glucose tolerance J:300456
Larp4bem1(IMPC)Wtsi/Larp4bem1(IMPC)Wtsi
(C57BL/6N-Larp4bem1(IMPC)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Lbptm1b(EUCOMM)Hmgu/Lbptm1b(EUCOMM)Hmgu
(C57BL/6N-Lbptm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Lcattm1Hgc/Lcattm1Hgc
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA) 		decreased circulating glucose level J:89015
decreased circulating insulin level J:89015
Lclat1tm1Yugs/Lclat1tm1Yugs
(B6.Cg-Lclat1tm1Yugs) 		decreased circulating glucose level J:163077
decreased circulating insulin level J:163077
increased insulin sensitivity J:163077
Lcmt1Gt(CSC099)Byg/Lcmt1Gt(CSC099)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:201873
increased circulating insulin level J:201873
insulin resistance J:201873
Lcn2tm1Aade/Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade) 		impaired glucose tolerance J:169355
increased circulating insulin level J:169355
increased fasting circulating glucose level J:169355
insulin resistance J:169355
Lcn2tm1b(KOMP)Wtsi/Lcn2tm1b(KOMP)Wtsi
(C57BL/6N-Lcn2tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Lcp1tm1e.1(KOMP)Wtsi/Lcp1+
(C57BL/6N-Lcp1tm1e.1(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Ldlrtm1Her/Ldlr+
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		hyperglycemia J:100916
Ldlrtm1Her/Ldlr+
Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		hyperglycemia J:100916
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal glucose homeostasis J:84844
impaired glucose tolerance J:84844
increased circulating glucose level J:84844
increased circulating insulin level J:84844
insulin resistance J:84844
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her) 		hyperglycemia J:100916, J:130278
impaired glucose tolerance J:130278
increased circulating insulin level J:130278
Ldlrtm1Her/Ldlrtm1Her
Mobq6CAST/EiJ/Mobq6CAST/EiJ
(B6.CAST-Mobq6CAST/EiJ) 		improved glucose tolerance J:116503
Ldlrtm1Her/Ldlrtm1Her
Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		hyperglycemia J:100916
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst) 		impaired glucose tolerance J:167736
increased circulating glucose level J:167736
increased circulating insulin level J:167736
insulin resistance J:167736
Lepob/Lepob
(involves: C57BL/6J) 		abnormal glucose homeostasis J:92558
abnormal insulin secretion J:14402, J:22634
hyperglycemia J:219118, J:92558
impaired glucose tolerance J:219118, J:86303
increased circulating insulin level J:92558
increased fasting circulating glucose level J:219118
insulin resistance J:219118
Lepob/Lepob
(B6.Cg-Lepob/J) 		abnormal circulating glucose level J:5400
decreased circulating glucose level J:129554, J:145998, J:189019
decreased insulin secretion J:145998
hyperglycemia J:65486, J:122746, J:5400
hypoglycemia J:5400
impaired glucose tolerance J:107486, J:104171
increased circulating insulin level J:104171, J:122746, J:5400
increased insulin secretion J:145998
insulin resistance J:104171
Lepob/Lepob
(D2.Cg-Lepob/Chua) 		hyperglycemia J:78850
increased circulating insulin level J:78850
Lepob/Lepob
(FVB.Cg-Lepob/Chua) 		hyperglycemia J:78850
increased circulating insulin level J:78850
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6) 		hyperglycemia J:107169
increased circulating insulin level J:107169, J:76479
Lepob/Lepob
(involves: 129 * C57BL/6) 		increased circulating insulin level J:121534
increased insulin secretion J:121534
insulin resistance J:121534
Lepob/Lepob
(BKS.Cg-Lepob/J) 		abnormal circulating glucose level J:5400
hyperglycemia J:5400
increased circulating insulin level J:5400
increased urine glucose level J:5400
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs) 		abnormal glucose homeostasis J:7702
hyperglycemia J:7702
impaired glucose tolerance J:7702
increased circulating insulin level J:7702
Lepob/Lepob
(BTBR.Cg-Lepob) 		hyperglycemia J:65486
Lepob/Lepob
(involves: BTBR * C57BL/6 * V stock) 		hyperglycemia J:65486
increased circulating insulin level J:65486
Lepob/Lepob
(BTBR.Cg-Lepob/WiscJ) 		hyperglycemia J:106121, J:185261
impaired glucose tolerance J:106121
increased circulating insulin level J:106121
insulin resistance J:106121
Lepob/Lepob
Mapk8tm1Wag/Mapk8tm1Wag
(B6.Cg-Lepob Mapk8tm1Wag) 		decreased circulating glucose level J:80452
decreased circulating insulin level J:80452
Lepob/Lepob
Mir375tm1Stf/Mir375tm1Stf
(B6.Cg-Mir375tm1Stf Lepob) 		abnormal gluconeogenesis J:147572
decreased circulating insulin level J:147572
increased circulating glucose level J:147572
Lepob/Lepob
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae) 		increased circulating glucose level J:231617
increased circulating insulin level J:231617
insulin resistance J:231617
Lepob/Lepob
Nfe2l2tm1.1Jgpi/Nfe2l2tm1.1Jgpi
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		increased circulating glucose level J:208590
insulin resistance J:208590
Lepob/Lepob
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob) 		hyperglycemia J:208590
insulin resistance J:208590
Lepob/Lepob
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		abnormal circulating glucose level J:107169
abnormal circulating insulin level J:107169
Lepob/Lepob
Npy2rtm1Pern/Npy2rtm1Pern
(involves: 129 * BALB/c * C57BL/10J) 		decreased circulating glucose level J:102651
Lepob/Lepob
Pmchtm1.1(HBEGF)Rpa/Pmch+
(B6.Cg-Lepob Pmchtm1.1(DTR)Rpa) 		improved glucose tolerance J:181947
Lepob/Lepob
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:85176
abnormal glucose tolerance J:85176
decreased circulating glucose level J:85176
increased circulating insulin level J:85176
Lepob/Lepob
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		abnormal glucose homeostasis J:116568
increased circulating glucose level J:116568
increased circulating insulin level J:116568
insulin resistance J:116568
Lepob/Lepob
Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:121534
abnormal insulin secretion J:121534
decreased circulating insulin level J:121534
hyperglycemia J:121534
increased circulating glucose level J:121534
increased circulating insulin level J:121534
increased urine glucose level J:121534
insulin resistance J:121534
Lepob/Lepob
Ptprvtm1Asmi/Ptprv+
(involves: 129P2/OlaHsd * C57BL/10J) 		increased circulating insulin level J:145998
Lepob/Lepob
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/10J) 		decreased circulating glucose level J:145998
improved glucose tolerance J:145998
increased circulating insulin level J:145998
Lepob/Lepob
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		impaired glucose tolerance J:70695
increased circulating insulin level J:70695
Lepob/Lepob
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:189021
increased circulating glucose level J:189021
increased urine glucose level J:189021
insulin resistance J:189021
Lepob/Lepob
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		increased circulating glucose level J:187736
Lepob/Lepob
Stxbp5lT2dm1/Stxbp5lT2dm1
(B6.Cg-Lepob Chr 16BTNTTF) 		decreased circulating insulin level J:178002
increased circulating glucose level J:178002
Lepob/Lepob
Stxbp5lT2dm1/Stxbp5lT2dm1
T2dm2C57BL/6J/T2dm2C57BL/6J
(involves: BTBR * C57BL/6J) 		hyperglycemia J:65486
Lepob/Lepob
T2dm2BTBR/T2dm2BTBR
(involves: BTBR * C57BL/6J) 		increased circulating insulin level J:65486
Lepob/Lepob
T2dm2BTBR/T2dm2C57BL/6J
(involves: BTBR * C57BL/6J) 		increased circulating insulin level J:65486
Lepob/Lepob
Tg(Ins2-Mir184)4Mnpy/0
(involves: C57BL/10J) 		decreased circulating insulin level J:210552
decreased insulin secretion J:210552
hyperglycemia J:210552
Lepob/Lepob
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:210552
increased circulating glucose level J:210552
Lepob/Lepob
Tg(Myh6-Med13)1Eno/0
(involves: C57BL/6) 		improved glucose tolerance J:186193
Lepob/Lepob
Tg(Pmch-ATXN3*)3Rck/0
(involves: C57BL/6J * FVB/NJ) 		decreased circulating glucose level J:104264
Lepob/Lepob
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:55722
Leprbrta/Leprbrta
(C57BL/6JSfdAnu-Leprbrta/Anu) 		hyperglycemia J:104190
Leprdb-3J/Leprdb-3J
(129P3/J-Leprdb-3J/J) 		hyperglycemia J:6337
hypoglycemia J:6337
increased circulating glucagon level J:6337
increased circulating insulin level J:6337
Leprdb-3J/Leprdb-3J
(B6.129-Leprdb-3J) 		abnormal circulating glucose level J:78850
abnormal circulating insulin level J:78850
abnormal glucose homeostasis J:78850
increased insulin sensitivity J:78850
Leprdb-5J/Leprdb-5J
(NOD/ShiLtJ-Leprdb-5J/LtJ) 		hyperglycemia J:87061
increased circulating insulin level J:87061
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J) 		abnormal circulating glucose level J:118305
hyperglycemia J:118305
increased circulating insulin level J:118305
Leprdb-9J/Leprdb-9J
(involves: C57BL/6 * CBA * SWR) 		decreased circulating insulin level J:129982
hyperglycemia J:129982
increased liver glycogen level J:129982
Leprdb-ad/Leprdb-ad
(Not Specified) 		increased circulating glucose level J:31691
increased circulating insulin level J:31691
LeprDb-Btlr/LeprDb-Btlr
(C57BL/6J-LeprDb-Btlr) 		hyperglycemia J:133632
Leprdb-dmpg/Leprdb-dmpg
(involves: B10.D2-H8b/Sn * C57BL/6) 		hyperglycemia J:83762
increased circulating insulin level J:83762
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl) 		insulin resistance J:171755
Leprdb-NCSU/Leprdb-NCSU
(involves: CD-1) 		increased circulating glucose level J:60363
increased circulating insulin level J:60363
increased urine glucose level J:60363
insulin resistance J:60363
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl) 		impaired glucose tolerance J:313303
increased circulating insulin level J:313303
increased fasting circulating glucose level J:313303
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas) 		hyperglycemia J:174584
increased circulating insulin level J:174584
Leprdb-rlpy/Leprdb-rlpy
(involves: NU/J) 		hyperglycemia J:83762
increased circulating insulin level J:83762
Leprdb-rtnd/Leprdb-rtnd
(involves: C57BL/6 * CBA/J) 		hyperglycemia J:83762
increased circulating insulin level J:83762
Leprdb/Lepr+
(involves: C57BLKS/J) 		abnormal circulating insulin level J:71934
abnormal glucose homeostasis J:71934
decreased circulating insulin level J:219658
impaired glucose tolerance J:219658, J:71934
increased circulating glucose level J:71934
Leprdb/Lepr+
Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J) 		impaired glucose tolerance J:186924
increased circulating glucose level J:186924
increased circulating insulin level J:186924
insulin resistance J:186924
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl) 		impaired glucose tolerance J:313303
increased circulating insulin level J:313303
increased fasting circulating glucose level J:313303
Leprdb/Leprdb
(involves: C57BLKS/J) 		abnormal glucose homeostasis J:107138, J:80996
decreased circulating glucose level J:117919
decreased circulating insulin level J:117919
hyperglycemia J:106871, J:117919, J:104790, J:96047, J:232827, J:210493, J:106597
impaired glucose tolerance J:89242
increased circulating glucose level J:89242, J:5010, J:80996
increased circulating insulin level J:104790, J:232827, J:106597, J:89242, J:5010, J:80996
insulin resistance J:117919
Leprdb/Leprdb
(FVB.BKS-Leprdb) 		abnormal circulating glucose level J:78850
hyperglycemia J:78850
impaired glucose tolerance J:78850
increased circulating insulin level J:78850
insulin resistance J:78850
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J) 		abnormal glucose homeostasis J:82334
hyperglycemia J:18161
increased circulating glucose level J:82334
increased circulating insulin level J:82334
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J) 		abnormal circulating glucose level J:43162
decreased circulating glucose level J:91813, J:43162
decreased circulating insulin level J:91813, J:43162
hyperglycemia J:185546, J:135864
improved glucose tolerance J:43162
increased circulating glucose level J:6323
increased glucagon secretion J:6264
Leprdb/Leprdb
(involves: C57BL/6 * C57BLKS/J) 		hyperglycemia J:142218
impaired glucose tolerance J:164339, J:142218
increased circulating glucose level J:164339
increased circulating insulin level J:164339
insulin resistance J:164339, J:142218
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/Jcl) 		hyperglycemia J:156725
increased circulating insulin level J:156725
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/J) 		impaired glucose tolerance J:166105
insulin resistance J:166105
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb) 		impaired glucose tolerance J:313303
increased circulating insulin level J:313303
increased fasting circulating glucose level J:313303
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb) 		hyperglycemia J:346348
increased circulating insulin level J:346348
Leprdb/Leprdb
Nos3tm1Unc/Nos3tm1Unc
(BKS.Cg-Leprdb Nos3tm1Unc) 		hyperglycemia J:135864
Leprdb/Leprdb
Ptentm1Hwu/Ptentm1Hwu
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BLKS/J * DBA) 		increased insulin secretion J:170206
insulin resistance J:170206
Leprdb/Leprdb
Repin1tm1.2Arte/Repin1tm1.2Arte
(involves: BALB/c * C57BL/6 * C57BLKS/J) 		decreased circulating glucose level J:238672
increased insulin sensitivity J:238672
Leprdb/Leprdb
Rock1tm1Leiw/Rock1tm1Leiw
(involves: 129S7/SvEvBrd * C57BLKS/J * FVB/N) 		hyperglycemia J:182287
Leprdb/Leprdb
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6 * C57BLKS/J) 		hyperglycemia J:127478
Leprdb/Leprdb
Tg(Fabp4-Fcor)1Jnak/0
(involves: C57BL/6 * C57BLKS/J * DBA/2) 		improved glucose tolerance J:184684
increased insulin sensitivity J:184684
Leprdb/Leprdb
Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA) 		hyperglycemia J:232827
increased circulating insulin level J:232827
LeprKK/LeprKK
(involves: C57BL/6J * KK/HlLt) 		increased circulating glucose level J:53637
increased circulating insulin level J:53637
Leprm5Btlr/Leprm5Btlr
(C57BL/6-Leprm5Btlr) 		impaired glucose tolerance J:166105
increased circulating insulin level J:166105
insulin resistance J:166105
Leprm7Btlr/Leprm7Btlr
(C57BL/6J-Leprm7Btlr) 		increased circulating glucose level J:236685
LeprTg(Mth11)1Aig/LeprTg(Mth11)1Aig
(involves: Him:OF1) 		hyperglycemia J:61119
increased circulating insulin level J:61119
increased urine glucose level J:61119
Leprtm1.1Chua/Leprtm1.1Chua
(involves: 129 * C57BL/6) 		decreased circulating glucose level J:94019
Leprtm1.1Chua/Leprtm1.1Chua
Prlhtm1(cre)Smln/Prlh+
(involves: 129 * C57BL/6J) 		increased circulating insulin level J:215557
Leprtm1.1Chua/Leprtm1.1Chua
Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac) 		abnormal circulating glucose level J:174691
increased circulating insulin level J:174691
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6 * CBA) 		increased insulin secretion J:145998
Leprtm1.1Chua/Leprtm1.2Chua
Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating glucose level J:183754
increased circulating insulin level J:183754
Leprtm1.2Chua/Leprtm1.2Chua
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:94019
hyperglycemia J:94019
increased circulating insulin level J:94019
Leprtm1.2Chua/Leprtm1.2Chua
Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating glucose level J:183754
increased circulating insulin level J:183754
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H) 		increased circulating glucose level J:211773
Leprtm1Chua/Leprtm1Chua
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:94019
increased circulating glucose level J:94019
increased circulating insulin level J:94019
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J) 		abnormal gluconeogenesis J:184572
abnormal glucose homeostasis J:184572
hyperglycemia J:184572
increased circulating glucagon level J:184572
increased circulating insulin level J:184572
increased insulin secretion J:184572
increased insulin sensitivity J:184572
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ) 		hyperglycemia J:216393
increased circulating insulin level J:216393
Leprtm1Jke/Leprtm1Jke
Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal glucose homeostasis J:184572
decreased circulating glucose level J:184572
decreased circulating insulin level J:184572
increased circulating insulin level J:184572
increased insulin secretion J:184572
increased insulin sensitivity J:184572
Leprtm1Mgmj/Leprtm1Mgmj
(B6.129-Leprtm1Mgmj) 		abnormal glucose homeostasis J:82334
increased circulating glucose level J:82334
increased circulating insulin level J:82334
Leprtm1Rck/Leprtm1.1Rck
Tg(Syn1-cre)671Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hyperglycemia J:72241
increased circulating insulin level J:72241
Leprtm1Yli/Leprtm1Yli
(B6.129-Leprtm1Yli) 		abnormal circulating glucose level J:142218
impaired glucose tolerance J:142218
increased circulating insulin level J:142218
insulin resistance J:142218
Leprtm2Mgmj/Lepr+
(B6.Cg-Leprtm2Mgmj) 		decreased circulating insulin level J:122056
Leprtm2Mgmj/Leprtm2Mgmj
(B6.Cg-Leprtm2Mgmj) 		decreased circulating insulin level J:122056
Leprtm2Mgmj/Leprtm2Mgmj
(Not Specified) 		decreased insulin secretion J:145998
Leprtm2Yli/Leprtm2Yli
(B6.129-Leprtm2Yli) 		abnormal circulating glucose level J:142218
impaired glucose tolerance J:142218
increased circulating insulin level J:142218
insulin resistance J:142218
Leprtm3.1Yli/Leprtm3.1Yli
(B6.129-Leprtm3.1Yli) 		increased circulating glucose level J:161732
increased circulating insulin level J:161732
Leprtm4Mgmj/Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj) 		impaired glucose tolerance J:164339
increased circulating glucose level J:164339
increased circulating insulin level J:164339
insulin resistance J:164339
Leprtm5Mgmj/Leprtm5Mgmj
(B6.129-Leprtm5Mgmj) 		abnormal insulin secretion J:221245
insulin resistance J:221245
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		abnormal glucose homeostasis J:222017
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		abnormal glucose homeostasis J:222017
Letmd1em1(IMPC)Kmpc/Letmd1em1(IMPC)Kmpc
(C57BL/6NTac-Letmd1em1(IMPC)Kmpc/Kmpc) 		increased fasting circulating glucose level J:211773
Letmd1em1Mbp/Letmd1em1Mbp
(C57BL/6J-Letmd1em1Mbp) 		impaired glucose tolerance J:321533
insulin resistance J:321533
Lgals12tm1Ftl/Lgals12tm1Ftl
(B6.129-Lgals12tm1Ftl) 		improved glucose tolerance J:180097
increased circulating insulin level J:180097
increased insulin sensitivity J:180097
Lifrtm1Imx/Lifrtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd * C57BL/6) 		increased liver glycogen level J:25253
Lin28atm1.1Gqda/Lin28atm1.1Gqda
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:199720
Lin28atm1Gqda/Lin28atm1Gqda
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		impaired glucose tolerance J:177113
insulin resistance J:177113
Lin28btm1Gqda/Lin28btm1Gqda
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		impaired glucose tolerance J:199720
insulin resistance J:199720
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		impaired gluconeogenesis J:270182
improved glucose tolerance J:270182
increased insulin sensitivity J:270182
Lipatm1Ggb/Lipatm1Ggb
(involves: 129P2/OlaHsd * CF-1) 		increased circulating insulin level J:68812
insulin resistance J:68812
Lipetm1b(KOMP)Wtsi/Lipetm1b(KOMP)Wtsi
(C57BL/6N-Lipetm1b(KOMP)Wtsi/Ucd) 		increased circulating insulin level J:211773
Lipetm1Gam/Lipetm1Gam
(involves: 129S4/SvJae * BALB/c) 		increased circulating glucose level J:82299
Lipetm1Ishi/Lipetm1Ishi
(B6.129S7-Lipetm1Ishi) 		increased circulating glucose level J:152385
Lipetm1Ishi/Lipetm1Ishi
Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129S7-Nceh1tm1Ishi Lipetm1Ishi) 		increased circulating glucose level J:152385
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J) 		hyperglycemia J:85540
increased circulating insulin level J:85540
insulin resistance J:85540
Lipetm1Land/Lipetm1Land
(involves: 129) 		decreased skeletal muscle glycogen level J:106148
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd) 		abnormal hepatic glucose production J:84822
decreased circulating insulin level J:84822
increased circulating glucose level J:84822
Lipetm2Rze/Lipetm2Rze
Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA) 		abnormal glucose homeostasis J:144744
abnormal insulin secretion J:144744
impaired glucose tolerance J:144744
increased circulating glucose level J:144744
Lipntm1.1(KOMP)Vlcg/Lipntm1.1(KOMP)Vlcg
(C57BL/6N-Lipntm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Lmnaem1Fenz/Lmna+
(C57BL/6-Lmnaem1Fenz) 		impaired glucose tolerance J:338760
insulin resistance J:338760
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased liver glycogen level J:221850
hypoglycemia J:221850
Lmnatm1.1Otin/Lmna+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:177632
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating insulin level J:177632
hypoglycemia J:177632
Lmnatm1b(EUCOMM)Wtsi/Lmna+
(C57BL/6N-Lmnatm1b(EUCOMM)Wtsi/Ics) 		improved glucose tolerance J:211773
Lmnatm1Gbon/Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6) 		decreased circulating glucose level J:95528
Lmnatm1Stw/Lmna+
(involves: 129S1/Sv * C57BL/6J) 		increased circulating insulin level J:75101
insulin resistance J:75101
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6J) 		decreased circulating glucose level J:75101
Lmnatm2.1Gbon/Lmnatm2.1Gbon
(involves: 129 * C57BL/6) 		decreased circulating insulin level J:180603
hypoglycemia J:180603
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd) 		increased circulating insulin level J:211773
Lmod3em1Eno/Lmod3em1Eno
(involves: C3H * C57BL/6) 		increased skeletal muscle glycogen level J:222174
Lncenc1em1Smoc/Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc) 		impaired glucose tolerance J:306153
improved glucose tolerance J:306153
increased insulin sensitivity J:306153
insulin resistance J:306153
Lncenc1em2Smoc/Lncenc1em2Smoc
(C57BL/6J-Lncenc1em2Smoc) 		impaired glucose tolerance J:306153
insulin resistance J:306153
Lnpeptm1Ske/Lnpeptm1Ske
(involves: 129S/SvEv * Black Swiss) 		abnormal glucose homeostasis J:76570
insulin resistance J:76570
Lnpeptm1Ske/Lnpeptm1Ske
(B6.129S-Lnpeptm1Ske) 		improved glucose tolerance J:220356
increased insulin sensitivity J:220356
Lonrf2em2(IMPC)H/Lonrf2em2(IMPC)H
(C57BL/6N-Lonrf2em2(IMPC)H/H) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Loricrintm1.1(KOMP)Vlcg/Loricrin+
(C57BL/6N-Loricrintm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Loxl1tm1.1(KOMP)Vlcg/Loxl1+
(B6N(Cg)-Loxl1tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Lpar4tm1.1(KOMP)Vlcg/Lpar4tm1.1(KOMP)Vlcg
(C57BL/6N-Lpar4tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Lpcat3tm1a(EUCOMM)Wtsi/Lpcat3tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased circulating glucose level J:220827
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased circulating glucose level J:220827
decreased circulating insulin level J:220827
Lpin1fld-2J/Lpin1fld-2J
(C3H/HeJ-Lpin1fld-2J/J) 		insulin resistance J:66739
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld/J) 		abnormal gluconeogenesis J:121022
abnormal glucose homeostasis J:121022
increased circulating glucose level J:121022
increased glycogen level J:121022
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld) 		decreased insulin secretion J:63448
impaired glucose tolerance J:63448
increased circulating insulin level J:63448
insulin resistance J:63448
Lpin2tm1Reue/Lpin2tm1Reue
(involves: C57BL/6J) 		decreased fasting circulating glucose level J:189894
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6) 		abnormal glucose homeostasis J:90737
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N) 		abnormal glucose homeostasis J:110484
Lrig3tm1.1Hhed/Lrig3tm1.1Hhed
(B6.129(Cg)-Lrig3tm1.1Hhed) 		decreased circulating insulin level J:242435
Lrp1tm2Her/Lrp1tm2Her
Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal glucose homeostasis J:127398
decreased circulating glucose level J:127398
decreased circulating insulin level J:127398
improved glucose tolerance J:127398
Lrp1tm2Her/Lrp1tm2Her
Tg(Syn1-cre)671Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		decreased circulating insulin level J:93329
hypoglycemia J:93329
Lrp5tm1Jsak/Lrp5+
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:81174
impaired glucose tolerance J:81174
Lrp5tm1Jsak/Lrp5tm1Jsak
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:81174
decreased insulin secretion J:81174
impaired glucose tolerance J:81174
insulin resistance J:81174
Lrp6Gt(LST067)Byg/Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg) 		decreased circulating glucose level J:182772
improved glucose tolerance J:182772
increased insulin sensitivity J:182772
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma) 		insulin resistance J:210538
Lrrc8aem1Uia/Lrrc8aem1Uia
Tg(Adipoq-cre)1Evdr/0
(involves: 129 * C57BL/6 * FVB/NJ) 		impaired glucose tolerance J:246515
insulin resistance J:246515
Lrrc8ctm1Maim/Lrrc8ctm1Maim
(B6J.129S2-Lrrc8ctm1Maim) 		increased insulin sensitivity J:247160
Lrrc15tm1b(KOMP)Wtsi/Lrrc15tm1b(KOMP)Wtsi
(C57BL/6N-Lrrc15tm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
Lrrc41em1(IMPC)J/Lrrc41em1(IMPC)J
(C57BL/6NJ-Lrrc41em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Lrrn3tm1Lex/Lrrn3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		improved glucose tolerance J:171883
Ltbp2tm2b(KOMP)Wtsi/Ltbp2tm2b(KOMP)Wtsi
(C57BL/6N-Ltbp2tm2b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Lyarem1(IMPC)J/Lyarem1(IMPC)J
(C57BL/6NJ-Lyarem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Lyplal1em1Espel/Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel) 		abnormal glucose homeostasis J:340413
Lysttm1b(EUCOMM)Wtsi/Lysttm1b(EUCOMM)Wtsi
(C57BL/6N-Lysttm1b(EUCOMM)Wtsi/Tcp) 		increased fasting circulating glucose level J:211773
Lztfl1tm1.2Zpl/Lztfl1tm1.2Zpl
Tg(Camk2a-cre)#Stl/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N) 		impaired glucose tolerance J:287261
insulin resistance J:287261
Lztfl1tm1.3Zpl/Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		impaired glucose tolerance J:287261
increased circulating glucose level J:287261
insulin resistance J:287261
Macirtm1.1(KOMP)Vlcg/Macir+
(B6N(Cg)-Macirtm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Macrod2tm1.1(KOMP)Vlcg/Macrod2+
(C57BL/6N-Macrod2tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Macrod2tm1.1(KOMP)Vlcg/Macrod2tm1.1(KOMP)Vlcg
(C57BL/6N-Macrod2tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac) 		decreased liver glycogen level J:234643
hyperglycemia J:234643
impaired glucose tolerance J:234643
increased circulating insulin level J:234643
insulin resistance J:234643
Mad2l1bptm1.2Itl/Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		decreased liver glycogen level J:234643
Maddtm1Bpra/Maddtm1Bpra
Tg(Ins2-cre/ERT)1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased circulating insulin level J:225256
decreased insulin secretion J:225256
hyperglycemia J:225256
impaired glucose tolerance J:225256
increased fasting circulating glucose level J:225256
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6) 		increased insulin sensitivity J:222253
MafOfl/MafOfl
(either: 102/ElH or C3H/HeH) 		increased urine glucose level J:82475
Mafatm1Staka/Mafa+
(involves: ICR) 		decreased circulating insulin level J:99126
impaired glucose tolerance J:99126
Mafatm1Staka/Mafatm1Staka
(involves: ICR) 		decreased circulating insulin level J:99126
decreased insulin secretion J:99126
impaired glucose tolerance J:99126
increased circulating glucose level J:99126
increased urine glucose level J:99126
Magel2tm1.1Mus/Magel2+
(B6.129S2-Magel2tm1.1Mus) 		decreased circulating glucose level J:166548
Man2b2tm1b(KOMP)Wtsi/Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp) 		increased circulating glucose level J:211773
Man2c1tm1.1Tbec/Man2c1tm1.1Tbec
(B6N.129P2-Man2c1tm1.1Tbec) 		increased glycogen level J:205550
increased liver glycogen level J:205550
Manftm1a(KOMP)Wtsi/Manftm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * ICR) 		abnormal glucose homeostasis J:211812
decreased circulating insulin level J:211812
hyperglycemia J:211812
Manftm1c(KOMP)Wtsi/Manftm1c(KOMP)Wtsi
(involves: C57BL/6N * FVB/N) 		decreased circulating insulin level J:211812
hyperglycemia J:211812
Map3k1tm1a(KOMP)Wtsi/Map3k1+
(C57BL/6N-Map3k1tm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Mapk8tm1.1Jcbr/Mapk8tm1.1Jcbr
(involves: 129S4/SvJae * C57BL/6) 		decreased insulin secretion J:195844
improved glucose tolerance J:195844
increased insulin sensitivity J:195844
Mapk8tm1Jcbr/Mapk8tm1Jcbr
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		abnormal glucose homeostasis J:158650
decreased circulating glucose level J:158650
decreased circulating insulin level J:158650
improved glucose tolerance J:158650
increased insulin sensitivity J:158650
Mapk8tm1Rjd/Mapk8tm1Rjd
Mapk9tm2.1Rjd/Mapk9tm2.1Rjd
Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd) 		abnormal gluconeogenesis J:192551
abnormal glucose homeostasis J:192551
abnormal glycogen homeostasis J:192551
decreased circulating glucose level J:192551
decreased circulating insulin level J:192551
improved glucose tolerance J:192551
increased insulin secretion J:192551
increased insulin sensitivity J:192551
Mapk8tm1Wag/Mapk8tm1Wag
(B6.129P2-Mapk8tm1Wag) 		decreased circulating glucose level J:80452
decreased circulating insulin level J:80452
improved glucose tolerance J:80452
increased insulin sensitivity J:80452
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd
Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd
(involves: 129S6/SvEvTac * 129X1/SvJ) 		hypoglycemia J:152617
Mapk8ip1tm3.1Rjd/Mapk8ip1tm3.1Rjd
(B6.129S6-Mapk8ip1tm3.1Rjd) 		abnormal gluconeogenesis J:163808
increased insulin sensitivity J:163808
Mapk13tm2.1Lex/Mapk13tm2.1Lex
(B6.129S5-Mapk13tm2.1Lex) 		decreased circulating glucose level J:146185
improved glucose tolerance J:146185
increased circulating insulin level J:146185
increased insulin secretion J:146185
increased insulin sensitivity J:146185
Mapk14tm1.1Dvb/Mapk14+
(B6(FVB)-Mapk14tm1.1Dvb) 		decreased circulating glucose level J:151980
Mapk15tm1b(EUCOMM)Hmgu/Mapk15tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapk15tm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Mapkapk2tm1b(EUCOMM)Hmgu/Mapkapk2tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkapk2tm1b(EUCOMM)Hmgu/H) 		increased circulating glucose level J:211773
Mapkbp1tm1b(EUCOMM)Hmgu/Mapkbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkbp1tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Marchf3tm1b(EUCOMM)Hmgu/Marchf3tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf3tm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Marchf6tm1b(EUCOMM)Hmgu/Marchf6tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf6tm1b(EUCOMM)Hmgu/Ccpcz) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:120128
decreased circulating insulin level J:120128
hypoglycemia J:120128
improved glucose tolerance J:120128
increased insulin sensitivity J:120128
Mark3tm1Hpw/Mark3tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:163905
decreased liver glycogen level J:163905
hypoglycemia J:163905
improved glucose tolerance J:163905
Mark4Gt(XG191)Byg/Mark4Gt(XG191)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:192469
decreased circulating glucose level J:192469
decreased circulating insulin level J:192469
increased insulin sensitivity J:192469
Mars2tm1.1(KOMP)Vlcg/Mars2+
(C57BL/6N-Mars2tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh) 		hyperglycemia J:323838
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		abnormal glucose homeostasis J:192212
decreased circulating glucose level J:192212
decreased circulating insulin level J:192212
hypoglycemia J:192212
improved glucose tolerance J:192212
increased insulin sensitivity J:192212
Mbd6tm1.1(KOMP)Vlcg/Mbd6+
(C57BL/6N-Mbd6tm1.1(KOMP)Vlcg/Ucd) 		increased fasting circulating glucose level J:211773
Mboat4tm1Vlcg/Mboat4tm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		decreased circulating glucose level J:159327
improved glucose tolerance J:159327
Mc2rtm1Dchi/Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi) 		abnormal gluconeogenesis J:127445
abnormal glucose homeostasis J:127445
hypoglycemia J:127445
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl) 		increased circulating insulin level J:178147
Mc3rtm1Lvp/Mc3rtm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased circulating insulin level J:64365
Mc4rGlu3/Mc4r+
(involves: C57BL/6J) 		hyperglycemia J:85113
Mc4rGlu3/Mc4r+
(involves: 129S6/SvEvTac) 		hyperglycemia J:85113
Mc4rtm1.1Fbz/Mc4rtm1.1Fbz
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NTac) 		impaired glucose tolerance J:225022
Mc4rtm1Dhu/Mc4rtm1Dhu
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose homeostasis J:38224
hyperglycemia J:38224
increased circulating insulin level J:38224
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		increased circulating insulin level J:115192
Mc4rtm1Lowl/Mc4rtm1Lowl
Chattm1(cre)Lowl/Chat+
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased circulating insulin level J:193452
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu) 		increased circulating insulin level J:285412
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA) 		increased circulating glucose level J:192213
increased skeletal muscle glycogen level J:192213
Mchr1tm1Yush/Mchr1tm1Yush
(involves: 129 * C57BL/6) 		decreased circulating insulin level J:106819
Mcutm1b(EUCOMM)Hmgu/Mcu+
(C57BL/6N-Mcutm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Mdktm1.1(KOMP)Mbp/Mdktm1.1(KOMP)Mbp
(C57BL/6N-Mdktm1.1(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Me1em1(IMPC)Tcp/Me1em1(IMPC)Tcp
(C57BL/6NCrl-Me1em1(IMPC)Tcp/Tcp) 		improved glucose tolerance J:211773
Med11tm1.1(KOMP)Vlcg/Med11+
(C57BL/6N-Med11tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Med13tm1Eno/Med13tm1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N) 		impaired glucose tolerance J:186193
increased circulating insulin level J:186193
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		hyperglycemia J:298822
impaired glucose tolerance J:298822
increased circulating insulin level J:298822
insulin resistance J:298822
Meis3tm1b(EUCOMM)Hmgu/Meis3tm1b(EUCOMM)Hmgu
(C57BL/6N-Meis3tm1b(EUCOMM)Hmgu/Ccpcz) 		impaired glucose tolerance J:211773
Memo1tm1.1Neh/Memo1tm1.1Neh
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		improved glucose tolerance J:206626
increased insulin sensitivity J:206626
Men1tm1.2Ctre/Men1tm1.2Ctre
Tg(Ins2-cre)1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased circulating glucose level J:85042
increased circulating insulin level J:85042
Men1tm1.2Ctre/Men1tm1.2Ctre
Tg(Ins2-cre)1Heed/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased circulating glucose level J:85042
increased circulating insulin level J:85042
Men1tm1.2Ctre/Men1tm1.2Ctre
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased circulating glucose level J:85042
increased circulating insulin level J:85042
Men1tm1.2Zqw/Men1tm1.2Zqw
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		hypoglycemia J:85133
increased circulating insulin level J:85133
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		increased circulating insulin level J:67128
Men1tm1Ctre/Men1+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased circulating insulin level J:146440
Men1tm1Ctre/Men1tm1Ctre
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		decreased circulating glucose level J:146440
increased circulating insulin level J:146440
Men1tm1Mmey/Men1+
(involves: 129S6/SvEvTac * FVB/N) 		hypoglycemia J:102494
Mep1atm1a(KOMP)Wtsi/Mep1atm1a(KOMP)Wtsi
(C57BL/6N-Mep1atm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Mettm1Sst/Mettm1Sst
Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased circulating insulin level J:196854
decreased insulin secretion J:196854
impaired glucose tolerance J:196854
increased circulating glucose level J:196854
Mettl6em1(IMPC)J/Mettl6em1(IMPC)J
(C57BL/6NJ-Mettl6em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Mettl15em1Pvs/Mettl15em1Pvs
(involves: C57BL/6 * CBA) 		hypoglycemia J:325995
Mettl18em1(IMPC)J/Mettl18em1(IMPC)J
(C57BL/6NJ-Mettl18em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Mfap2tm1a(KOMP)Wtsi/Mfap2tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		hyperglycemia J:236092
increased fasting circulating glucose level J:236092
insulin resistance J:236092
Mgamtm1Lex/Mgamtm1Lex
(129/Sv-Mgamtm1Lex) 		decreased circulating insulin level J:146501
decreased glycogen catabolism rate J:146501
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hypoglycemia J:80661
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm
(B6.Cg-Mgat4atm1.1Jxm) 		abnormal circulating insulin level J:117542
decreased circulating insulin level J:117542
hyperglycemia J:117542
impaired glucose tolerance J:117542
increased circulating glucose level J:117542
insulin resistance J:117542
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm
Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:212313
Mgat5btm1.1Cfg/Mgat5btm1.1Cfg
(involves: 129S6/SvEvTac) 		increased circulating glucose level J:217719
Mglcq1M16/?
(involves: ICR * M16) 		increased circulating glucose level J:101200
Mglltm1.1Rzim/Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:172679
decreased circulating insulin level J:172679
improved glucose tolerance J:172679
increased insulin sensitivity J:172679
Mgme1em1(IMPC)J/Mgme1em1(IMPC)J
(C57BL/6NJ-Mgme1em1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Mgmttm1Lds/Mgmttm1Lds
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:118148
Mier1tm1a(EUCOMM)Wtsi/Mier1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Mier1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:165965
Minar2tm1b(KOMP)Wtsi/Minar2tm1b(KOMP)Wtsi
(C57BL/6N-Minar2tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Mir10bem1Rosay/Mir10bem1Rosay
(C57BL/6J-Mir10bem1Rosay) 		hyperglycemia J:342486
impaired glucose tolerance J:342486
insulin resistance J:342486
Mir26a-1em1Xfu/Mir26a-1em1Xfu
Mir26a-2em1Xfu/Mir26a-2em1Xfu
(involves: C57BL/6) 		increased circulating glucose level J:286108
increased circulating insulin level J:286108
increased fasting circulating glucose level J:286108
insulin resistance J:286108
Mir32em1Gpt/Mir32em1Gpt
Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt) 		improved glucose tolerance J:344660
increased insulin sensitivity J:344660
Mir92bem22Gpt/Mir92bem22Gpt
(involves: C57BL/6JGpt) 		improved glucose tolerance J:346344
increased insulin sensitivity J:346344
increased skeletal muscle glycogen level J:346344
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6) 		decreased liver glycogen level J:190066
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased liver glycogen level J:190067
Mir129-2em1(IMPC)Kmpc/Mir129-2em1(IMPC)Kmpc
(C57BL/6NTac-Mir129-2em1(IMPC)Kmpc/Kmpc) 		impaired glucose tolerance J:211773
Mir184tm1Ics/Mir184tm1Ics
(Not Specified) 		decreased fasting circulating glucose level J:210552
improved glucose tolerance J:210552
increased circulating insulin level J:210552
increased insulin secretion J:210552
Mir375tm1Stf/Mir375tm1Stf
(B6.129-Mir375tm1Stf) 		abnormal gluconeogenesis J:147572
abnormal glucose homeostasis J:147572
hyperglycemia J:147572
increased circulating glucagon level J:147572
increased circulating glucose level J:147572
increased glucagon secretion J:147572
increased insulin secretion J:147572
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6) 		decreased circulating glucose level J:190154
Mir485em1Ycao/Mir485em1Ycao
(C57BL/6-Mir485em1Ycao) 		impaired glucose tolerance J:335039
insulin resistance J:335039
Mir802em3Gpt/Mir802em3Gpt
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA) 		abnormal circulating insulin level J:287584
improved glucose tolerance J:287584
increased circulating insulin level J:287584
increased insulin secretion J:287584
Mirc13tm1.1Mtm/Mirc13tm1.1Mtm
(Not Specified) 		decreased fasting circulating glucose level J:256444
Mirc13tm1Biat/Mirc13+
Mirc4tm1.1Biat/Mirc4tm1.1Biat
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		abnormal circulating glucose level J:314874
Mirc13tm1Biat/Mirc13tm1Biat
(involves: C57BL/6J * C57BL/6N) 		abnormal circulating glucose level J:314874
abnormal glucose homeostasis J:314874
Mirc13tm1Biat/Mirc13tm1Biat
Mirc4tm1.1Biat/Mirc4tm1.1Biat
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		abnormal circulating glucose level J:314874
Mirc29tm1.1Wtsi/Mirc29tm1.1Wtsi
Mirc33tm1.1Wtsi/Mirc33tm1.1Wtsi
(C57BL/6N-Mirc29tm1.1Wtsi Mirc33tm1.1Wtsi) 		decreased circulating glucose level J:267719
decreased circulating insulin level J:267719
increased fasting circulating glucose level J:267719
Mirc32tm1Thbr/Mirc32tm1Thbr
(involves: 129) 		improved glucose tolerance J:176266
increased insulin sensitivity J:176266
Mirc36tm1.1Jcav/Mirc36+
(B6.129-Mirc36tm1.1Jcav) 		abnormal glucose homeostasis J:216177
abnormal insulin secretion J:216177
decreased circulating glucose level J:216177
hypoglycemia J:216177
increased liver glycogen level J:216177
Mirc54tm1.1Syu/Mirc54tm1.1Syu
(Not Specified) 		decreased circulating glucose level J:310890
improved glucose tolerance J:310890
increased insulin sensitivity J:310890
Mkrn3em1(IMPC)Tcp/Mkrn3em1(IMPC)Tcp
(C57BL/6NCrl-Mkrn3em1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Mldhrem1Zhgn/Mldhrem1Zhgn
(involves: C57BL/6) 		abnormal glucose homeostasis J:303725
Mlxtm1.1(KOMP)Vlcg/Mlxtm1.1(KOMP)Vlcg
(C57BL/6N-Mlxtm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Mlxipltm1Kuy/Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:89865
increased circulating glucose level J:89865
increased circulating insulin level J:89865
increased liver glycogen level J:89865
insulin resistance J:89865
Mlxipltm1Kuy/Mlxipltm1Kuy
(B6.129S6-Mlxipltm1Kuy/J) 		decreased circulating glucose level J:273754
increased circulating glucose level J:273754
Mlycdtm1Jish/Mlycdtm1Jish
(B6.129S7-Mlycdtm1Jish) 		abnormal glucose homeostasis J:126455
Mmgt2tm1b(EUCOMM)Wtsi/Mmgt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Mmgt2tm1b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ) 		abnormal glucose homeostasis J:116503
decreased circulating glucose level J:116503
Mocs2tm1b(EUCOMM)Wtsi/Mocs2+
(C57BL/6N-Mocs2tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Mogat2tm1Far/Mogat2tm1Far
(B6.129S4-Mogat2tm1Far) 		decreased circulating insulin level J:149373
improved glucose tolerance J:149373
Mon1aem1(IMPC)J/Mon1aem1(IMPC)J
(C57BL/6NJ-Mon1aem1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
Mpc1tm1c(EUCOMM)Wtsi/Mpc1tm1c(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		improved glucose tolerance J:236662
increased insulin sensitivity J:236662
Mpc1tm1c(EUCOMM)Wtsi/Mpc1tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		abnormal gluconeogenesis J:236662
decreased circulating glucose level J:236662
improved glucose tolerance J:236662
Mpc1tm1c(EUCOMM)Wtsi/Mpc1tm1c(EUCOMM)Wtsi
Tg(Six3-cre)69Frty/0
(involves: C57BL/6N * DBA/2) 		abnormal glucose homeostasis J:271892
Mpc2em2Finc/Mpc2em2Finc
(involves: C57BL/6) 		decreased circulating insulin level J:211781
decreased insulin secretion J:211781
impaired glucose tolerance J:211781
increased circulating glucose level J:211781
mpc165H/mpc165H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc168H/mpc168H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc172H/mpc172H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc190H/mpc190H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc201H/mpc201H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc225H/mpc225H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc231H/mpc231H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		increased fasting circulating glucose level J:234901
mpc234H/mpc234H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		increased fasting circulating glucose level J:234901
mpc282H/mpc282H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
increased urine glucose level J:234901
mpc285H/mpc285H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc286H/mpc286H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc291H/mpc291H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
mpc312H/mpc312H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
Mpdzem1(IMPC)J/Mpdzem1(IMPC)J
(C57BL/6NJ-Mpdzem1(IMPC)J/J) 		improved glucose tolerance J:211773
Mpgtm1Lds/Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:118148
Mpgtm1Rhe/Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating glucose level J:70603
Mpp2tm1b(KOMP)Wtsi/Mpp2tm1b(KOMP)Wtsi
(C57BL/6N-Mpp2tm1b(KOMP)Wtsi/BayMmucd) 		impaired glucose tolerance J:211773
Mpp3tm1b(EUCOMM)Wtsi/Mpp3tm1b(EUCOMM)Wtsi
(C57BL/6N-Mpp3tm1b(EUCOMM)Wtsi/BayMmucd) 		decreased circulating glucose level J:211773
Mpv17em1(IMPC)J/Mpv17em1(IMPC)J
(C57BL/6NJ-Mpv17em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Mpv17lem1Riida/Mpv17lem1Riida
(C57BL/6N-Mpv17lem1Riida) 		improved glucose tolerance J:319850
Mpzem1(IMPC)Tcp/Mpzem1(IMPC)Tcp
(C57BL/6NCrl-Mpzem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz) 		improved glucose tolerance J:199257
Mrap2tm1a(EUCOMM)Wtsi/Mrap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Mrap2tm1a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Mraptm1.2Geno/Mraptm1.2Geno
(involves: C57BL/6) 		decreased liver glycogen level J:278935
Mrm3tm1.1(KOMP)Vlcg/Mrm3+
(C57BL/6N-Mrm3tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Mrpl22tm1b(KOMP)Mbp/Mrpl22+
(C57BL/6N-Mrpl22tm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Mrpl51tm1.1(KOMP)Vlcg/Mrpl51+
(B6N(Cg)-Mrpl51tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Mrps25tm1.1(KOMP)Vlcg/Mrps25+
(C57BL/6N-Mrps25tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Mss51tm1(KOMP)Vlcg/Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		impaired glucose tolerance J:280597
increased circulating insulin level J:280597
increased fasting circulating glucose level J:280597
increased skeletal muscle glycogen level J:280597
insulin resistance J:280597
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean) 		abnormal gluconeogenesis J:146513
abnormal glucose homeostasis J:146513
decreased circulating glucose level J:146513
decreased circulating insulin level J:146513
improved glucose tolerance J:146513
increased insulin sensitivity J:146513
insulin resistance J:146513
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		increased urine glucose level J:126620
mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal glucose homeostasis J:344247
impaired glucose tolerance J:344247
increased circulating glucose level J:344247
increased circulating insulin level J:344247
insulin resistance J:344247
Mtf1tm1b(KOMP)Wtsi/Mtf1+
(C57BL/6N-Mtf1tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Mtmr3Gt(OST416539)Lex/Mtmr3Gt(OST416539)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:103485
Mtmr3tm1b(EUCOMM)Hmgu/Mtmr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Mtmr3tm1b(EUCOMM)Hmgu/J) 		impaired glucose tolerance J:211773
Mtnr1btm1.1(KOMP)Vlcg/Mtnr1btm1.1(KOMP)Vlcg
(C57BL/6N-Mtnr1btm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Mtortm1.2Koz/Mtortm1.2Koz
Tg(ACTA1-cre)79Jme/?
(involves: 129S4/SvJae * C57BL/6J * SJL) 		decreased circulating glucose level J:162918
increased skeletal muscle glycogen level J:162918
Mtss2tm1a(KOMP)Wtsi/Mtss2tm1a(KOMP)Wtsi
(C57BL/6N-tss2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating glucose level J:211773
Mtx2em1(IMPC)J/Mtx2+
(C57BL/6NJ-Mtx2em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd) 		abnormal glucose homeostasis J:124334
hyperglycemia J:148283
Myd88tm1Jcbr/Myd88tm1Jcbr
Tg(Nes-cre)1Kln/0
(B6.Cg-Myd88tm1Jcbr Tg(Nes-cre)1Kln) 		abnormal glucose homeostasis J:153664
decreased circulating insulin level J:153664
increased insulin sensitivity J:153664
Myf5tm3(cre)Sor/Myf5+
Sik1tm1.1Berd/Sik1tm1.1Berd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL) 		abnormal gluconeogenesis J:236223
abnormal glucose homeostasis J:236223
decreased circulating insulin level J:236223
improved glucose tolerance J:236223
increased insulin sensitivity J:236223
Myf5tm3(cre)Sor/Myf5+
Stat5btm1Mam/Stat5btm1Mam
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		impaired glucose tolerance J:119237
Myh1tm1b(KOMP)Wtsi/Myh1tm1b(KOMP)Wtsi
(C57BL/6N-Myh1tm1b(KOMP)Wtsi/J) 		decreased urine glucose level J:211773
Myh10em1(IMPC)J/Myh10+
(C57BL/6NJ-Myh10em1(IMPC)J/J) 		increased fasting circulating glucose level J:211773
Myl1tm1(cre)Sjb/0
Ndufab1tm1Xiwa/Ndufab1tm1Xiwa
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:293657
decreased liver glycogen level J:293657
decreased skeletal muscle glycogen level J:293657
hypoglycemia J:293657
Myl1tm1(cre)Sjb/Myl1+
Smarcd3tm1Jddl/Smarcd3tm1Jddl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		impaired glucose tolerance J:256788
increased circulating glucose level J:256788
insulin resistance J:256788
Myo3atm1b(KOMP)Wtsi/Myo3atm1b(KOMP)Wtsi
(C57BL/6N-Myo3atm1b(KOMP)Wtsi/J) 		impaired glucose tolerance J:211773
Myo5btm1a(KOMP)Wtsi/Myo5btm1a(KOMP)Wtsi
(C57BL/6N-Myo5btm1a(KOMP)Wtsi) 		hypoglycemia J:229427
Myo7btm1b(EUCOMM)Hmgu/Myo7btm1b(EUCOMM)Hmgu
(C57BL/6N-Myo7btm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Myorgtm1b(KOMP)Wtsi/Myorgtm1b(KOMP)Wtsi
(B6N(Cg)-Myorgtm1b(KOMP)Wtsi/2J) 		decreased circulating glucose level J:211773
Myriptm1Tiz/Myriptm1Tiz
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		decreased insulin secretion J:258210
impaired glucose tolerance J:258210
Myt1tm1Ggu/Myt1tm1.1Ggu
Tg(Pdx1-cre)89.1Dam/?
(involves: 129 * C57BL/6 * CBA * CD-1 * SJL) 		decreased insulin secretion J:127471
impaired glucose tolerance J:127471
Naa10em1(IMPC)Mbp/Naa10em1(IMPC)Mbp
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
Naa40tm1Qwzh/Naa40tm1Qwzh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh) 		improved glucose tolerance J:183119
increased circulating glucose level J:183119
Nacadtm1(KOMP)Wtsi/Nacadtm1(KOMP)Wtsi
(C57BL/6N-Nacadtm1(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
increased circulating insulin level J:211773
Nacc1em1(IMPC)Hmgu/Nacc1em1(IMPC)Hmgu
(C57BL/6N-Nacc1em1(IMPC)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Nadk2em1(IMPC)J/Nadk2+
(C57BL/6NJ-Nadk2em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
Nae1tm1b(EUCOMM)Wtsi/Nae1+
(C57BL/6N-Nae1tm1b(EUCOMM)Wtsi/Ics) 		increased fasting circulating glucose level J:211773
Nagktm1b(EUCOMM)Hmgu/Nagktm1b(EUCOMM)Hmgu
(C57BL/6N-Nagktm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
NamptGt(RRT307)Byg/Nampt+
(B6.129P2-NamptGt(RRT307)Byg) 		decreased circulating glucose level J:130534
decreased insulin secretion J:130534
impaired glucose tolerance J:130534
Nat8f2tm1.1(KOMP)Vlcg/Nat8f2tm1.1(KOMP)Vlcg
(C57BL/6N-Nat8f2tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Nbr1tm1b(KOMP)Wtsi/Nbr1tm1b(KOMP)Wtsi
(C57BL/6N-Nbr1tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg
(C57BL/6N-Ncaldtm1.1(KOMP)Vlcg/J) 		increased circulating insulin level J:211773
Ncoa1tm1.1(KOMP)Vlcg/Ncoa1tm1.1(KOMP)Vlcg
(C57BL/6N-Ncoa1tm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
Ncoa2em1(IMPC)Mbp/Ncoa2+
(C57BL/6N-Ncoa2em1(IMPC)Mbp/MbpMmucd) 		increased circulating insulin level J:211773
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J) 		abnormal glucose homeostasis J:161276
decreased circulating glucagon level J:161276
hyperglycemia J:161276
impaired glucose tolerance J:161276
increased liver glycogen level J:161276
insulin resistance J:161276
Ncoa3tm1b(EUCOMM)Wtsi/Ncoa3+
(C57BL/6N-Ncoa3tm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating glucose level J:144060
decreased circulating insulin level J:144060
improved glucose tolerance J:144060
increased insulin sensitivity J:144060
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating glucose level J:120086
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:207622
increased fasting circulating glucose level J:207622
insulin resistance J:207622
Ncoa5tm1Hxia/Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia) 		impaired glucose tolerance J:207622
increased fasting circulating glucose level J:207622
Ncor1tm1.1Ics/Ncor1tm1.1Ics
(involves: 129 * C57BL/6J) 		decreased liver glycogen level J:206152
Ncor1tm1Laz/Ncor1tm1Laz
(C57BL/6-Ncor1tm1Laz) 		abnormal glucose homeostasis J:142342
increased insulin sensitivity J:142342
Ncor2Gt(RRM275)Byg/Ncor2+
(B6.129P2-Ncor2Gt(RRM275)Byg) 		decreased circulating insulin level J:164558
increased insulin sensitivity J:164558
Ncor2tm1Rev/Ncor2tm1Rev
(involves: 129/Sv * C57BL/6) 		abnormal gluconeogenesis J:142665
increased circulating glucose level J:142665
insulin resistance J:142665
Ndrg1tm2b(KOMP)Wtsi/Ndrg1tm2b(KOMP)Wtsi
(C57BL/6N-Ndrg1tm2b(KOMP)Wtsi/Tcp) 		decreased fasting circulating glucose level J:211773
Ndufa1tm1.1Nay/Y
(involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac) 		abnormal glucose homeostasis J:257477
Ndufb9tm1b(EUCOMM)Hmgu/Ndufb9+
(C57BL/6N-Ndufb9tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating insulin level J:211773
Nedd4tm2b(EUCOMM)Hmgu/Nedd4+
(C57BL/6N-Nedd4tm2b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6) 		increased circulating insulin level J:106077
Nek2tm1b(KOMP)Wtsi/Nek2tm1b(KOMP)Wtsi
(C57BL/6N-Nek2tm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Nek11tm1b(KOMP)Wtsi/Nek11tm1b(KOMP)Wtsi
(C57BL/6N-Nek11tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Nemftm1b(EUCOMM)Hmgu/Nemf+
(B6N(Cg)-Nemftm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Neurl2tm1.1(KOMP)Vlcg/Neurl2tm1.1(KOMP)Vlcg
(C57BL/6N-Neurl2tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Neurod1tm1Jle/Neurod1tm1Jle
(involves: 129S4/SvJaeSor * C57BL/6) 		hyperglycemia J:74715
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * C57BL/6) 		hyperglycemia J:43010
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J) 		hyperglycemia J:59932
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1(Neurog3,cre/ERT)Ggu
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased circulating glucose level J:150074
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1(Neurog3,cre/ERT)Ggu
Tg(Pdx1-cre/Esr1*)1Mga/0
(involves: 129S6/SvEvTac) 		impaired glucose tolerance J:150074
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1.1(cre/ERT)Ggu
(involves: 129S6/SvEvTac) 		impaired glucose tolerance J:150074
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1.1(cre/ERT)Ggu
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased circulating glucose level J:150074
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1.1(cre/ERT)Ggu
Tg(Pdx1-cre/Esr1*)1Mga/0
(involves: 129S6/SvEvTac) 		abnormal circulating insulin level J:150074
hyperglycemia J:150074
impaired glucose tolerance J:150074
increased circulating glucose level J:150074
Neurog3tm1.1(cre/ERT)Ggu/Neurog3+
(involves: 129S6/SvEvTac) 		impaired glucose tolerance J:150074
Neurog3tm1Fgu/Neurog3tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased circulating glucose level J:60642
increased urine glucose level J:60642
Neurog3tm1Fgu/Neurog3tm3.1Ggr
Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		decreased circulating glucose level J:161480
improved glucose tolerance J:161480
increased insulin sensitivity J:161480
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr
Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		decreased circulating glucose level J:161480
improved glucose tolerance J:161480
increased insulin sensitivity J:161480
Nfat5tm1b(KOMP)Wtsi/Nfat5+
(C57BL/6N-Nfat5tm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
Nfatc4tm1.1(KOMP)Vlcg/Nfatc4tm1.1(KOMP)Vlcg
(C57BL/6N-Nfatc4tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Nfe2l1tm1.1Mym/Nfe2l1+
(B6J.Cg-Nfe2l1tm1.1Mym) 		decreased circulating glucose level J:230118
decreased circulating insulin level J:230118
Nfe2l2em1(IMPC)Ccpcz/Nfe2l2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nfe2l2em1(IMPC)Ccpcz/Ccpcz) 		decreased circulating glucose level J:211773
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6) 		hypoglycemia J:136120
Nhlh2em1(IMPC)Mbp/Nhlh2em1(IMPC)Mbp
(C57BL/6N-Nhlh2em1(IMPC)Mbp/Ucd) 		impaired glucose tolerance J:211773
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased brain glycogen level J:165994
increased cardiac muscle glycogen level J:165994
increased glycogen level J:165994
increased skeletal muscle glycogen level J:165994, J:218959
Nhlrc1tm1Bmin/Nhlrc1tm1Bmin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		decreased glycogen catabolism rate J:181674
increased liver glycogen level J:181674
increased skeletal muscle glycogen level J:181674
Nidd1NON/LtHl/Nidd1NON/LtHl
(involves: NON/LtHl * NZO/Hl) 		abnormal glucose homeostasis J:48957
Nidd1NON/LtHl/Nidd1NZO/Hl
(involves: NON/LtHl * NZO/Hl) 		abnormal glucose homeostasis J:48957
Nidd1NZO/Hl/Nidd1NZO/Hl
(involves: NON/LtHl * NZO/Hl) 		abnormal glucose homeostasis J:48957
Nidd1kKK-A(y)/Jcl/Nidd1kKK-A(y)/Jcl
(involves: KK * PWK) 		hyperglycemia J:76775
Nidd1nC3H/HeCrj/Nidd1nNSY
(involves: C3H/HeCrj * NSY) 		impaired glucose tolerance J:55284
Nidd1nNSY/Nidd1nNSY
(involves: C3H/HeCrj * NSY) 		impaired glucose tolerance J:55284
Nidd2NON/LtHl/Nidd2NON/LtHl
(involves: NON/LtHl * NZO/Hl) 		abnormal circulating glucose level J:48957
abnormal glucose homeostasis J:48957
Nidd2NON/LtHl/Nidd2NZO/Hl
(involves: NON/LtHl * NZO/Hl) 		abnormal circulating glucose level J:48957
abnormal glucose homeostasis J:48957
Nidd2kKK/TaJcl/Nidd2kKK/TaJcl
(involves: KK * PWK) 		hyperglycemia J:76775
Nidd2nNSY/Nidd2nNSY
(involves: C3H/HeCrj * NSY) 		impaired glucose tolerance J:55284
Nidd3NON/LtHl/Nidd3NZO/Hl
(involves: NON/LtHl * NZO/Hl) 		abnormal glucose homeostasis J:48957
Nidd3NZO/Hl/Nidd3NZO/Hl
(involves: NON/LtHl * NZO/Hl) 		abnormal glucose homeostasis J:48957
Nidd3kKK/TaJcl/Nidd3kKK/TaJcl
(involves: KK * PWK) 		abnormal glucose homeostasis J:76775
Nidd3nC3H/HeCrj/Nidd3nNSY
(involves: C3H/HeCrj * NSY) 		impaired glucose tolerance J:55284
Nidd3nNSY/Nidd3nNSY
(involves: C3H/HeCrj * NSY) 		impaired glucose tolerance J:55284
Nidd4TSOD/Nidd4TSOD
(involves: BALB/cA * TSOD) 		hyperglycemia J:55285
Nidd4kKK/TaJcl/Nidd4kKK/TaJcl
(involves: KK * PWK) 		hyperglycemia J:76775
Nidd4nNSY/Nidd4nNSY
(involves: C3H/HeCrj * NSY) 		impaired glucose tolerance J:55284
Nidd5BALB/cA/Nidd5TSOD
(involves: BALB/cA * TSOD) 		decreased circulating insulin level J:55285
Nidd5TSOD/Nidd5TSOD
(involves: BALB/cA * TSOD) 		decreased circulating insulin level J:55285
Nidd5kKK/TaJcl/Nidd5kKK/TaJcl
(involves: KK * PWK) 		hyperglycemia J:76775
Nidd6kPWK/Nidd6kPWK
(involves: KK/Jcl-Ay * PWK) 		hypoglycemia J:76775
Nidd7kKK/TaJcl/Nidd7kKK/TaJcl
(involves: KK * PWK) 		hyperglycemia J:76775
NiddsNZO/HlBom/NiddsSJL/NBom
(involves: NZO/HlBom * SJL/NBom) 		decreased circulating insulin level J:64158
hyperglycemia J:64158
NiddsSJL/NBom/?
(involves: NZO/HlBom * SJL/NBom) 		hyperglycemia J:78920
NiddsSJL/NBom/?
Tbc1d1Nobq1-NZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom) 		abnormal glucose homeostasis J:78920
Nischtm1b(EUCOMM)Hmgu/Nisch+
(C57BL/6N-Nischtm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Nischtm1b(EUCOMM)Hmgu/Nischtm1b(EUCOMM)Hmgu
(C57BL/6N-Nischtm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr
(involves: 129X1/SvJ) 		decreased glucagon secretion J:48576
decreased insulin secretion J:48576
hyperglycemia J:48576
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * C57BL/6J * SJL) 		hyperglycemia J:177838
Nkx2-2tm5.1Suss/Nkx2-2tm5.1Suss
Tg(Pdx1-cre)6Tuv/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * NTac:NIHBS * SJL) 		hyperglycemia J:204869
increased circulating glucose level J:204869
Nkx6-1tm1Jlr/Nkx6-1tm1.1Msan
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL) 		hyperglycemia J:195153
Nkx6-1tm1Jlr/Nkx6-1tm1Jlr
(involves: 129 * C57BL/6J) 		decreased insulin secretion J:65594
NlnGt(NPX481)Byg/NlnGt(NPX481)Byg
(B6.129P2-NlnGt(NPX481)Byg) 		abnormal gluconeogenesis J:214116
improved glucose tolerance J:214116
increased insulin sensitivity J:214116
Nlrp1am2Btlr/Nlrp1am2Btlr
(C57BL/6J-Nlrp1am2Btlr) 		hypoglycemia J:265174
nma/nma
(B6C3Fe a/a-nma/J) 		decreased circulating glucose level J:60439
Nmutm1Mko/Nmutm1Mko
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:93213
hyperglycemia J:93213
increased circulating insulin level J:93213
Nmur2tm1Dgen/Nmur2tm1Dgen
(B6N.Cg-Nmur2tm1Dgen) 		decreased circulating glucose level J:152371
Nnattm1.1Geno/Nnat+
Ins1tm1.1(cre)Thor/Ins1+
(involves: 129S2/SvPas * C57BL/6J) 		decreased insulin secretion J:265677
impaired glucose tolerance J:265677
increased fasting circulating glucose level J:265677
Nnattm1.2Geno/Nnat+
(either: 129S2(Cg)-Nnattm1.2Geno or B6.129S2(Cg)-Nnattm1.2Geno) 		decreased insulin secretion J:265677
increased circulating insulin level J:265677
NntC57BL/6J/NntC57BL/6J
(C57BL/6J) 		decreased insulin secretion J:109356
impaired glucose tolerance J:109356
NntG745D/NntG745D
(involves: BALB/c * C3H/HeH) 		decreased insulin secretion J:108421
impaired glucose tolerance J:108421
NntN68K/NntN68K
(involves: BALB/c * C3H/HeH) 		decreased insulin secretion J:108421
impaired glucose tolerance J:108421
Noboxtm1.1(KOMP)Vlcg/Nobox+
(C57BL/6N-Noboxtm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
Nobq2NZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom) 		increased circulating insulin level J:66744
Nocttm1Bjc/Nocttm1Bjc
(B6.129S2-Nocttm1Bjc) 		impaired glucose tolerance J:122301
increased circulating glucose level J:122301
increased insulin sensitivity J:122301
Nol8tm1b(EUCOMM)Hmgu/Nol8+
(C57BL/6N-Nol8tm1b(EUCOMM)Hmgu/Ics) 		increased fasting circulating glucose level J:211773
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae) 		insulin resistance J:62229
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		abnormal circulating glucose level J:155090
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6) 		improved glucose tolerance J:72215
increased insulin sensitivity J:72215
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		abnormal glucose homeostasis J:95957
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal circulating glucose level J:65562
abnormal glucose homeostasis J:65562
improved glucose tolerance J:72215
increased insulin sensitivity J:72215
Nos3em1(IMPC)Mbp/Nos3em1(IMPC)Mbp
(C57BL/6N-Nos3em1(IMPC)Mbp/Ucd) 		decreased fasting circulating glucose level J:211773
Nos3tm1.2Taka/Nos3tm1.2Taka
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		increased circulating glucose level J:187860
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae) 		insulin resistance J:62229
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		abnormal circulating glucose level J:155090
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating glucose level J:133437
decreased circulating insulin level J:133437
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd) 		abnormal glucose homeostasis J:103153
increased circulating insulin level J:103153
insulin resistance J:103153
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating insulin level J:198075
insulin resistance J:198075
Nos3tm3.1Plh/Nos3tm3.1Plh
(involves: 129S4/SvJae * C57BL/6) 		improved glucose tolerance J:198075
increased circulating glucose level J:198075
increased circulating insulin level J:198075
Notch3tm1.1(KOMP)Vlcg/Notch3tm1.1(KOMP)Vlcg
(C57BL/6N-Notch3tm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Npbwr1tm1Rck/Npbwr1tm1Rck
(involves: 129P/Ola * C57BL/6J) 		hyperglycemia J:94820
increased circulating insulin level J:94820
Npc1l1tm1Yaio/Npc1l1tm1Yaio
(C57BL/6-Npc1l1tm1Yaio) 		decreased circulating glucose level J:98568
Npffr2tm1.1Hhzg/Npffr2tm1.1Hhzg
(involves: C57BL/6) 		increased circulating insulin level J:267918
Npm3tm1.1(KOMP)Vlcg/Npm3tm1.1(KOMP)Vlcg
(C57BL/6N-Npm3tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Npy1rtm1Mnak/Npy1rtm1Mnak
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:51684
increased circulating insulin level J:51684
Npy1rtm1Snby/Npy1rtm1Snby
Npy5rtm1Snby/Npy5rtm1Snby
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:225097
increased circulating glucose level J:225097
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating insulin level J:47972
Npy1rtm1Tped/Npy1rtm1Tped
(B6.129P2-Npy1rtm1Tped) 		abnormal glucose homeostasis J:102554
abnormal glycogen level J:102554
hyperglycemia J:102554
increased circulating insulin level J:87424, J:102554
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:77345
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6) 		decreased circulating insulin level J:84570
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		abnormal circulating insulin level J:77345
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd) 		increased circulating insulin level J:87424
Npy6rtm1Hhzg/Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:210546
impaired glucose tolerance J:210546
improved glucose tolerance J:210546
increased circulating glucose level J:210546
increased circulating insulin level J:210546
Npytm1(rtTA,tetO-cre/EGFP)Snby/Npy+
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:162000
Nqo1tm1Akj/Nqo1tm1Akj
(involves: C57BL/6) 		abnormal gluconeogenesis J:120478
decreased circulating glucose level J:120478
increased circulating glucagon level J:120478
insulin resistance J:120478
Nr1d1tm1.1Rev/Nr1d1tm1.1Rev
Nr1d2tm1.1Rev/Nr1d2tm1.1Rev
Tg(CAG-cre/Esr1*)5Amc/0
(involves: BALB/cJ * C57BL/6 * C57BL/6J * CBA) 		decreased circulating glucose level J:183855
Nr1h2tm1.1Nph/Nr1h2tm1.1Nph
(B6.129-Nr1h2tm1.1Nph) 		abnormal glucose homeostasis J:169945
abnormal glycogen homeostasis J:169945
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj) 		decreased circulating glucose level J:200842
decreased circulating insulin level J:200842
impaired glucose tolerance J:200842
Nr1i3tm1Ddm/Nr1i3tm1Ddm
(C3.129S7-Nr1i3tm1Ddm) 		increased circulating glucose level J:92777
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj) 		abnormal glucose homeostasis J:169333
decreased circulating glucose level J:169333
decreased circulating insulin level J:169333
Nr2c2tm1b(EUCOMM)Wtsi/Nr2c2+
(C57BL/6N-Nr2c2tm1b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Nr2f2tm1Vco/Nr2f2+
Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA) 		abnormal glucose homeostasis J:98195
decreased circulating glucose level J:98195
decreased insulin secretion J:98195
impaired glucose tolerance J:98195
increased circulating insulin level J:98195
increased insulin secretion J:98195
insulin resistance J:98195
Nrastm1b(EUCOMM)Hmgu/Nras+
(C57BL/6N-Nrastm1b(EUCOMM)Hmgu/H) 		increased circulating glucose level J:211773
Nrcamtm2e.1(KOMP)Wtsi/Nrcam+
(C57BL/6N-Nrcamtm2e.1(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Nrde2tm2a(KOMP)Wtsi/Nrde2+
(C57BL/6N-Nrde2tm2a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Nrn1ltm1.1(KOMP)Vlcg/Nrn1ltm1.1(KOMP)Vlcg
(C57BL/6N-Nrn1ltm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Nrsn1tm1.1(KOMP)Vlcg/Nrsn1tm1.1(KOMP)Vlcg
(C57BL/6N-Nrsn1tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Nrxn1tm1b(KOMP)Wtsi/Nrxn1tm1b(KOMP)Wtsi
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Nsftm1b(KOMP)Mbp/Nsf+
(C57BL/6N-Nsftm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased circulating glucose level J:213427
improved glucose tolerance J:213427
Nsun5tm2b(EUCOMM)Wtsi/Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6N-Nsun5tm2b(EUCOMM)Wtsi/J) 		increased fasting circulating glucose level J:211773
Nt5c1btm1b(KOMP)Wtsi/Nt5c1btm1b(KOMP)Wtsi
(C57BL/6N-Nt5c1btm1b(KOMP)Wtsi/J) 		impaired glucose tolerance J:211773
Nt5dc1em1(IMPC)J/Nt5dc1em1(IMPC)J
(C57BL/6NJ-Nt5dc1em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Nt5dc3em1(IMPC)J/Nt5dc3em1(IMPC)J
(C57BL/6NJ-Nt5dc3em1(IMPC)J/Mmjax) 		decreased fasting circulating glucose level J:211773
Ntrk2tm1Mini/Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating insulin level J:210229
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		impaired glucose tolerance J:210229
increased circulating insulin level J:210229
Nuak1tm1Esu/Nuak1tm1Esu
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Nuak1tm1Esu Tg(Ckmm-cre)5Khn) 		decreased circulating glucose level J:185463
improved glucose tolerance J:185463
increased insulin sensitivity J:185463
increased skeletal muscle glycogen level J:185463
Nuak2tm1Esu/Nuak2+
(B6.129S4-Nuak2tm1Esu) 		increased circulating glucose level J:139603
Nucb2tm1.1Vdix/Nucb2tm1.1Vdix
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:270674
insulin resistance J:270674
Nucb2tm1.1Vdix/Nucb2tm1.1Vdix
Tg(Adipoq-cre/Esr1*)1Evdr/0
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:270674
Nucb2tm1.2Vdix/Nucb2tm1.2Vdix
(involves: C57BL/6) 		abnormal glucose homeostasis J:270674
increased hepatic glucose production J:270674
Nucks1tm1.2Vter/Nucks1tm1.2Vter
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NSlc * FVB/N * SJL) 		impaired glucose tolerance J:211777
increased circulating glucose level J:211777
increased circulating insulin level J:211777
insulin resistance J:211777
Nudcd3em1(IMPC)Wtsi/Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
increased circulating insulin level J:211773
Nudt13tm2b(EUCOMM)Hmgu/Nudt13tm2b(EUCOMM)Hmgu
(C57BL/6N-Nudt13tm2b(EUCOMM)Hmgu/BayMmucd) 		increased fasting circulating glucose level J:211773
Nxnem1(IMPC)J/Nxn+
(C57BL/6NJ-Nxnem1(IMPC)J/J) 		increased fasting circulating glucose level J:211773
Oas1gtm1b(KOMP)Wtsi/Oas1g+
(C57BL/6N-Oas1gtm1b(KOMP)Wtsi/Ucd) 		increased circulating glucose level J:211773
Oasl2tm1a(EUCOMM)Wtsi/Oasl2tm1a(EUCOMM)Wtsi
(C57BL/6N-Oasl2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Obrq13A/J/Obrq13A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased circulating glucose level J:145148
decreased circulating insulin level J:145148
insulin resistance J:145148
Obrq14A/J/Obrq14A/J
(C57BL/6J-Chr 17A/J/NaJ) 		insulin resistance J:145148
Obscntm1Chen/Obscntm1Chen
Obsl1tm1.1Slan/Obsl1tm1.1Slan
Tg(Myog-cre)1Eno/0
(involves: 129 * Black Swiss * C57BL/6 * SJL) 		abnormal glycogen catabolism J:283623
Oca2p-30PUb/Oca2p-x
(Not Specified) 		abnormal glucose homeostasis J:89922
hyperglycemia J:89922
increased circulating insulin level J:89922
Ociad1em1(IMPC)J/Ociad1em1(IMPC)J
(C57BL/6NJ-Ociad1em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Ocstamptm2b(KOMP)Wtsi/Ocstamptm2b(KOMP)Wtsi
(C57BL/6N-Ocstamptm2b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Odad3tm1b(EUCOMM)Hmgu/Odad3+
(C57BL/6N-Odad3tm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Ogntm1b(KOMP)Wtsi/Ogntm1b(KOMP)Wtsi
(C57BL/6N-Ogntm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		abnormal glucose homeostasis J:184716
decreased circulating insulin level J:184716
impaired glucose tolerance J:184716
increased insulin sensitivity J:184716
Onecut1tm1.1Mga/Onecut1tm1.1Mga
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		abnormal glucose homeostasis J:155058
increased circulating glucose level J:155058
Onecut1tm1Flem/Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		decreased circulating glucagon level J:62595
decreased circulating glucose level J:62595
decreased circulating insulin level J:62595
impaired glucose tolerance J:62595
increased circulating glucose level J:62595
Opa1tm1.1Hise/Opa1tm1.2Hise
Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL) 		decreased circulating insulin level J:183074
decreased insulin secretion J:183074
impaired glucose tolerance J:183074
increased circulating glucose level J:183074
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl) 		decreased liver glycogen level J:181670
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep) 		improved glucose tolerance J:147786
increased circulating insulin level J:147786
increased insulin secretion J:147786
Oprm1tm1Loh/Oprm1tm1Loh
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal circulating glucose level J:106857
Or2y1gtm1.1Itl/Or2y1gtm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac) 		improved glucose tolerance J:278264
increased urine glucose level J:278264
Or4m1em1Tshu/Or4m1em1Tshu
(involves: C57BL/6J) 		abnormal circulating glucose level J:314392
abnormal glucose homeostasis J:279017
decreased circulating glucose level J:279017
decreased circulating insulin level J:279017
decreased fasting circulating glucose level J:279017
decreased hepatic glucose production J:279017
improved glucose tolerance J:279017
increased insulin sensitivity J:279017
Or5b112em1(IMPC)Hmgu/Or5b112em1(IMPC)Hmgu
(C57BL/6NCrl-Or5b112em1(IMPC)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Osbpl11tm1b(EUCOMM)Hmgu/Osbpl11+
(C57BL/6N-Osbpl11tm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Osmtm1b(KOMP)Wtsi/Osmtm1b(KOMP)Wtsi
(C57BL/6N-Osmtm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		decreased liver glycogen level J:214124
impaired glucose tolerance J:214124
increased circulating glucose level J:214124
increased circulating insulin level J:214124
insulin resistance J:214124
OtpM1H/Otp+
(C3H.Cg-OtpM1H) 		impaired glucose tolerance J:251771
increased circulating insulin level J:251771
insulin resistance J:251771
Otptm1Asim/Otp+
(C3H.129P2(B6)-Otptm1Asim) 		impaired glucose tolerance J:251771
insulin resistance J:251771
Oxct1tm1a(KOMP)Wtsi/Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi) 		abnormal glucose homeostasis J:170537
hypoglycemia J:170537
P2rx2em1(IMPC)H/P2rx2em1(IMPC)H
(C57BL/6NTac-P2rx2em1(IMPC)H/H) 		decreased circulating glucose level J:211773
P2ry13tm1Dgen/P2ry13tm1Dgen
(B6N.Cg-P2ry13tm1Dgen) 		increased circulating glucose level J:170217
P2ry14em1(IMPC)H/P2ry14em1(IMPC)H
(C57BL/6NTac-P2ry14em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
P2ry14tm1.1Shbg/P2ry14tm1.1Shbg
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating insulin level J:223427
decreased insulin secretion J:223427
impaired glucose tolerance J:223427
Pacsin2tm1b(EUCOMM)Hmgu/Pacsin2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pacsin2tm1b(EUCOMM)Hmgu/J) 		increased fasting circulating glucose level J:211773
Palb2tm1.1(KOMP)Vlcg/Palb2+
(C57BL/6N-Palb2tm1.1(KOMP)Vlcg/J) 		increased circulating insulin level J:211773
Pald1em1(IMPC)Kmpc/Pald1em1(IMPC)Kmpc
(C57BL/6NTac-Pald1em1(IMPC)Kmpc/Kmpc) 		impaired glucose tolerance J:211773
Palmem1(IMPC)Wtsi/Palmem1(IMPC)Wtsi
(C57BL/6N-Palmem1(IMPC)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Pamtm1Jep/Pam+
(involves: 129S7/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:103533
Pamtm1Jep/Pam+
(involves: 129S7/SvEvBrd) 		impaired glucose tolerance J:103533
Pank1tm1.1Suja/Pank1tm1.1Suja
(involves: 129S/SvEv * C57BL/6J) 		abnormal gluconeogenesis J:161798
decreased circulating glucose level J:161798
Pank1tm1.1Suja/Pank1tm1.1Suja
Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		hypoglycemia J:189609
Paoxtm1.1(KOMP)Wtsi/Paoxtm1.1(KOMP)Wtsi
(C57BL/6N-Paoxtm1.1(KOMP)Wtsi/Ieg) 		decreased fasting circulating glucose level J:211773
Pard6atm1.1(KOMP)Vlcg/Pard6atm1.1(KOMP)Vlcg
(C57BL/6N-Pard6atm1.1(KOMP)Vlcg/J) 		impaired glucose tolerance J:211773
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:92244
Parvbtm1a(EUCOMM)Wtsi/Parvbtm1a(EUCOMM)Wtsi
(C57BL/6N-Parvbtm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating glucose level J:165965
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng) 		abnormal glucose homeostasis J:125307
decreased circulating insulin level J:125307
decreased insulin secretion J:125307
improved glucose tolerance J:125307
increased insulin sensitivity J:125307
Pate4tm1.1(KOMP)Mbp/Pate4tm1.1(KOMP)Mbp
(C57BL/6N-Pate4tm1.1(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Patl1tm1b(EUCOMM)Wtsi/Patl1+
(C57BL/6N-Patl1tm1b(EUCOMM)Wtsi/Bay) 		decreased fasting circulating glucose level J:211773
Pax5tm1b(EUCOMM)Wtsi/Pax5+
(C57BL/6N-Pax5tm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Pax6m1Lsli/Pax6+
(involves: C3H/HeJ * C57BL/6J) 		impaired glucose tolerance J:146325
Pax6tm1Pgr/Pax6tm2Pgr
Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI) 		decreased circulating insulin level J:90642
hyperglycemia J:90642
Pax6tm2Pgr/Pax6tm2Pgr
Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB * NMRI) 		decreased circulating insulin level J:90642
hyperglycemia J:90642
Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased insulin secretion J:75811
impaired glucose tolerance J:75811
increased insulin sensitivity J:75811
Pcbd1tm1Grc/Pcbd1tm1Grc
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		impaired glucose tolerance J:78257
increased circulating insulin level J:78257
Pccatm1Tmiy/Pccatm1Tmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver glycogen level J:71660
Pcdh8em1(IMPC)H/Pcdh8em1(IMPC)H
(C57BL/6N-Pcdh8em1(IMPC)H/H) 		impaired glucose tolerance J:211773
Pcgf1tm1.1(KOMP)Vlcg/Pcgf1+
(C57BL/6N-Pcgf1tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Pck1tm1.1Lre/Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		hyperglycemia J:73977
Pck1tm1.1Mgn/Pck1tm1.1Mgn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac) 		decreased liver glycogen level J:63929
Pck1tm1.2Mgn/Pck1tm1.2Mgn
(involves: 129S6/SvEvTac) 		decreased liver glycogen level J:63929
hypoglycemia J:63929
Pck1tm1Rwh/Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:145210
decreased liver glycogen level J:145210
Pclaftm1a(EUCOMM)Wtsi/Pclaftm1a(EUCOMM)Wtsi
(C57BL/6N-Pclaftm1a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Pcm1em1(IMPC)Tcp/Pcm1em1(IMPC)Tcp
(C57BL/6NCrl-Pcm1em1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Pcsk1em2Irli/Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli) 		decreased circulating glucose level J:324309
increased circulating insulin level J:324309
Pcsk1mpc242H/Pcsk1mpc242H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:234901
insulin resistance J:234901
Pcsk1tm1Dfs/Pcsk1+
(involves: 129 * C57BL/6J) 		abnormal glucose tolerance J:78369
decreased circulating insulin level J:78369
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J) 		decreased circulating glucagon level J:78369
decreased circulating insulin level J:78369
hypoglycemia J:78369
Pcsk2em1(IMPC)H/Pcsk2em1(IMPC)H
(C57BL/6NTac-Pcsk2em1(IMPC)H/H) 		decreased circulating glucose level J:211773
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:41505
decreased circulating insulin level J:41505
decreased glucagon secretion J:41505
decreased insulin secretion J:41505
impaired glucose tolerance J:41505
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J) 		decreased circulating glucagon level J:236905
decreased glucagon secretion J:236905
improved glucose tolerance J:236905
increased circulating insulin level J:236905
Pcsk5tm1b(KOMP)Mbp/Pcsk5+
(C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Pcxtm1c(EUCOMM)Wtsi/Pcxtm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL) 		abnormal insulin clearance J:332296
abnormal insulin secretion J:332296
decreased circulating glucose level J:332296
decreased fasting circulating glucose level J:332296
hypoglycemia J:332296
impaired gluconeogenesis J:332296
improved glucose tolerance J:332296
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac) 		hyperglycemia J:123785
Pde3btm1Yhc/Pde3btm1Yhc
(129X1/SvJ-Pde3btm1Yhc) 		abnormal glucose homeostasis J:117353
increased circulating insulin level J:117353
increased insulin secretion J:117353
insulin resistance J:117353
Pde10atm1Smsh/Pde10atm1Smsh
(B6NTac.Cg-Pde10atm1Smsh) 		abnormal circulating glucose level J:209032
abnormal circulating insulin level J:209032
decreased circulating insulin level J:209032
increased insulin sensitivity J:209032
Pdha1tm1Ptl/Y
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB) 		increased circulating insulin level J:141289
Pdha1tm1Ptl/Pdha1+
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB) 		increased circulating insulin level J:141289
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J) 		decreased circulating insulin level J:288824
increased fasting circulating glucose level J:288824
insulin resistance J:288824
Pdk1tm1a(EUCOMM)Hmgu/Pdk1tm1a(EUCOMM)Hmgu
Pdk2tm1Rhar/Pdk2tm1Rhar
Pdk3em1Eze/Pdk3em1Eze
Pdk4tm1Rhar/Pdk4tm1Rhar
(involves: 129 * C57BL/6J * C57BL/6N) 		decreased circulating glucose level J:303714
Pdk4tm1Rhar/Pdk4tm1Rhar
(B6.129-Pdk4tm1Rhar) 		abnormal glucose homeostasis J:115895
decreased circulating glucose level J:115895
decreased liver glycogen level J:115895
improved glucose tolerance J:115895
increased circulating insulin level J:115895
Pdlim4em1(IMPC)Ics/Pdlim4em1(IMPC)Ics
(C57BL/6N-Pdlim4em2(IMPC)Ics/Ics) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Pdp1em1(IMPC)Mbp/Pdp1em1(IMPC)Mbp
(C57BL/6NCrl-Pdp1em1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Pdpk1tm1Dral/Pdpk1tm1Dral
(B6.129P2-Pdpk1tm1Dral) 		impaired glucose tolerance J:136089
increased circulating insulin level J:136089
insulin resistance J:136089
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:134336
decreased circulating glucose level J:134336
decreased insulin secretion J:134336
improved glucose tolerance J:134336
increased circulating glucose level J:134336
increased insulin sensitivity J:134336
Pdpk1tm1Maka/Pdpk1tm1Maka
Stat3tm2Aki/Stat3tm2Aki
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * 129P2/OlaHsd * FVB/N) 		abnormal glucose homeostasis J:109359
impaired glucose tolerance J:109359
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * FVB/N) 		abnormal glucose homeostasis J:109359
impaired glucose tolerance J:109359
increased circulating glucose level J:109359
increased circulating insulin level J:109359
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat,-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		hypoglycemia J:162892
increased insulin sensitivity J:162892
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased circulating insulin level J:109010
hyperglycemia J:109010
increased circulating glucose level J:109010
Pdprtm1b(EUCOMM)Wtsi/Pdprtm1b(EUCOMM)Wtsi
(C57BL/6N-Pdprtm1b(EUCOMM)Wtsi/Ics) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Pdx1tm1.1Stof/Pdx1+
(involves: 129/Sv * C57BL/6) 		decreased circulating insulin level J:152582
impaired glucose tolerance J:152582
Pdx1tm1.1Stof/Pdx1tm1.1Stof
(involves: 129/Sv * C57BL/6) 		decreased circulating insulin level J:152582
hyperglycemia J:152582
impaired glucose tolerance J:152582
Pdx1tm1b(EUCOMM)Wtsi/Pdx1+
(C57BL/6N-Pdx1tm1b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Pdx1tm1Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased insulin secretion J:165268
impaired glucose tolerance J:165268
increased circulating glucose level J:165268
Pdx1tm1Cvw/Pdx1+
Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased insulin secretion J:75811
hyperglycemia J:75811
impaired glucose tolerance J:75811
increased insulin sensitivity J:75811
increased urine glucose level J:75811
Pdx1tm1Cvw/Pdx1+
SpopGt(BGB118)Byg/Spop+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased insulin secretion J:165268
improved glucose tolerance J:165268
increased circulating glucose level J:165268
Pdx1tm1Cvw/Pdx1tm1.1Stof
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:152582
Pdx1tm1Cvw/Pdx1tm4Cvw
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA) 		decreased circulating insulin level J:130389
impaired glucose tolerance J:130389
increased circulating glucose level J:130389
Pdx1tm1Heed/Pdx1tm1Heed
Tg(Ins2-cre)1Heed/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased circulating glucose level J:48516
increased urine glucose level J:48516
Pdx1tm1Macd/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ) 		impaired glucose tolerance J:79206, J:101742
Pdx1tm1Macd/Pdx1tm1Macd
Tg(tetO-Ipf1,EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased circulating glucose level J:101742
decreased insulin secretion J:101742
impaired glucose tolerance J:79206, J:101742
increased circulating glucose level J:79206
increased glucagon secretion J:101742
Pdx1tm1Macd/Pdx1tm1Macd
Tg(tetO-Ipf1,lacZ)958.1Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		impaired glucose tolerance J:103522
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd) 		decreased insulin secretion J:82969
impaired glucose tolerance J:82969, J:48516
increased circulating glucose level J:82969
Pdx1tm1Ted/Pdx1tm1Ted
(involves: 129P2/OlaHsd) 		increased circulating glucose level J:20779
Pdx1tm2Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		decreased insulin secretion J:75664
impaired glucose tolerance J:75664
increased glucagon secretion J:75664
Pdx1tm2Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		impaired glucose tolerance J:104617
Pdx1tm2Cvw/Pdx1+
(involves: 129/Sv * Black Swiss) 		decreased insulin secretion J:97234
impaired glucose tolerance J:97234
Pdx1tm2Cvw/Pdx1+
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL) 		decreased circulating insulin level J:97234
decreased insulin secretion J:97234
impaired glucose tolerance J:97234
increased circulating glucose level J:97234
Pdx1tm3Cvw/Pdx1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N) 		decreased circulating insulin level J:104617
impaired glucose tolerance J:104617
increased circulating glucose level J:104617
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating glucagon level J:122399
decreased circulating glucose level J:122399
Pdzd2Gt(S3-7A1)Sor/Pdzd2Gt(S3-7A1)Sor
(involves: 129S/SvEv * 129S4/SvJaeSor) 		decreased circulating glucose level J:307008
improved glucose tolerance J:307008
increased circulating insulin level J:307008
increased insulin secretion J:307008
Pdzd2Gt(S7-9G1)Sor/Pdzd2Gt(S7-9G1)Sor
(involves: 129S/SvEv * 129S4/SvJaeSor) 		decreased circulating glucose level J:307008
improved glucose tolerance J:307008
increased circulating insulin level J:307008
increased insulin secretion J:307008
Pedm14/Pedm14+
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
Pedm35/Pedm35+
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Peli1tm1b(EUCOMM)Wtsi/Peli1tm1b(EUCOMM)Wtsi
(C57BL/6N-Peli1tm1b(EUCOMM)Wtsi/Ucd) 		improved glucose tolerance J:211773
Pepdtm1a(KOMP)Wtsi/Pepdtm1a(KOMP)Wtsi
(C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd) 		increased circulating insulin level J:211773
Per2tm1Drw/Per2tm1Drw
(B6.129-Per2tm1Drw/J) 		improved glucose tolerance J:208598
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac) 		decreased liver glycogen level J:278655
hyperglycemia J:278655
Pex5tm1Pec/Pex5tm1Pec
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal glucose homeostasis J:112503
Pex11btm1Sjg/Pex11btm1Sjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver glycogen level J:76782
Pex16tm1c(EUCOMM)Hmgu/Pex16tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ * SJL) 		impaired glucose tolerance J:270463
Pfdn6tm1.1(KOMP)Vlcg/Pfdn6+
(C57BL/6N-Pfdn6tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Pfkfb2tm1.2Dap/Pfkfb2tm1.2Dap
(involves: C57BL/6) 		increased kidney glycogen level J:296139
Pfkfb2tm1b(KOMP)Wtsi/Pfkfb2tm1b(KOMP)Wtsi
(C57BL/6N-Pfkfb2tm1b(KOMP)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Pfkfb3tm1.1Pec/Pfkfb3tm1.1Pec
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA) 		decreased glycogen catabolism rate J:296552
PfkmGT(OST56064)Lex/PfkmGT(OST56064)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal glucose homeostasis J:125530
decreased circulating insulin level J:125530
decreased insulin secretion J:125530
impaired glucose tolerance J:125530
increased circulating glucose level J:125530
Pfkmtm1Fbos/Pfkmtm1Fbos
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:152153
increased cardiac muscle glycogen level J:152153
increased skeletal muscle glycogen level J:152153
Pfn1tm1a(EUCOMM)Wtsi/Pfn1+
(B6Brd;B6Dnk;B6N-Tyrc-Brd Pfn1tm1a(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Pgam5tm1b(EUCOMM)Wtsi/Pgam5tm1b(EUCOMM)Wtsi
(C57BL/6N-Pgam5tm1b(EUCOMM)Wtsi/Ics) 		decreased circulating glucose level J:211773
Pgbd5em1(IMPC)Tcp/Pgbd5em1(IMPC)Tcp
(C57BL/6NCrl-Pgbd5em1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Pgdtm1.1Pse/Pgdtm1.1Pse
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		increased glycogen level J:306553
Pgm3em1(IMPC)Hmgu/Pgm3+
(C57BL/6NCrl-Pgm3em1(IMPC)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased circulating glucose level J:125584
improved glucose tolerance J:125584
increased circulating insulin level J:125584
increased insulin secretion J:125584
PhexHyp/Y
(involves: C57BL/6) 		abnormal renal glucose reabsorption J:8335
Phf8tm1dIcs/Y
(C57BL/6N-Phf8tm1dIcs/Ics) 		improved glucose tolerance J:211773
PhipGt(RRJ571)Byg/PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		hypoglycemia J:164354
increased insulin sensitivity J:164354
Phka1I/FnLn/Y
((I/FnLn x C57BL/FnLn)F1) 		increased skeletal muscle glycogen level J:5156
Phka1I/FnLn/Y
(I/FnLn) 		increased skeletal muscle glycogen level J:5156
Phka1I/FnLn/Phka1+
((C57BL/FnLn x I/FnLn)F1) 		increased skeletal muscle glycogen level J:5156
Phka1I/FnLn/Phka1+
((I/FnLn x C57BL/FnLn)F1) 		increased skeletal muscle glycogen level J:5156
Phka1I/FnLn/Phka1I/FnLn
(I/FnLn) 		increased skeletal muscle glycogen level J:5156
Phkbem1(IMPC)J/Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax) 		decreased circulating glucose level J:330539
decreased fasting circulating glucose level J:330539
decreased glycogen catabolism rate J:330539
enhanced gluconeogenesis J:330539
increased liver glycogen level J:330539
Phox2a/Inppl1tm1Ssch/Phox2a/Inppl1tm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal gluconeogenesis J:96443
decreased circulating insulin level J:96443
hypoglycemia J:96443
increased insulin sensitivity J:96443
Phox2a/Inppl1tm1Ssch/Phox2a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glycogen homeostasis J:96443
improved glucose tolerance J:96443
Phox2a/Inppl1tm1Ssch/Inppl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glycogen homeostasis J:96443
improved glucose tolerance J:96443
Phox2a/Inppl1tm1Ssch/Phox2a/Inppl1tm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal gluconeogenesis J:96443
decreased circulating insulin level J:96443
hypoglycemia J:96443
increased insulin sensitivity J:96443
Phpt1tm1.1Eys/Phpt1tm1.1Eys
(involves: C57BL/6J * FVB/N) 		decreased circulating glucose level J:262099
decreased circulating insulin level J:262099
decreased insulin secretion J:262099
impaired glucose tolerance J:262099
increased circulating insulin level J:262099
Pias2tm1a(KOMP)Wtsi/Pias2tm1a(KOMP)Wtsi
(C57BL/6N-Pias2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Pigcem1(IMPC)J/Pigc+
(C57BL/6NJ-Pigcem1(IMPC)J/J) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Pigqtm2b(EUCOMM)Wtsi/Pigq+
(C57BL/6N-Pigqtm2b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Pigzem1(IMPC)J/Pigzem1(IMPC)J
(C57BL/6NJ-Pigzem1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Pik3c2gtm1Ehi/Pik3c2gtm1Ehi
(involves: 129 * C57BL/6) 		decreased liver glycogen level J:223018
impaired glucose tolerance J:223018
increased circulating glucose level J:223018
increased circulating insulin level J:223018
insulin resistance J:223018
Pik3c3tm1c(EUCOMM)Wtsi/Pik3c3tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		decreased liver glycogen level J:182628
Pik3catm1Bvan/Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:109024
increased circulating insulin level J:109024
insulin resistance J:109024
Pik3catm1Nbm/Pik3ca+
Pik3cbtm1Nbm/Pik3cb+
(involves: 129S6/SvEvTac) 		impaired glucose tolerance J:96761
increased circulating insulin level J:96761
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi) 		decreased liver glycogen level J:152332
impaired gluconeogenesis J:152332
increased circulating glucose level J:152332
increased insulin secretion J:152332
insulin resistance J:152332
Pik3cbtm1Jjz/Pik3cbtm1Jjz
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:138565
insulin resistance J:138565
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J) 		decreased insulin secretion J:234657
hyperglycemia J:234657
impaired glucose tolerance J:234657
increased circulating insulin level J:234657
insulin resistance J:234657
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal glucose homeostasis J:65523
decreased circulating insulin level J:65523
hypoglycemia J:65523
improved glucose tolerance J:65523
Pik3r1tm1Khn/Pik3r1tm1Khn
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose homeostasis J:87598
decreased circulating insulin level J:87598
increased insulin sensitivity J:87598
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA) 		decreased circulating glucose level J:52576
decreased circulating insulin level J:52576
hypoglycemia J:52576
increased insulin sensitivity J:52576
Pik3r1tm2Dfr/Pik3r1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		hypoglycemia J:94077
improved glucose tolerance J:94077
increased insulin sensitivity J:94077
Pik3r1tm2Dfr/Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6)) 		hypoglycemia J:94077
Pik3r2tm1Lca/Pik3r2tm1Lca
(involves: 129S6/SvEvTac) 		decreased circulating glucose level J:73703
decreased circulating insulin level J:73703
increased insulin sensitivity J:73703
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd
Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL) 		increased skeletal muscle glycogen level J:198770
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi
Tg(Ckm-cre)28Arte/0
(involves: C57BL/6) 		impaired glucose tolerance J:199213
increased circulating insulin level J:199213
insulin resistance J:199213
Pip4k2bGt(Betageo)1Lca/Pip4k2bGt(Betageo)1Lca
(involves: 129S/SvEv * C57BL/6) 		abnormal circulating insulin level J:91023
increased insulin sensitivity J:91023
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(C57BL/6N-Pip4k2ctm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		decreased circulating glucagon level J:85204
decreased circulating insulin level J:85204
decreased glycogen catabolism rate J:85204
hypoglycemia J:85204
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		decreased circulating glucagon level J:85204
decreased circulating insulin level J:85204
decreased glycogen catabolism rate J:85204
hypoglycemia J:85204
Pitpnc1em1(IMPC)Kmpc/Pitpnc1em1(IMPC)Kmpc
(C57BL/6NTac-Pitpnc1em1(IMPC)Kmpc/Kmpc) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Pitx3tm1.1(KOMP)Vlcg/Pitx3tm1.1(KOMP)Vlcg
(C57BL/6N-Pitx3tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Pkd1tm2Som/Pkd1tm2.1Som
Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL) 		decreased circulating glucose level J:135301
Pkd1tm2Som/Pkd1tm2Som
Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL) 		decreased circulating glucose level J:135301
Pkd2l2tm1b(EUCOMM)Wtsi/Pkd2l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Pkd2l2tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Pkn1tm1b(KOMP)Wtsi/Pkn1tm1b(KOMP)Wtsi
(C57BL/6N-Pkn1tm1b(KOMP)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Pkn3tm1.1(KOMP)Vlcg/Pkn3tm1.1(KOMP)Vlcg
(C57BL/6N-Pkn3tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Pla2g1btm1Dyh/Pla2g1btm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6) 		abnormal circulating glucose level J:80216
abnormal glucose homeostasis J:80216
decreased circulating insulin level J:80216
improved glucose tolerance J:80216
increased insulin sensitivity J:80216
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(NOD.129P2(B6)-Pla2g4atm1Tksh) 		impaired glucose tolerance J:99775
Plaat3em1(IMPC)Tcp/Plaat3em1(IMPC)Tcp
(C57BL/6NCrl-Plaat3em1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Plaat3tm1.1Hsul/Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul) 		abnormal glucose homeostasis J:239202
abnormal glycogen homeostasis J:239202
increased circulating glucose level J:239202
increased circulating insulin level J:239202
increased fasting circulating glucose level J:239202
insulin resistance J:239202
Plac9tm1b(EUCOMM)Hmgu/Plac9tm1b(EUCOMM)Hmgu
(C57BL/6N-Plac9tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Plautm1Mlg/Plautm1Mlg
(B6.129S2-Plautm1Mlg) 		decreased liver glycogen level J:164542
Plaurem1(IMPC)H/Plaurem1(IMPC)H
(C57BL/6NTac-Plaurem1(IMPC)H/H) 		increased circulating glucose level J:211773
Plcz1em1(IMPC)H/Plcz1em1(IMPC)H
(C57BL/6N-Plcz1em1(IMPC)H/H) 		increased fasting circulating glucose level J:211773
Plekha1tm1.1Arte/Plekha1tm1.1Arte
Plekha2tm1.1Arte/Plekha2tm1.1Arte
(C57BL/6J-Plekha1tm1.1Arte Plekha2tm1.1Arte) 		increased insulin sensitivity J:169475
Plet1em1(IMPC)Wtsi/Plet1em1(IMPC)Wtsi
(C57BL/6N-Plet1em1(IMPC)Wtsi/WtsiIeg) 		increased circulating insulin level J:211773
Plin1tm1Cdl/Plin1tm1Cdl
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal glucose homeostasis J:69629
impaired glucose tolerance J:69629
increased circulating insulin level J:69629
Plin5tm1e(KOMP)Wtsi/Plin5tm1e(KOMP)Wtsi
(involves: C57BL/6N) 		decreased skeletal muscle glycogen level J:221539
improved glucose tolerance J:221539
increased insulin sensitivity J:221539
insulin resistance J:221539
Plpp7em1Eno/Plpp7em1Eno
(involves: C3H * C57BL/6 * C57BL/6N) 		hypoglycemia J:302139
Plscr1tm1Lex/Plscr1tm1Lex
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S7/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:92404
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S/SvEvBrd * C57BL/6J) 		abnormal glucose homeostasis J:92404
hyperglycemia J:92404
impaired glucose tolerance J:92404
insulin resistance J:92404
Pm20d1em1Brsp/Pm20d1em1Brsp
(C57BL/6J-Pm20d1em1Brsp) 		impaired glucose tolerance J:264104
insulin resistance J:264104
pnc/pnc
(involves: PERU-COPPOCK) 		increased circulating insulin level J:13889
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:124658
insulin resistance J:124658
Pnliprp1tm1Smoc/Pnliprp1tm1Smoc
(involves: 129S/SvEv * C57BL/6) 		impaired glucose tolerance J:278344
insulin resistance J:278344
Pnmttm1.1(KOMP)Vlcg/Pnmttm1.1(KOMP)Vlcg
(C57BL/6N-Pnmttm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Pnpla2tm1.1Hsul/Pnpla2tm1.1Hsul
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL) 		decreased circulating glucose level J:176083
decreased circulating insulin level J:176083
increased insulin sensitivity J:176083
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating glucose level J:108546
abnormal circulating insulin level J:108546
abnormal glucose tolerance J:108546
decreased circulating glucose level J:108546
decreased circulating insulin level J:108546
improved glucose tolerance J:108546
increased insulin sensitivity J:108546
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd) 		increased cardiac muscle glycogen level J:176252
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm) 		decreased circulating glucose level J:333442
decreased circulating insulin level J:333442
increased liver glycogen level J:333442
Pnpla8tm1Rigr/Pnpla8tm1Rigr
(involves: 129X1/SvJ) 		decreased circulating glucose level J:333442
Poc1atm1.1(KOMP)Mbp/Poc1a+
(C57BL/6N-Poc1atm1.1(KOMP)Mbp/J) 		decreased fasting circulating glucose level J:211773
Pold3tm1b(EUCOMM)Wtsi/Pold3+
(C57BL/6N-Pold3tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Pold4em1(IMPC)J/Pold4em1(IMPC)J
(C57BL/6NJ-Pold4em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Pole2em1(IMPC)Mbp/Pole2+
(C57BL/6NCrl-Pole2em1(IMPC)Mbp/Mmucd) 		impaired glucose tolerance J:211773
Polgtm1Jiha/Polgtm1Jiha
(involves: C57BL/6JJcl) 		decreased circulating glucose level J:199416
Pomcem1(IMPC)Rbrc/Pomc+
(C57BL/6NJcl-Pomcem1(IMPC)Rbrc/Rbrc) 		impaired glucose tolerance J:211773
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low) 		impaired glucose tolerance J:115712
increased circulating insulin level J:115712
Pomctm2Low/Pomctm2Low
(B6.129S4-Pomctm2Low) 		increased circulating glucose level J:194013
increased circulating insulin level J:194013
insulin resistance J:194013
Pomctm2Low/Pomctm2Low
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		increased circulating glucose level J:194013
increased circulating insulin level J:194013
insulin resistance J:194013
Pomgnt1tm1Lex/Pomgnt1tm1Lex
(B6;129S5-Pomgnt1tm1Lex/Mmucd) 		decreased circulating glucose level J:171883
Pou2af3tm1b(NCOM)Mfgc/Pou2af3tm1b(NCOM)Mfgc
(C57BL/6N-Pou2af3tm1b(NCOM)Mfgc/Tcp) 		decreased fasting circulating glucose level J:211773
Pou3f3urehr2/Pou3f3urehr2
(C3HeB/FeJ-Pou3f3urehr2) 		decreased circulating glucose level J:121470
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		decreased liver glycogen level J:50024
hypoglycemia J:50024
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz) 		abnormal circulating glucose level J:72932
abnormal circulating insulin level J:72932
abnormal glucose homeostasis J:56056
insulin resistance J:72932
Pparatm1Gonz/Pparatm1Gonz
(B6.129S4-Pparatm1Gonz) 		abnormal circulating glucose level J:72932
abnormal circulating insulin level J:72932
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae) 		decreased circulating glucose level J:127793
increased circulating insulin level J:127793
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose homeostasis J:129848
improved glucose tolerance J:129848
increased insulin sensitivity J:129848
Pparatm1Gonz/Pparatm1Gonz
Tg(Ckm-Ppard)LEDpk/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA) 		abnormal glucose tolerance J:129848
Ppardtm1(PPARD)Bsls/Ppardtm1(PPARD)Bsls
(B6.Cg-Ppardtm1(PPARD)Bsls) 		hypoglycemia J:211453
Ppardtm1Dsvg/Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6) 		impaired glucose tolerance J:219677
Ppargtm1.1Auw/Ppargtm1.1Auw
(B6.Cg-Ppargtm1.1Auw) 		improved glucose tolerance J:144344
increased insulin sensitivity J:144344
Ppargtm1.1Unc/Ppargtm1.1Unc
(involves: 129S6/SvEvTac * C57BL/6J) 		impaired glucose tolerance J:154767
Ppargtm1Auw/Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J)) 		abnormal glucose homeostasis J:86705
impaired glucose tolerance J:86705
insulin resistance J:86705
Ppargtm1b(KOMP)Wtsi/Pparg+
(C57BL/6N-Ppargtm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Ppargtm1Laz/Ppargtm1Laz
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal glucose homeostasis J:135904
improved glucose tolerance J:135904
increased insulin sensitivity J:135904
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ) 		increased circulating insulin level J:98786
insulin resistance J:98786
Ppargtm1Mae/Pparg+
(involves: 129S6/SvEvTac * C57BL/6) 		improved glucose tolerance J:91362
Ppargtm1Rev/Pparg+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose homeostasis J:60354
increased insulin sensitivity J:60354
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:58222
increased insulin sensitivity J:58222
Ppargtm1Yec/Ppargtm1Yec
(involves: 129S4/SvJae * C57BL/6) 		insulin resistance J:91479
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		hyperglycemia J:125992
impaired glucose tolerance J:125992
increased circulating insulin level J:125992
insulin resistance J:125992
Ppargtm2Avp/Ppargtm2Avp
(Not Specified) 		abnormal glucose homeostasis J:121693
impaired glucose tolerance J:121693
increased circulating glucose level J:121693
Ppargtm2Rev/Ppargtm2Rev
Tg(Fabp4-cre)1Rev/0
(involves: 129S4/SvJae * C57BL/6) 		increased circulating insulin level J:88210
insulin resistance J:88210
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		increased circulating insulin level J:125992
Ppargc1atm1Aztc/Ppargc1atm1Aztc
(C57BL/6-Ppargc1atm1Aztc) 		decreased circulating glucose level J:82809
decreased circulating insulin level J:82809
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		abnormal gluconeogenesis J:93896
abnormal glucose homeostasis J:93896
decreased circulating insulin level J:93896
hypoglycemia J:93896
improved glucose tolerance J:93896
increased insulin sensitivity J:93896
Ppargc1atm1Brsp/Ppargc1atm2Brsp
Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal glucose homeostasis J:127403
decreased circulating insulin level J:127403
hyperglycemia J:127403
impaired glucose tolerance J:127403
increased circulating glucose level J:127403
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6) 		improved glucose tolerance J:96306
increased insulin sensitivity J:96306
Ppargc1atm1Dpk/Ppargc1atm1Dpk
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N) 		decreased circulating glucose level J:137598
Ppargc1atm2.1Brsp/Ppargc1atm2.1Brsp
Tg(Myog-cre)1Eno/0
(involves: 129 * BALB/c * C57BL/6J * C57BL/6N) 		decreased circulating glucose level J:208380
decreased circulating insulin level J:208380
impaired glucose tolerance J:208380
insulin resistance J:208380
Ppargc1atm2Brsp/Ppargc1a+
Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:127403
increased circulating glucose level J:127403
Ppargc1btm1Lowl/Ppargc1btm1Lowl
(involves: C57BL/6) 		insulin resistance J:129775
Ppdpftm1Nju/Ppdpftm1Nju
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		impaired glucose tolerance J:307283
insulin resistance J:307283
Ppm1atm1b(EUCOMM)Hmgu/Ppm1atm1b(EUCOMM)Hmgu
(C57BL/6N-Ppm1atm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd) 		impaired glucose tolerance J:151980
Ppm1ltm1Dgen/Ppm1ltm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		improved glucose tolerance J:134171
increased circulating glucose level J:134171
Ppp1r3atm1Adpr/Ppp1r3atm1Adpr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6J)) 		decreased skeletal muscle glycogen level J:68370
Ppp1r3atm1Ptwc/Ppp1r3atm1Ptwc
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased skeletal muscle glycogen level J:82422
impaired glucose tolerance J:82422
insulin resistance J:82422
Ppp1r3atm2Adpr/Ppp1r3a+
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glycogen homeostasis J:134157
decreased skeletal muscle glycogen level J:134157
Ppp1r3atm2Adpr/Ppp1r3atm2Adpr
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glycogen homeostasis J:134157
decreased skeletal muscle glycogen level J:134157
Ppp1r3btm1.1Arte/Ppp1r3b+
(involves: C57BL/6J * C57BL/6N) 		improved glucose tolerance J:157291
Ppp1r3btm1.1Arte/Ppp1r3btm1.1Arte
(involves: C57BL/6J * C57BL/6N) 		decreased circulating glucose level J:157291
improved glucose tolerance J:157291
Ppp1r3ctm1Adpr/Ppp1r3ctm1Adpr
(involves: C57BL/6J) 		abnormal glycogen homeostasis J:242755
Ppp1r3ctm1Adpr/Ppp1r3ctm1Adpr
(B6.Cg-Ppp1r3ctm1Adpr) 		abnormal glucose homeostasis J:242758
increased insulin sensitivity J:242758
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars) 		abnormal glucose homeostasis J:83297
abnormal glycogen homeostasis J:83297
decreased adipose tissue glycogen level J:83297
decreased cardiac muscle glycogen level J:83297
decreased glycogen level J:83297
decreased liver glycogen level J:83297
decreased skeletal muscle glycogen level J:83297
impaired glucose tolerance J:83297
increased circulating insulin level J:83297
insulin resistance J:83297
Ppp1r3gtm1Nju/Ppp1r3gtm1Nju
(B6.129-Ppp1r3gtm1Nju) 		abnormal glucose homeostasis J:249135
decreased adipose tissue glycogen level J:249135
decreased liver glycogen level J:249135
increased insulin sensitivity J:249135
Ppp1r35tm1.1(KOMP)Vlcg/Ppp1r35+
(C57BL/6N-Ppp1r35tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ppp2r1btm1b(EUCOMM)Wtsi/Ppp2r1btm1b(EUCOMM)Wtsi
(C57BL/6N-Ppp2r1btm1b(EUCOMM)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Ppp2r2aigt10/Ppp2r2a+
(involves: C3H/HeH * C57BL/6J) 		increased circulating insulin level J:246319
insulin resistance J:246319
Ppp2r2btm1b(KOMP)Wtsi/Ppp2r2btm1b(KOMP)Wtsi
(C57BL/6N-Ppp2r2btm1b(KOMP)Wtsi/Tcp) 		increased fasting circulating glucose level J:211773
Ppp3catm1Jse/Ppp3catm1Jse
(involves: 129S4/SvJae) 		decreased circulating glucose level J:110350
Ppp4r3btm1b(EUCOMM)Hmgu/Ppp4r3btm1b(EUCOMM)Hmgu
(C57BL/6N-Ppp4r3btm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(B6Dnk;B6Brd;B6N-Ppp5ctm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH) 		decreased circulating glucose level J:175295
Ppp6ctm1b(EUCOMM)Hmgu/Ppp6c+
(C57BL/6N-Ppp6ctm1b(EUCOMM)Hmgu/Ics) 		increased fasting circulating glucose level J:211773
Ppytm1b(KOMP)Wtsi/Ppytm1b(KOMP)Wtsi
(C57BL/6N-Ppytm1b(KOMP)Wtsi/Ieg) 		increased circulating insulin level J:211773
Pradc1Gt(OST419896)Lex/Pradc1Gt(OST419896)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating glucose level J:171883
Prag1em2(IMPC)Tcp/Prag1em2(IMPC)Tcp
(C57BL/6NCrl-Prag1em2(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Prdm4tm1b(EUCOMM)Hmgu/Prdm4tm1b(EUCOMM)Hmgu
(C57BL/6N-Prdm4tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Prdm8em1(IMPC)Wtsi/Prdm8em1(IMPC)Wtsi
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Prdm14tm1a(EUCOMM)Wtsi/Prdm14tm1a(EUCOMM)Wtsi
(C57BL/6N-Prdm14tm1a(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		improved glucose tolerance J:213153
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N) 		increased circulating insulin level J:208683
insulin resistance J:208683
Prdx3tm1Hjha/Prdx3tm1Hjha
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:228860
increased circulating insulin level J:228860
increased fasting circulating glucose level J:228860
insulin resistance J:228860
Prdx5tm1Dsle/Prdx5tm1Dsle
(involves: C57BL/6) 		impaired glucose tolerance J:294801
increased circulating insulin level J:294801
insulin resistance J:294801
Prex2Gt(AH0440)Wtsi/Prex2Gt(AH0440)Wtsi
(B6.129P2-Prex2Gt(AH0440)Wtsi) 		impaired glucose tolerance J:206382
increased circulating glucose level J:206382
insulin resistance J:206382
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz) 		abnormal circulating glucose level J:43468
Prf1tm1Sdz/Prf1tm1Sdz
Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/SzJ) 		increased circulating glucose level J:91764
Prg4em1(IMPC)Ccpcz/Prg4em1(IMPC)Ccpcz
(C57BL/6N-Prg4em1(IMPC)Ccpcz/Ccpcz) 		improved glucose tolerance J:211773
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6) 		abnormal glucose homeostasis J:81120
abnormal glycogen homeostasis J:81120
decreased circulating insulin level J:81120
decreased insulin secretion J:81120
decreased skeletal muscle glycogen level J:81120
hyperglycemia J:81120
impaired glucose tolerance J:81120
insulin resistance J:81120
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas) 		decreased circulating insulin level J:87719
decreased skeletal muscle glycogen level J:87719
impaired glucose tolerance J:87719
Prkaa2tm1b(EUCOMM)Hmgu/Prkaa2tm1b(EUCOMM)Hmgu
(C57BL/6N-Prkaa2tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Prkaa2tm1Vio/Prkaa2tm1Vio
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N) 		abnormal gluconeogenesis J:108399
abnormal glucose homeostasis J:108399
impaired glucose tolerance J:108399
increased circulating glucose level J:108399
increased circulating insulin level J:108399
Prkab1em1(IMPC)J/Prkab1em1(IMPC)J
(C57BL/6NJ-Prkab1em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/MbpMmucd) 		impaired glucose tolerance J:211773
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ccpcz) 		increased fasting circulating glucose level J:211773
Prkab1tm1Eihl/Prkab1tm1Eihl
(involves: C57BL/6) 		decreased circulating insulin level J:158295
increased insulin sensitivity J:158295
Prkab1tm1Grst/Prkab1tm1Grst
Prkab2tm1Grst/Prkab2tm1Grst
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB) 		increased circulating glucose level J:176578
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi) 		decreased circulating glucose level J:186658
decreased glycogen catabolism rate J:186658
decreased skeletal muscle glycogen level J:186658
impaired glucose tolerance J:186658
increased circulating insulin level J:186658
insulin resistance J:186658
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6) 		abnormal glucose homeostasis J:167339
decreased liver glycogen level J:167339
decreased skeletal muscle glycogen level J:167339
increased circulating insulin level J:167339
insulin resistance J:167339
Prkacatm3Gsm/Prkacatm3Gsm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		abnormal glucose homeostasis J:103418
abnormal glycogen homeostasis J:103418
decreased circulating insulin level J:103418
decreased insulin secretion J:103418
decreased liver glycogen level J:103418
impaired glucose tolerance J:103418
increased circulating glucose level J:103418
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno) 		decreased circulating insulin level J:235379
impaired glucose tolerance J:235379
increased cardiac muscle glycogen level J:256296
insulin resistance J:235379
Prkag3tm1Sson/Prkag3tm1Sson
(involves: C57BL/6J) 		abnormal glucose homeostasis J:92821
decreased skeletal muscle glycogen level J:92821
Prkar2btm1Gsm/Prkar2btm1Gsm
(B6.129-Prkar2btm1Gsm) 		decreased circulating insulin level J:72414
improved glucose tolerance J:72414
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm) 		decreased circulating insulin level J:196157
improved glucose tolerance J:196157
Prkcdtm1.1Khn/Prkcdtm1.1Khn
(B6.129P2-Prkcdtm1.1Khn) 		improved glucose tolerance J:173902
increased insulin sensitivity J:173902
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		decreased insulin secretion J:120293
impaired glucose tolerance J:120293
Prkcdtm1Qxu/Prkcdtm1Qxu
(B6.129P2-Prkcdtm1Qxu) 		improved glucose tolerance J:173902
increased insulin sensitivity J:173902
Prkcitm1Kido/Prkcitm1Kido
Tg(Ins2-cre)25Mgn/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		decreased circulating glucose level J:95378
impaired glucose tolerance J:95378
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal glucose homeostasis J:123964
impaired glucose tolerance J:123964
increased circulating glucose level J:123964
increased circulating insulin level J:123964
insulin resistance J:123964
Prkcitm1Rfar/Prkcitm1Rfar
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal glucose homeostasis J:123964
impaired glucose tolerance J:123964
increased circulating glucose level J:123964
increased circulating insulin level J:123964
insulin resistance J:123964
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:92834
increased insulin sensitivity J:92834
Prkd1em2(IMPC)Wtsi/Prkd1+
(C57BL/6N-Prkd1em2(IMPC)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid/J) 		increased circulating glucose level J:91764
Prkdcscid/Prkdcscid
Tg(B2M)55Hpl/0
Mcph1Tg(HLA-A2.1)1Enge/Mcph1+
(NOD.Cg-Mcph1Tg(HLA-A2.1)1Enge Prkdcscid Tg(B2M)55Hpl/Sz) 		increased circulating glucose level J:91764
Prkdcscid/Prkdcscid
Tg(INS-HBEGF*L148S*P149T)70Rin/0
(C.BKa-Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin) 		decreased circulating insulin level J:204420
hyperglycemia J:204420
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon) 		impaired glucose tolerance J:144729
increased circulating insulin level J:144729
insulin resistance J:144729
Prlhtm2Smln/Prlhtm2Smln
(involves: C57BL/6J) 		hyperglycemia J:215557
increased circulating insulin level J:215557
Prlhrtm1Askr/Prlhrtm1Askr
(involves: 129S5/SvEvBrd * C57BL/6) 		increased circulating insulin level J:90533
insulin resistance J:90533
Prlhrtm1Dgen/Prlhrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:127335
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased insulin secretion J:106829
impaired glucose tolerance J:106829
Prmt9em1(IMPC)J/Prmt9em1(IMPC)J
(C57BL/6NJ-Prmt9em1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased circulating glucagon level J:102652
increased circulating insulin level J:102652
Prpf6tm1.1(KOMP)Vlcg/Prpf6+
(C57BL/6N-Prpf6tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Prss35em1(IMPC)Ccpcz/Prss35em1(IMPC)Ccpcz
(C57BL/6N-Prss35em1(IMPC)Ccpcz/Ccpcz) 		impaired glucose tolerance J:211773
Prxl2atm1(KOMP)Vlcg/Prxl2atm1(KOMP)Vlcg
(C57BL/6N-Prxl2atm1(KOMP)Vlcg) 		increased circulating insulin level J:234040
Psg22em1(IMPC)Wtsi/Psg22em1(IMPC)Wtsi
(C57BL/6N-Psg22em1(IMPC)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Psg27em1(IMPC)Wtsi/Psg27em1(IMPC)Wtsi
(C57BL/6N-Psg27em1(IMPC)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Pskh1tm1b(EUCOMM)Wtsi/Pskh1+
(C57BL/6N-Pskh1tm1b(EUCOMM)Wtsi/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Pstpip2em1(IMPC)Tcp/Pstpip2em1(IMPC)Tcp
(C57BL/6NCrl-Pstpip2em1(IMPC)Tcp/Tcp) 		improved glucose tolerance J:211773
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg) 		impaired glucose tolerance J:256004
insulin resistance J:256004
Ptch2tm3b(EUCOMM)Hmgu/Ptch2tm3b(EUCOMM)Hmgu
(C57BL/6N-Ptch2tm3b(EUCOMM)Hmgu/Bay) 		increased fasting circulating glucose level J:211773
Ptentm1Hwu/Ptentm1Hwu
Rictortm1.1Mgn/Rictortm1.1Mgn
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal glucose homeostasis J:170129
decreased circulating insulin level J:170129
hypoglycemia J:170129
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		decreased circulating glucose level J:88441
decreased circulating insulin level J:88441
improved glucose tolerance J:88441
increased insulin sensitivity J:88441
increased liver glycogen level J:88441
Ptentm1Hwu/Ptentm1Hwu
Tg(Ckmm-cre)5Khn/?
(involves: 129S4/SvJae * FVB) 		decreased circulating glucose level J:169364
decreased circulating insulin level J:169364
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp4-cre)1Abel/0
(involves: 129S4/SvJae) 		decreased circulating insulin level J:97588
improved glucose tolerance J:97588
increased insulin sensitivity J:97588
Ptentm1Hwu/Ptentm1Hwu
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA) 		hypoglycemia J:106937
improved glucose tolerance J:170206
increased insulin secretion J:170206
increased insulin sensitivity J:170206
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		decreased circulating insulin level J:90905
decreased fasting circulating glucose level J:90905
increased insulin sensitivity J:90905
Ptf1atm1Pkwe/Ptf1atm1Pkwe
(involves: 129P2/OlaHsd * C57BL/6) 		hypoglycemia J:51571
Ptgs2tm1Unc/Ptgs2+
(D1.129P2-Ptgs2tm1Unc) 		increased circulating insulin level J:102779
Pthlhtm2Ack/Pthlhtm2Ack
(involves: 129S2/SvPas * C57BL/6) 		decreased circulating glucose level J:142669
Ptp4a3tm1.2Xhan/Ptp4a3tm1.2Xhan
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N) 		decreased circulating glucose level J:197019
Ptpn1tm1Bbk/Ptpn1+
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating insulin level J:63236
Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating glucose level J:63236
decreased circulating insulin level J:63236
improved glucose tolerance J:63236
increased insulin sensitivity J:63236
Ptpn1tm1Bpk/Ptpn1+
(involves: 129S4/SvJae * BALB/c) 		decreased circulating glucose level J:53437
Ptpn1tm1Bpk/Ptpn1tm1Bpk
(involves: 129S4/SvJae * BALB/c) 		decreased circulating glucose level J:53437
decreased circulating insulin level J:53437
improved glucose tolerance J:53437
increased insulin sensitivity J:53437
Ptpn1tm2Bbk/Ptpn1+
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased circulating glucose level J:111969
decreased circulating insulin level J:111969
Ptpn1tm2Bbk/Ptpn1tm2Bbk
Ptpn2tm1.1Ttig/Ptpn2tm1.1Ttig
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL) 		abnormal glucose homeostasis J:179621
decreased circulating glucose level J:179621
increased insulin sensitivity J:179621
Ptpn1tm2Bbk/Ptpn1tm2Bbk
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased circulating glucose level J:111969
decreased circulating insulin level J:111969
improved glucose tolerance J:111969
increased insulin sensitivity J:111969, J:179621
Ptpn2tm1.1Kry/Ptpn2tm1.1Kry
Tg(Col1a1-cre)1Kry/0
(involves: 129 * C57BL/6J * FVB) 		increased insulin sensitivity J:183709
Ptpn2tm1.1Ttig/Ptpn2tm1.1Ttig
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL) 		abnormal glucose homeostasis J:179621
decreased circulating glucose level J:179621
decreased circulating insulin level J:179621
increased insulin sensitivity J:179621
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		decreased circulating glucose level J:216593
decreased circulating insulin level J:216593
improved glucose tolerance J:216593
increased insulin sensitivity J:216593
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal glucose homeostasis J:94738
hyperglycemia J:94738
hypoglycemia J:94738
increased circulating insulin level J:94738
increased liver glycogen level J:94738
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB) 		impaired glucose tolerance J:144767
increased circulating insulin level J:144767
insulin resistance J:144767
Ptpn11tm3Bgn/Ptpn11tm3Bgn
(involves: 129X1/SvJ * C57BL/6J) 		improved glucose tolerance J:167406
Ptpn11tm3Bgn/Ptpn11tm3Bgn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA) 		decreased circulating glucose level J:167406
decreased circulating insulin level J:167406
improved glucose tolerance J:167406
increased insulin sensitivity J:167406
Ptprdtm2a(KOMP)Wtsi/Ptprdtm2a(KOMP)Wtsi
(C57BL/6N-Ptprdtm2a(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Ptprmem1(IMPC)Rbrc/Ptprmem1(IMPC)Rbrc
(C57BL/6NJcl-Ptprmem1(IMPC)Rbrc/Rbrc) 		abnormal circulating glucose level J:211773
Ptprn2tm1Aln/Ptprn2tm1Aln
(involves: 129S4/SvJae * C57BL/6N) 		impaired glucose tolerance J:91889
Ptprntm1Aln/Ptprntm1Aln
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:108765
Ptprutm1.1(KOMP)Vlcg/Ptprutm1.1(KOMP)Vlcg
(C57BL/6N-Ptprutm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd) 		decreased circulating glucose level J:126780
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating glucose level J:152695
increased circulating insulin level J:152695
Ptprvtm1Kry/Ptprvtm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		abnormal glucose homeostasis J:126780
decreased circulating glucose level J:126780
hypoglycemia J:126780
improved glucose tolerance J:126780
increased circulating insulin level J:126780
increased insulin secretion J:126780
increased insulin sensitivity J:126780
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating insulin level J:82724
hyperglycemia J:82724
Pudptm1.1(KOMP)Vlcg/Pudptm1.1(KOMP)Vlcg
(C57BL/6N-Pudptm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Puf60em1(IMPC)Bay/Puf60+
(C57BL/6N-Puf60em1(IMPC)Bay/BayMmucd) 		impaired glucose tolerance J:211773
Pus7em1(IMPC)J/Pus7+
(C57BL/6NJ-Pus7em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Pvrem1(IMPC)Wtsi/Pvrem1(IMPC)Wtsi
(C57BL/6N-Pvrem1(IMPC)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Pwwp2bem1(IMPC)J/Pwwp2bem1(IMPC)J
(C57BL/6NJ-Pwwp2bem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Pwwp2btm1.1Bcgen/Pwwp2btm1.1Bcgen
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		improved glucose tolerance J:319940
increased insulin sensitivity J:319940
Pycr1tm1(KOMP)Vlcg/Pycr1tm1(KOMP)Vlcg
(C57BL/6NTac-Pycr1tm1(KOMP)Vlcg) 		impaired glucose tolerance J:308336
Pycr2tm1a(EUCOMM)Wtsi/Pycr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Pycr2tm1a(EUCOMM)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi) 		decreased fasting circulating glucose level J:284765
decreased hepatic glucose production J:284765
hypoglycemia J:284765
increased liver glycogen level J:330539, J:284765
Pygmtm1.1Adru/Pygmtm1.1Adru
(involves: 129 * C57BL/6J) 		increased skeletal muscle glycogen level J:226312
Pyytm1(cre)Hhzg/Pyytm1(cre)Hhzg
(involves: 129) 		impaired glucose tolerance J:111480
increased circulating insulin level J:111480
Qsox1em1(IMPC)Kmpc/Qsox1em1(IMPC)Kmpc
(C57BL/6NTac-Qsox1em1(IMPC)Kmpc/Kmpc) 		decreased fasting circulating glucose level J:211773
Qsox2em1(IMPC)Kmpc/Qsox2em1(IMPC)Kmpc
(C57BL/6NTac-Qsox2em1(IMPC)Kmpc/Kmpc) 		increased fasting circulating glucose level J:211773
Rab10tm1c(KOMP)Wtsi/Rab10tm1c(KOMP)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		increased circulating insulin level J:249843
increased hepatic glucose production J:249843
insulin resistance J:249843
Rab11atm1b(KOMP)Wtsi/Rab11a+
(C57BL/6N-Rab11atm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
Rab11fip1em1(IMPC)Bay/Rab11fip1em1(IMPC)Bay
(C57BL/6N-Rab11fip1em1(IMPC)Bay/BayMmucd) 		increased fasting circulating glucose level J:211773
Rab11fip5tm1.1(KOMP)Vlcg/Rab11fip5tm1.1(KOMP)Vlcg
(C57BL/6N-Rab11fip5tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Rab15tm1a(KOMP)Wtsi/Rab15tm1a(KOMP)Wtsi
(C57BL/6N-Rab15tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating insulin level J:211773
Rab37tm1Hsliu/Rab37tm1Hsliu
(involves: C57BL/6J * C57BL/6N) 		decreased insulin secretion J:334080
hyperglycemia J:334080
Rab43tm1.1(KOMP)Vlcg/Rab43tm1.1(KOMP)Vlcg
(C57BL/6N-Rab43tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Rabgap1tm1b(EUCOMM)Hmgu/Rabgap1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rabgap1tm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Rabl2tm1.1(KOMP)Wtsi/Rabl2tm1.1(KOMP)Wtsi
(C57BL/6N-Rabl2tm1.1(KOMP)Wtsi/Ucd) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Rad21ltm1b(KOMP)Wtsi/Rad21ltm1b(KOMP)Wtsi
(C57BL/6N-Rad21ltm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased circulating glucose level J:111874
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraTcrbNY8.3)1Pesa/0
(NOD.Cg-Rag2tm1Fwa Tg(TcraTcrbNY8.3)1Pesa) 		increased circulating glucose level J:94192
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J) 		increased circulating insulin level J:287672
increased fasting circulating glucose level J:287672
insulin resistance J:287672
Ralgapa1tm2c(KOMP)Wtsi/Ralgapa1tm2c(KOMP)Wtsi
Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N) 		improved glucose tolerance J:287672
increased circulating insulin level J:287672
Ranbp2Gt(pGT0pfs)630Wcs/Ranbp2+
(129P2/OlaHsd-Ranbp2Gt(pGT0pfs)630Wcs) 		impaired glucose tolerance J:116134
Ranbp10tm1.1(KOMP)Vlcg/Ranbp10tm1.1(KOMP)Vlcg
(C57BL/6N-Ranbp10tm1.1(KOMP)Vlcg/Ucd) 		increased circulating glucose level J:211773
Rap2btm1.1(KOMP)Vlcg/Rap2btm1.1(KOMP)Vlcg
(C57BL/6N-Rap2btm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Rapgef3tm1.1Chen/Rapgef3tm1.1Chen
(B6.129(Cg)-Rapgef3tm1.1Chen) 		abnormal glucose homeostasis J:207599
decreased circulating glucose level J:207599
decreased circulating insulin level J:207599
improved glucose tolerance J:207599
increased insulin sensitivity J:207599
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified) 		decreased circulating insulin level J:201171
decreased insulin secretion J:201171
hyperglycemia J:201171
impaired glucose tolerance J:201171
insulin resistance J:201171
Rapgef4em1(IMPC)H/Rapgef4em1(IMPC)H
(C57BL/6NTac-Rapgef4em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Rapgef4tm1.1Sse/Rapgef4tm1.1Sse
(Not Specified) 		abnormal insulin secretion J:128493
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk) 		abnormal gluconeogenesis J:206120
decreased insulin secretion J:206120
impaired glucose tolerance J:206120
increased circulating glucose level J:206120
Rasa1tm1b(EUCOMM)Hmgu/Rasa1+
(C57BL/6N-Rasa1tm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Rasa3tm1b(KOMP)J/Rasa3+
(C57BL/6N-Rasa3tm1b(KOMP)J/J) 		decreased circulating glucose level J:211773
Rasgrf1tm1Esn/Rasgrf1tm1Esn
(involves: 129/Sv * C57BL/6N) 		decreased circulating insulin level J:83950
impaired glucose tolerance J:83950
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Ren-cre)#Kwg/0
(involves: 129 * 129P2/OlaHsd) 		increased circulating glucagon level J:216559
Rbl1tm1b(EUCOMM)Hmgu/Rbl1+
(C57BL/6N-Rbl1tm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Rbm4tm1Wtarn/Rbm4tm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:192831
decreased circulating insulin level J:192831
hyperglycemia J:192831
impaired glucose tolerance J:192831
Rbm4btm1Wtarn/Rbm4btm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:192831
impaired glucose tolerance J:192831
Rbm6em1(IMPC)J/Rbm6em1(IMPC)J
(C57BL/6NJ-Rbm6em1(IMPC)J/Mmjax) 		decreased fasting circulating glucose level J:211773
Rbms1tm1b(EUCOMM)Wtsi/Rbms1+
(C57BL/6N-Rbms1tm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
Rbmxtm2a(KOMP)Wtsi/Rbmxtm2a(KOMP)Wtsi
(C57BL/6N-Rbmxtm2a(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Rbp1tm2b(EUCOMM)Hmgu/Rbp1tm2b(EUCOMM)Hmgu
(C57BL/6N-Rbp1tm2b(EUCOMM)Hmgu/Bay) 		decreased fasting circulating glucose level J:211773
Rbpjtm1b(EUCOMM)Hmgu/Rbpj+
(C57BL/6N-Rbpjtm1b(EUCOMM)Hmgu/J) 		improved glucose tolerance J:211773
Rcan2tm1Ypt/Rcan2tm1Ypt
(B6.129-Rcan2tm1Ypt) 		improved glucose tolerance J:169558
increased insulin sensitivity J:169558
Rcn3tm1Rzm/Rcn3tm1Rzm
(involves: 129S6/SvEvTac * C57BL/6J) 		increased lung glycogen level J:265611
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6J.Cg-Reep1Gt(OST398247)Tigm) 		decreased circulating insulin level J:239250
Reg3btm1Lex/Reg3btm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:171883
Reltm1b(EUCOMM)Wtsi/Reltm1b(EUCOMM)Wtsi
(C57BL/6N-Reltm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
Retntm1Laz/Retntm1Laz
(involves: 129S/SvEv * C57BL/6) 		decreased circulating glucose level J:90033
improved glucose tolerance J:90033
Retntm1Laz/Retntm1Laz
Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6) 		impaired glucose tolerance J:171262
increased circulating insulin level J:171262
insulin resistance J:171262
Retnlatm1Mer/Retnlatm1Mer
(C57BL/6-Retnlatm1Mer) 		improved glucose tolerance J:144784
Retnlatm1Mer/Retnlatm1Mer
(C.B6-Retnlatm1Mer) 		improved glucose tolerance J:144784
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex) 		impaired glucose tolerance J:235058
Retnlbtm1Lex/Retnlbtm1Lex
(B6.129S5-Retnlbtm1Lex) 		impaired glucose tolerance J:235058
Rexo2tm1b(EUCOMM)Wtsi/Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Rfx6tm1.1(KOMP)Vlcg/Rfx6+
(C57BL/6N-Rfx6tm1.1(KOMP)Vlcg/Ucd) 		impaired glucose tolerance J:211773
Rfx7tm2b(EUCOMM)Hmgu/Rfx7+
(C57BL/6N-Rfx7tm2b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Rgp1tm1.1(KOMP)Vlcg/Rgp1+
(C57BL/6N-Rgp1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Rgs2em1(IMPC)H/Rgs2em1(IMPC)H
(C57BL/6NTac-Rgs2em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Rgs5tm1.1Rgan/Rgs5tm1.1Rgan
Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh) 		hypoglycemia J:136259
Rgs7tm1Lex/Rgs7tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:103485
Rgs10Gt(OST24334)Lex/Rgs10Gt(OST24334)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:103485
increased circulating glucose level J:103485
Rgsc25/Rgsc25+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
increased urine glucose level J:133634
Rgsc160/Rgsc160+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
Rgsc1361/Rgsc1361+
(involves: KJR * MSM) 		increased circulating glucose level J:133634
Rictortm1.1Mgn/Rictortm1.1Mgn
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal glucose homeostasis J:170129
decreased insulin secretion J:170129
hyperglycemia J:170129
impaired glucose tolerance J:170129
Rictortm1.1Mnh/Rictortm1.1Mnh
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev) 		improved glucose tolerance J:150064
increased circulating insulin level J:150064
insulin resistance J:150064
Rigiem1(IMPC)Mbp/Rigiem1(IMPC)Mbp
(C57BL/6N-Rigiem1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Rilpl1tm1b(EUCOMM)Hmgu/Rilpl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rilpl1tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Rims2tm1Sse/Rims2tm1Sse
(B6.Cg-Rims2tm1Sse) 		decreased circulating glucose level J:163080
decreased circulating insulin level J:163080
decreased insulin secretion J:163080
impaired glucose tolerance J:163080
increased circulating glucagon level J:163080
increased circulating glucose level J:163080
Rin3tm1.1(KOMP)Vlcg/Rin3tm1.1(KOMP)Vlcg
(C57BL/6N-Rin3tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Rint1tm1b(KOMP)Wtsi/Rint1+
(C57BL/6N-Rint1tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Ripk1tm1.1Vmd/Ripk1+
Ripk3tm2Vmd/Ripk3tm2Vmd
(involves: C57BL/6N) 		decreased liver glycogen level J:209137
Rln3tm1Lex/Rln3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:181242
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6) 		abnormal glucose tolerance J:168271
decreased circulating glucose level J:168271
Rnaset2btm1b(EUCOMM)Hmgu/Rnaset2btm1b(EUCOMM)Hmgu
(C57BL/6N-Rnaset2btm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Rnf10em1(IMPC)Mbp/Rnf10em1(IMPC)Mbp
(C57BL/6N-Rnf10em1(IMPC)Mbp/Ucd) 		increased circulating glucose level J:211773
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics) 		improved glucose tolerance J:211773
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Rnf14em1(IMPC)Ccpcz/Rnf14em1(IMPC)Ccpcz
(C57BL/6N-Rnf14em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Rnf133tm1.1(KOMP)Vlcg/Rnf133tm1.1(KOMP)Vlcg
(C57BL/6N-Rnf133tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1) 		decreased circulating insulin level J:244583
decreased insulin secretion J:244583
impaired glucose tolerance J:244583
increased circulating glucose level J:244583
Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N) 		decreased circulating glucose level J:200802
decreased insulin secretion J:200802
Rnf216tm1b(EUCOMM)Wtsi/Rnf216tm1b(EUCOMM)Wtsi
(C57BL/6N-Rnf216tm1b(EUCOMM)Wtsi/Tcp) 		increased fasting circulating glucose level J:211773
Robo3em1(IMPC)H/Robo3+
(C57BL/6NTac-Robo3em1(IMPC)H/H) 		decreased circulating glucose level J:211773
Robo4tm1Kzh/Robo4tm1Kzh
(Not Specified) 		decreased circulating glucose level J:294754
decreased fasting circulating glucose level J:294754
improved glucose tolerance J:294754
Rock1tm1.1Itl/Rock1tm1.1Itl
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased circulating insulin level J:204885
insulin resistance J:204885
Rock2tm1Zpj/Rock2+
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		improved glucose tolerance J:224630
Rpa1tm1b(KOMP)Wtsi/Rpa1+
(C57BL/6N-Rpa1tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Rpap3em1(IMPC)Mbp/Rpap3+
(C57BL/6N-Rpap3em1(IMPC)Mbp/Ucd) 		decreased circulating glucose level J:211773
Rph3altm1Sse/Rph3altm1Sse
(B6.129-Rph3altm1Sse) 		decreased insulin secretion J:90669
impaired glucose tolerance J:90669
increased circulating glucose level J:90669
Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(FVB.129S5(Cg)-Rpl13atm1.1Jesc) 		abnormal circulating glucose level J:237822
improved glucose tolerance J:237822
increased insulin secretion J:237822
Rps6tm1Om/Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased circulating insulin level J:100952
decreased insulin secretion J:100952
impaired glucose tolerance J:100952
increased insulin sensitivity J:100952
Rps6ka3tm1Ljg/Y
(involves: 129 * C57BL/6) 		decreased skeletal muscle glycogen level J:67575
impaired glucose tolerance J:83536
increased circulating glucose level J:83536
increased circulating insulin level J:83536
insulin resistance J:83536
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating insulin level J:66406
decreased insulin secretion J:66406
hyperglycemia J:66406
impaired glucose tolerance J:66406
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(B6.129P2-Rps6kb1tm1Gtho) 		decreased circulating insulin level J:144599
increased insulin sensitivity J:144599
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
Rps6kb2tm1Gtho/Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd) 		increased skeletal muscle glycogen level J:129852
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb) 		decreased circulating glucose level J:144599
decreased circulating insulin level J:144599
increased insulin sensitivity J:144599
Rps6kl1tm1.1(KOMP)Vlcg/Rps6kl1tm1.1(KOMP)Vlcg
(C57BL/6N-Rps6kl1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Rptortm1Rueg/Rptortm1Rueg
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased skeletal muscle glycogen level J:143748
Rptortm1Rueg/Rptortm1Rueg
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating glucose level J:143749
decreased circulating insulin level J:143749
improved glucose tolerance J:143749
Rr266em1Hino/Rr266em1Hino
Rr268em1Hino/Rr268em1Hino
(C57BL/6J-Rr266em1Hino Rr268em1Hino) 		decreased insulin secretion J:312429
hyperglycemia J:312429
impaired glucose tolerance J:312429
Rr327em1Mgn/Rr327em1Mgn
(C57BL/6J-Rr327em1Mgn) 		increased insulin secretion J:340414
Rr344em1Jfer/Rr344em1Jfer
(B6.Cg-Rr344em1Jfer) 		decreased circulating insulin level J:328047
decreased glucagon secretion J:328047
decreased insulin secretion J:328047
hyperglycemia J:328047
Rr124128tm1.1Jfer/Rr124128tm1.1Jfer
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6 * FVB/N) 		decreased circulating insulin level J:332319
hyperglycemia J:332319
impaired glucose tolerance J:332319
Rr124128tm1.2Jfer/Rr124128tm1.2Jfer
(involves: C57BL/6 * FVB/N) 		decreased circulating insulin level J:332319
impaired glucose tolerance J:332319
Rragatm1.1Dmsa/Rragatm1.1Dmsa
(involves: 129 * C57BL/6 * C57BL/6J) 		abnormal gluconeogenesis J:194401
abnormal glycogen homeostasis J:194401
hypoglycemia J:194401
Rragatm2Dmsa/Rragatm2Dmsa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		decreased circulating glucose level J:213516
increased insulin sensitivity J:213516
Rrasem1(IMPC)H/Rrasem1(IMPC)H
(C57BL/6N-Rrasem1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased circulating glucose level J:186071
Rrp8tm1.1(KOMP)Vlcg/Rrp8+
(C57BL/6N-Rrp8tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Rspo4tm1a(KOMP)Wtsi/Rspo4tm1a(KOMP)Wtsi
(C57BL/6N-Rspo4tm1a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Rtbdntm1a(EUCOMM)Wtsi/Rtbdntm1a(EUCOMM)Wtsi
(C57BL/6N-Rtbdntm1a(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Rtn2tm1Lex/Rtn2tm1Lex
(involves: 129S/SvEvBrd) 		abnormal circulating glucose level J:158249
Rubcnlem1Qsun/Rubcnlem1Qsun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Rubcnlem1Qsun) 		increased liver glycogen level J:272052
Rufy2tm1a(EUCOMM)Wtsi/Rufy2tm1a(EUCOMM)Wtsi
(C57BL/6N-Rufy2tm1a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Runx3tm1b(KOMP)Wtsi/Runx3+
(C57BL/6N-Runx3tm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Runx3tm1Yito/Runx3tm1Yito
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:75869
Rxfp4tm1.1(KOMP)Vlcg/Rxfp4tm1.1(KOMP)Vlcg
(C57BL/6N-Rxfp4tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Samd1tm1Pfi/Samd1+
(involves: C57BL/6J * C57BL/6N) 		abnormal circulating insulin level J:333561
abnormal glucose tolerance J:333561
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr) 		abnormal glucose homeostasis J:208616
decreased circulating glucose level J:208616
decreased circulating insulin level J:208616
decreased insulin secretion J:208616
decreased skeletal muscle glycogen level J:208616
increased insulin sensitivity J:208616
Sap30em1(IMPC)J/Sap30em1(IMPC)J
(C57BL/6NJ-Sap30em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Sbdstm1Jrom/Sbdstm3.1Jrom
Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) 		impaired glucose tolerance J:189357
Sbf1em1(IMPC)Mbp/Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Sc5dtm1Fdp/Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ) 		decreased liver glycogen level J:84450
Scamp2em1(IMPC)J/Scamp2em1(IMPC)J
(C57BL/6NJ-Scamp2em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
Scarb2tm1Psa/Scarb2tm1Psa
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased urine glucose level J:82474
Scd1tm1Ntam/Scd1tm1Ntam
(involves: 129S6/SvEvTac) 		decreased circulating insulin level J:78607
improved glucose tolerance J:78607
Scd1tm1Ntam/Scd1tm1Ntam
(involves: C57BL/6) 		abnormal glucose homeostasis J:130441
decreased circulating glucose level J:130441
improved glucose tolerance J:130441
increased insulin sensitivity J:130441
Scd1tm1Ntam/Scd1tm1Ntam
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		increased insulin sensitivity J:178653
Scd1tm2Ntam/Scd1tm2Ntam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam) 		abnormal gluconeogenesis J:130441
decreased circulating glucose level J:130441
decreased liver glycogen level J:130441
Scg3Gt(VICTR20)13Lex/Scg3Gt(VICTR20)13Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:256077
impaired glucose tolerance J:256077
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		abnormal circulating insulin level J:53349
abnormal glucose homeostasis J:77510
decreased circulating glucagon level J:53349
hypoglycemia J:53349
increased liver glycogen level J:77510
Scinem1(IMPC)Mbp/Scinem1(IMPC)Mbp
(C57BL/6NCrl-Scinem1(IMPC)Mbp/Mmucd) 		decreased circulating glucose level J:211773
Scml4em1(IMPC)J/Scml4em1(IMPC)J
(C57BL/6NJ-Scml4em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Scn2btm1Lex/Scn2btm1Lex
(B6;129S5-Scn2btm1Lex/Mmucd) 		impaired glucose tolerance J:171883
Scn3aGt(OST52130)Lex/Scn3a+
(involves: 129S5/SvEvBrd * C57BL/6J) 		improved glucose tolerance J:103485
Scn4am1Aaa/Scn4a+
(involves: BALB/c * C57BL/6J) 		improved glucose tolerance J:217522
Sctrtm1Bkcc/Sctrtm1Bkcc
(B6.129S7-Sctrtm1Bkcc) 		increased circulating glucose level J:121376
Scube3m1Mhda/Scube3m1Mhda
(C3HeB/FeJ-Scube3m1Mhda) 		decreased circulating glucose level J:237904
decreased urine glucose level J:237904
improved glucose tolerance J:237904
Sdc1em1(IMPC)H/Sdc1em1(IMPC)H
(C57BL/6NTac-Sdc1em1(IMPC)H/H) 		improved glucose tolerance J:211773
Sdc3tm1Rau/Sdc3tm1Rau
(B6.129S-Sdc3tm1Rau) 		decreased circulating insulin level J:94417
improved glucose tolerance J:94417
Sdhatm2b(KOMP)Wtsi/Sdha+
(C57BL/6N-Sdhatm2b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Sdhbtm1b(EUCOMM)Hmgu/Sdhb+
(C57BL/6N-Sdhbtm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Sdhbtm1c(EUCOMM)Hmgu/Sdhbtm1c(EUCOMM)Hmgu
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased circulating insulin level J:326592
decreased insulin secretion J:326592
hyperglycemia J:326592
impaired glucose tolerance J:326592
increased fasting circulating glucose level J:326592
Sdhctm1c(EUCOMM)Wtsi/Sdhctm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1.1(rtTA,tetO-cre)Bkmn/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		decreased circulating glucose level J:284745
decreased circulating insulin level J:284745
Seboxem1(IMPC)J/Seboxem1(IMPC)J
(C57BL/6NJ-Seboxem1(IMPC)J/J) 		increased fasting circulating glucose level J:211773
Sec23bGt(AD0407)Wtsi/Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi) 		decreased circulating glucose level J:186391
Sec24dem1(IMPC)Rbrc/Sec24d+
(C57BL/6NJcl-Sec24dem1(IMPC)Rbrc/Rbrc) 		impaired glucose tolerance J:211773
Sec31aem3(IMPC)H/Sec31a+
(C57BL/6N-Sec31aem3(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Sec61a1m1Gek/Sec61a1+
(C57BL/6J-Sec61a1m1Gek) 		decreased circulating insulin level J:164159
hyperglycemia J:164159
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		abnormal glucose homeostasis J:164159
decreased circulating insulin level J:164159
hyperglycemia J:164159
impaired glucose tolerance J:164159
increased circulating glucagon level J:164159
Sec61bem1(IMPC)Mbp/Sec61bem1(IMPC)Mbp
(C57BL/6NCrl-Sec61bem1(IMPC)Mbp/Mmucd) 		increased circulating insulin level J:211773
Selenbp1tm1b(KOMP)Wtsi/Selenbp1tm1b(KOMP)Wtsi
(C57BL/6N-Selenbp1tm1b(KOMP)Wtsi/Ucd) 		increased circulating insulin level J:211773
Selenottm1.1Ics/Selenottm1.1Ics
Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA) 		decreased circulating insulin level J:203279
decreased insulin secretion J:203279
impaired glucose tolerance J:203279
increased circulating glucose level J:203279
Senp1tm1.1Eyeh/Senp1+
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6) 		impaired glucose tolerance J:226392
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh
(Not Specified) 		decreased insulin secretion J:226392
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6) 		decreased circulating insulin level J:226392
decreased insulin secretion J:226392
impaired glucose tolerance J:226392
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh
Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6) 		decreased insulin secretion J:226392
impaired glucose tolerance J:226392
Senp1tm1Wami/Senp1tm1Wami
Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Senp1tm1Wami Tg(Adipoq-cre)1Evdr) 		decreased insulin secretion J:228009
hyperglycemia J:228009
Senp1tm1Wami/Senp1tm1Wami
Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		decreased circulating insulin level J:228009
decreased insulin secretion J:228009
hyperglycemia J:228009
impaired glucose tolerance J:228009
insulin resistance J:228009
Senp1tm1Wami/Senp1tm1Wami
Tg(Pdgfra-cre)1Clc/0
(B6.Cg-Senp1tm1Wami Tg(Pdgfra-cre)1Clc) 		hyperglycemia J:228009
Senp2Gt(OST66117)Lex/Senp2+
(B6;129S5-Senp2Gt(OST66117)Lex/Orl) 		decreased circulating glucose level J:82809
Septin5tm1b(EUCOMM)Hmgu/Septin5+
(C57BL/6N-Septin5tm1b(EUCOMM)Hmgu/Rbrc) 		improved glucose tolerance J:211773
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen) 		increased liver glycogen level J:326672
Serinc2em1(IMPC)J/Serinc2em1(IMPC)J
(C57BL/6NJ-Serinc2em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Serp1tm1Hori/Serp1tm1Hori
(B6.Cg-Serp1tm1Hori) 		decreased circulating insulin level J:109619
impaired glucose tolerance J:109619
Serp1tm1Hori/Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:109619
impaired glucose tolerance J:109619
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc) 		impaired glucose tolerance J:343846
insulin resistance J:343846
Serpina12tm1Jwada/Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada) 		insulin resistance J:208508
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6 * C57BLKS/J) 		hyperglycemia J:127478
Sertad1tm1Srn/Sertad1tm1Srn
(B6.129-Sertad1tm1Srn) 		decreased insulin secretion J:157231
impaired glucose tolerance J:157231
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex) 		abnormal glucose homeostasis J:194928
decreased circulating glucose level J:194928
decreased circulating insulin level J:194928
improved glucose tolerance J:194928
increased insulin sensitivity J:194928
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd) 		abnormal gluconeogenesis J:189021
impaired glucose tolerance J:189021
insulin resistance J:189021
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi
(involves: 129P2/OlaHsd * C57BL/6N) 		impaired glucose tolerance J:189021
insulin resistance J:189021
Setd4tm1a(KOMP)Wtsi/Setd4tm1a(KOMP)Wtsi
(C57BL/6N-Setd4tm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Setxtm1b(EUCOMM)Wtsi/Setxtm1b(EUCOMM)Wtsi
(C57BL/6N-Setxtm1b(EUCOMM)Wtsi/Ics) 		improved glucose tolerance J:211773
Sfxn1tm1b(EUCOMM)Wtsi/Sfxn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sfxn1tm1b(EUCOMM)Wtsi/J) 		increased fasting circulating glucose level J:211773
Sfxn3tm1b(KOMP)Wtsi/Sfxn3tm1b(KOMP)Wtsi
(C57BL/6N-Sfxn3tm1b(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Sfxn5tm1b(EUCOMM)Hmgu/Sfxn5+
(C57BL/6N-Sfxn5tm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Sgf29tm1a(EUCOMM)Hmgu/Sgf29+
(C57BL/6N-Sgf29tm1a(EUCOMM)Hmgu/Cnrm) 		decreased circulating glucose level J:165965
Sgk3tm1Dpea/Sgk3tm1Dpea
(involves: 129X1/SvJ * C57BL/6) 		decreased fasting circulating glucose level J:279604
Sgms1tm1Kenw/Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6) 		decreased circulating insulin level J:168726
decreased insulin secretion J:168726
hyperglycemia J:168726
impaired glucose tolerance J:168726
increased insulin sensitivity J:168726
Sgms2tm1Kenw/Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw) 		abnormal circulating glucose level J:175924
improved glucose tolerance J:175924
increased insulin sensitivity J:175924
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp) 		decreased circulating insulin level J:235035
decreased insulin secretion J:235035
Sh2b1em1(IMPC)Ics/Sh2b1+
(C57BL/6N-Sh2b1em1(IMPC)Ics/Ics) 		impaired glucose tolerance J:211773
Sh2b1tm1Lr/Sh2b1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:92794
Sh2b1tm1Lr/Sh2b1tm1Lr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:92794
impaired glucose tolerance J:92794
insulin resistance J:92794
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		decreased circulating insulin level J:209019
decreased insulin secretion J:209019
impaired glucose tolerance J:209019
increased circulating glucose level J:209019
Sh2b2tm1Yeb/Sh2b2tm1Yeb
(involves: C57BL/6) 		decreased circulating insulin level J:86301
Sh3tc2tm1b(KOMP)Wtsi/Sh3tc2tm1b(KOMP)Wtsi
(C57BL/6N-Sh3tc2tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Shhtm1b(EUCOMM)Wtsi/Shh+
(C57BL/6N-Shhtm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
Shisal1em1(IMPC)Ccpcz/Shisal1em1(IMPC)Ccpcz
(C57BL/6N-Shisal1em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Shld1em1(IMPC)Mbp/Shld1em1(IMPC)Mbp
(C57BL/6NCrl-Shld1em1(IMPC)Mbp/Mmucd) 		impaired glucose tolerance J:211773
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal insulin secretion J:204228
decreased circulating insulin level J:204228
impaired glucose tolerance J:204228
increased circulating glucose level J:204228
Sik1tm1.2Berd/Sik1tm1.2Berd
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL) 		abnormal glucose homeostasis J:236223
decreased circulating glucose level J:236223
increased circulating insulin level J:236223
increased insulin sensitivity J:236223
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd) 		impaired glucose tolerance J:229999
increased circulating glucose level J:229999
increased circulating insulin level J:229999
insulin resistance J:229999
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N) 		abnormal glucose homeostasis J:183827
decreased circulating glucose level J:183827
decreased circulating insulin level J:183827
improved glucose tolerance J:183827
Sim1Rgsc646/Sim1+
(involves: C57BL/6JJcl * DBA/2JJcl) 		hyperglycemia J:133634
increased circulating insulin level J:133634
increased urine glucose level J:133634
insulin resistance J:133634
Sim1tm1.1Az/Sim1+
(involves: 129X1/SvJ * C57BL/6 * FVB) 		increased circulating glucose level J:95410
increased circulating insulin level J:95410
Sim1tm1Fan/Sim1+
(involves: 129/Sv * C57BL/6) 		abnormal glucose homeostasis J:70586
increased circulating insulin level J:70586
Sirpatm1b(EUCOMM)Hmgu/Sirpatm1b(EUCOMM)Hmgu
(C57BL/6N-Sirpatm1b(EUCOMM)Hmgu/Bay) 		impaired glucose tolerance J:211773
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal glucose tolerance J:133127
increased insulin secretion J:133127
Sirt1tm2.1Mcby/Sirt1tm2.1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal glucose homeostasis J:180628
abnormal glucose tolerance J:180628
decreased circulating insulin level J:180628
Sirt1tm3Fwa/Sirt1tm3Fwa
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		decreased circulating glucose level J:155802
decreased circulating insulin level J:155802
impaired glucose tolerance J:155802
increased insulin sensitivity J:155802
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac) 		hyperglycemia J:178653
increased circulating insulin level J:178653
insulin resistance J:178653
Sirt6tm1.1Cxd/Sirt6tm1.1Cxd
Tg(Alb1-cre)1Dlr/0
(involves: 129S6/SvEvTac * FVB/N) 		increased circulating glucose level J:166368
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased circulating glucose level J:112817
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * BALB/cJ) 		decreased circulating insulin level J:247143
impaired glucose tolerance J:247143
Sirt6tm2.1Cxd/Sirt6tm2.1Cxd
(involves: 129S6/SvEvTac * NIH Black Swiss) 		abnormal glucose homeostasis J:167023
decreased circulating glucose level J:167023
decreased circulating insulin level J:167023
hypoglycemia J:167023
increased insulin sensitivity J:167023
Sirt6tm2.2Cxd/Sirt6tm2.2Cxd
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		abnormal glucose homeostasis J:167023
decreased circulating glucose level J:167023
decreased circulating insulin level J:167023
hypoglycemia J:167023
increased insulin sensitivity J:167023
Sirt6tm2.2Cxd/Sirt6tm2.2Cxd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N * NIH Black Swiss) 		decreased circulating glucose level J:167023
Sisem1(IMPC)J/Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J) 		decreased circulating glucose level J:344683
Siva1tm1b(EUCOMM)Hmgu/Siva1tm1b(EUCOMM)Hmgu
(C57BL/6N-Siva1tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
skimp/skimp
(involves: C3H/HeH) 		decreased circulating glucose level J:77535
decreased glycogen level J:77535
Skor1em1(IMPC)J/Skor1+
(C57BL/6NJ-Skor1em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Slc1a4tm1e(KOMP)Wtsi/Slc1a4tm1e(KOMP)Wtsi
(C57BL/6N-Slc1a4tm1e(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Slc2a1tm1Dcdv/Slc2a1+
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:108250
Slc2a2tm1b(KOMP)Wtsi/Slc2a2+
(C57BL/6N-Slc2a2tm1b(KOMP)Wtsi/Rbrc) 		increased fasting circulating glucose level J:211773
Slc2a2tm1Thor/Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:43839
abnormal glucose tolerance J:43839
decreased circulating insulin level J:43839
hyperglycemia J:43839
increased circulating glucagon level J:43839
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6) 		abnormal circulating glucose level J:75418
abnormal glucose tolerance J:75418
hyperglycemia J:75418
increased liver glycogen level J:75418
insulin resistance J:75418
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB) 		abnormal glucose homeostasis J:110773
increased circulating glucose level J:110773
increased circulating insulin level J:110773
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Fabp4-cre)1Abel/?
(involves: 129S4/SvJae * FVB) 		abnormal glucose homeostasis J:67292
abnormal glucose tolerance J:67292
abnormal glycogen homeostasis J:67292
insulin resistance J:67292
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * FVB) 		abnormal glucose homeostasis J:59054
abnormal glucose tolerance J:59054
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * C57BL/6 * FVB) 		increased cardiac muscle glycogen level J:108830
Slc2a4tm1Jdz/Slc2a4tm1Jdz
(involves: 129S1/Sv * C57BL/6) 		increased circulating glucose level J:123335
increased circulating insulin level J:123335
Slc2a4tm1Jdz/Slc2a4tm1Jdz
Tg(ACTA1-cre)1Jdz/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased circulating glucose level J:123335
increased circulating insulin level J:123335
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL) 		abnormal glucose homeostasis J:43935
abnormal glycogen homeostasis J:43935
hyperglycemia J:43650
increased circulating insulin level J:43935, J:43650
insulin resistance J:43935, J:43650
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6 * SJL) 		impaired glucose tolerance J:97234
increased insulin secretion J:97234
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL) 		abnormal circulating glucose level J:49328
increased circulating insulin level J:49328
insulin resistance J:49328
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL) 		decreased skeletal muscle glycogen level J:75600
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: C57BL/6 * CBA) 		abnormal glucose homeostasis J:69914
Slc2a8tm1Khm/Slc2a8tm1Khm
(involves: 129X1/SvJ) 		increased circulating insulin level J:189148
Slc2a9tm1Khm/Slc2a9tm1Khm
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		increased circulating insulin level J:221544
insulin resistance J:221544
Slc2a13em1(IMPC)Mbp/Slc2a13em1(IMPC)Mbp
(C57BL/6NCrl-Slc2a13em1(IMPC)Mbp/Mmucd) 		impaired glucose tolerance J:211773
Slc5a1Gt(OST315271)Lex/Slc5a1Gt(OST315271)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal circulating glucose level J:195941
abnormal glucose homeostasis J:195941
decreased circulating insulin level J:195941
improved glucose tolerance J:195941
Slc5a1Gt(OST315271)Lex/Slc5a1Gt(OST315271)Lex
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased circulating glucose level J:195941
decreased circulating insulin level J:195941
improved glucose tolerance J:195941
increased urine glucose level J:195941
Slc5a1tm1.1Koep/Slc5a1tm1.1Koep
(B6.129P2-Slc5a1tm1.1Koep) 		abnormal renal glucose reabsorption J:186790
decreased circulating glucose level J:186790
decreased circulating insulin level J:186790
increased urine glucose level J:186790
Slc5a2tm1Lex/Slc5a2tm1Lex
(B6.129S5-Slc5a2tm1Lex) 		abnormal renal glucose reabsorption J:169917
increased urine glucose level J:169917
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal circulating glucose level J:195941
decreased circulating glucose level J:195941
decreased circulating insulin level J:195941
improved glucose tolerance J:195941
increased urine glucose level J:195941
Slc5a10tm1Csk/Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk) 		increased circulating insulin level J:199406
Slc6a2tm1b(EUCOMM)Hmgu/Slc6a2+
(C57BL/6N-Slc6a2tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Slc6a6em1(IMPC)Mbp/Slc6a6em1(IMPC)Mbp
(C57BL/6N-Slc6a6em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Slc6a8tm1e(KOMP)Wtsi/Y
(involves: C57BL/6J * C57BL/6N) 		decreased circulating glucose level J:264220
decreased fasting circulating glucose level J:264220
improved glucose tolerance J:264220
Slc6a19tm1Dgen/Slc6a19tm1Dgen
(involves: 129 * C57BL/6J) 		decreased circulating insulin level J:175382
insulin resistance J:175382
Slc7a5tm1.1Daca/Slc7a5tm1.1Daca
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		insulin resistance J:213820
Slc7a11tm1b(EUCOMM)Wtsi/Slc7a11tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc7a11tm1b(EUCOMM)Wtsi/Ics) 		increased circulating glucose level J:211773
Slc8a1tm1Herc/Slc8a1+
(involves: 129 * CD-1) 		abnormal glucose homeostasis J:186743
increased insulin secretion J:186743
Slc9b2Gt(D174F03)Wrst/Slc9b2Gt(D174F03)Wrst
(involves: 129S2/SvPas * C57BL/6) 		decreased insulin secretion J:197386
increased circulating glucose level J:197386
Slc9b2tm1.1Dgfu/Slc9b2+
(involves: 129 * C57BL/6) 		increased circulating glucose level J:197386
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu
(involves: 129 * C57BL/6) 		decreased circulating insulin level J:197386
decreased insulin secretion J:197386
increased circulating glucose level J:197386
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu
(B6.129-Slc9b2tm1.1Dgfu) 		decreased insulin secretion J:197386
increased circulating glucose level J:197386
Slc12a1tm1Tkh/Slc12a1tm1Tkh
(involves: 129S6/SvEvTac) 		decreased circulating glucose level J:62224
Slc12a1urehr3/Slc12a1urehr3
(C3HeB/FeJ-Slc12a1urehr3) 		decreased circulating glucose level J:121470
Slc12a5em1(IMPC)Mbp/Slc12a5+
(C57BL/6N-Slc12a5em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf) 		abnormal glucose homeostasis J:176732
decreased circulating glucose level J:176732
decreased circulating insulin level J:176732
improved glucose tolerance J:176732
increased insulin sensitivity J:176732
Slc16a1tm2.1Lupel/Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel) 		decreased circulating insulin level J:205481
improved glucose tolerance J:205481
increased insulin sensitivity J:205481
Slc16a10Tn(sb-lacZ,GFP)1.4Tcb/Slc16a10Tn(sb-lacZ,GFP)1.4Tcb
(NOD/ShiLt-Slc16a10Tn(sb-lacZ,GFP)1.4Tcb) 		increased urine glucose level J:227341
Slc16a13em1Tac/Slc16a13em1Tac
(C57BL/6N-Slc16a13em1Tac) 		improved glucose tolerance J:309785
increased insulin sensitivity J:309785
Slc17a5tm1Lex/Slc17a5+
(involves: 129S5/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:103485
Slc17a6tm1Lowl/Slc17a6tm1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Nr5a1-cre)2Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB) 		decreased circulating glucagon level J:129860
hypoglycemia J:129860
Slc17a9tm1Nomu/Slc17a9tm1Nomu
(involves: 129 * C57BL/6J) 		decreased circulating insulin level J:256580
hypoglycemia J:256580
improved glucose tolerance J:256580
increased insulin sensitivity J:256580
Slc19a2tm1Gelb/Slc19a2tm1Gelb
(involves: 129X1/SvJ) 		decreased circulating insulin level J:79974
impaired glucose tolerance J:79974
increased insulin sensitivity J:79974
Slc20a2tm1b(EUCOMM)Wtsi/Slc20a2+
(C57BL/6N-Slc20a2tm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Slc22a1tm1Kmgi/Slc22a1tm1Kmgi
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		abnormal fasting circulating glucose level J:122106
abnormal hepatic glucose production J:122106
Slc22a5jvs/Slc22a5jvs
(C3.OH-H2o2 Slc22a5jvs) 		abnormal glucose homeostasis J:31000
hypoglycemia J:31000
Slc24a5tm1b(KOMP)Mbp/Slc24a5tm1b(KOMP)Mbp
(C57BL/6N-Slc24a5tm1b(KOMP)Mbp/J) 		decreased fasting circulating glucose level J:211773
Slc25a4tm1a(EUCOMM)Wtsi/Slc25a4tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Slc25a4tm1a(EUCOMM)Wtsi/WtsiH) 		improved glucose tolerance J:211773
increased circulating insulin level J:211773
Slc25a13tm1Lct/Slc25a13+
(either: 129/Sv-Slc25a13tm1Lct or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		abnormal gluconeogenesis J:87578
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.129-Slc25a13tm1Lct) 		decreased circulating insulin level J:124766
hypoglycemia J:124766
Slc25a13tm1Lct/Slc25a13tm1Lct
(either: 129/Sv-Slc25a13tm1Lct or (involves: 129S1/Sv * 129X1/SvJ * CD-1)) 		abnormal gluconeogenesis J:87578
Slc25a18tm1b(KOMP)Wtsi/Slc25a18tm1b(KOMP)Wtsi
(C57BL/6N-Slc25a18tm1b(KOMP)Wtsi/Kmpc) 		impaired glucose tolerance J:211773
Slc25a34em1Duna/Slc25a34em1Duna
(C57BL/6J-Slc25a34em1Duna) 		abnormal glucose tolerance J:344152
decreased circulating glucose level J:344152
decreased fasting circulating glucose level J:344152
impaired glucose tolerance J:344152
insulin resistance J:344152
Slc25a46em1(IMPC)J/Slc25a46+
(C57BL/6NJ-Slc25a46em1(IMPC)J/J) 		increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Slc26a2em1(IMPC)Bay/Slc26a2+
(C57BL/6N-Slc26a2em1(IMPC)Bay/BayMmucd) 		impaired glucose tolerance J:211773
Slc27a1tm1Jkk/Slc27a1tm1Jkk
(involves: 129S/SvEv * C57BL/6J) 		abnormal glucose homeostasis J:88657
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129/Sv * C57BL/6) 		increased circulating glucose level J:124917
increased circulating insulin level J:124917
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129) 		improved glucose tolerance J:124916
Slc29a1tm2b(NCOM)Mfgc/Slc29a1tm2b(NCOM)Mfgc
(C57BL/6N-Slc29a1tm2b(NCOM)Mfgc/Tcp) 		improved glucose tolerance J:211773
Slc29a3em1(IMPC)Wtsi/Slc29a3em1(IMPC)Wtsi
(C57BL/6N-Slc29a3em1(IMPC)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Slc30a2em1(IMPC)Tcp/Slc30a2+
(C57BL/6N-Slc30a2em1(IMPC)Tcp/Tcp) 		increased fasting circulating glucose level J:211773
Slc30a8tm1.1Geno/Slc30a8tm1.1Geno
(involves: 129/Sv * C57BL/6JRj) 		decreased insulin secretion J:153253
impaired glucose tolerance J:153253
increased circulating glucose level J:153253
Slc30a8tm1.1Htwt/Slc30a8tm1.1Htwt
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * CBA/JNCrlj * DBA) 		abnormal insulin clearance J:204003
impaired glucose tolerance J:204003
increased insulin secretion J:204003
Slc30a8tm1Lex/Slc30a8tm1Lex
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating insulin level J:152629
decreased insulin secretion J:152629
Slc30a10tm1.1Sommu/Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA) 		decreased liver glycogen level J:243657
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:86005
hypoglycemia J:86005
increased kidney glycogen level J:86005
increased liver glycogen level J:86005
Slc38a2tm1a(KOMP)Wtsi/Slc38a2+
(C57BL/6N-Slc38a2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Slc38a3m1Ingm/Slc38a3m1Ingm
(B6.C3Fe-Slc38a3m1Ingm) 		decreased circulating glucose level J:234835
decreased circulating insulin level J:234835
Slc39a4tm1.1(KOMP)Wtsi/Slc39a4+
(C57BL/6N-Slc39a4tm1.1(KOMP)Wtsi/Ucd) 		increased fasting circulating glucose level J:211773
Slc39a8tm1.1Brvo/Slc39a8tm1.1Brvo
(involves: C57BL/6) 		decreased circulating glucose level J:341571
increased circulating glucose level J:341571
increased circulating insulin level J:341571
increased insulin secretion J:341571
increased urine glucose level J:341571
insulin resistance J:341571
Slc39a14tm1Thir/Slc39a14tm1Thir
(involves: 129 * C57BL/6) 		abnormal gluconeogenesis J:171670
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		abnormal circulating glucose level J:237439
decreased fasting circulating glucose level J:237439
Slc44a4tm1b(EUCOMM)Hmgu/Slc44a4tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc44a4tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Slc46a1tm1b(KOMP)Mbp/Slc46a1+
(C57BL/6N-Slc46a1tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Slc52a3tm2a(KOMP)Wtsi/Slc52a3tm2a(KOMP)Wtsi
(involves: C57BL/6N) 		hypoglycemia J:236029
Slitrk1tm1.1(KOMP)Vlcg/Slitrk1tm1.1(KOMP)Vlcg
(C57BL/6N-Slitrk1tm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Slntm1Peri/Slntm1Peri
(involves: C57BL/6J) 		impaired glucose tolerance J:193427
increased circulating glucose level J:193427
Slurp1tm1Lex/Slurp1tm1Lex
(Not Specified) 		decreased circulating insulin level J:210836
Slx4tm1a(EUCOMM)Wtsi/Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi) 		impaired glucose tolerance J:168567
increased circulating glucose level J:168567
Smarcb1tm1Mya/Smarcb1tm2Mya
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N) 		decreased glycogen catabolism rate J:103919
decreased liver glycogen level J:103919
hypoglycemia J:103919
impaired gluconeogenesis J:103919
Smc5tm1b(KOMP)Wtsi/Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics) 		decreased circulating glucose level J:211773
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased circulating glucose level J:220422
Smg9em1(IMPC)J/Smg9+
(C57BL/6NJ-Smg9em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Smstm1a(EUCOMM)Wtsi/Y
(B6JTyr;B6N-Smstm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Snap25Bdr/Snap25+
(involves: BALB/cAnNCrl) 		decreased glucagon secretion J:119733
decreased insulin secretion J:119733
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified) 		abnormal insulin secretion J:226064
hyperglycemia J:226064
improved glucose tolerance J:226064
increased circulating insulin level J:226064
insulin resistance J:226064
Sncaem1(IMPC)H/Sncaem1(IMPC)H
(C57BL/6NTac-Sncaem1(IMPC)H/H) 		increased fasting circulating glucose level J:211773
Sncbtm1b(EUCOMM)Hmgu/Sncbtm1b(EUCOMM)Hmgu
(C57BL/6N-Sncbtm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Snord116tm1.1Uta/Snord116+
(involves: C57BL/6J) 		decreased circulating glucose level J:131662
increased insulin sensitivity J:131662
Snord116tm1Uta/Snord116+
Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J) 		decreased circulating glucose level J:131427
increased insulin sensitivity J:131427
Snrktm1.1Hxu/Snrktm1.1Hxu
Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr) 		impaired glucose tolerance J:257980
insulin resistance J:257980
Snrktm1Hxu/Snrk+
(C57BL/6-Snrktm1Hxu) 		increased circulating glucose level J:257980
Snrktm1Hxu/Snrktm1Hxu
(C57BL/6-Snrktm1Hxu) 		decreased circulating glucose level J:257980
Snrnp27tm1b(EUCOMM)Wtsi/Snrnp27+
(C57BL/6N-Snrnp27tm1b(EUCOMM)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Snrpntm2Cbr/Snrpn+
(involves: 129S1/Sv * C57BL/6) 		decreased circulating glucose level J:47318
Snx15tm1.1(KOMP)Vlcg/Snx15tm1.1(KOMP)Vlcg
(C57BL/6N-Snx15tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J) 		abnormal glucose homeostasis J:186227
impaired glucose tolerance J:186227
increased circulating glucose level J:186227
increased circulating insulin level J:186227
insulin resistance J:186227
Socs3tm1Ayos/Socs3tm1Ayos
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6) 		improved glucose tolerance J:91796
increased insulin sensitivity J:91796
Socs3tm1Ayos/Socs3tm1Ayos
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6) 		improved glucose tolerance J:91796
increased insulin sensitivity J:91796
Socs3tm1Jni/Socs3+
(B6.129P2-Socs3tm1Jni) 		improved glucose tolerance J:91797
increased insulin sensitivity J:91797
Socs7tm1Pbro/Socs7tm1Pbro
(B6.129S1-Socs7tm1Pbro) 		hypoglycemia J:100915
Socs7tm1Pbro/Socs7tm1Pbro
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:100915
improved glucose tolerance J:100915
increased insulin sensitivity J:100915
Sod2tm1Cje/Sod2tm1Cje
(D2.Cg-Sod2tm1Cje) 		decreased circulating glucose level J:73998
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J) 		decreased circulating glucose level J:73998
Sod2tm1Shs/Sod2tm1Shs
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6CrSlc * FVB) 		increased cardiac muscle glycogen level J:117386
Sorbs1tm1Krc/Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc) 		abnormal circulating insulin level J:121762
abnormal glucose homeostasis J:121762
improved glucose tolerance J:121762
increased insulin sensitivity J:121762
Sorbs2tm1.1(KOMP)Mbp/Sorbs2tm1.1(KOMP)Mbp
(C57BL/6N-Sorbs2tm1.1(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Sordem1Mko/Sordem1Mko
(C57BL/6N-Sordem1Mko) 		impaired glucose tolerance J:326078
insulin resistance J:326078
Sox4Igt4/Sox4+
(involves: C3H/HeH * C57BL/6) 		decreased circulating insulin level J:141688
decreased insulin secretion J:141688
impaired glucose tolerance J:141688
Sox4M91Ark/Sox4+
(involves: C3H/HeH) 		decreased circulating insulin level J:141688
decreased insulin secretion J:141688
impaired glucose tolerance J:141688
Sox9tm1Gsr/Sox9+
Tg(Pdx1-cre)6Cvw/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * FVB/N) 		decreased glucagon secretion J:141017
decreased insulin secretion J:141017
Sox17SHIVA/Sox17+
(either: C57BL/6-Sox17SHIVA or (involves: C57BL/6 * C3H/HeN)) 		decreased fasting circulating glucose level J:219119
Sox30tm1b(KOMP)Wtsi/Sox30tm1b(KOMP)Wtsi
(C57BL/6N-Sox30tm1b(KOMP)Wtsi/Bay) 		increased fasting circulating glucose level J:211773
Sp5tm1b(KOMP)Wtsi/Sp5tm1b(KOMP)Wtsi
(C57BL/6N-Sp5tm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Spag4tm1.1(KOMP)Mbp/Spag4tm1.1(KOMP)Mbp
(C57BL/6N-Spag4tm1.1(KOMP)Mbp/Ucd) 		increased fasting circulating glucose level J:211773
Sparttm2b(EUCOMM)Hmgu/Sparttm2b(EUCOMM)Hmgu
(C57BL/6N-Sparttm2b(EUCOMM)Hmgu/Cnrm) 		increased fasting circulating glucose level J:211773
Spata7tm1.1(KOMP)Vlcg/Spata7tm1.1(KOMP)Vlcg
(C57BL/6N-Spata7tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-cat,-Creg1)#Yal/0
(involves: C57BL/6J * DBA) 		abnormal glucose homeostasis J:263073
decreased circulating glucose level J:263073
decreased circulating insulin level J:263073
impaired glucose tolerance J:263073
increased liver glycogen level J:263073
insulin resistance J:263073
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-Dusp26)#Jhxia/0
(involves: C57BL/6 * DBA) 		impaired glucose tolerance J:279111
insulin resistance J:279111
Sphkaptm1.1Nina/Sphkaptm1.1Nina
(Not Specified) 		decreased circulating glucose level J:272327
decreased circulating insulin level J:272327
decreased insulin secretion J:272327
increased circulating insulin level J:272327
increased insulin secretion J:272327
Spice1tm1b(EUCOMM)Hmgu/Spice1tm1b(EUCOMM)Hmgu
(C57BL/6N-Spice1tm1b(EUCOMM)Hmgu/H) 		improved glucose tolerance J:211773
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased circulating glucose level J:213427
Spock1em1(IMPC)H/Spock1em1(IMPC)H
(C57BL/6N-Spock1em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss) 		decreased circulating glucose level J:127389
decreased circulating insulin level J:127389
improved glucose tolerance J:127389
increased insulin sensitivity J:127389
Spry4tm1b(KOMP)Mbp/Spry4tm1b(KOMP)Mbp
(C57BL/6N-Spry4tm1b(KOMP)Mbp/Kmpc) 		decreased fasting circulating glucose level J:211773
Spryd3tm1b(EUCOMM)Hmgu/Spryd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Spryd3tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating insulin level J:211773
Spryd4em1(IMPC)Ccpcz/Spryd4em1(IMPC)Ccpcz
(C57BL/6N-Spryd4em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1) 		decreased circulating glucose level J:44313
Sptssatm1b(KOMP)Wtsi/Sptssa+
(C57BL/6N-Sptssatm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Sptssbtm1b(KOMP)Mbp/Sptssbtm1b(KOMP)Mbp
(C57BL/6N-Sptssbtm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Sqstm1em1Kmts/Sqstm1+
(involves: C57BL/6N) 		hypoglycemia J:342766
Sqstm1tm1a(KOMP)Wtsi/Sqstm1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Sqstm1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Sqstm1tm1Keta/Sqstm1tm1Keta
(involves: 129) 		hyperglycemia J:130839
Sqstm1tm1Keta/Sqstm1tm1Keta
(B6.129-Sqstm1tm1Keta) 		impaired glucose tolerance J:201732
Sqstm1tm2.1Jmos/Sqstm1tm2.1Jmos
Tg(Fabp4-cre)1Rev/0
(Not Specified) 		impaired glucose tolerance J:194291
insulin resistance J:194291
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N) 		decreased circulating insulin level J:214131
improved glucose tolerance J:214131
increased insulin sensitivity J:214131
Sritm1.1Hhv/Sritm1.1Hhv
(involves: 129S1/SvImJ) 		decreased circulating insulin level J:246708
impaired glucose tolerance J:246708
Srp9tm1.1(KOMP)Vlcg/Srp9+
(C57BL/6N-Srp9tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Srsf3tm1Pjln/Srsf3tm1Pjln
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA) 		abnormal glucose tolerance J:205756
decreased liver glycogen level J:205756
hypoglycemia J:205756
increased insulin sensitivity J:205756
Ss18em1(IMPC)J/Ss18+
(C57BL/6NJ-Ss18em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Ssttm1Ute/Ssttm1Ute
(involves: 129S4/SvJae * C57BL/6J) 		increased circulating insulin level J:179095
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129) 		increased insulin secretion J:179577
Sstr5tm1Fcb/Sstr5tm2Fcb
Tg(Ins2-cre)1Heed/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal insulin clearance J:99786
decreased circulating glucose level J:99786
decreased insulin secretion J:99786
impaired glucose tolerance J:99786
increased circulating insulin level J:99786
increased insulin secretion J:99786
Sstr5tm1Hawi/Sstr5tm1Hawi
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased circulating glucose level J:101259
decreased circulating insulin level J:101259
improved glucose tolerance J:101259
increased circulating glucagon level J:101259
increased insulin secretion J:101259
increased insulin sensitivity J:101259
St3gal5tm1Rlp/St3gal5tm1Rlp
(involves: 129S/SvEv * C57BL/6) 		abnormal glucose homeostasis J:82723
hypoglycemia J:82723
improved glucose tolerance J:82723
increased insulin sensitivity J:82723
Stard13tm1.1Fms/Stard13tm1.1Fms
Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA * SJL) 		impaired glucose tolerance J:191071
Stat3tm1Flv/Stat3tm1Flv
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal glucose homeostasis J:89242
hyperglycemia J:89242
impaired glucose tolerance J:89242
increased circulating insulin level J:89242
insulin resistance J:89242
Stat3tm2Aki/Stat3tm2Aki
(involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased circulating glucose level J:131301
increased circulating insulin level J:131301
Stat3tm2Aki/Stat3tm2Aki
Tg(Alb1-cre)1Dlr/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal glucose homeostasis J:109359
Stat4tm1Gru/Stat4+
(NOD.129S2-Stat4tm1Gru) 		abnormal circulating glucose level J:90600
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru) 		abnormal insulin secretion J:90600
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		impaired glucose tolerance J:119237
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased insulin secretion J:127051
impaired glucose tolerance J:127051
increased circulating glucose level J:127051
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL) 		impaired glucose tolerance J:132806
increased circulating insulin level J:132806
insulin resistance J:132806
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		impaired glucose tolerance J:127051
Stat5btm1Mam/Stat5btm1Mam
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased insulin secretion J:127051
impaired glucose tolerance J:127051
increased circulating glucose level J:127051
Stat5btm1Mam/Stat5btm1Mam
Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL) 		impaired glucose tolerance J:132806
increased circulating insulin level J:132806
insulin resistance J:132806
Stat5btm1Mam/Stat5btm1Mam
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		impaired glucose tolerance J:127051
Steap3tm1.1Atel/Steap3tm1.1Atel
(involves: C57BL/6) 		increased circulating glucose level J:154356
Steap3tm1b(EUCOMM)Hmgu/Steap3tm1b(EUCOMM)Hmgu
(C57BL/6N-Steap3tm1b(EUCOMM)Hmgu/J) 		impaired glucose tolerance J:211773
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal gluconeogenesis J:187736
decreased circulating insulin level J:187736
impaired glucose tolerance J:187736
increased circulating glucose level J:187736
insulin resistance J:187736
Stim1tm3Ics/Stim1+
(involves: C57BL/6N) 		decreased circulating glucose level J:277842
improved glucose tolerance J:277842
increased circulating insulin level J:277842
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S6/SvEvTac) 		abnormal circulating glucose level J:174020
abnormal gluconeogenesis J:174020
increased circulating glucose level J:174020
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR) 		improved glucose tolerance J:134078
increased circulating glucose level J:134078
Stk11tm1Keis/Stk11tm1Keis
Tg(Pomc1-cre)1Gsb/0
(involves: FVB/N) 		abnormal gluconeogenesis J:170130
abnormal glycogen homeostasis J:170130
impaired glucose tolerance J:170130
insulin resistance J:170130
Stk33em1(IMPC)J/Stk33em1(IMPC)J
(C57BL/6NJ-Stk33em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Stk38tm1b(KOMP)Wtsi/Stk38+
(C57BL/6N-Stk38tm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Stk40tm1Nju/Stk40tm1Nju
(B6.129-Stk40tm1Nju) 		increased lung glycogen level J:196001
Stmn4tm1b(KOMP)Wtsi/Stmn4tm1b(KOMP)Wtsi
(C57BL/6N-Stmn4tm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
Stoml2tm1(KOMP)Vlcg/Stoml2tm1(KOMP)Vlcg
(C57BL/6N-Stoml2tm1(KOMP)Vlcg/MbpMmucd) 		increased circulating insulin level J:211773
Stox2tm2b(EUCOMM)Hmgu/Stox2+
(C57BL/6N-Stox2tm2b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Stra6tm1Nbg/Stra6tm1Nbg
(involves: 129S2/SvPas * C57BL/6 * SJL) 		improved glucose tolerance J:203449
increased insulin sensitivity J:203449
Strn3tm1b(KOMP)Wtsi/Strn3+
(C57BL/6N-Strn3tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Stx4atm1Jpes/Stx4a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		impaired glucose tolerance J:69598
increased circulating insulin level J:69598
insulin resistance J:69598
Stx6em1(IMPC)H/Stx6em1(IMPC)H
(C57BL/6NTac-Stx6em1(IMPC)H/H) 		decreased circulating glucose level J:211773
Stx16tm1b(KOMP)Wtsi/Stx16tm1b(KOMP)Wtsi
(C57BL/6N-Stx16tm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Stx18tm2b(KOMP)Wtsi/Stx18+
(C57BL/6N-Stx18tm2b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Stx19tm1.1(KOMP)Vlcg/Stx19tm1.1(KOMP)Vlcg
(C57BL/6N-Stx19tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Stxbp1tm1b(EUCOMM)Hmgu/Stxbp1+
(C57BL/6N-Stxbp1tm1b(EUCOMM)Hmgu/J) 		impaired glucose tolerance J:211773
Stxbp3tm1Jpes/Stxbp3+
(B6.129-Stxbp3tm1Jpes) 		decreased insulin secretion J:96731
hyperglycemia J:96731
impaired glucose tolerance J:96731
insulin resistance J:96731
Stzid2NOD/Stzid2NOD
(involves: C3H/Or * NOD) 		abnormal glucose homeostasis J:95957
Stzid3NSY/Stzid3NSY
(C3H/He-Chr 11NSY) 		hyperglycemia J:95507
increased urine glucose level J:95507
StzidNOD/StzidNOD
(involves: C3H/Or * NOD) 		abnormal glucose homeostasis J:95957
StzidNOD/StzidNOD
Stzid2NOD/Stzid2NOD
(involves: C3H/Or * NOD) 		abnormal glucose homeostasis J:95957
SucoGt(KST050)Byg/SucoGt(KST050)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		hypoglycemia J:159823
Surf4em1(IMPC)J/Surf4+
(C57BL/6NJ-Surf4em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Svep1tm1b(EUCOMM)Hmgu/Svep1+
(C57BL/6N-Svep1tm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Swt1em1(IMPC)J/Swt1em1(IMPC)J
(C57BL/6NJ-Swt1em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Syce1tm1b(KOMP)Wtsi/Syce1tm1b(KOMP)Wtsi
(C57BL/6N-Syce1tm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr) 		increased circulating glucose level J:188422
Syncriptm1b(EUCOMM)Hmgu/Syncrip+
(C57BL/6N-Syncriptm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Syne3tm1b(KOMP)Wtsi/Syne3tm1b(KOMP)Wtsi
(C57BL/6N-Syne3tm1b(KOMP)Wtsi/Ucd) 		decreased circulating glucose level J:211773
Sytl1tm1Tiz/Sytl1tm1Tiz
(C3.Cg-Sytl1tm1Tiz) 		decreased insulin secretion J:200233
Sytl1tm1Tiz/Sytl1tm1Tiz
Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac) 		decreased insulin secretion J:200233
Sytl4em1(IMPC)Hmgu/Y
(C57BL/6N-Sytl4em1(IMPC)Hmgu/Ieg) 		improved glucose tolerance J:211773
Sytl4em1(IMPC)Hmgu/Sytl4em1(IMPC)Hmgu
(C57BL/6N-Sytl4em1(IMPC)Hmgu/Ieg) 		improved glucose tolerance J:211773
Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * C3H/He) 		decreased circulating glucose level J:102610
increased insulin secretion J:102610
T2dm1saSM/JNshm/?
(involves: A/J * SM/J) 		hyperglycemia J:80998
T2dm2C57BL/6J/T2dm2C57BL/6J
(BTBR.B6-T2dm2C57BL/6J) 		decreased circulating insulin level J:109581
T2dm2saA/JNshm/T2dm2saA/JNshm
(involves: SM/J * SMXA5) 		impaired glucose tolerance J:107889
increased circulating glucose level J:107889
increased circulating insulin level J:107889
T2dm2saA/JNshm/T2dm2saA/JNshm
(involves: SM.A-(D2Mit295-D2Mit281)) 		increased circulating glucose level J:107889
increased circulating insulin level J:107889
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng) 		increased circulating glucose level J:100831
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
(B6.TLHO-Tabw2TALLYHO/Jng) 		insulin resistance J:100831
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
Tanidd1TALLYHO/Jng/Tanidd1TALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng) 		increased circulating glucose level J:100831
Tacr2tm1(KOMP)Wtsi/Tacr2tm1(KOMP)Wtsi
(involves: C57BL/6N) 		increased circulating glucose level J:302970
Taf15em1(IMPC)Mbp/Taf15em1(IMPC)Mbp
(C57BL/6NCrl-Taf15em1(IMPC)Mbp/MbpMmucd) 		increased fasting circulating glucose level J:211773
Tafa2em1(IMPC)H/Tafa2em1(IMPC)H
(C57BL/6NTac-Tafa2em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Tanc2em1(IMPC)Hmgu/Tanc2em1(IMPC)Hmgu
(C57BL/6NCrl-Tanc2em1(IMPC)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Tanidd1TALLYHO/Jng/Tanidd1TALLYHO/Jng
(either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng)) 		hyperglycemia J:70227
Tanidd2TALLYHO/Jng/Tanidd2TALLYHO/Jng
(either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng)) 		hyperglycemia J:70227
Tanidd3TALLYHO/Jng/Tanidd3TALLYHO/Jng
(either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng)) 		hyperglycemia J:70227
Tbc1d1Nobq1-NZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom) 		increased circulating insulin level J:66744
Tbc1d1Nobq1-SJL/NBom/Tbc1d1Nobq1-SJL/NBom
(B6.SJL-(D5Mit302-D5Mit307)) 		decreased circulating glucose level J:143559
Tbc1d4tm1.1Arte/Tbc1d4tm1.1Arte
(involves: C57BL/6) 		impaired glucose tolerance J:169477
insulin resistance J:169477
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA) 		abnormal gluconeogenesis J:194026
abnormal glucose homeostasis J:194026
decreased circulating glucose level J:194026
decreased circulating insulin level J:194026
impaired glucose tolerance J:194026
insulin resistance J:194026
Tbc1d4tm1Lex/Tbc1d4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N) 		abnormal glycogen homeostasis J:191749
decreased circulating glucose level J:191749
decreased circulating insulin level J:191749
impaired glucose tolerance J:191749
insulin resistance J:191749
Tbccd1tm1b(EUCOMM)Hmgu/Tbccd1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tbccd1tm1b(EUCOMM)Hmgu/Bay) 		impaired glucose tolerance J:211773
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		impaired glucose tolerance J:198124
insulin resistance J:198124
Tbr1tm1.1(KOMP)Mbp/Tbr1+
(C57BL/6N-Tbr1tm1.1(KOMP)Mbp/Ucd) 		decreased circulating glucose level J:211773
Tbx19tm1Jdr/Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c)) 		hypoglycemia J:82562
increased circulating glucose level J:82562
Tcerg1ltm1a(KOMP)Wtsi/Tcerg1ltm1a(KOMP)Wtsi
(C57BL/6N-Tcerg1ltm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Tcf7l2em1Nobr/Tcf7l2+
(involves: CD-1) 		decreased circulating glucose level J:175874
decreased circulating insulin level J:175874
hypoglycemia J:175874
improved glucose tolerance J:175874
Tcf7l2em1Nobr/Tcf7l2em1Nobr
(involves: CD-1) 		hypoglycemia J:175874
Tcf7l2em2Nobr/Tcf7l2+
(involves: CD-1) 		decreased circulating glucose level J:175874
decreased circulating insulin level J:175874
hypoglycemia J:175874
improved glucose tolerance J:175874
Tcf7l2em2Nobr/Tcf7l2em2Nobr
(involves: CD-1) 		hypoglycemia J:175874
Tcf7l2em3Nobr/Tcf7l2em3Nobr
(involves: CD-1) 		hypoglycemia J:175874
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
(C57BL/6-Tcf7l2tm1a(EUCOMM)Wtsi) 		abnormal glucose homeostasis J:190447
impaired glucose tolerance J:190447
increased circulating glucose level J:190447
Tcf7l2tm1Geno/Tcf7l2tm1Geno
Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		decreased insulin secretion J:189204
impaired glucose tolerance J:189204
increased circulating insulin level J:189204
Tcf20em1(IMPC)Wtsi/Tcf20em1(IMPC)Wtsi
(C57BL/6N-Tcf20em1(IMPC)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Tcirg1oc/Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J) 		decreased circulating insulin level J:116082
decreased insulin secretion J:116082
Tcnq1C3H/HeJJcl/Tcnq1C3H/HeJJcl
Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD) 		increased circulating insulin level J:130968
Tcnq1C3H/HeJJcl/Tcnq1NOD
Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD) 		increased circulating insulin level J:130968
Tcnq2C3H/HeJJcl/Tcnq2C3H/HeJJcl
Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD) 		increased circulating glucose level J:130968
Tcnq2C3H/HeJJcl/Tcnq2NOD
Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD) 		increased circulating glucose level J:130968
Tcnq4NOD/Tcnq4NOD
Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD) 		increased circulating glucose level J:130968
Tcnq5C3H/HeJJcl/Tcnq5C3H/HeJJcl
Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD) 		increased circulating insulin level J:130968
Tdmq1DBA/2/Tdmq1DBA/2
(involves: BKS.Cg M +/+ Leprdb * DBA/2) 		increased circulating glucose level J:97535
Tdrkhtm1b(KOMP)Wtsi/Tdrkhtm1b(KOMP)Wtsi
(C57BL/6N-Tdrkhtm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Tenm4em1(IMPC)Tcp/Tenm4em1(IMPC)Tcp
(C57BL/6NCrl-Tenm4em1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Tent5aem1(IMPC)Ccpcz/Tent5aem1(IMPC)Ccpcz
(C57BL/6N-Tent5aem1(IMPC)Ccpcz/Ccpcz) 		decreased circulating glucose level J:211773
Terctm1Rdp/Terctm1Rdp
Wrntm1Lgu/Wrntm1Lgu
(involves: 129/Sv * BALB/c * C57BL/6 * SLJ) 		hyperglycemia J:91715
impaired glucose tolerance J:91715
increased circulating insulin level J:91715
Terf2ipem1(IMPC)Mbp/Terf2ipem1(IMPC)Mbp
(C57BL/6N-Terf2ipem1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N) 		impaired glucose tolerance J:199372
increased circulating glucose level J:199372
increased circulating insulin level J:199372
insulin resistance J:199372
Tex101tm1b(KOMP)Wtsi/Tex101tm1b(KOMP)Wtsi
(C57BL/6N-Tex101tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Tfamtm1Lrsn/Tfamtm1Lrsn
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal circulating insulin level J:65522
decreased insulin secretion J:65522
increased insulin sensitivity J:65522
Tfap4tm1.1(KOMP)Vlcg/Tfap4tm1.1(KOMP)Vlcg
(C57BL/6N-Tfap4tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Tfb2mtm1a(KOMP)Wtsi/Tfb2m+
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased circulating insulin level J:256448
decreased insulin secretion J:256448
impaired glucose tolerance J:256448
Tfb2mtm1a(KOMP)Wtsi/Tfb2mtm1a(KOMP)Wtsi
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased circulating insulin level J:256448
decreased insulin secretion J:256448
hyperglycemia J:256448
increased circulating glucose level J:256448
Tg(ACTA1-UCP3)1Clap/0
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:142293
increased insulin sensitivity J:142293
Tg(Adipoq-Apol6)#Hsul/0
(C57BL/6J-Tg(Adipoq-Apol6)#Hsul) 		impaired glucose tolerance J:344362
insulin resistance J:344362
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		decreased fasting circulating glucose level J:249843
improved glucose tolerance J:249843
Tg(Adipoq-cre)1Evdr/0
Tg(CAG-Jmjd8)#Kaso/0
(involves: C57BL/6 * FVB/NJ) 		impaired glucose tolerance J:319518
increased circulating insulin level J:319518
insulin resistance J:319518
Tg(Adipoq-LPL)1Fnln/?
(B6.Cg-Tg(Adipoq-LPL)1Fnln) 		decreased fasting circulating glucose level J:226970
improved glucose tolerance J:226970
increased insulin sensitivity J:226970
Tg(Adipoq-Zc3h10)#Hsul/0
(Not Specified) 		improved glucose tolerance J:287066
increased insulin sensitivity J:287066
Tg(Alb-Nos2)1Mkan/?
(FVB-Tg(Alb-Nos2)1Mkan) 		abnormal glucose homeostasis J:177591
abnormal glycogen homeostasis J:177591
decreased liver glycogen level J:177591
hyperglycemia J:177591
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6) 		increased circulating glucose level J:185313
increased circulating insulin level J:185313
insulin resistance J:249664, J:185313
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL) 		hyperglycemia J:50770
increased circulating insulin level J:50770, J:249664
increased fasting circulating glucose level J:249664
increased hepatic glucose production J:249664
insulin resistance J:50770, J:249664
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2) 		abnormal glucose homeostasis J:57075
decreased circulating insulin level J:57075
decreased liver glycogen level J:57075
increased insulin sensitivity J:57075
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N) 		abnormal glucose homeostasis J:69591
decreased circulating glucose level J:69591
decreased circulating insulin level J:69591
increased insulin sensitivity J:69591
Tg(APCS-RARRES2)9Yktk/0
(involves: C57BL/6) 		improved glucose tolerance J:206120
increased insulin secretion J:206120
Tg(APOB)11Rub/0
Tg(UcpDta)1Kz/0
(involves: C57BL/6J * FVB/N) 		abnormal glucose homeostasis J:73122
increased circulating insulin level J:73122
insulin resistance J:73122
Tg(Apoe-Fgf21)1Sakl/0
(Not Specified) 		abnormal gluconeogenesis J:150831
increased liver glycogen level J:150831
Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
(involves: C57BL/6 * DBA) 		decreased circulating glucose level J:172091
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6;C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) 		impaired glucose tolerance J:129021
increased circulating insulin level J:129021
Tg(AZIP/F)1Vsn/0
(involves: FVB/N) 		abnormal glucose homeostasis J:50807
hyperglycemia J:50807
increased circulating insulin level J:50807
Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J) 		decreased circulating glucose level J:145998
increased circulating insulin level J:145998
increased insulin secretion J:145998
Tg(BAC144D14)5A2Masu/0
(B6J.Cg-Tg(BAC144D14)5A2Masu) 		hypoglycemia J:232408
Tg(BAC144D14)5D3Masu/0
(B6J.Cg-Tg(BAC144D14)5D3Masu) 		hypoglycemia J:232408
Tg(CAG-Angptl6)8.1Yo/0
(involves: C57BL/6 * CBA) 		increased insulin sensitivity J:97552
Tg(CAG-Bgeo/ALPP)1Lbe/0
Tg(Ins2-cre/ERT)1Dam/0
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-DTA)1Gfi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		hyperglycemia J:127412
Tg(CAG-EPM2A*C266S)1Bmin/0
(involves: 129 * C57BL/6 * SJL) 		increased skeletal muscle glycogen level J:120356
Tg(CAG-Map3k7*K63W)1232Mds/0
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N) 		increased cardiac muscle glycogen level J:117108
Tg(CAG-Ndufab1)#Xiwa/0
(involves: C57BL/6J) 		decreased circulating glucose level J:293657
decreased fasting circulating glucose level J:293657
improved glucose tolerance J:293657
increased insulin sensitivity J:293657
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD/MrkTac-Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		hyperglycemia J:87013, J:86540
Tg(Ckm-Cd36)1Naa/0
(involves: FVB) 		increased circulating glucose level J:57650
increased circulating insulin level J:57650
Tg(Ckm-DGAT2)10Far/0
(involves: C57BL/6NHsd) 		abnormal glucose homeostasis J:129495
impaired glucose tolerance J:129495
insulin resistance J:129495
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr) 		abnormal glucose homeostasis J:71205
abnormal glycogen homeostasis J:71205
hyperglycemia J:210518
impaired glucose tolerance J:71205
increased circulating glucose level J:71205
increased circulating insulin level J:71205
insulin resistance J:71205
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J) 		increased skeletal muscle glycogen level J:101818
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J) 		increased skeletal muscle glycogen level J:101818
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA) 		abnormal glucose homeostasis J:129848
impaired glucose tolerance J:129848
increased circulating glucose level J:129848
increased circulating insulin level J:129848
insulin resistance J:129848
Tg(Ckm-Ppard)MEDpk/0
(involves: C57BL/6 * CBA) 		impaired glucose tolerance J:129848
insulin resistance J:129848
Tg(Ckm-Prkaa2*K45R)1Mbb/0
(involves: C57BL/6J * SJL/J) 		abnormal circulating glucose level J:110092
Tg(Ckm-PTPN1)45Bbk/0
(involves: FVB) 		abnormal glucose homeostasis J:122895
abnormal glycogen homeostasis J:122895
insulin resistance J:122895
Tg(Ckm-PTPN1)45Bbk/?
Tg(Ckm-PTPRF)13Bbk/?
(involves: FVB) 		abnormal glucose homeostasis J:122895
abnormal glycogen homeostasis J:122895
insulin resistance J:122895
Tg(Ckm-PTPRF)13Bbk/0
(involves: FVB) 		abnormal glucose homeostasis J:122895
abnormal glycogen homeostasis J:122895
insulin resistance J:122895
Tg(Ckm-Slc2a4)1Klip/Tg(Ckm-Slc2a4)1Klip
(Not Specified) 		impaired glucose tolerance J:151818
Tg(CMV-APPL2)1Smoc/0
(Not Specified) 		impaired glucose tolerance J:230004
insulin resistance J:230004
Tg(Col1a1-Atf4)1Kry/0
(involves: FVB) 		abnormal circulating glucose level J:152695
decreased circulating insulin level J:152695
decreased insulin secretion J:152695
impaired glucose tolerance J:152695
increased circulating glucose level J:152695
Tg(Col1a1-Ptprv)1Kry/?
(Not Specified) 		abnormal glucose homeostasis J:126780
decreased circulating insulin level J:126780
decreased insulin secretion J:126780
hyperglycemia J:126780
impaired glucose tolerance J:126780
insulin resistance J:126780
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ) 		decreased circulating insulin level J:97926
decreased insulin secretion J:97926
hyperglycemia J:97926
increased circulating glucagon level J:97926
increased urine glucose level J:97926
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove) 		hyperglycemia J:106851, J:94602
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
Tg(Myh6-SOD2,Tyr)3Pne/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove Tg(Myh6-SOD2,Tyr)3Pne) 		hyperglycemia J:106815
Tg(Cyp17a1-NGF)2456Oje/Tg(Cyp17a1-NGF)2456Oje
(involves: C57BL/6J * DBA/2J) 		impaired glucose tolerance J:218686
increased circulating insulin level J:218686
insulin resistance J:218686
Tg(EEF1A1-Socs6)1Pwg/?
(B6.129P2-Tg(EEF1A1-Socs6)1Pwg) 		decreased circulating glucose level J:181312
decreased circulating insulin level J:181312
improved glucose tolerance J:181312
increased insulin sensitivity J:181312
Tg(EEF1A1-Socs6)2Pwg/?
(B6.129P2-Tg(EEF1A1-Socs6)2Pwg) 		decreased circulating glucose level J:181312
decreased circulating insulin level J:181312
improved glucose tolerance J:181312
increased insulin sensitivity J:181312
Tg(Fabp4-Adissp)#Yxw/0
(involves: C57BL/6J * SJL) 		abnormal glucose homeostasis J:332979
improved glucose tolerance J:332979
Tg(Fabp4-Aebp1)1Hsro/?
(involves: FVB) 		increased circulating insulin level J:125334
Tg(Fabp4-Angptl2)5Yo/0
(involves: C57BL/6) 		impaired glucose tolerance J:152387
insulin resistance J:152387
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul) 		impaired glucose tolerance J:344362
insulin resistance J:344362
Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N) 		abnormal gluconeogenesis J:110277
abnormal glucose homeostasis J:110277
impaired glucose tolerance J:110277
increased circulating glucose level J:110277
insulin resistance J:110277
Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J) 		impaired glucose tolerance J:182179
increased circulating insulin level J:182179
insulin resistance J:182179
Tg(Fabp4-Fabp5)1Hota/0
(involves: C57BL/6) 		impaired glucose tolerance J:81609
increased circulating glucose level J:81609
Tg(Fabp4-Fam13a)1Iked/0
(C57BL/6J-Tg(Fabp4-Fam13a)1Iked) 		improved glucose tolerance J:258290
increased insulin sensitivity J:258290
Tg(Fabp4-Fcor)1Jnak/0
(involves: C57BL/6 * DBA/2) 		increased insulin sensitivity J:184684
Tg(Fabp4-FOXC2)ASven/0
(involves: C57BL/6J * CBA) 		decreased circulating glucose level J:94144
decreased circulating insulin level J:94144
increased insulin sensitivity J:94144
Tg(Fabp4-Hsd11b1)7Jesf/0
(FVB-Tg(Fabp4-Hsd11b1)7Jesf) 		abnormal glucose homeostasis J:107046
hyperglycemia J:107046
impaired glucose tolerance J:107046
increased circulating insulin level J:107046
insulin resistance J:107046
Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J) 		decreased circulating glucose level J:67311
decreased circulating insulin level J:67311
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc) 		abnormal glucose homeostasis J:84349
decreased circulating glucose level J:84349
increased insulin secretion J:84349
Tg(Fabp4-LMNA*R482Q)11ACdl/0
(FVB-Tg(Fabp4-LMNA*R482Q)11ACdl) 		abnormal glucose homeostasis J:149858
decreased glycogen catabolism rate J:149858
increased circulating glucose level J:149858
increased circulating insulin level J:149858
insulin resistance J:149858
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1) 		impaired glucose tolerance J:230172
increased circulating insulin level J:230172
insulin resistance J:230172
Tg(Fabp4-Phb*Y114F)#Smis/0
(Not Specified) 		abnormal glucose homeostasis J:227976
impaired glucose tolerance J:227976
increased circulating insulin level J:227976
insulin resistance J:227976
Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl) 		decreased circulating insulin level J:208508
increased insulin sensitivity J:208508
Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB) 		hyperglycemia J:189510
impaired glucose tolerance J:189510
increased circulating insulin level J:189510
insulin resistance J:189510
Tg(Fabp4-TLE3)#aPton/0
(involves: C57BL/6) 		abnormal glucose homeostasis J:172245
decreased circulating glucose level J:172245
decreased circulating insulin level J:172245
improved glucose tolerance J:172245
increased insulin sensitivity J:172245
Tg(Fabp4-Wdct1*)1Jmgr/?
(involves: ICR) 		increased circulating glucose level J:129966
Tg(Fabp4-Wdtc1)1Jmgr/?
(involves: ICR) 		decreased circulating glucose level J:129966
decreased circulating insulin level J:129966
increased insulin sensitivity J:129966
Tg(Fabp4-Zfp516)#Hsul/0
(Not Specified) 		improved glucose tolerance J:218161
increased insulin sensitivity J:218161
Tg(GAS7)63.2Lus/0
(involves: FVB/N) 		decreased circulating glucose level J:148831
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron) 		impaired glucose tolerance J:210298
increased circulating insulin level J:210298
Tg(GHRL-TAg)3-1Hiwa/0
(C57BL/6-Tg(GHRL-TAg)3-1Hiwa) 		decreased circulating insulin level J:152492
impaired glucose tolerance J:152492
increased circulating glucose level J:152492
Tg(Gpbar1)1Auw/0
(involves: C57BL/6J) 		improved glucose tolerance J:152388
increased circulating insulin level J:152388
increased insulin secretion J:152388
Tg(H2-K-AKR1B1)1Tj/0
(involves: C57BL/6 * DBA/2) 		abnormal glucose homeostasis J:120049
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish) 		decreased circulating glucose level J:128016
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified) 		decreased liver glycogen level J:81098
Tg(HCRT-tTA)1Ahky/0
Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi) 		increased circulating insulin level J:211045
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J) 		abnormal glucose homeostasis J:96353
decreased circulating insulin level J:96353
impaired glucose tolerance J:96353
Tg(IGFBP1)2Miel/0
(involves: C57BL * CBA) 		abnormal glucose homeostasis J:128964
impaired glucose tolerance J:128964
increased circulating glucose level J:128964
increased circulating insulin level J:84652, J:128964
Tg(IGFBP2)1Miel/0
(FVB/N-Tg(IGFBP2)1Miel) 		abnormal circulating insulin level J:121961
abnormal glucose homeostasis J:121961
decreased circulating glucose level J:121961
improved glucose tolerance J:121961
increased insulin sensitivity J:121961
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		increased circulating glucose level J:91865
Tg(Ins1-Cat,Tyr)25Pne/0
(involves: FVB) 		decreased circulating glucose level J:59275
increased insulin secretion J:59275
Tg(Ins1-Cd80)378Psoh/0
Tg(Ins2-GP)#Psoh/0
(involves: C57BL/6 * FVB/N) 		hyperglycemia J:209714
Tg(Ins1-Cd80)378Psoh/0
Tg(Ins2-GP)#Psoh/0
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		hyperglycemia J:209714
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		decreased circulating insulin level J:127015
impaired glucose tolerance J:127015
Tg(Ins1-Kcnj11*)#Nich/?
(B6.Cg-Tg(Ins1-Kcnj11*)#Nich) 		increased insulin secretion J:94610
Tg(Ins2-Akt1*)3Mbb/0
(involves: C57BL/6 * SJL) 		abnormal insulin secretion J:72216
decreased circulating glucose level J:72216
improved glucose tolerance J:72216
increased circulating insulin level J:72216
Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Tg(Ins2-Akt1*)3Mbb) 		hypoglycemia J:144599
improved glucose tolerance J:144599
increased circulating insulin level J:144599
Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj) 		increased circulating glucose level J:26618
increased urine glucose level J:26618
Tg(Ins2-CD80)3B7Flv/0
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca) 		increased circulating glucose level J:93555
Tg(Ins2-CD86)12B70Flv/0
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		increased circulating glucose level J:93555
Tg(Ins2-CD86)12B70Flv/0
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca) 		increased circulating glucose level J:93555
Tg(Ins2-CDKN1B)1Maka/0
(involves: C57BL/6J) 		decreased circulating insulin level J:96047
hyperglycemia J:96047
Tg(Ins2-Cebpb)2Maka/0
(involves: C57BL/6) 		decreased circulating insulin level J:156725
decreased insulin secretion J:156725
increased circulating glucose level J:156725
Tg(Ins2-Chrm3*)1Jwe/0
(involves: C57BL/6) 		abnormal glucose homeostasis J:129643
hypoglycemia J:129643
improved glucose tolerance J:129643
increased circulating insulin level J:129643
increased insulin secretion J:129643
Tg(Ins2-cre)23Herr/0
Tsc2tm1Kido/Tsc2tm1Kido
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J) 		decreased circulating insulin level J:135811
hypoglycemia J:135811
improved glucose tolerance J:135811
increased circulating glucose level J:135811
increased circulating insulin level J:135811
increased insulin sensitivity J:135811
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		decreased insulin secretion J:127051
impaired glucose tolerance J:127051
Tg(Ins2-cre)25Mgn/0
(either: (B6.Cg-Tg(Ins2-cre)25Mgn/J) or (involves: 129 * C57BL/6 * DBA/2)) 		abnormal circulating insulin level J:108244
abnormal insulin secretion J:108244
impaired glucose tolerance J:108244
Tg(Ins2-GAD2)2Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)2Lt) 		abnormal urine glucose level J:100251
Tg(Ins2-GLUD1*H454Y)1Csta/0
(involves: C57BL/6 * SJL) 		hypoglycemia J:113458
increased insulin secretion J:113458
Tg(Ins2-GLUD1*H454Y)2Csta/0
(involves: C57BL/6 * SJL) 		abnormal insulin secretion J:113458
hypoglycemia J:113458
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6) 		decreased circulating insulin level J:81287
increased circulating glucose level J:81287
Tg(Ins2-GP)#Psoh/0
(involves: C57BL/6) 		hyperglycemia J:81285
increased urine glucose level J:81285
Tg(Ins2-GP)#Psoh/0
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2) 		hyperglycemia J:81285
increased urine glucose level J:81285
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL) 		decreased insulin secretion J:127706
hyperglycemia J:127706
increased circulating glucose level J:93555, J:127706
Tg(Ins2-HA)165Bri/0
Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2) 		hyperglycemia J:99756
Tg(Ins2-HA)165Bri/?
Tg(TcraCl4,TcrbCl4)1Shrm/?
(involves: BALB/c * C57BL/6 * C57BL/10) 		hyperglycemia J:99756
Tg(Ins2-HBEGF)5Rin/?
(C57BL/6-Tg(Ins2-HBEGF)5Rin) 		decreased circulating insulin level J:204420
hyperglycemia J:204420
increased urine glucose level J:204420
Tg(Ins2-Hnf1a)#Cbw/0
(involves: C57BL/6 * CBA/J) 		decreased circulating insulin level J:134757
decreased insulin secretion J:134757
impaired glucose tolerance J:134757
increased circulating glucose level J:134757
increased glucagon secretion J:134757
Tg(Ins2-IAPP)L13Gjsc/0
(FVB/N-Tg(Ins2-IAPP)L13Gjsc) 		decreased circulating insulin level J:142009
decreased insulin secretion J:142009
hyperglycemia J:142009
impaired glucose tolerance J:142009
increased circulating glucagon level J:142009
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N) 		decreased circulating insulin level J:130022
decreased insulin secretion J:130022
hyperglycemia J:130022
Tg(Ins2-Irs2)13Mfw/0
(involves: C57BL/6) 		improved glucose tolerance J:94000
increased circulating insulin level J:94000
increased insulin secretion J:94000
Tg(Ins2-Mir184)4Mnpy/0
(Not Specified) 		decreased circulating insulin level J:210552
decreased insulin secretion J:210552
hyperglycemia J:210552
Tg(Ins2-Mir184)96Mnpy/0
(Not Specified) 		decreased insulin secretion J:210552
impaired glucose tolerance J:210552
Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat) 		decreased circulating insulin level J:314874
decreased insulin secretion J:314874
hyperglycemia J:314874
Tg(Ins2-Nos2)31Okam/0
(involves: C57BL/6 * CD-1 * DBA/2) 		decreased circulating insulin level J:45520
hyperglycemia J:45520
increased urine glucose level J:45520
Tg(Ins2-Nos2)40Okam/0
(involves: C57BL/6 * CD-1 * DBA/2) 		decreased circulating insulin level J:45520
hyperglycemia J:45520
increased urine glucose level J:45520
Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2) 		hyperglycemia J:116040
Tg(Ins2-Nos2)40Okam/0
Tg(Kdr-AGER)102Hyam/0
(involves: C57BL/6J * CBA/J * CD-1 * DBA/2) 		hyperglycemia J:70495
Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6) 		decreased circulating insulin level J:81287
increased circulating glucose level J:81284, J:81287
Tg(Ins2-OVA)307Wehi/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * C57BL/6JWehi) 		increased urine glucose level J:99451
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA) 		decreased insulin secretion J:210552
increased circulating glucose level J:210552
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA) 		hyperglycemia J:127412
improved glucose tolerance J:127412
increased circulating glucose level J:127412
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:210552
impaired glucose tolerance J:210552
increased circulating glucose level J:210552
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-Sri)1Hhv/0
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:246708
increased circulating insulin level J:246708
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-Sri)10Hhv/0
(involves: C57BL/6 * CBA) 		decreased fasting circulating glucose level J:246708
improved glucose tolerance J:246708
increased circulating insulin level J:246708
Tg(Ins2-rtTA)2Efr/0
Tg(tetO-TAg)1Efr/0
(involves: C3HeB/FeJ * C57BL/6 * CBA) 		hypoglycemia J:130049
Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL) 		decreased insulin secretion J:73760
hyperglycemia J:73760
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL) 		hyperglycemia J:141527
increased circulating glucose level J:141527
increased circulating insulin level J:141527
increased insulin secretion J:141527
insulin resistance J:141527
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL) 		hyperglycemia J:141527
increased circulating insulin level J:141527
insulin resistance J:141527
Tg(INS-Il10)#Sar/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD) 		increased circulating glucose level J:64051
Tg(INS-Il10)#Sar/0
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD) 		increased circulating glucose level J:64051
Tg(INS-MT2A,Tyr)1Pne/0
(FVB-Tg(INS-MT2A,Tyr)1Pne) 		hyperglycemia J:90564
Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2) 		abnormal glucose homeostasis J:230118
hyperglycemia J:230118
increased circulating insulin level J:230118
insulin resistance J:230118
Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2) 		hyperglycemia J:230118
increased circulating insulin level J:230118
insulin resistance J:230118
Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno) 		improved glucose tolerance J:186193
Tg(Myh6-MT2A)15Pne/?
(involves: FVB) 		increased circulating insulin level J:126583
Tg(Myh6-Pfkfb3)7Pne/0
(FVB-Tg(Myh6-Pfkfb3)7Pne) 		abnormal glucose homeostasis J:94475
increased cardiac muscle glycogen level J:94475
Tg(Myh6-Ppard)HEDpk/0
(involves: C57BL/6 * CBA) 		increased cardiac muscle glycogen level J:130750
Tg(Myh6-Prkaa2*D157A)1Rti/0
Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB) 		increased cardiac muscle glycogen level J:123005
Tg(Myh6-PRKAG2)2Dca/0
(involves: C57BL/10 * CBA/Ca) 		increased cardiac muscle glycogen level J:108517
Tg(Myh6-PRKAG2*N488I)4623Jse/0
(involves: FVB) 		increased cardiac muscle glycogen level J:128648
Tg(Myh6-PRKAG2*R302Q)#Rro/0
(involves: FVB) 		increased cardiac muscle glycogen level J:108102
Tg(Myh6-PRKAG2*R531G)22Dca/0
(involves: C57BL/10 * CBA/Ca) 		abnormal glycogen homeostasis J:108517
increased cardiac muscle glycogen level J:108517
Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB/N) 		increased cardiac muscle glycogen level J:123005
Tg(Myh6-rtTA)8585Jam/0
Tg(Myh6*/tetO-SCN5A*F1759A)#Marx/0
(involves: C57BL/6 * CBA * FVB/NTac) 		increased cardiac muscle glycogen level J:229825
Tg(Myh6-SLC2A1)54Rti/0
(FVB-Tg(Myh6-SLC2A1)54Rti) 		increased cardiac muscle glycogen level J:106467
Tg(Myh6-tTA)55Rbns/0
Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0
(Not Specified) 		increased cardiac muscle glycogen level J:145090
Tg(Myl1-Prkag3*R225Q)1Sson/0
(involves: C57BL/6J * CBA) 		abnormal glucose homeostasis J:92821
increased skeletal muscle glycogen level J:92821
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		decreased circulating glucagon level J:76323
decreased circulating glucose level J:76323
decreased circulating insulin level J:76323
improved glucose tolerance J:76323
increased insulin sensitivity J:76323
Tg(Myl2SLC2A1)2Mue/0
(involves: C57BL/6 * SJL) 		decreased circulating glucose level J:93868
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		increased insulin sensitivity J:207713
Tg(Neurog3-cre)C1Able/0
Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub/0
(involves: 129 * C57BL/6 * CD-1) 		hyperglycemia J:158215
impaired glucose tolerance J:158215
increased circulating glucose level J:158215
increased circulating insulin level J:158215
insulin resistance J:158215
Tg(PAH-INSR)1Rjv/0
(involves: C57BL/6 * CBA) 		hypoglycemia J:80773
improved glucose tolerance J:80773
Tg(Pdx1-Ffar1)AHeed/0
(Not Specified) 		decreased insulin secretion J:129843
impaired glucose tolerance J:129843
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA) 		abnormal glucose homeostasis J:185488
Tg(Pmch-ATXN3*)3Rck/0
(involves: FVB/NJ) 		decreased circulating glucose level J:104264
decreased circulating insulin level J:104264
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:182671
decreased fasting circulating glucose level J:182671
increased insulin sensitivity J:182671
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6J * DBA/2J) 		hypoglycemia J:50695, J:205389
Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh) 		hypoglycemia J:136259
Tg(RIR-Tag)87Dh/0
(involves: C57BL/6J * DBA/2J) 		hypoglycemia J:50695
Tg(RP3-340H11)29Kel/0
(involves: C57BL/6J * CBA/Ca) 		hyperglycemia J:91709
impaired glucose tolerance J:91709
increased insulin secretion J:91709
increased insulin sensitivity J:91709
Tg(RP11-466I19/Tcf7l2)1Nobr/0
(involves: CD-1) 		impaired glucose tolerance J:175874
Tg(RP11-578M14)5Mkru/0
(involves: FVB/N) 		impaired glucose tolerance J:256501
increased circulating insulin level J:256501
increased fasting circulating glucose level J:256501
Tg(RP23-352G18)1Coppa/0
(C57BL/6-Tg(RP23-352G18)1Coppa) 		decreased circulating glucose level J:229077
improved glucose tolerance J:229077
increased insulin sensitivity J:229077
Tg(SFTPC-Il18)AThos/0
(B6N.Cg-Tg(SFTPC-Il18)AThos) 		impaired glucose tolerance J:219136
Tg(Sirt1)ASrn/?
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:137868
Tg(SLC2A4-OGT)15Jaha/0
(involves: C57BL/6) 		increased circulating insulin level J:93113
insulin resistance J:93113
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N) 		abnormal glucose homeostasis J:91800
decreased circulating insulin level J:91800
increased circulating glucose level J:91800
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL) 		decreased circulating insulin level J:91800
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J) 		abnormal glucose homeostasis J:111280
Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh) 		improved glucose tolerance J:100328
increased circulating glucose level J:100328
increased circulating insulin level J:100328
insulin resistance J:100328
Tg(TcraTcrbNY8.3)1Pesa/?
(involves: C57BL/6 * NOD * SJL) 		increased circulating glucose level J:44202
Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcrbAI4)1Dvs) 		abnormal circulating glucose level J:93553
Tg(Ttr-Cdkn1a)36Tvd/?
(B6.Cg-Tg(Ttr-Cdkn1a)36Tvd) 		hyperglycemia J:94077
Tg(Ttr-Foxo1)305Dac/0
(involves: FVB * C57BL/6) 		decreased circulating insulin level J:79560
hyperglycemia J:79560
impaired glucose tolerance J:79560
insulin resistance J:79560
Tg(Ttr-Foxo1)307Dac/0
(involves: FVB * C57BL/6) 		hyperglycemia J:79560
impaired glucose tolerance J:79560
increased circulating insulin level J:79560
increased insulin sensitivity J:79560
Tg(Ttr-IGF1)1Sykr/0
(FVB/N-Tg(Ttr-IGF1)1Sykr) 		decreased circulating insulin level J:157350
Tg(TTR-p19Cdkn2a)2Tvd/0
(involves: C57BL/6J * DBA/2J) 		increased circulating glucose level J:94077
Tg(Ttr-Retn)1Laz/?
(involves: C57BL/6 * SJL) 		hyperglycemia J:91890
impaired glucose tolerance J:91890
increased circulating glucose level J:91890
Tg(Ucp1-cre)1Evdr/0
Zc3h10tm1c(EUCOMM)Wtsi/Zc3h10tm1c(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6N * FVB) 		impaired glucose tolerance J:287066
insulin resistance J:287066
Tg(UcpDta)1Kz/?
(involves: FVB/N) 		abnormal glucose homeostasis J:78211
hyperglycemia J:78211
increased circulating insulin level J:78211
insulin resistance J:78211
Tg(UcpDta)1Kz/0
(FVB/N-Tg(UcpDta)1Kz/J) 		impaired glucose tolerance J:129848
Tg(Vil1-cre)997Gum/?
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J) 		increased fasting circulating glucose level J:229155
Tgem1(IMPC)J/Tgem1(IMPC)J
(C57BL/6NJ-Tgem1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Tgm4Btlr/Tgm4Btlr
(C57BL/6J-Tgm4Btlr) 		increased fasting circulating glucose level J:272522
Tgfb1tm1(Tgfb3)Kul/Tgfb1tm1(Tgfb3)Kul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:204892
improved glucose tolerance J:204892
Tgfb1i1tm1b(KOMP)Wtsi/Tgfb1i1tm1b(KOMP)Wtsi
(C57BL/6N-Tgfb1i1tm1b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Tgfbitm1Jwu/Tgfbitm1Jwu
(B6.129-Tgfbitm1Jwu) 		decreased insulin secretion J:213611
Tgm2tm1Gml/Tgm2tm1Gml
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:78633
hyperglycemia J:78633
impaired glucose tolerance J:78633
increased insulin sensitivity J:78633
Tgm6tm1a(KOMP)Wtsi/Tgm6tm1a(KOMP)Wtsi
(C57BL/6N-Tgm6tm1a(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Thap12em1(IMPC)J/Thap12+
(C57BL/6NJ-Thap12em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Thratm1.1Fcas/Thratm1.1Fcas
(B6.Cg-Thratm1.1Fcas) 		abnormal glucose homeostasis J:179839
abnormal insulin secretion J:179839
impaired glucose tolerance J:179839
increased circulating glucagon level J:179839
increased circulating glucose level J:179839
increased circulating insulin level J:179839
increased glucagon secretion J:179839
increased insulin secretion J:179839
increased insulin sensitivity J:179839
insulin resistance J:179839
Thratm1b(EUCOMM)Wtsi/Thra+
(C57BL/6N-Thratm1b(EUCOMM)Wtsi/Ics) 		improved glucose tolerance J:211773
Thratm1Brnt/Thra+
(involves: 129S4/SvJae * C57BL/6) 		increased circulating glucose level J:85803
increased circulating insulin level J:85803
insulin resistance J:85803
Thrap3tm1c(KOMP)Wtsi/Thrap3tm1c(KOMP)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		decreased circulating glucose level J:339439
decreased circulating insulin level J:339439
improved glucose tolerance J:339439
increased insulin sensitivity J:339439
Tigd3em1(IMPC)J/Tigd3em1(IMPC)J
(C57BL/6NJ-Tigd3em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Timo/Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		abnormal glucose homeostasis J:127183
impaired glucose tolerance J:127183
increased circulating glucose level J:127183
increased circulating insulin level J:127183
insulin resistance J:127183
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J) 		decreased fasting circulating glucose level J:250417
Tle4em1(IMPC)Mbp/Tle4em1(IMPC)Mbp
(C57BL/6NCrl-Tle4em1(IMPC)Mbp/Mmucd) 		impaired glucose tolerance J:211773
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:124334
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		abnormal circulating glucose level J:158035
abnormal circulating insulin level J:158035
abnormal glucose homeostasis J:158035
Tlr2tm1Aki/Tlr2tm1Aki
(NOD.129P2-Tlr2tm1Aki) 		abnormal glucose homeostasis J:124334
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		abnormal glucose homeostasis J:162168
decreased circulating insulin level J:162168
improved glucose tolerance J:162168
increased insulin secretion J:162168
increased insulin sensitivity J:162168
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv) 		hyperglycemia J:135353
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d) 		abnormal circulating glucose level J:126488
abnormal glucose homeostasis J:126488
decreased circulating insulin level J:126488
improved glucose tolerance J:126488
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:158055
increased circulating insulin level J:158055
insulin resistance J:158055
Tm4/Tm4+
(involves: C3H/HeH * C57BL/6J) 		impaired glucose tolerance J:169366
Tm45/?
(involves: C3H/HeH * C57BL/6J) 		abnormal glucose tolerance J:169366
Tm59/?
(involves: C3H/HeH * C57BL/6J) 		abnormal glucose tolerance J:169366
increased circulating insulin level J:169366
Tm60/?
(involves: C3H/HeH * C57BL/6J) 		abnormal glucose tolerance J:169366
increased circulating insulin level J:169366
Tmem18tm1b(EUCOMM)Wtsi/Tmem18tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmem18tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Tmem79tm1.1(KOMP)Wtsi/Tmem79tm1.1(KOMP)Wtsi
(C57BL/6N-Tmem79tm1.1(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Tmem116tm1b(EUCOMM)Hmgu/Tmem116tm1b(EUCOMM)Hmgu
(C57BL/6N-Tmem116tm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Tmem117tm1.1Thor/Tmem117tm1.1Thor
(involves: C57BL/6N) 		increased glucagon secretion J:339175
Tmem163em1(IMPC)Mbp/Tmem163em1(IMPC)Mbp
(C57BL/6N-Tmem163em1(IMPC)Mbp/MbpMmucd) 		increased circulating insulin level J:211773
Tmem240em1(IMPC)Ccpcz/Tmem240em1(IMPC)Ccpcz
(C57BL/6N-Tmem240em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Tmem260tm1a(KOMP)Wtsi/Tmem260tm1a(KOMP)Wtsi
(C57BL/6N-Tmem260tm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Tmem263em1Gww/Tmem263em1Gww
(C57BL/6J-Tmem263em1Gww) 		decreased circulating glucose level J:345905
decreased circulating insulin level J:345905
Tmprss2tm2b(EUCOMM)Hmgu/Tmprss2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tmprss2tm2b(EUCOMM)Hmgu/Orl) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Tmprss6tm1b(EUCOMM)Wtsi/Tmprss6tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics) 		increased fasting circulating glucose level J:211773
Tmt1btm1.1(KOMP)Vlcg/Tmt1btm1.1(KOMP)Vlcg
(C57BL/6N-Timt1btm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Tmtc4tm1.1(KOMP)Vlcg/Tmtc4tm1.1(KOMP)Vlcg
(C57BL/6N-Tmtc4tm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		abnormal glucose homeostasis J:42579
decreased circulating glucose level J:42579
decreased circulating insulin level J:42579
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6) 		abnormal glucose homeostasis J:204922
Tnfaip1tm1a(EUCOMM)Wtsi/Tnfaip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfaip1tm1a(EUCOMM)Wtsi/H) 		increased circulating glucose level J:165965
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb) 		decreased fasting circulating glucose level J:324062
increased circulating insulin level J:324062
insulin resistance J:324062
Tnfrsf9em1Ygch/Tnfrsf9em1Ygch
(NOD/ShiLtDvs-Tnfrsf9em1Ygch) 		abnormal glucose homeostasis J:208927
Tnfrsf9em2Ygch/Tnfrsf9em2Ygch
(NOD/ShiLtDvs-Tnfrsf9em2Ygch) 		abnormal glucose homeostasis J:208927
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J) 		decreased circulating glucose level J:241611
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H) 		decreased circulating glucose level J:211773
Tnksem1(IMPC)Hmgu/Tnksem1(IMPC)Hmgu
(C57BL/6N-Tnksem1(IMPC)Hmgu/Ieg) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
TnksGt(RRC239)Byg/TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		hypoglycemia J:154388
increased circulating insulin level J:154388
Tnni2tm1.1(KOMP)Vlcg/Tnni2+
(C57BL/6N-Tnni2tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Tnni3kB/Tnni3kB
(involves: C57BL/6J * DBA/2J) 		decreased circulating insulin level J:339644
hyperglycemia J:339644
insulin resistance J:339644
Tns3em1(IMPC)Bay/Tns3+
(C57BL/6N-Tns3em1(IMPC)Bay/Bay) 		increased fasting circulating glucose level J:211773
Tox4tm1b(KOMP)Mbp/Tox4+
(C57BL/6N-Tox4tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Tph1tm1c(KOMP)Wtsi/Tph1tm1c(KOMP)Wtsi
Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		impaired glucose tolerance J:284574
Tpoem1(IMPC)H/Tpo+
(C57BL/6NTac-Tpoem1(IMPC)H/H) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		hypoglycemia J:37065
Traj18em1Hwata/Traj18em1Hwata
(C57BL/6-Traj18em1Hwata) 		decreased fasting circulating glucose level J:256533
improved glucose tolerance J:256533
increased insulin sensitivity J:256533
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:226880
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		impaired glucose tolerance J:294716
increased circulating insulin level J:294716
Trappc10tm1b(KOMP)Wtsi/Trappc10tm1b(KOMP)Wtsi
(C57BL/6N-Trappc10tm1b(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Trarg1tm1a(KOMP)Wtsi/Trarg1tm1a(KOMP)Wtsi
(C57BL/6N-Trarg1tm1a(KOMP)Wtsi) 		abnormal circulating insulin level J:234039
abnormal fasting circulating glucose level J:234039
hyperglycemia J:234039
increased circulating insulin level J:234039
insulin resistance J:234039
Trehtm1Tkam/Trehtm1Tkam
(involves: C57BL/6 * CBA) 		abnormal glucose homeostasis J:99998
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N) 		abnormal glucose homeostasis J:242126
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA * ICR) 		decreased circulating insulin level J:43657
decreased insulin secretion J:43657
hyperglycemia J:43657
Trhrtm1Hzg/Trhrtm1Hzg
(involves: 129/Sv * 129S1/SvImJ) 		increased circulating glucose level J:125915
Trib1tm1Aki/Trib1tm1Aki
(involves: 129P2/OlaHsd) 		impaired glucose tolerance J:196449
insulin resistance J:196449
Trim25tm2b(EUCOMM)Hmgu/Trim25tm2b(EUCOMM)Hmgu
(C57BL/6N-Trim25tm2b(EUCOMM)Hmgu/Wtsi) 		impaired glucose tolerance J:211773
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		decreased circulating insulin level J:232482
increased fasting circulating glucose level J:232482
Trim39tm1b(EUCOMM)Hmgu/Trim39tm1b(EUCOMM)Hmgu
(C57BL/6N-Trim39tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Trim55tm2b(EUCOMM)Hmgu/Trim55tm2b(EUCOMM)Hmgu
(C57BL/6N-Trim55tm2b(EUCOMM)Hmgu/Bay) 		decreased fasting circulating glucose level J:211773
Trim56tm1a(EUCOMM)Wtsi/Trim56tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim56tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Trioem1(IMPC)H/Trio+
(C57BL/6NTac-Trioem1(IMPC)H/H) 		impaired glucose tolerance J:211773
Triobpem1(IMPC)J/Triobpem1(IMPC)J
(C57BL/6NJ-Triobpem1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Trip10tm1Sejc/Trip10tm1Sejc
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased circulating glucose level J:159952
Trip13tm1.1(KOMP)Vlcg/Trip13tm1.1(KOMP)Vlcg
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd) 		increased fasting circulating glucose level J:211773
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6) 		hyperglycemia J:233434
impaired glucose tolerance J:233434
increased circulating insulin level J:233434
insulin resistance J:233434
Trpc4apem1Cya/Trpc4apem1Cya
(C57BL/6J-Trpc4apem1Cya/Cya) 		increased circulating insulin level J:300649
increased fasting circulating glucose level J:300649
insulin resistance J:300649
Trpm1tm1b(KOMP)Wtsi/Trpm1tm1b(KOMP)Wtsi
(C57BL/6N-Trpm1tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
Trps1em1(IMPC)Wtsi/Trps1+
(C57BL/6N-Trps1em1(IMPC)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Tsc1tm1Djk/Tsc1tm1Djk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		impaired glucose tolerance J:171445
insulin resistance J:171445
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ) 		abnormal glucose homeostasis J:223992
increased circulating insulin level J:223992
Tspan13em1(IMPC)Kmpc/Tspan13em1(IMPC)Kmpc
(C57BL/6NTac-Tspan13em1(IMPC)Kmpc/Kmpc) 		decreased fasting circulating glucose level J:211773
Tspan18tm1.1(KOMP)Vlcg/Tspan18tm1.1(KOMP)Vlcg
(C57BL/6N-Tspan18tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Ttbk1em1(IMPC)J/Ttbk1em1(IMPC)J
(C57BL/6NJ-Ttbk1em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Ttll6tm1.1(KOMP)Vlcg/Ttll6tm1.1(KOMP)Vlcg
(C57BL/6N-Ttll6tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ttll10em1(IMPC)J/Ttll10em1(IMPC)J
(C57BL/6NJ-Ttll10em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Ttll10tm1b(EUCOMM)Hmgu/Ttll10tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttll10tm1b(EUCOMM)Hmgu/Wtsi) 		impaired glucose tolerance J:211773
Tubtub/Tubtub
(B6(AU)-Tubtub/J) 		increased circulating insulin level J:32415
Tubtub/Tubtub
(C57BL/6J-Tubtub) 		increased circulating insulin level J:13772
increased liver glycogen level J:13772
Tubb4atm1.1(KOMP)Wtsi/Tubb4atm1.1(KOMP)Wtsi
(C57BL/6N-Tubb4atm1.1(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Tuft1tm1a(KOMP)Wtsi/Tuft1tm1a(KOMP)Wtsi
(C57BL/6N-Tuft1tm1a(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Tulp3tm1b(EUCOMM)Hmgu/Tulp3+
(C57BL/6N-Tulp3tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ) 		decreased liver glycogen level J:81485
decreased skeletal muscle glycogen level J:81485
hypoglycemia J:81485
Txndc5tm1.1(KOMP)Vlcg/Txndc5+
(C57BL/6N-Txndc5tm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Txndc5tm1.1(KOMP)Vlcg/Txndc5tm1.1(KOMP)Vlcg
(C57BL/6N-Txndc5tm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Txniptm1.1Rlee/Txniptm1.1Rlee
(involves: 129S4/SvJae) 		decreased circulating glucose level J:141487
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road) 		abnormal gluconeogenesis J:132756
abnormal glucose homeostasis J:132756
hypoglycemia J:132756
improved glucose tolerance J:132756
increased insulin sensitivity J:132756
Txniptm1Jjy/Txniptm1Jjy
(involves: C57BL/6 * CBA) 		abnormal circulating insulin level J:104563
abnormal glucose homeostasis J:104563
decreased circulating glucose level J:104563
Txniptm1Road/Txniptm1Road
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB) 		hypoglycemia J:132756
improved glucose tolerance J:132756
Tyk2tm1Shmd/Tyk2tm1Shmd
(either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		impaired glucose tolerance J:195099
increased circulating insulin level J:195099
U2surpem1(IMPC)J/U2surp+
(C57BL/6NJ-U2surpem1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Ubap2em1(IMPC)J/Ubap2em1(IMPC)J
(C57BL/6NJ-Ubap2em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Ube2wtm1b(EUCOMM)Wtsi/Ube2wtm1b(EUCOMM)Wtsi
(C57BL/6N-Ube2wtm1b(EUCOMM)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Ube4aem1(IMPC)Tcp/Ube4aem1(IMPC)Tcp
(C57BL/6N-Ube4aem1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Ubl4atm1.2Arte/Y
(involves: C57BL/6) 		abnormal glycogen homeostasis J:226059
Ubl4atm1.2Arte/Ubl4atm1.2Arte
(involves: C57BL/6) 		abnormal glycogen homeostasis J:226059
Ubr1tm1Avar/Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J)) 		hypoglycemia J:72859
Ubr7em1(IMPC)Tcp/Ubr7em1(IMPC)Tcp
(C57BL/6NCrl-Ubr7em1(IMPC)Tcp/Tcp) 		improved glucose tolerance J:211773
Uchl4em1(IMPC)Ccpcz/Uchl4em1(IMPC)Ccpcz
(C57BL/6N-Uchl4em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Ucn3tm1Pbl/Ucn3tm1Pbl
(Not Specified) 		decreased circulating insulin level J:119417
decreased insulin secretion J:119417
improved glucose tolerance J:119417
Ucp2tm1Rcq/Ucp2tm1Rcq
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:122094
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/?
Tg(Pmch-cre)1Lowl/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/NJ) 		impaired glucose tolerance J:167906
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Pmch-cre)1Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/NJ) 		decreased circulating glucose level J:167906
decreased circulating insulin level J:167906
improved glucose tolerance J:167906
Ucp3tm1Rei/Ucp3tm1Rei
(involves: 129S6/SvEvTac * Black Swiss) 		decreased circulating glucose level J:62312
Ucp3tm1Rei/Ucp3tm1Rei
(involves: 129S6/SvEvTac) 		improved glucose tolerance J:142293
increased insulin sensitivity J:142293
UmodUrehd1/Umod+
(C3HeB/FeJ-UmodUrehd1) 		decreased circulating glucose level J:121470
Unc13atm1Bros/Unc13a+
(involves: 129) 		decreased insulin secretion J:215257, J:108689
impaired glucose tolerance J:108689
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli) 		decreased insulin secretion J:271949
impaired glucose tolerance J:271949
Upf3bem1(IMPC)Tcp/Y
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp) 		increased fasting circulating glucose level J:211773
Upf3bem1(IMPC)Tcp/Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp) 		increased fasting circulating glucose level J:211773
urehr1/urehr1
(C3HeB/FeJ-urehr1) 		decreased circulating glucose level J:121470
Uri1tm1a(EUCOMM)Wtsi/Uri1tm1a(EUCOMM)Wtsi
(C57BL/6N-Uri1tm1a(EUCOMM)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Ush1ctm1a(KOMP)Wtsi/Ush1ctm1a(KOMP)Wtsi
(C57BL/6N-Ush1ctm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Usp1tm1b(KOMP)Wtsi/Usp1tm1b(KOMP)Wtsi
(C57BL/6N-Usp1tm1b(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Usp12tm1b(EUCOMM)Hmgu/Usp12tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp12tm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Usp15tm1b(EUCOMM)Wtsi/Usp15tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp15tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Usp20em1Cya/Usp20em1Cya
(Not Specified) 		improved glucose tolerance J:299971
increased insulin sensitivity J:299971
Usp20em1Gpt/Usp20em1Gpt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA) 		decreased circulating glucose level J:299971
decreased circulating insulin level J:299971
decreased fasting circulating glucose level J:299971
improved glucose tolerance J:299971
increased insulin sensitivity J:299971
Usp30tm2b(EUCOMM)Hmgu/Usp30tm2b(EUCOMM)Hmgu
(C57BL/6N-Usp30tm2b(EUCOMM)Hmgu/Wtsi) 		impaired glucose tolerance J:211773
Usp32em1(IMPC)Mhzh/Usp32+
(C57BL/6N-Usp32em1(IMPC)Mhzh/Mhzh) 		decreased circulating glucose level J:211773
Usp36tm1b(EUCOMM)Hmgu/Usp36+
(C57BL/6N-Usp36tm1b(EUCOMM)Hmgu/Nju) 		increased circulating glucose level J:211773
Usp47tm1b(EUCOMM)Wtsi/Usp47tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp47tm1b(EUCOMM)Wtsi/Nju) 		increased circulating glucose level J:211773
Vapbem1(IMPC)H/Vapbem1(IMPC)H
(C57BL/6NTac-Vapbem1(IMPC)H/H) 		improved glucose tolerance J:211773
Vax1tm1b(KOMP)Mbp/Vax1+
(C57BL/6N-Vax1tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Vcpem1Kene/Vcp+
(C57BL/6J-Vcpem1Kene) 		increased insulin sensitivity J:325062
Vcpkmttm1.1(KOMP)Vlcg/Vcpkmttm1.1(KOMP)Vlcg
(C57BL/6N-Vcpkmttm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Vdac1tm1b(EUCOMM)Wtsi/Vdac1+
(C57BL/6N-Vdac1tm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Vdrtm1Ska/Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ) 		abnormal glucose tolerance J:127787
Vegfbtm1b(EUCOMM)Hmgu/Vegfbtm1b(EUCOMM)Hmgu
(C57BL/6N-Vegfbtm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Vezttm1b(EUCOMM)Hmgu/Vezt+
(C57BL/6N-Vezttm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Vgfem1(IMPC)H/Vgfem1(IMPC)H
(C57BL/6NTac-Vgfem1(IMPC)H/H) 		decreased circulating glucose level J:211773
Vgftm1Srjs/Vgftm1Srjs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:56499
decreased circulating insulin level J:56499
Vipr1tm1Msod/Vipr1tm1Msod
(B6.129-Vipr1tm1Msod) 		abnormal glucose homeostasis J:177616
hypoglycemia J:177616
impaired glucose tolerance J:177616
increased insulin sensitivity J:177616
Vipr2tm1Hmh/Vipr2tm1Hmh
(involves: 129P2/OlaHsd * C57BL/6) 		increased insulin sensitivity J:106803
Vkorc1l1em1(IMPC)J/Vkorc1l1em1(IMPC)J
(C57BL/6NJ-Vkorc1l1em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Vps13bem1(IMPC)Tcp/Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Vps13ctm1.1Geno/Vps13ctm1.1Geno
(involves: C57BL/6) 		decreased circulating insulin level J:241413
decreased circulating insulin level J:241413
impaired glucose tolerance J:241413
Vsig4tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Vsig4tm1b(EUCOMM)Hmgu/Vsig4tm1b(EUCOMM)Hmgu
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
Vsig8tm1.1(KOMP)Mbp/Vsig8tm1.1(KOMP)Mbp
(C57BL/6N-Vsig8tm1.1(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Vtcn1tm1Xxz/Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased circulating glucose level J:177612
Vti1atm1.1(KOMP)Vlcg/Vti1atm1.1(KOMP)Vlcg
(C57BL/6N-Vti1atm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
Vwa8tm1b(EUCOMM)Wtsi/Vwa8tm1b(EUCOMM)Wtsi
(C57BL/6N-Vwa8tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Washc4em1(IMPC)J/Washc4+
(C57BL/6NJ-Washc4em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Wdfy2tm1.1Wgz/Wdfy2tm1.1Wgz
(involves: C57BL/6J) 		decreased liver glycogen level J:296933
impaired glucose tolerance J:296933
increased circulating insulin level J:296933
increased hepatic glucose production J:296933
insulin resistance J:296933
Wdr6em1(IMPC)J/Wdr6em1(IMPC)J
(C57BL/6NJ-Wdr6em1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Wdr11em1(IMPC)Mbp/Wdr11+
(C57BL/6NCrl-Wdr11em1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		decreased circulating glucose level J:225111
improved glucose tolerance J:225111
increased circulating insulin level J:225111
Wdr36tm1.1(KOMP)Vlcg/Wdr36+
(C57BL/6N-Wdr36tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Wdr37tm1a(KOMP)Wtsi/Wdr37tm1a(KOMP)Wtsi
(C57BL/6N-Wdr37tm1a(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Wdr45em1Wrst/Y
(involves: C57BL/6N * FVB) 		increased circulating glucose level J:307284
Wdr45em1Wrst/Wdr45em1Wrst
(involves: C57BL/6N * FVB) 		impaired glucose tolerance J:307284
increased circulating glucose level J:307284
Wdr53em1(IMPC)J/Wdr53em1(IMPC)J
(C57BL/6NJ-Wdr53em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Wdtc1Gt(RRF015)Byg/Wdtc1+
(involves: 129P2/OlaHsd * ICR) 		increased circulating glucose level J:129966
increased circulating insulin level J:129966
insulin resistance J:129966
Wdtc1tm1a(KOMP)Wtsi/Wdtc1tm1a(KOMP)Wtsi
(C57BL/6N-Wdtc1tm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Wfs1tm1Koks/Wfs1+
(involves: 129S6/SvEvTac * C57BL/6) 		impaired glucose tolerance J:145548
Wfs1tm1Koks/Wfs1tm1Koks
(involves: 129S6/SvEvTac * C57BL/6) 		impaired glucose tolerance J:145548, J:157967
Wfs1tm1Koks/Wfs1tm1Koks
(129S6/SvEvTac-Wfs1tm1Koks) 		decreased circulating glucose level J:221943
decreased circulating insulin level J:221943
hyperglycemia J:221943
impaired glucose tolerance J:157967, J:221943
Wfs1tm1Perm/Wfs1tm1Perm
Tg(Ins2-cre)23Herr/0
(involves: 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal glucose homeostasis J:104712
decreased circulating insulin level J:104712
decreased insulin secretion J:104712
hyperglycemia J:104712
impaired glucose tolerance J:104712
Wfs1tm1Yoka/Wfs1tm1Yoka
(involves: 129/Sv * C57BL/6) 		increased circulating glucose level J:90420
increased glucagon secretion J:90420
Wfs1tm1Yoka/Wfs1tm1Yoka
(B6.Cg-Wfs1tm1Yoka) 		decreased circulating insulin level J:90420
impaired glucose tolerance J:90420
increased glucagon secretion J:90420
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs) 		decreased circulating glucose level J:5538
decreased liver glycogen level J:5538
Wrntm1Led/Wrntm1Led
(B6.129S6(BKSW)-Wrntm1Led) 		hyperglycemia J:106446
increased circulating insulin level J:106446
insulin resistance J:106446
Wwoxtm1.1Mald/Wwoxtm1.1Mald
(involves: C57BL/6 * FVB/N) 		decreased circulating glucose level J:155406
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J) 		hypoglycemia J:138140
Wwoxtm2.1Ria/Wwoxtm2.1Ria
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		hypoglycemia J:198845
Wwp1em1(IMPC)H/Wwp1em1(IMPC)H
(C57BL/6N-Wwp1em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Xkr5tm1b(KOMP)Mbp/Xkr5tm1b(KOMP)Mbp
(C57BL/6N-Xkr5tm1b(KOMP)Mbp/Ieg) 		increased fasting circulating glucose level J:211773
Xrn1em1Tya/Xrn1em1Tya
Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6N * FVB/N) 		impaired glucose tolerance J:342928
increased circulating glucose level J:342928
increased circulating insulin level J:342928
insulin resistance J:342928
Ydjctm1.1(KOMP)Vlcg/Ydjctm1.1(KOMP)Vlcg
(C57BL/6N-Ydjctm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ylpm1tm1b(KOMP)Wtsi/Ylpm1+
(C57BL/6N-Ylpm1tm1b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Yme1l1tm1Tlan/Yme1l1tm1Tlan
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6NCrl * FVB) 		decreased circulating insulin level J:229455
impaired glucose tolerance J:229455
Ywhabem1Gpt/Ywhabem1Gpt
Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Ywhabem1Gpt Albem1(icre)Gpt) 		decreased liver glycogen level J:323777
enhanced gluconeogenesis J:323777
impaired glucose tolerance J:323777
increased circulating glucose level J:323777
Ywhabtm1b(EUCOMM)Hmgu/Ywhabtm1b(EUCOMM)Hmgu
(C57BL/6N-Ywhabtm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating glucose level J:211773
Zbed6tm1.2Sson/Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6) 		increased insulin sensitivity J:265506
Zbtb20tm1.1Wpjz/Zbtb20tm1.1Wpjz
(involves: 129S4/SvJae * C57BL/6) 		abnormal glycogen homeostasis J:148992
decreased circulating insulin level J:148992
decreased liver glycogen level J:148992
hypoglycemia J:148992
improved glucose tolerance J:148992
increased circulating glucagon level J:148992
increased insulin sensitivity J:148992
Zbtb22em1Yga/Zbtb22em1Yga
(Not Specified) 		decreased fasting circulating glucose level J:344976
improved glucose tolerance J:344976
increased insulin sensitivity J:344976
Zbtb32tm1b(KOMP)Mbp/Zbtb32tm1b(KOMP)Mbp
(C57BL/6N-Zbtb32tm1b(KOMP)Mbp/J) 		increased circulating insulin level J:211773
Zbtb43tm1b(KOMP)Mbp/Zbtb43+
(C57BL/6N-Zbtb43tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Zbtb43tm1b(KOMP)Mbp/Zbtb43tm1b(KOMP)Mbp
(C57BL/6N-Zbtb43tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Zbtb48em1(IMPC)Mbp/Zbtb48em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb48em1(IMPC)Mbp/Mmucd) 		impaired glucose tolerance J:211773
Zdhhc2tm1b(KOMP)Wtsi/Zdhhc2tm1b(KOMP)Wtsi
(C57BL/6N-Zdhhc2tm1b(KOMP)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Zdhhc4em1Smoc/Zdhhc4em1Smoc
(C57BL/6-Zdhhc4em1Smoc) 		decreased circulating glucose level J:270120
Zdhhc5tm1.1Smoc/Zdhhc5tm1.1Smoc
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/NJ) 		decreased circulating glucose level J:270120
Zeb1tm1.1Ajg/Zeb1tm2.1Ajg
(C57BL/6-Zeb1tm1.1Ajg/Zeb1tm2.1Ajg) 		impaired glucose tolerance J:177274
increased circulating insulin level J:177274
insulin resistance J:177274
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw) 		impaired glucose tolerance J:177274
increased circulating insulin level J:177274
insulin resistance J:177274
Zer1em1(IMPC)J/Zer1em1(IMPC)J
(C57BL/6NJ-Zer1em1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
Zfand3em1(IMPC)J/Zfand3em1(IMPC)J
(C57BL/6NJ-Zfand3em1(IMPC)J/Mmjax) 		decreased circulating glucose level J:211773
Zfp36tm1(KOMP)Vlcg/Zfp36+
(C57BL/6N-Zfp36tm1(KOMP)Vlcg/Nju) 		increased fasting circulating glucose level J:211773
Zfp202em1(IMPC)J/Zfp202em1(IMPC)J
(C57BL/6NJ-Zfp202em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Zfp217em1Sjia/Zfp217+
(involves: C57BL/6J) 		improved glucose tolerance J:307358
increased insulin sensitivity J:307358
Zfp219em1(IMPC)J/Zfp219em1(IMPC)J
(C57BL/6NJ-Zfp219em1(IMPC)J/J) 		decreased circulating glucose level J:211773
increased urine glucose level J:211773
Zfp251em1Hgseo/Zfp251em1Hgseo
(C57BL/6J-Zfp251em1Hgseo) 		impaired glucose tolerance J:334395
increased fasting circulating glucose level J:334395
increased insulin sensitivity J:334395
Zfp422em1(IMPC)J/Zfp422em1(IMPC)J
(C57BL/6NJ-Zfp422em1(IMPC)J/J) 		improved glucose tolerance J:211773
Zfp462em1(IMPC)Tcp/Zfp462+
(C57BL/6N-Zfp462em1(IMPC)Tcp/Tcp) 		impaired glucose tolerance J:211773
Zfp467tm1.1(KOMP)Vlcg/Zfp467tm1.1(KOMP)Vlcg
(B6(Cg)-Zfp467tm1.1(KOMP)Vlcg) 		improved glucose tolerance J:302865
Zfp503em1(IMPC)Mbp/Zfp503+
(C57BL/6N-Zfp503em1(IMPC)Mbp/Ucd) 		decreased circulating glucose level J:211773
Zfp513em1(IMPC)J/Zfp513em1(IMPC)J
(C57BL/6NJ-Zfp513em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Zfp558em1(IMPC)Mbp/Zfp558em1(IMPC)Mbp
(C57BL/6NCrl-Zfp558em1(IMPC)Mbp/Mmucd) 		decreased circulating glucose level J:211773
Zfp595tm1b(KOMP)Wtsi/Zfp595tm1b(KOMP)Wtsi
(C57BL/6N-Zfp595tm1b(KOMP)Wtsi/Bay) 		decreased circulating glucose level J:211773
Zfp616tm1b(KOMP)Wtsi/Zfp616tm1b(KOMP)Wtsi
(C57BL/6N-Zfp616tm1b(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Zfp664tm1b(EUCOMM)Wtsi/Zfp664tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfp664tm1b(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Zfp787em1(IMPC)J/Zfp787em1(IMPC)J
(C57BL/6NJ-Zfp787em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Zfp961tm1.1(KOMP)Mbp/Zfp961tm1.1(KOMP)Mbp
(C57BL/6N-Zfp961tm1.1(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Zfyve19em1(IMPC)J/Zfyve19em1(IMPC)J
(C57BL/6NJ-Zfyve19em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Zgpattm1b(EUCOMM)Hmgu/Zgpattm1b(EUCOMM)Hmgu
(C57BL/6N-Zgpattm1b(EUCOMM)Hmgu/Tcp) 		increased fasting circulating glucose level J:211773
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating glucose level J:79501
Znhit2em1(IMPC)J/Znhit2+
(C57BL/6NJ-Znhit2em1(IMPC)J/Mmjax) 		increased circulating glucose level J:211773
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory